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Abstract 
Reproduction is the only certain constant within animals and maintaining the integrity 
of this process is key to ensuring survival of the species. However, male fertility rates in 
the Western world are in decline and the use of assisted reproductive techniques rising 
(Makarow and Hojgaard, 2010). With emerging technologies such as nanotechnologies 
presenting both enormous benefits alongside new risks, there is a clear need to 
understand and manage these potential novel threats to male reproductive health. 
However, the animal burden associated with such research is extreme, therefore 
consideration of how to reduce, refine or replace animal use in the associated 
developmental and reproductive toxicity (DART) testing is paramount. 
This research aimed to assess the toxicity of engineered nanomaterials (ENM) in the 
male reproductive system and develop an improved testing strategy for hazard 
assessment of DART.  Using a panel of highly representative ENM, assays to screen for 
toxicity in male testicular cell lines were established and optimised in vitro. Findings 
were then validated for reliability and reproducibility against those generated using 
similar test systems with cells from alternative organs of the body. Assessment of cell 
and endocrine function also provided a deeper understanding of cellular responses 
following acute sub-lethal ENM exposure. 
Comparison of outcomes in vitro to in vivo was enabled by appraisal of tissues from 
animals exposed orally to the same ENM. Through this, a new method by which to stage 
tubules for histopathological analysis was developed, and for the first time a truly 
thorough morphological and stereological examination of tissues for markers of effect 
provided. Assimilation of key findings made it possible to conclude that silver ENM are 
reproductive toxicants and potential endocrine disruptors. The accumulated results 
were also used to guide development of a novel Integrated Approach to Testing and 
Assessment (IATA) for male reproductive toxicity from ENM. 
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Chapter 1: Introduction and Literature Review    
 
Introduction  
The reproductive system is complex in both males and females, and consequently 
reproductive toxicity can manifest as a diverse set of endpoints. As a result, it is 
necessary to understand normal reproductive anatomy and physiology to understand 
and investigate the potential toxicity of novel materials. Whilst the anatomy of the 
reproductive system has been relatively well studied, only recently has a more in-depth 
understanding begun to emerge on the complex cellular and hormonal processes 
underlying production of viable gametes (Gupta, 2011). Similarly, a fuller understanding 
of the integration of the reproductive system with, and dependency upon, multiple 
organs within the body is also relatively recent.  
 
Male Reproductive Anatomy  
Structures associated with male reproduction usually include paired testes, a duct 
system, accessory sex glands (seminal vesicles, prostate etc.), the scrotum (with 
thermoregulatory function) and a penis. The primary functions of the testis are 
spermatogenesis (production of male gametes), and steroidogenesis (production of 
steroid hormones, androgens). Unlike females, where the full complement of oogonia 
is present at birth, spermatogonia are proliferating continually and developing into 
spermatozoa for maximal sperm production (Evans and Ganjam, 2011).  
The testis is divided into lobules of parenchyma which have avascular tubular and 
vascular interstitial compartments (Sharpe, 1983). Within the tubular compartment, the 
seminiferous tubules form highly convoluted loops beginning and ending with straight 
portions, forming the functional units of the compartment. The seminiferous tubules 
connect to the rete tubules, which in turn join efferent ductules which attach to the 
epididymis (Evans and Ganjam, 2011). The epididymis leads to the vans deferens (ductus 
deferens) and onto the ejaculatory duct (Fig. 1).  
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Figure 1: Basic testicular anatomy, showing the major architecture of this aspect of the male reproductive system. From (Bhimji 
and Leslie, 2018) 
 
The vasculature of the testis begins with the internal spermatic artery, which originates 
from the abdominal aorta, running through the spermatic cord toward the testis. It gives 
off superior and inferior epididymal branches, supplying parts of the epididymis, before 
continuing as the testicular artery. On arrival at the testis, it moves in a line down the 
epididymal border, before forming a series of loops at the caudal pole leading to the 
rete testis, finally entering the testicular parenchyma. Here it divides into radiate 
arteries and then intertubular arterioles, which in turn supply intertubular and 
peritubular capillaries which run parallel to and circumferentially around the 
seminiferous tubules (Creasy and Chapin, 2013). The lymphatic system of the testis 
forms distinct vessels in the human, which enter the peritubular layer of the 
seminiferous tubules.  Conversely, in the rat, they form channels between Leydig and 
peritubular cells of the seminiferous tubules but remain in the interstitial space (Creasy 
and Chapin, 2013). The veins leaving the testis form the pampiniform plexus as the enter 
the spermatic cord, which forms a heat exchange system, maintaining the testis at a few 
degrees below body temperature for optimal spermatogenesis (Fig. 1).   
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The seminiferous tubules contain germ cells at various stages of differentiation. They 
also contain Sertoli cells (SC), which provide structural support, nutrients and regulatory 
factors to the germ cells. SC divide the seminiferous epithelium into basal and luminal 
compartments - the basal compartment containing spermatogonia up to their pre-
leptotene stage, and the ad- luminal compartment containing spermatocytes 
spermatids and spermatozoa (Evans and Ganjam, 2011). Sperm are generated through 
a cycle that takes 6-9 weeks to complete in humans, during which a coordinated set of 
mitotic and meiotic divisions accompany elaborate cytodifferentiation and intercellular 
interactions (Schlatt and Ehmcke, 2014). 
Junctions between SC create the blood- testes-barrier (BTB), forming an important 
immuno-privileged environment which prevents spermatozoa from entering the blood 
circulation or lymphatic systems. This prevents exposure of immunogenic sperm to the 
body’s immune system, which can lead to autoimmune attack and disorders such as 
cryptic orchitis (Fig.2). Seminiferous tubules are surrounded by peritubular myoid cells 
which participate in important interactions with Sertoli cells (Evans and Ganjam, 2011). 
 
  
Figure 2: Schematic showing structure of the seminiferous tubule. Within tubules, Sertoli cells (SC) sit on the basal membrane, their 
cytoplasm projecting toward the central lumen at varying lengths depending on stage of the spermatogenic cycle, ‘nursing’ 
developing spermatozoa along their length. SC are connected via highly controlled cellular junctions to form the Blood Testis Barrier. 
Within the interstitium lie blood capillaries, lymphatic vessels and Leydig cells (LC), which are responsible for generation of 
androgens to support SC in managing spermatogenesis, amongst other roles in maintenance of the male reproductive system. From 
(Barrett et al., 2019) 
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The duct system of the testis, which conducts spermatozoa and associated secretory 
products away from the testis to the ejaculatory duct, consists of effluent ductules, the 
epididymal duct, and the vas deferens (Fig. 1). Upon maturation, spermatozoa are 
released from the cellular syncytium in which they are developed, and into the lumen 
of seminiferous tubules in a process called spermiation. From here, they enter the 
epididymis via efferent ductules, and during passage through the epididymis (a process 
which takes approximately 7 to 14 days) they acquire motility and undergo final 
maturation. At this stage, defective spermatozoa are also recognised and eliminated, 
before final secretory contributions are made to the seminal fluid prior to ejaculation 
(Evans and Ganjam, 2011).  
The interstitial compartment of the testis contains venous and lymphatic systems, 
connective tissue, a few other key cell types (including specialised testicular 
macrophages) and Leydig cells (LC). Leydig cells are polyhedral cells, distributed within 
the interstitium, but often found loosely grouped around blood capillaries. Their primary 
role is the production of androgens, which not only play a key role in managing SC and 
in turn spermatogenesis, but also a number of important wider physiological roles. The 
capillaries around which LC tend to gather, and interstitial fluid from the lymphatic 
system are the primary mechanisms through which all hormones and nutrients are 
transported to and from the bloodstream to cells of the testis (Sharpe, 1983). There exist 
species differences in abundance of LC and it is important to take this into account when 
measuring response to toxicant exposure, if effects on number of LC are being used as 
an endpoint (Evans and Ganjam, 2011). 
Management of male fertility is an exquisitely complex process, involving production of 
millions of spermatozoa daily, alongside associated sexual behaviour, and adjustments 
for external influences such as stress, nutrition or seasonality (Schlatt and Ehmcke, 
2014). Much of this is heavily dependent on gonadotrophic hormones secreted by the 
adenohypophysis (anterior pituitary), which in turn are controlled by release of 
gonadotrophin releasing hormone (GnRH) from the hypothalamus. Because of the clear 
reliance of the major cells controlling function of the testis on external hormone 
influence, it is important to understand the basics of reproductive physiology, and in 
particular, the role of the Hypothalamus-Pituitary-Gonad axis in its control.  
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Male Reproductive Physiology  
Control of reproduction is managed by the hypothalamus, pituitary and testes acting in 
concert, known as the Hypothalamus-Pituitary-Gonadal (HPG) axis.  
In his 1955 monograph, Geoffrey Harris outlined his views and evidence for the neural 
mechanisms controlling the pituitary-gonadal axis (Harris, 1955). While the link between 
the pituitary and gonads was already well known at the time, relatively little was known 
about the neural influence on this from the hypothalamus. At the time, Harris outlined 
his fundamental hypothesis that “nerve fibres from the hypothalamus liberate some 
humoral substance(s) into the capillaries of the primary plexus in the median eminence 
and that this substance is carried by the portal vessels to excite or inhibit the cells of the 
pars distalis [adenohypophysis]” (Harris, 1955).  
Since then, numerous refinements and additional complexities have been added to this 
model, leading to a much broader understanding of the neuroendocrine control of 
gonadal function (Plant, 2015). It is now well established that endocrine events 
regulating reproductive and sexual behaviours are distinct in males and females, as 
illustrated in Fig. 3. This occurs via a complex series of hormonal pathways, targets and 
feedback loops, enacting control both systemically and locally, via autocrine, paracrine 
and endocrine interactions. 
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Figure 3: Gonadal hormone targets, pathways, feedback loops and route of metabolism and excretion in males and females. From: 
(Netter, 1997). 
In males, pulsatile release of Gonadotrophin Releasing Hormone (GnRH) from the 
hypothalamus acts as a master on/off switch to the system by controlling release of 
luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the 
adenohypophysis of the pituitary. This system is responsive to physiological and 
environmental changes that may require up- or down-regulation of the HPG axis and 
managing reproductive function accordingly. Recently it has emerged that timing of 
hypothalamic GnRH release is initiated in the KNDy neuronal network of the arcuate 
nucleus (representing a population of kisspeptin, neurokinin B & dynorphin neurones) 
by reciprocating interplay of stimulatory neurokinin B signals and inhibitory dynorphin 
inputs. This output is then thought to be relayed from the arcuate nucleus to the GnRH 
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neuronal network by release of kisspeptin from axonal terminals originating from KNDy 
neurons (Plant, 2015).  
GnRH release leads to release of pulses of LH and FSH into the peripheral circulation 
throughout the day, facilitating LH-dependent testosterone production and FSH 
dependent Sertoli function (Gupta, 2011). FSH acts specifically on FSH receptors of SC 
within the seminiferous tubules of the testis, which in turn release a number of 
substances (e.g. androgen binding protein, glial cell line-derived neurotrophic factor 
(GNDF) and potentially oestradiol, amongst others) which regulate spermatogenesis by 
controlling expansion of germ cells (Carreau et al., 2006, Carreau et al., 2011).  
LH acts on Leydig cells (LC) via the LH-receptor, in turn activate cAMP (cyclic adenosine 
monophosphate) and stimulate the production of androgens from cholesterol. Within 
the male, the primary gonadal androgens are testosterone (T) and di-hydrotestosterone 
(DHT). Locally, androgens prompt paracrine management of germ cell development by 
SC. This includes production of androgen binding protein by the SC which increases 
testosterone concentrations in the seminiferous tubules to lightly stimulate 
spermatogenesis. Systemically, the testis is responsible for 95% of testosterone 
circulating in post-pubertal males (Sherbet and Auchus, 2007). Upon diffusion into the 
circulation, testosterone equilibrates between protein bound (98%) and free fractions 
(2%), of which the free form is believed to be the active form (Sherbet and Auchus, 
2007). Along with DHT, this circulating testosterone is responsible for maintenance of 
the male phenotype, management of androgen-controlled actions in the periphery, 
secondary sexual characteristics such as increased bone mass, muscle and body hair, as 
well as associated behaviours (Schlatt and Ehmcke, 2014).  
The positive and negative feedback loops of the HPG axis shown in Fig. 3 maintain an 
environment conducive to normal reproductive function. At the most basic level, the 
feedback loops controlling LH and FSH production by feeding back at the hypothalamic 
level are inhibin and activin produced by SC, and testosterone produced by LC. Every site 
of production, pathway, target and feedback loop may be potentially disrupted by 
xenobiotics (Evans and Ganjam, 2011).  
Bryony L Ross PhD 37 
Interference of exogenous substances with the HPG axis has been shown to lead to sub-
fertility or even infertility, depending on the severity of action and duration of exposure. 
Such substances are known as Endocrine Disruptors, and are defined “an exogenous 
chemical or mixture of chemicals that interferes with any aspect of hormone action” 
(Gore et al., 2014). For example, brominated flame-retardants (BFR) such as 1, 2-
dibromo-4-(1, 2-dibromoethyl) cyclohexane (TBECH), are androgen receptor agonists, 
which interfere with androgen receptor signalling, leading to not only local effects in the 
testis but also systemic effects via the HPG axis (Kharlyngdoh et al., 2018). Another 
important family of compounds known for their endocrine disrupting action are 
phthalates. Excessive exposure to phthalates has been linked to both testicular 
dysgenesis syndrome (TGS) which manifests as effects on germ cell development, and 
to incidence of testicular germ-cell cancer (TGCC) (Jobling et al., 2011, Hutchison et al., 
2008). Consideration of potential endocrine effects is therefore important when 
evaluating toxicity to any new substance.  
 
Nanotechnologies and the emergence of nanotoxicology 
Nanomaterials are “natural, incidental or manufactured materials containing particles, 
in an unbound state or as an aggregate or as an agglomerate and where, for 50 % or 
more of the particles in the number size distribution, one or more external dimensions 
is in the size range 1 nm - 100 nm” (EC, 2011). Humans have been exposed incidentally 
to naturally occurring NP such as those generated by volcanic activity for thousands of 
years. More recently, with the development of more advanced technologies, humans 
are now exposed to anthropogenic NP generated both unintentionally (e.g. diesel 
nanoparticles generated by automobile engines) and intentionally (engineered 
nanomaterials, ENM) (Oberdorster et al., 2005). Nanomaterials (NM) form a field of 
materials science, within which nanoparticles and nanostructures exist in a multitude of 
compositions, ranging from simple (e.g. pristine silver particles), to incredibly complex 
structures such as nano constructs used in medical technologies, modified by multiple 
surface ligands (Donaldson et al., 2004).  
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Harnessing the properties of NM can provide many benefits to society across a wide 
range of applications, from revolutionary medical solutions to advanced automotive 
parts, textiles and building materials (Aitken et al., 2011). Their small size means that 
their properties are often vastly different from their bulk counterparts (larger sized 
particles with the same chemical composition), typical examples including high tensile 
strength, low weight, high electrical and thermal conductivity, and unique electronic 
properties. 
However, it is crucial to the responsible development of nanotechnologies to ascertain 
and understand any potential environment, health and safety (EHS) implications, and 
where necessary, implement strategies for their control. Because of the large gaps in 
our knowledge relating to potential risk, activity concerned with the EHS aspects of 
nanotechnologies has been growing for almost 2 decades. However, by comparison to 
many other modern environmental toxicants, research into the potential health and 
environmental impacts of nanotechnology remains in its infancy. 
The advent of nanotoxicology 
Investigation of EHS aspects of nanomaterials began using evidence gathered from 
many years of research within the mature field of particle toxicology. A seminal review 
which shaped much of the research following was that of the Royal Society and the Royal 
Academy of Engineering into the “opportunities and uncertainties” surrounding 
nanomaterials (RS-RAE, 2004). This highlighted potential risks to health and the 
environment arising from exposure, concluding that while for many nanotechnologies, 
there were no foreseeable risks to health or to the environment, for ‘nanoparticles and 
nanotubes’ there were potential risks which required further investigation and where 
appropriate, control. In the same year Donaldson and colleagues  (Donaldson et al., 
2004) proposed that there should exist a sub-category of toxicology specific to 
nanomaterials;  nanotoxicology.  
The nanotechnologies market is growing exponentially, and is expected to be worth 
$125bn by 2025 (ResearchAndMarkets, 2018). In parallel with this growth, efforts have 
developed to understand and manage any associated risks. In 2009, one review 
identified over 600 research projects working in the area, a number of which will have 
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grown significantly since this time (Aitken R.J et al., 2009). However, it is only in recent 
years that data on nanotoxicology of the reproductive system began to emerge, making 
it a very new area for research.  
Why are ENM different?  
One key reason ENM are receiving much attention is their novel physico-chemical 
properties, which mean they pose novel challenges for researchers, risk assessors and 
regulators alike. Their key distinguishing property is that of size, or more accurately 
specific surface area (the total surface area per unit mass). This hugely increased surface 
reactivity has been linked to enhanced toxicity (RS-RAE, 2004, Oberdorster et al., 2005). 
In addition, their small size confers an increased potential to translocate resulting in an 
adsorption, distribution, metabolism and excretion (ADME) profile which may be vastly 
different to their bulk counterparts, and could allow them access across barriers in the 
body such as the blood-brain, placental barrier and BTB  to access immunopriviledged 
sites and penetrate cells therein (Oberdorster et al., 2009, Takeda et al., 2009, Hankin 
et al., 2008). Furthermore, it is thought that those with a high aspect ratio (HARN) may 
conform to the fibre paradigm of toxicity (Tran CL 2008). Figure 4 summarises key 
properties of interest and their potential effects on ENM biointeractions.  
Human exposure to ENM may be from a number of sources and via a number of routes, 
including inhalation, ingestion, trans-dermal permeation, or in some cases by injection 
(in the case of medicines). Following exposure, is it thought that ENM will interact with 
proteins at the site of entry termed the ‘nano-bio interface’, causing ENM to undergo 
continuous dynamic changes dependent on interactions (Savolainen et al., 2010, 
Colognato et al., 2012). The combination of this interface and the inherent properties of 
the ENM will determine its onward distribution. Potential adverse effects may therefore 
occur at the portal of entry, primary target organs (e.g. the lung or GI tract), and 
secondary target organs (e.g. the reproductive system or kidney). 
 
Bryony L Ross PhD 40 
 
Figure 4: Physicochemical properties of nanomaterials that should be considered with high priority in toxicological assessments. 
From (Johnston et al., 2010) 
The complex interaction of ENM with the physiological environment into which they are 
entered introduces a multitude of complexities which must be considered when 
appraising potential toxicity. For example, upon entry to the body ENM will be coated 
with a bio-corona (made up of a variety of biomolecules dependent on both the site of 
entry and characteristics of the ENM itself) which will evolve and change as the ENM 
passes through different compartments in the body (Pietroiusti et al., 2013). In addition, 
the novel physico-chemical characteristics and behaviour of ENM means they may 
interfere with toxicity testing, as has already been demonstrated for a number of key 
assays (Kroll et al., 2012).  
With an obvious need for investigation of the interaction of ENM with biological 
systems, research using a multidisciplinary approach which combines chemistry, 
biology, physics, and engineering knowledge has begun in earnest. However, 
reproductive and developmental nanotoxicity is to date in its infancy, and although it is 
now gathering momentum, there remains relatively limited information on the 
interaction of ENM with this complex body system. 
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Reproductive & Developmental Toxicity & DART Testing  
Reproductive toxicity is defined as an adverse effect induced by a substance on male or 
female reproductive ability or capacity, including developmental effects on the offspring 
and effects on or via lactation (UNECE, 2005). It is a younger field of science than many 
others; research into the reproductive and developmental effects of substances only 
began in earnest over the last 100 years. Disasters involving environmental and medical 
toxicants in the 1950s and 1960s contributed to the area of reproductive toxicity being 
more exhaustively scrutinised. The first of these was the thalidomide tragedy, where 
from 1957-1961 pregnant women were prescribed thalidomide to help with morning 
sickness in their first trimesters. Whilst the drug had minimal toxicity to the adult, it was 
highly embryotoxic, and over 10,000 babies were born with severe birth defects 
including phocomelia and amelia following exposure in utero (Gupta, 2011). This was 
shortly followed by the Minamata incident in Japan (1956), and ‘wonder wheat’ disaster 
in Iraq (1971) where around 3,000 and 100,000 people respectively who had eaten fish 
and wheat high in methylmercury saw severe neurological damage in their children 
(Gupta, 2011).  
These, and other similar tragedies led to a growing interest in teratology, and increased 
efforts by both pharmaceutical and chemical regulators to ensure the safety of drugs 
and chemicals. As such, testing for developmental and reproductive toxicity (DART) is 
now a standard part of development and regulatory approval for any chemical, 
pharmaceutical or cosmetic product.  
Categorisation of DART testing, and relevant regulatory frameworks for DART   
DART testing covers two broad categories (developmental and reproductive) and three 
classes of toxicity (fertility, parturition and lactation). Depending on the study type, 
endpoints typically evaluated include reproductive function or capacity i.e. adverse 
effects on libido & sexual behaviour, the oestrus cycle or any aspect of spermatogenesis, 
hormonal activity or physiological response which would interfere with the capacity to 
fertilize, fertilization itself or development of the fertilized ovum up to and including 
implantation. Developmental endpoints include non-heritable effects on the offspring 
which interfere with normal development both peri- and post-natally; manifested, for 
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example, by altered body weight, developmental defects, and impaired mental or 
physical development up to and including puberty (ECHA, 2008) (Beekhuijzen, 2017).  
 
 
Figure 5: Stages of the reproductive and developmental cycle according to the two major regulatory approaches: US Food and 
Drug Administration (FDA) and the International Conference on Harmonisation (ICH). Segments I (fertility), II 
(embryotoxicity/teratogenicity) and III (peri/post-natal toxicity) represent the FDA testing strategy. Stages A (pre-mating to 
conception), B (conception to implantation), C (implantation to closure of the hard palate), D (closure of hard palate to end of 
pregnancy), E (birth to weaning) and F (weaning to sexual maturity) represent the ICH approach. NB. ICH stage C spans both 
segment II and III, as indicated by the dotted white line). Adapted from (Spielmann, 2009). 
 
Despite the wide range of products to which DART testing may be applied (chemical, 
drugs, agrochemicals, industrial chemicals, food etc), the testing approach remains fairly 
similar in terms of endpoints evaluated. As an example, Fig. 5 provides an outline of the 
stages considered for DART testing, according to two both the European Medicines 
Agency and the US Food and Drug Administration (EMA, 2017, FDA, 1966). However, 
although endpoints are similar, approach may differ depending on industry, e.g. the 
chemical and agrochemical industries use similar methodologies as their exposures are 
more likely to be uncontrolled (for dose and duration) compared to the pharmaceutical 
industry, where control over exposure is key to a drug’s efficacy and safety. Traditionally, 
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testing used within each segment or stage has been heavily dependent on in vivo 
methods. As such, the animal burden associated with conducting the suite of DART 
testing required for registration of a chemical, or approval of a drug is extremely large, 
several thousand animals being required to complete a full complement of DART testing 
for any given industry. Table 1 provides an outline of the major testing regimes for 
chemicals, pharmaceuticals and agrochemicals, along with an estimation of animal 
number required per test. For the agrochemical and pharmaceutical industries, testing 
requirements remain fairly static. Conversely, for industrial chemicals the EC regulation 
for the Registration, Evaluation Authorisation and restriction of Chemicals (REACH) 
implements an incremental approach to DART testing depending on tonnage production 
or import per year (as a proxy for likelihood of human exposure). Substances <1 tonne 
per year (tpa) do not require registration, and DART testing is scaled for those produced 
at >10tpa, >100tpa and >1000tpa (EC, 2006).  
More recently, specific consideration has also been given to the potential for substances 
to interrupt the normal function of the endocrine system (endocrine disruptors, ED), 
which if affected can have direct influence on the reproductive system via the HPG axis. 
This has resulted in development of specific guidance for testing, at least for chemicals. 
One such piece of guidance is  the OECD’s ‘Revised guidance document 150 on 
standardised test guidelines for evaluating chemicals for endocrine disruption’ (OECD, 
2018b). This contains a conceptual framework for testing and assessment of ED 
chemicals, alongside useful information on the applicability of existing Test Guidelines 
(TG) to identification of EDs via a weight of evidence approach.  
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Table 1: Summary of guidelines for DART testing. Adapted from Beekhuijzen 2017 and with reference to ICH, EPA, REACH & the EC Plant based Product regulations (Beekhuijzen, 2017, EPA, 2000, EPA, 2019, EMA, 
2017, EC, 2006, EC, 2014) 
INDUSTRY TEST When Required Number of Animals1 
Ph
ar
m
ac
eu
tic
al
 
ICH S5 (R2) Section 4.1.1 Study of fertility and early 
embryonic development to implantation and Part II: 
Toxicity to Male Fertility 
Completed before the initiation of large scale / long duration clinical trials (e.g. phase 3), as 
an evaluation of the reproductive organs is performed in earlier repeated-dose toxicity 
studies. 
F0: 80 males and 80 
females  
F1: Approx. 960 foetuses 
ICH S5 (R2) Section 4.1.3. Study for effects on embryo-
foetal development in rats 
EU & Japan: definitive developmental toxicity studies in 2 species are required for inclusion 
of women of childbearing potential (WOCBP) in any clinical study. However, there are 
defined situations where clinical trials with WOCBP may progress without these. US: 
assessments of embryo-foetal development may be deferred until before phase 3 clinical 
studies for WOCBP using precautions to prevent pregnancy. 
F0: 88 females 
F1: Approx. 1,056 foetuses 
ICH S5 (R2) Section 4.1.3. Study for effects on embryo-
foetal development in rabbits 
See above  
F0: 88 females 
F1: Approx. 792 foetuses 
ICH S5 (R2) Section 4.1.2. Study for effects on pre-and 
postnatal development, including maternal function 
Should be submitted for marketing approval. 
F0: 96 females 
F1: Approx. 1,152 pups 
Ch
em
ica
l 
OECD 421, Reproduction/Developmental Toxicity 
Screening Test (2016) 
REACH Annex VIII (applicable for any registration of 10t or more / year) 
F0: 48 females & 40 males 
F1: Approx. 480 pups 
OECD 422, Combined Repeated Dose Toxicity Study with 
the Reproduction/Developmental Toxicity Screening Test 
(2016) 
REACH Annex VIII 
F0: 48 females & 40 males 
F1: Approx. 480 pups 
OECD 414, Prenatal Developmental Toxicity Study in rats 
(2001) 
REACH Annex IX (applicable for any registration of 100t or more / year) 
F0: 88 females 
F1: Approx. 1,056 foetuses 
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OECD 414, Prenatal Developmental Toxicity Study in 
rabbits (2001) 
REACH Annex X (applicable for any registration of 1000t or more / year) 
F0: 88 females 
F1: Approx. 792 foetuses 
OECD 443, Extended One-Generation Reproductive 
Toxicity Study (2012) 
REACH Annex X 
F0: 100 females & 100 
males 
F1: Approx. 1,200 pups 
Ag
ro
ch
em
ica
l 
US 
OPPTS 870.3700, Prenatal Developmental Toxicity Study 
in rats (1998) 
Before registration 
F0: 88 females 
F1: Approx. 1,056 foetuses 
OPPTS 870.3700, Prenatal Developmental Toxicity Study 
in rabbits (1998) 
Before registration 
F0: 88 females 
F1: Approx. 792 foetuses 
OPPTS 870.3800, Reproduction and Fertility Effects 
(1998) 
Before registration 
F0: 96 females & 96 males 
F1: Approx. 1,152 pups 
F2: approx. 1,152 pups 
OPPTS 870.3550 Reproduction/ Developmental Toxicity 
Screening Test (2000) 
Must be reported 
F0: min. 10 females & 10 
males  
F1: min. 96 pups 
EU (Plant 
protection 
products, 
PPP) 
EC 545/2011: Prenatal Developmental toxicity study 
(after OECD TG414)  
Before registration 
At least 20 females with 
implantation per group 
EC 545/2011: Multi-generation toxicity study (after OECD 
TG416, in rat and rabbit2) 
Before registration 
F0: 96 females & 96 males 
F1: Approx. 1,152 pups 
F2: approx. 1,152 pups 
 
1 Number of animals estimated in part from Beekhuijzen (Beekhuijzen, 2018). Assumes a litter size of 12 rats/litter, and 9 rabbits. This excludes satellite animals for 
toxicokinetic studies.  
2 Animal number is only shown for rats against this row. It could be considered that the numbers for rabbit would reflect those reported in the OPPTS 870.3700
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The applicability of DART frameworks to nanotechnologies  
One important consideration faced by the nanotoxicology industry was whether existing 
DART frameworks take into account the novel properties and behaviour of ENM. This is 
especially relevant, because despite differences in the characteristics and often toxicity 
of materials on the nanoscale, many ENM share the same chemical identity as their bulk 
counterparts, making them no different on paper. Since then, the EC have confirmed 
that Regulation 1271/2008 in relation to the Classification and Labelling of Packaging 
(CLP) of substances and mixes applies to nanomaterials as substances in their own right, 
or special forms of the parent substance (EC, 2008). As such, it was not possible to wholly 
include ‘nano’ forms of a substance in their ‘parent’ substance’s REACH registration 
dossier. In October 2018 the European Commission adopted regulation EU 2018/1881 
which modified several REACH annexes (I, III, and VI-XII), including those relevant to 
DART, to assist with fulfilment of testing requirements when using ENM (EC, 2018). No 
mention of nanomaterials was identified in the agrochemical/Plant Protection Products 
(PPP) regulatory guidance. However, despite no specific mention, 5-fluorouracil-loaded 
PLLA-PEG/PEG nanoparticles are mentioned within the EMA’s ICH S5 as an example of a 
compound which qualified for use of alternative assays.  
 
DART and the 3Rs 
Over recent years there has been increased demand for and effort put into developing 
non-animal methods to assess toxicity. This is in line with the principle of the 3Rs – 
Reduction, Refinement and Replacement of animals in scientific testing, first introduced 
by Russel & Burch (Russel and Burch, 1959). This initiative has been strongly supported 
in major regulatory frameworks such as the REACH regulations (Registration, Evaluation, 
Authorisation and Restriction of Chemicals) and the Globally Harmonised System of 
Classification Labelling and Packaging of Chemicals (GHS, CLP). 
For DART testing, validation of alternative methods is problematic, as in vitro or ex vivo 
methods cannot for example address the contribution of the multitude of intra- and 
inter- cellular signalling pathways, auto- para- and endocrine effects of the hormonal 
HPG axis, influence of other hormonal systems such as the Hypothalamus-Pituitary-
Adrenal (HPA) axis, or indeed the multiple other organs which influence reproduction in 
Bryony L Ross PhD 47 
vivo. Nor can it form a readily available replacement for mammalian models when 
considering whether maternal factors may be at play in toxicities. However, efforts to 
provide useful and relevant alternative testing strategies for ENM in reproductive 
toxicology are ongoing. 
Part of the effort to reduce animal use comes in the form of Integrated Approaches to 
Testing and Assessment (IATA). IATAs are approaches based on multiple information 
sources that may be used for hazard identification and characterisation, one form of 
which is an Integrated Testing Strategy (ITS). Data included within an IATA may be from 
various sources, i.e. physicochemical properties, in silico models, grouping and read-
across approaches, in vitro methods, in vivo tests and human data. Through this process, 
data generated from non-animal testing methods is expected to contribute to the 
reduction of animal testing (OECD, 2016). The latest amendments to REACH also make 
it clear the EC are open to use of non-validated non-animal testing methods, should they 
be “relevant and reproducible” (ECHA, 2017). The Chapter R7a (human health hazard 
identification) appendix for nanomaterials also mentions that Adverse Outcome 
Pathways (AOPs) specific to nanomaterials are under development at the OECD.  
 
Whilst promising, there remain significant barriers in place to making better use of 
non-animal tests in establishing DART for ENM, including:  
i) Many in vitro test methods still require investigation for interference from 
ENM and associated optimisation, 
ii) The wide array of variations in nanomaterial, and previous lack of 
standardisation in gathering physico-chemical characterisation and basic 
toxicity analysis in vitro are rate limiters in driving power to Quantitative 
Structure Activity Relationship (QSAR) modelling in silico, 
iii) A lack of accurate and extensive toxicokinetic or Absorption, Distribution, 
Metabolism and Excretion (ADME) profiles for ENM makes it difficult to 
build Physiologically-based Pharmacokinetic (PBPK) models in silico, to help 
in predicting hazard for similar ENM. 
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Whilst the need for formation of integrated approaches to testing and assessment is 
undeniable, consideration of the barriers in place to achieving this and a work plan that 
contributes tangibly toward breaking these down must be prioritised in development of 
nanotoxicological research.  
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Current understanding of male reproductive nanotoxicology  
 
The ability of ENM to cross biological barriers  
In order for ENM to have a direct effect on the production of spermatozoa, they must 
first reach, and second translocate the BTB. The BTB is formed by SC, which are linked 
by a variety of junction types (gap, tight, basal ectoplasmic specialisations etc), in order 
to provide a highly controlled environment the process of spermatogenesis within the 
adluminal compartment of seminiferous tubules of the testis. There is a myriad of 
considerations to take into account concerning distribution of ENM within the body, 
including the influence of its physico-chemical characteristics and dynamic biomolecule 
‘corona’ (acquired on entry to the body) to its cross-barrier and cellular uptake, action 
and ultimately excretion (or accumulation) from any given organ. In relation to the 
ability of ENM to reach the testis and accumulate therein, evidence to date is mainly 
from radiolabelling of ENM, measurement of total elemental content in organs, or 
visualisation of ENM in organ tissues through electron microscopy.   
Oberdorster et al followed the biodistribution of gold nanoparticles (Au NP) following 
intravenous injection to the tail vein in rats, observing that the smallest ENM tested 
(10nm Au) were able to translocate widely within the body including into the 
reproductive system (Oberdorster et al., 2009). Transport to, and accumulation of ENM 
in the testis has been demonstrated both short- and long- term exposure to silver and 
silica ENM via oral and intravenous routes (van der Zande et al., 2012, van der Zande et 
al., 2014a, Buzulukov et al., 2017, Garcia et al., 2014). Interestingly, both van der Zande 
& Garcia found through elemental analysis that silver accumulated in the testis and was 
not excreted, even 4 months after treatment had ceased. This observation is not seen 
as frequently for ENM passing the blood-brain-barrier (BBB), suggesting that the BTB is 
less efficient following more prolonged challenge with ENM (Pietroiusti et al., 2013). 
Evidence has also been presented for silica ENM accessing the testis following both oral 
and intravenous exposure routes (Morishita et al., 2012, van der Zande et al., 2014a). 
Morishita et al went on to characterise the intratesticular distribution of silica NPs using 
transmission electron microscopy (TEM) at 24 hours post exposure, identifying ENM 
within Sertoli cells and spermatocytes, including in the nuclei of spermatozoa (Morishita 
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et al., 2012). This adds weight to the argument that ENM can pass the BTB without 
producing noticeable testicular injury (at least in doing so).  
How exactly ENM traverse the BTB is still not well understood. It is known that the BTB 
undergoes considerable restructuring during the process of germ cell translocation from 
basal to adluminal compartments to facilitate maturation, management of which is 
complex, involving an array of cellular signal transduction pathways (MAP kinase, TNF-
a, TGF-b and others). The main mechanisms by which ENM may traverse the BTB are via 
passive transport, active transport or endocytosis, and it is thought that similar to the 
BBB, the BTB uses influx and efflux pumps to regulate the rate at which substances cross 
(Pietroiusti et al., 2013).  
There is some thought that as cytokines produced in response to modulation by FSH and 
androgens help to modulate the BTB, disturbance of LC in which they are synthesised 
may be a contributing factor to passage of ENM into the adluminal compartment of 
seminiferous tubules (Lan and Yang, 2012, Pietroiusti et al., 2013). Recent research into 
the use of mesoporous silica nanoparticles as vehicles in which to transport and deliver 
male contraceptive drugs to the adluminal compartment of the testis has also 
highlighted endocytic vesicle-mediated pathways or GTPase (e.g. Rac1 or Cdc42)-
mediated micropinocytosis as potential routes of entry (Chen et al., 2016). Although this 
area is still not well understood, it is clear that ENM are able to i) translocate to the testis 
via a variety of exposure routes and ii) cross the BTB, leading in some cases to 
accumulation.  
Nanomaterial-specific evidence for DART 
ENM are defined by differences in their physico-chemical characteristics and, and the 
form taken and their subsequent behaviour within biological systems can vary greatly. 
Metals and metal oxides are inorganic nanoparticles, examples of which include gold, 
silver, aluminium, titanium, molybdenum and silica. Recognising their particular 
importance either in terms of potential health effects, or as solutions to industry, this  
review focusses on studies relating to silver, titanium, zinc, silica and CNTs which are 
synthesised using a variety of both ‘top down’ and ‘bottom up’ methodologies and are 
utilised for a myriad of applications. 
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Silver ENM 
Silver ENM (Ag NP) have applications in optics, electronics, textile engineering, water 
treatment and cosmetic products. In particular its antimicrobial properties have been 
harnessed for use in wound dressings, antimicrobial coatings on surgical masks and 
prostheses. A review of the literature returned by far the most literature for any material 
included, with a total of 27 relevant studies identified. Of these, 7 were conducted in 
vitro using cell lines, 6 ex vivo on murine and zebrafish embryos, and 14 in vivo on 
rodents (Table 2). Importantly, all studies reported adverse findings regardless of dose, 
exposure route, or exposure length.  
In vivo, toxicity to the male reproductive organs is consistently reported. Eight studies 
expose both mice, rats and rabbits to Ag ENM via injection (intravenous, intraperitoneal 
and intramuscular), and another 6 expose rodents orally, either via food or gavage. The 
dosing regimens applied varied greatly, from sub-acute low-dose (1mg/kg) applications 
over 12 days (Garcia et al., 2014), through more standardised 28-day protocols with a 
range of doses from low to extremely high (1000mg/kg) (Kim et al., 2008) to low dose 
chronic approaches lasting over 120 days (Castellini et al., 2014). Although effects 
observed varied in line with the exposure route, characteristics of silver ENM chosen, 
dose regime and animal used, all studies reported adverse effects following exposure. 
One relevant theme that appeared was that of ion dissolution from ENMs and the 
effects this may have on reported toxicity. Bar-Ilan et al. (2009) exposed zebrafish 
embryos to size-matched silver and gold nanoparticles, finding that Ag produced almost 
100% mortality compared to a 3% mortality rate at the same time point post-exposure 
& highlighting the importance of nanoparticle chemistry in their toxicity (Bar-Ilan et al., 
2009). As Au and Ag were both shown to be taken up by the embryos, the authors 
suggested that Ag toxicity is caused by the physico-chemical attributes of the ENM 
themselves, or that Ag+ ions formed during in vivo nanoparticle destabilisation. This 
hypothesis is corroborated by the findings of Powers et al (2010), who undertook a 
comparison of the effects of Ag particles and ions on zebrafish embryos, finding that 
particles were less potent than ions (Powers et al., 2010). Li et al (2010) conducted a 
similar study in mouse embryos at the blastocyst stage, and found that, as in the 
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zebrafish studies, embryonic toxicity from Ag particles was lower than from Ag ions (Li 
et al., 2010).  
Research into the effect functionalization of Ag NPs may have on toxicity has also begun. 
It has been demonstrated that functionalising Ag NPs alters the activity and light 
responses of zebrafish embryos (Powers et al., 2011). This effect was further highlighted 
by Lee et al  (2010), who applied Ag ENM with varied functional characteristics to 
zebrafish embryos, and reported that both type and dose of Ag ENM altered the type of 
abnormalities observed in embryos (Lee et al., 2007). 
Studies in vitro report toxicity to male germ cells and defects in sperm function. 
Bradyich-Stolle et al. (2005) examined the suitability of a mouse spermatogonial stem 
cell line (C18-4) as a model to assess cytotoxicity, via the LDH and MTT assay using silver, 
molybdenum trioxide (MoO3), and aluminium (Al) nanoparticles (Braydich-Stolle et al., 
2005). They identified a concentration-dependent toxicity for all types of particles 
tested, with a toxicity ranking of Ag > Al > MoO3. Similarly, Asare et al (2012) investigated 
toxicity of 20nm and 200nm Ag ENM to the human NT2 pluripotent testicular embryonic 
carcinoma cell line, identifying loss of cellular viability via the MTT assay, and DNA 
damage (assessed via Comet assay) (Asare et al., 2012). Although the outcomes of these 
studies suggest that these cell lines may be valuable models by which to assess the 
cytotoxicity of nanoparticles in the germ line in vitro, it must be noted that evidence that 
ENM interfere with the MTT has now emerged (Kroll et al., 2012). Consideration of ENM 
interference with toxicity assays is therefore important and will be considered in later 
chapters.  
Other cell lines investigated include murine embryonic stem cells and fibroblasts, for 
which differential toxicity depending on whether Ag ENM were coated or not was 
reported (similarly to the findings of Braydich-Stolle et al, above) (Ahamed et al., 2008). 
Zhang et al (2015) also reported use of the complementary murine cell lines TM3 
(Leydig) and TM4 (Sertoli), reporting that  exposure of TM3 & TM4 cells to Ag ENM 
resulted in interference with cellular signalling pathways, as well as those related to and 
tight junction formation in the BTB (TM4), and testosterone synthesis (TM3), 
highlighting the potential for endocrine-disruption as a mechanism of action (Zhang et 
al., 2015a).  
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Table 2: In vivo and in vitro reproductive and developmental toxicity studies of Silver (Ag) ENP, outlining key parameters from each study identified, including study type, exposure type and method, and relevant 
findings 
Study ENM Animal/Cell/(n) Study Type 
in vivo / 
in vitro? 
Exposure Method Outcomes 
(Braydich-
Stolle et al., 
2005) 
Ag NP 15nm, 
MoO3 NP 30nm, 
Al NP 30nm 
Male mouse C18-4 cell line 
(established from type A 
spermatogonia isolated from 6-
day old mouse testes) 
Target 
organ 
toxicity 
in vitro Incubation Cells exposed at 5,10,25,50,100mg/ml 
Concentration. dependent toxicity for all types of NP tested, whereas 
comparative salts had no significant effect (CdCl, AlCl etc). Ag most toxic, 
MoO3 least toxic. Cell line a valid model for cytotoxicity of NP in germline cells 
in vivo. 
(Asare et al., 
2012) 
Ag NP 20nm & 
200nm  
Male 8-oxoguanine DNA 
glycolyase knockout mice (Ogg1-
/- KO), and Human NT2 
pluripotent testicular embryonic 
carcinoma cell line (which mimics 
the repair status of human 
testicular cells vs oxidative 
damage and authors claim is thus 
a suitable model for human male 
reproductive toxicity studies) 
Target 
organ 
toxicity 
in vitro Incubation Cells exposed to NPs @ 10/50/100ug/ml for 24/48/72h 
Ag NP and UF more cytotoxic and cytostatic than TiO2, causing apoptosis, 
necrosis and decreased proliferation in concentration and time dependent 
manner. 200nm Ag NPs cause concentration-dep increase in DNA strand 
breaks in NT2 cells. ROS formation leading to oxidative purine DNA base 
damage (comet) not found to be a significant MoA 
(Ahamed et al., 
2008) 
Ag NPs (size not 
stated) 
murine mammalian cells, 
embryonic stem cells and 
embryonic fibroblasts 
Target 
organ 
toxicity 
in vitro Incubation 
Ag NPs added to culture media 
containing cells and incubated. 
Cells were harvested at 4, 24, 48, 
and 72 h after Ag NP treatment 
Uncoated Ag NPs agglomerate and may be excluded from some organelles 
such as the nucleus and mitochondria while the coated Ag NPs do not 
agglomerate and are distributed throughout the cell. Both types of Ag NP 
stimulated apoptosis via up-regulation of cell cycle checkpoint protein p53, 
DNA damage repair proteins Rad51 and phosphorylated-H2AX expression. 
Surface chemistry of Ag NP induce different DNA damage responses, i.e., 
coated Ag NP induced more severe damage versus uncoated Ag NP.  
(Yoisungnern et 
al., 2015) 
Ag NPs av. 
diameter 40nm  BDF1 mice (8-12 weeks) / sperm 
Target 
organ 
toxicity 
in vitro Incubation dose of 0, 0.1, 1, 10, and 50μg/mL for 3h.  
Found internalisation of Ag NPs in spermatozoa, with even distribution inc. 
within mitochondrial area, in a dose dependent fashion. Flow cytometry 
showed negative effect on sperm viability although authors could not deduce 
whether this was a particle or ion effect. Morphological analysis of 
spermatozoa showed Ag NPs significantly increased sperm abnormalities, 
including coiled tails, roll tail, and bent tails, in a dose-dependent manner. 
Acrosome reaction was also decreased significantly in Ag NP exposed sperm, 
something which is required for sperm capacitation pre-fertilization of oocyte. 
Authors also looked at IVF and ICSI and found negative effects associated with 
Ag NP exposure.  
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2015a) Ag NPs 10/20nm  
Balb/c mice, 21 day old / TM3 
TM4 and Spermatogonial Stem 
Cells (SSC)  
Target 
organ 
toxicity 
in vitro Incubation  
Time/dose dep effect of TM3/4 proliferation, membrane damage and ROS 
generation. 10nm worse than 20. Via PCR/WB saw in TM3 and TM4 cells Ag 
NPs activated the p53, p38, and pErk1/2 signalling pathways and significantly 
downregulated the expression of genes related to testosterone synthesis 
(TM3) and tight junctions (TM4). Furthermore, the exposure of TM3 and TM4 
cells to Ag NPs inhibited proliferation and self-renewal of SSCs. 
(Moretti et al., 
2013) Au and Ag NPs  human sperm 
Target 
organ 
toxicity 
in vitro Incubation 
Semen samples from 10 donors 
exposed to 30/60/122/250 and 
500uM of Au and Ag NPs for 60 and 
120 mins.  
Examination for motility and viability showed dose dependent effect, with sig 
at 125+uM. Ag NPs seemed to be more potent tox than Au. Au NPs were 
localised within sperm, although Ag not detectable (maybe because they’d 
become ions?). However, toxicity not seen until higher levels of exposure 
(250-500uM) which are not usually easy to achieve in vivo.  
(Lee et al., 
2007) Ag NP 5–46 nm Zebrafish Embryos 
Developm
ental ex vivo Incubation 
Ag nanoparticle solutions 
(ranging from 0.04, to 0.71 nM) 
incubated chronically with 
cleavage-stage (8-cell) embryos 
in egg water for 120 hpf. 
single Ag nanoparticles were transported into and out of embryos through 
chorion pore canals (CPCs). NPs trapped inside CPCs and the inner mass of the 
embryos, showing restricted diffusion. Toxicity and biocompatibility of Ag NPs 
and the types of abnormalities observed in zebrafish are highly dependent on 
the dose of Ag nanoparticles, with a critical concentration of 0.19 nM.  
(Li et al., 2010) Ag NPs 5-25nm & Ag+ ions 
Mouse embryos @ blastocyst 
stage  
Developm
ental ex vivo Incubation 
Blastocysts treated with 50 microM 
Ag NP or Ag ions 
In vitro exposure induces apoptosis and retards early post-implantation 
development after transfer to host mice. However, Ag NP embryonic 
cytotoxicity appeared lower than that induced by the Ag+ ion. The results 
collectively show that Ag NP has the potential to induce embryo cytotoxicity. 
(Powers et al., 
2011) 
Ag NPs, Ag+ ions, 
10nm citrate-
coated Ag NP (Ag 
NP-C), and 10 or 
50nm 
polyvinylpyrrolido
ne-coated Ag NPs 
(Ag NP-PVP). 
Zebrafish Embryos Developmental ex vivo Incubation 
exposed developing zebrafish to 
Ag(+) or Ag NPs on days 0-5 post-
fertilization, Ag NPs of different 
sizes and coatings: 10nm citrate-
coated Ag NP (Ag NP-C), and 10 or 
50nm polyvinylpyrrolidone-coated 
Ag NPs (Ag NP-PVP).  
Ag NPs are less potent than Ag(+) with respect to dysmorphology and loss of 
viability, but nevertheless produce neurobehavioral effects that highly depend 
on particle coating and size, rather than just reflecting the release of Ag(+). 
Different Ag NP formulations are likely to produce distinct patterns of 
developmental neurotoxicity. 
(Powers et al., 
2010) 
Ag(+) ranging 
from 10nM to 
100microM 
Zebrafish Embryos Developmental ex vivo Incubation 
Zebrafish from 0 to 5days post-
fertilization to concentrations of 
Ag(+) ranging from 10nM to 
100microM  
Ag+ found to be a developmental toxicant. At low concentrations, Ag(+) acts 
as a neurobehavioral toxicant even in the absence of dysmorphology. Early 
behavioural impairment observed is predictive of subsequent decreases in 
survival.  
Bryony L Ross PhD 55 
(Bar-Ilan et al., 
2009) 
Ag / Au NPs (3, 
10, 50, and 100 
nm) 
Zebrafish Embryos Developmental ex vivo Incubation 
Exposure to various sizes at a 
concentration of 100 or 250 μM, 
from 4 to 120 hours post 
fertilisation (hpf) 
Ag NP produced almost 100% mortality at 120 hpf, while Au nanoparticles 
produced less than 3% mortality at the same time point. Au NP induced 
minimal sub-lethal toxic effects, but Ag NPs generate a variety of embryonic 
morphological malformations. Both Ag and Au were shown to be taken up by 
the embryos, suggesting that Ag toxicity is caused by the nanoparticles 
themselves or Ag ions that are formed. 
(Taylor et al., 
2014) 
ligand-free Au and 
Ag NPs  Murine Blastomeres/Embryos 
Developm
ental ex vivo injection 
Embryo culture to the blastocyst 
stage was assessed.  
Rate of development did not differ, and PCR for BAX, BCL2L2, TP53, OCT4, 
NANOG, DNMT3A showed comparable expression. Exposure of blastomeres 
to Ag+ ions in place of NPs caused immediate development arrest.  
(Thakur et al., 
2014) Ag NPs 10-12-week-old Wistar rats (16)  in vivo 
oral 
gavage  
Found disorganisation of STs, germinal epithelium, loss spermatogenic cells 
(esp. spermatocytes and spermatids) and exfoliation of FCs to lumen. Atrophy 
of tubular lumen, with loss of epithelium and SCO were present. V few mature 
sperm seen. TEM showed damage to tubular basement membrane, and 
apoptotic GCs, with separation from basal laminae. TEM for sertoli cells 
showed dissociation of nuclei from basal portion, vacuoles in cytoplasm. NPs 
containing lysosomal bodies were seen in SC cytoplasm. Spermatogonia, 
round spermatids and elongating plus mature spermatids were all affected.  
(Zhang et al., 
2015b) Ag NPs 
Inst of Cancer Res neonatal mice 
8 days old (PND8)  
Target 
organ 
toxicity 
in vivo 
Abdominal 
sub-cut 
injection  
injection of 5 doses over 13 days 
(PND 8 to 21).  
Analysis showed Ag NPs were 10-40nm in size. LDH assay showed 
proportional association between dose and cell death in TM3/4 cells. 
Increased rate of abnormal sperm recorded, alongside sig reduction in testis 
weight per body weight and diameter of convoluted tubules at PND 28 and 
42. PCR results showed drop in Cpy19a1 expression at PND 28/42 which 
recovered by PND 60. Cyp11a1 was upregulated in Ag NP treated. AMH was 
sig reduced in PND28 but recovered by PND42/60, indicating possible 
implications for development 
(Sleiman et al., 
2013) 
Ag NP 60nm 
diameter  male Wistar rats (30) 
Target 
organ 
toxicity 
in vivo gavage 
Rats exposed at PND23-53 50 to 
15ug/kg bw. by oral gavage and 
sacrificed at PND53 or 90 
Ag NP exposure delayed puberty onset in both treated groups compared to 
control. High dose treatment produced reduction in total and daily sperm 
production at PND53, seen in both groups at PND90. Morphometric analysis 
showed disorganisation of seminiferous epithelium, sloughing of GCs and 
debris in lumen. No sig difference in epithelial height or lumen/tubule 
diameters recorded. No change in serum testosterone or oestradiol 
concentrations from control at PND53 or 90.  
(Castellini et 
al., 2014) Ag NPs (45 nm)  Rabbits 
Target 
organ 
toxicity 
in vivo IV injection  
Injection of 0.6 mg/kg bw. Looked 
at sperm quality of rabbits 
throughout a 126-day study  
Reported sperm cells with a lower percent of motility, vigour and oxygen 
consumption and acrosome and mitochondrial damage. Ag NPs identified in 
spermatids and ejaculated sperm; however, no morphological effect seen nor 
was libido, serum testosterone, sperm concentration or semen volume 
altered  
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(Gromadzka-
Ostrowska et 
al., 2012) 
Ag NP (20 nm);  rats 
Target 
organ 
toxicity 
in vivo IV injection 
exposure to 5 mg/kg bw/day Ag NP 
(20 nm);  reported decreased sperm and germ count and DNA damage in germ cells  
(Rezazadeh-
Reyhani et al., 
2015) 
Ag NPs (50-
60nm).  albino mice 10-12 weeks (24) 
Target 
organ 
toxicity 
in vivo IP injection exposed intraperitoneally to 0.5, 1 and 5mg/kg daily for 25 days  
Histology showed alterations in tubular diameter and spermiogenesis index 
between control and treated. Ag NPs resulted in reduction of LCs in 
interstitium, and increased number of hypertrophied LCs. Testosterone LH 
and FSH assay showed dose dependent decrease in all three hormones. IHC 
for Hsp70-2 undertaken, as well as PCR. IHC showed increase in Hsp-70 
expression at low dose, then dig decrease in med/high dose, which was 
confirmed by PCR. Sperm count, motility, chromatin condensation and DNA 
damage were assessed – decreases in count, motility, chromatin and loss in 
DNA integrity seen. 
(Ahmed et al., 
2017) Ag NPs  adult albino rats (60) 
Target 
organ 
toxicity 
in vivo IP injection Effect after 7 or 28 days at L or H doses (100/1000mg/kg/day).  
7day low group testes showed congested blood vessels covering tunica 
albuginea. Some tubules with disorganized separated germinal epithelium 
from their basement membranes. 28day low group had thickened connective 
tissue, capsule studded with Ag NPs & congested sub-capsular blood vessels. 
Decrease in the thickness of germinal epithelium lining some tubules, others 
with exfoliated germ cells & vacuolated cytoplasm. Sig decrease in 
Testosterone seen within Ag NP treated groups. There was downregulation of 
Dazl, Tnp2 and GDNF in Ag NPs received rats of groups II and III. Decrease in 
Ki-67 IHC as marker of cell proliferation. Increase in CD68 by IHC as 
compensatory mechanism by release of testicular macrophages. TEM showed 
vacuolisation of SC and LC. 
(Garcia et al., 
2014) Ag NPs 10nm  CD1 mice  
Target 
organ 
toxicity 
in vivo iv injection 
injected 1mg/kg 10nm Ag NPs into 
CD1 mice for 12 days, and sacrificed 
at 15/60/120 days post exposure 
Ag still detectable in testis at 120d post exposure. Treatment resulted in no 
changes in body and testis weights, sperm concentration and motility, fertility 
indices, or follicle-stimulating hormone and luteinizing hormone serum 
concentrations; however, serum and intratesticular testosterone 
concentrations were significantly increased 15 days after initial treatment. 
Histologic evaluation revealed significant changes in epithelium morphology, 
germ cell apoptosis, and Leydig cell size. Additionally, gene expression 
analysis revealed Cyp11a1 and Hsd3b1 mRNA significantly upregulated in 
treated animals.  
(Fathi et al., 
2018) Ag NPs  200-250g adult Wistar rats (28)  
Target 
organ 
toxicity 
in vivo IP injection 
Single injection of 
30/125/300mg/kg.  28 days after 
injection, 25 tubules from each 
animal were examined for 
histological changes.  
Histomorphometry showed significant reduction in number of spermatogonia, 
sertoli and Leydig cells in M/H dose groups. No comment on morphology.  
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(Park et al., 
2010) 
Ag NPs. small 
(22/42/71) and 
large (323nm)  
Mice 
Target 
organ 
toxicity 
in vivo oral Dosed at 1mg/kg of small (22/42/71) and large (323nm)  
Saw testicular (and other multiple organ) presence of small but not large NPs. 
TGF-b (cytokine) and B cell (lymphocyte) distribution were increased in small 
exposed but not large exposed animals. Also looked at 28day rep dose of 
42nm Ag NPs at 0.25/0.5/1mg/kg. Cytokine assay showed increases in IL-
1/6/4/10/12 and TGF-B in a dose dep manner. B cell distribution and 
lymphocyte IgE production also increased. 
(Miresmaeili et 
al., 2013) Ag NPs Wistar rats (32) 
Target 
organ 
toxicity 
in vivo oral 
dosing was 25/50/100/200mg/kg. 
every 12 hours over one cycle of 
spermatogenesis (48days) 
Acrosome reaction evaluated by triple stain showed significant difference 
between control and exp group. Reduction in spermatogonia cells in highest 
dose group. 50-200 groups all showed significant reduction in number of 
primary spermatocytes and spermatids and spermatozoa. No significant effect 
on SC number.  
(Layali et al., 
2016) Ag NPs male Syrian rats (24) 
Target 
organ 
toxicity 
in vivo oral 
orally administered Ag NPs at 
concentrations of 0.07/0.14 and 
0.28ug daily for 5 weeks.  
Sperm count and motility significantly declined, especially in M/H dose 
groups. Malondialdehyde concentration in the seminal fluid of rats was 
significantly raised in M/ which they report indicates increased lipid 
peroxidation.  
(Kim et al., 
2008) Ag NPs Sprague Dawley Rats 
Biodistribu
tion in vivo oral 
Twenty-eight-day oral toxicity, 
genotoxicity, and gender- related 
tissue distribution of silver 
nanoparticles 
reported high distribution of Ag NPs to the testis  
(Mathias et al., 
2015) Ag NPs  Wistar rats (30) 
Target 
organ 
toxicity 
in vivo oral 
Oral exposure with 15/30ug/kg/day 
60nm Ag NPs from PND 12 to 
PND58, with sacrifice at PND102.  
Onset of puberty was delated in Ag NP treated animals. Interestingly, partner 
preference was altered in 15ug dosed animals – swing toward male partner 
seen in sexual partner preference testing. Acrosomal integrity (sperm 
function) decreased in a dose dependent manner. Sperm Plasma membrane 
integrity measured by eosin-y and nigrosin stain also showed decrease with 
increasing dose. Number of sperm abnormalities increased with Ag NP 
exposure. No change on serum hormone levels (testosterone, LH, FSH and 
oestradiol).  
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Titanium Dioxide ENM  
Titanium dioxide (TiO2) NPs are amongst the most commonly used metal oxide NPs. 
They tend to be available in either crystalline rutile or pure crystalline form, or as 
mixtures of crystalline anatase and rutile forms.  They are best known as a component 
in sunscreens, pigments and paints. However, TiO2 NP also have applications as drug 
delivery vehicles, photocatalysts, and in electronic data storage. Eighteen studies 
examining DART of TiO2 NP were identified and are outlined within Table 3. Of these, 3 
examine in vitro techniques involving cell lines (mouse TM3 Leydig cells, and human NT2 
testicular embryonic carcinoma cells) or direct application to sperm, and five examine 
in vivo toxicity studies following exposure via inhalation (3), oral (8) or injection (4).  
Both the in vitro and in vivo studies report varied outcomes following TiO2 NP exposure, 
with some finding dose dependent toxicity and others reporting transient or no effects 
(Smith et al., 2015). In vivo, a number of findings were reported, including detection of 
reactive oxygen species (ROS) and oxidative stress (imbalance between oxidants and 
antioxidants in favour of oxidant presence), morphological markers of altered 
spermatogenesis within the testis, and changes to circulating hormone levels, 
implicating both potential for either direct damage to the organ by TiO2 NP, or indirect 
effects via endocrine disruption. In vitro, It is interesting to note that the comparative 
study to examine the potential for TiO2 NP, diesel exhaust particles and ultrafine carbon 
black to impair the male mouse reproductive system undertaken by Komatsu et al. 
(2008) identified TiO2 as being more cytotoxic to TM3 Leydig cells than the other carbon 
based particles examined (Komatsu et al., 2008). Conversely, the comparative study 
undertaken by Asare et al (2012), found TiO2 NP to be less toxic than Ag NPs or TiO2 in 
its ultrafine form to male human NT2 testicular embryonic carcinoma cells (Asare et al., 
2012).   
This variation in outcome did not appear to be linked to exposure route, dose regimen, 
ENM size (where identifiable) or animal type as all reported a range of outcomes. Based 
on this it is possible that the variation in results could very well be linked to physical 
form, especially in the case of TiO2 NP for which differences in toxicity dependent on 
crystalline form and pH of the exposure environment have been previously 
demonstrated (De Matteis et al., 2016). This highlights further the importance of 
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understanding ENM characteristics well in establishing their toxicity, and the need for 
standardised reference materials in toxicity testing.  
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Table 3: In vivo and in vitro reproductive and developmental toxicity studies of titanium dioxide (TiO2) ENP, outlining key parameters from each study identified, including study type, exposure type and method, and 
relevant findings 
Paper ENM Animal/Cell Study Type In vitro / 
In vivo 
Exposure  Method Outcomes 
(Komatsu et 
al., 2008) 
25–70 nm TiO2 Mouse Leydig TM3 Cells  Fertility 
(mech) 
in vitro Incubation Cells exposed to different 
concentrations of the NP for 48h.  
TiO2 taken up into cells. Dose dependent decrease in cell viability. TiO2 
more toxic than the other NPs tested. TM3 cell proliferation supressed 
by TiO2.  
(Asare et al., 
2012) 
21nm TiO2 Male 8-oxoguanine DNA 
glycosylase knockout mice (Ogg1-/- 
KO), and Human NT2 pluripotent 
testicular embryonic carcinoma cell 
line  
Fertility 
(mech) 
in vitro Incubation Cells exposed @ 10/50/100ug/ml for 
24/48/72h 
Ag NP and UF more cytotoxic and cytostatic than TiO2, causing apoptosis, 
necrosis and decreased proliferation in concentration and time 
dependent manner. 200nm AgNPs cause concn. dependent increase in 
DNA strand breaks in NT2 cells. ROS formation leading to oxidative 
purine DNA base damage (comet) not found to be a significant MoA 
(Pawar and 
Kaul, 2012) 
TiO2 NP  buffalo sperm  Target 
organ 
toxicity 
in vitro incubation 1/10/100ug/ml concentrations 
(<100nm).  
Significant decrease in cell viability and membrane after 6h incubation 
with NPs. Significant increase in sperm capacitation observed for TiO2 NP 
albeit at lower concentrations. In DNA fragmentation assay, dose-
dependent increase in DNA fragmentation observed. Ultrathin cross-
sections revealed TiO2 NPs inside head and plasma membrane of the 
buffalo spermatozoa as assessed by TEM. 
(Jackson et al., 
2011) 
17nm TiO2 Mouse C57/6BomTac Developme
ntal 
in vivo Pulmonary Pulmonary exposure during gestation 
days 8-18. Measurements taken 5 and 
26d post exposure (maternal), and 
PND 2 and 22 (offspring) 
No DNA strand breaks in mated mice or offspring. Changes in gene 
expression relating to retinoic acid in F offspring, but no effect on M 
offspring. Changes may be secondary response to maternal 
inflammation, but this is only a hypothesis.  
(Boisen et al., 
2012) 
~100nm TiO2 Pregnant C57BL/6 mice Fertility - F1 in vivo inhalation Pregnant C57BL/6 mice were exposed 
by whole-body inhalation to the 
nanoTiO2 UV-Titan L181 (~42.4 mg 
UV-Titan/m3) or filtered clean air on 
gestation days (GD) 8-18. Female 
C57BL/6 F1 offspring raised to 
maturity and mated with unexposed 
CBA males. F2 descendants were 
collected and ESTR germline mutation 
rates estimated from full pedigrees 
(mother, father, offspring) of F1 
female mice (192 UV-Titan-exposed 
F2 offspring and 164 F2 controls).  
No evidence for increased ESTR mutation rates in F1 females exposed in 
utero to UV-Titan nanoparticles from GD8-18 relative to control females 
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(Yamashita et 
al., 2011) 
Si NP 70 nm 
(nSP70), 300 nm 
(nSP300) and 
1,000 nm 
(mSP1000), TiO2 
& fullerene NP 
65, 322, 1,140, 
217 and 143 nm 
Pregnant mice Fertility in vivo Injection To determine distribution, injection at 
GD16 and fluorescent examination 
24h afterwards. To determine 
fetotoxicity, injection (100 µl, 0.8 mg 
per mouse) into pregnant mice at 
GD16 and GD17 
SiNPs with <100 nm and nano-TiO2 35 nm induce resorption of embryos 
and foetal growth restriction. Maternal body weight ↓ SP70 & TiO2, but 
SP300, SP1000 and fullerenes did not show any changes. Modifying the 
surface of nSPs from –OH to –COOH or –NH2 functional groups can 
prevent these complications.  
(Hougaard et 
al., 2010) 
~21nm TiO2 Mouse C57/6BomTac Developme
ntal 
in vivo Pulmonary Pulmonary exposure during gestation 
days 8-18 
Long term lung inflammation seen in adult female mice. Negligible Ti in 
milk. Gestationally exposed offspring had moderate neurobehavioural 
alterations 
(Tassinari et 
al., 2013) 
TiO2 NPs  Sprague-Dawley rats (42) Target 
organ 
toxicity 
in vivo oral 0,1,2 mg/kg dose. Measured tubular 
diameter and relative area of 
seminiferous tubules. Also looked at 
sex steroid and thyroid hormone 
serum levels., as well as tissue 
distribution.   
Saw significant increase in testosterone levels at highest dose, but no 
histomorphological effect on testis.  
(Orazizadeh et 
al., 2014) 
TiO2 NP  NMRI mice (32) Target 
organ 
toxicity 
in vivo oral 300mg/kg Ti TiO2 O2 for 35 days, and 
beta carotene (BC) treatment for 10 
days before addition of TiO2. 
300mg/kg in 30g mouse = 0.1mg per 
mouse, equivalent to 19.5g in 65kg 
human. 
Saw significantly lowered T levels in TiO2 treated, which seemed to be 
reversed somewhat in the BC group. Sperm number, motility and 
normality reduced in TiO2 only, but sig increased by comparison to this in 
BC+T. Histology showed sloughing, detachment of basement membrane 
and vacuoles in T group, T+B group had vacuoles and sloughing but much 
less. Johnsen’s score for spermatogenesis gave much reduced score in T 
and T+B but not as much. Suggested beneficial effects on sertoli cell 
function due to loss of sloughing of GCs and vacuoles…also poss. due to 
restoration of Testosterone production…or antioxidative effect.  
(Meena et al., 
2015) 
21nm TiO2 8wk old Wistar rats  Target 
organ 
toxicity 
in vivo IV injection 5/25/50 mg/kg weekly for 30 days Oxidative stress markers SOD (reduced), Catalase (increased), GPx 
(decreased), lipid peroxidase (increased) following exposure, all dose 
dependently. Creatine kinase levels as markers of sperm maturity, dose 
dep elevated level seen with TiO2 is associated with an increased rate of 
functional abnormalities and increased cytoplasmic retention. Caspase-3 
as marker of apoptosis – increased with dose, alongside decrease in total 
sperm count. Testosterone levels by ELISA were decreased with TiO2 – 
sig at M/H doses, DNA damage by comet and DNA fragmentation assay 
showed fragmentation at M/H doses. Only changes histology seen at 
highest dose – cellular inflammation. TiO2 NPs were seen in testis 
although description is not clear. 
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(Khorsandi et 
al., 2017) 
TiO2 NMRI mice (32) Target 
organ 
toxicity 
in vivo oral 75mg/kg Q or 300mg/kg TiO2 for 42 
days, or 75mg/kg Quercetin for 7 days 
then add 300TiO2 for 35 days. Looked 
at potential benefits of quercetin 
(flavonoid polyphenol found in red 
onions and many other fruit/veg) 
Claimed that TiO2 showed decreased T and sperm quality, along with 
vacuolisation, sloughing and detachment from B membrane. Lipid 
Peroxidase levels increased, and SOD/CAT levels decreased indicating 
oxidative stress. Authors claim Quercetin supplementation improved all 
of these parameters. 
(Takeda et al., 
2009) 
TiO2 NP 25-70nm  pregnant ICR mouse dams  Target 
organ 
toxicity 
in vivo oral Dams dosed with 100ul 1mg/ml TiO2 
NP 25-70nm at 3,7,10 and 14 days 
post coitum 
Aggregates of TiO2 NPs found in both LCs, SCs and spermatids at 4 days 
and 6 weeks of age. Morphology in TiO2 exposed mice showed focal 
disruption, with disorganised tubules, less mature sperm in lumens at 
spermiation. Also, SC count showed reduced numbers in treated. This 
effect was dose dependent. 
(Smith et al., 
2015) 
TiO2 NP (anatase) adult male mice Target 
organ 
toxicity 
in vivo IP injection  2.5 or 5 mg/kg IP injection to adult 
male for 3 days followed by sacrifice 
1/2/3/5 weeks or 24/48/230h later.  
NPs found in scrotal adipose tissue 120h post injection. At 120 h and up 
to 3 weeks post injection, testicular histology revealed enlarged 
interstitial spaces. Numbers of apoptotic cells increased sig in all treated 
animals. Short term epididymal sperm abnormalities increased (not long 
term). Suggests transient effect – 4-8 days post injection effects were 
seen, 10 days -5 weeks post injection no effects detectable.  
(Jia et al., 2014) TiO2 NPs 25nm  60 Kunming mice (3weeks old).  Target 
organ 
toxicity 
in vivo oral 10/50/250mg/kg for 42 days from 
PND28-70 
Abnormalities in epididymis sperm was much higher in exposed animals, 
loss of GC layer (high dose) and vacuoles (all dose) in seminiferous 
tubules seen, and significant decrease =in serum T levels. Also saw 
decrease in expression of 17b-HSD and P450 17a-HSD, with increase of 
CytP450-19 (key for translation of T to Oestradiol) was increased. Nano- 
TiO2 exposure does not alter the mRNA levels of P450scc, 3β-HSD and AR 
Hong et al 
(2015) (Hong et 
al., 2015) 
TiO2 NP  ICR mice (40) 5 weeks old Target 
organ 
toxicity 
in vivo oral 2.5/5/10mg/kg bw  Exposure resulted in lesions of testis and epididymis, deductions in 
sperm concentration and sperm motility, and an increase of the number 
of abnormal sperm in mice. Lowered seminiferous tubule epithelium 
layer and degeneration, reductions of Leydig cells and mature sperm 
within the lumen, immature sperm, sperm breakages, acrosome fusion 
and/or pyknosis, and spermatolysis, cell pyknosis, necrosis and 
abscission, severe disorganization of tissue, and spano-sperm within the 
lumen. Caused major enzyme changes, and Ox stress marker changes.   
O2•−, H2O2, MDA, and PC levels were significantly elevated with 
increasing TiO2 dose. Marked increase in testicular 8-OHdG level was 
observed, indicating that excessive ROS production led to DNA damage in 
the testis due to TiO2 NP-induced toxicity.  
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Silica ENM  
Silica, the common name for materials composed of silicon dioxide (SiO2), occurs in both 
crystalline and amorphous forms. Silica nanoparticles (Si NP) are currently being 
produced on an industrial scale as additives to cosmetics, drugs, printer toners, 
varnishes, and food (Napierska et al., 2010). Of the literature examined, eleven studies 
on Si NP were identified, of which 9 were in vivo and 2 in vitro (Table 4). Of the studies 
in vitro, one was via direct application of Si ENM to boar sperm which showed no direct 
effect of Si ENM on sperm function (Barkalina et al., 2014), and the other a murine 
embryonic stem cell test which reported concentration dependent inhibition of stem 
cell differentiation, but only following exposure to the smallest of 4 particle sizes tested 
(Park et al., 2009). Interestingly, no studies on male germ cell lines were identified.  
The in vivo work of Yamashita et al (2011), who undertook a comparative study of 
adverse outcomes arising from prenatal exposure to Si, TiO2 and fullerene NPs via acute 
intravenous injection is noteworthy (Yamashita et al., 2011). They showed that Si NPs 
<100nm and TiO2 NPs <35nm induced resorption of embryos and foetal growth 
inhibition, but larger versions of the NPs and fullerenes did not induce any changes. In 
addition, they note the importance of functionalization of ENM to their toxicity, showing 
that surface modification with carboxyl groups could prevent the adverse outcomes 
described. In addition, Bara et al (2018) reported comparatively lower toxicity of 
mesoporous silica nanoparticles (MSN) to zinc oxide ENM to Swiss albino mice dams and 
pups following oral exposure during gestation (2 doses over gestational days 15-19). 
Interestingly, the group identified a decrease of testosterone levels in male pups 
compared to control at high but not low doses of MSN. They also  examined  
steroidogenesis in pups post-puberty, and found changes in expression of key proteins, 
enzymes and receptors involved compared to control (Bara et al., 2018). 
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Table 4: In vivo and in vitro reproductive and developmental toxicity studies of Silica ENP (Si), outlining key parameters from each study identified, including study type, exposure type and method and relevant findings 
described within the paper. 
Paper ENM Animal/Cell Study Type In vitro / 
In vivo 
Exposure  Method Outcomes 
(Park et al., 
2009) 
Si NP 10,30,80 & 
400nm 
Embryonic stem cell test Developmental in vitro Incubation Mouse embryonic stem cells 
were exposed to silica 
nanoparticles at concentrations 
ranging from 1 to 100 microg/ml.  
Concentration dependent inhibition of differentiation of stem cells into 
contracting cardiomyocytes by two Si NP of the two smaller primary sizes, 
while the two larger sizes had no effect up to the highest concentration 
tested. 
(Barkalina et al., 
2014) 
mesoporous 
silica NPs:138, 
270 & 280nm in 
size 
boar sperm Target organ 
toxicity 
in vitro 
  
Found no negative effect from MSNPs with hexagonal pore symmetry, 
functionalised with polyethileneimine and amino- propyltriethoxysilane, on 
sperm function including motility, viability, acrosomal status and DNA 
fragmentation index.  
(Kim et al., 2006) magnetic SiO2 
NPs 50nm 
thickness 
mice  Target organ 
toxicity 
in vivo IP 
injection 
Medical focus. IP admin to mice, 
for 4 weeks, 25,100,200mg/kg.  
MNPs were found in testis (and brain through BBB). However, no 
histopathological findings were made. 
(Chen et al., 
2003) 
NaCL modified Si 
NPs 
Male Kunming white mice  Fertility in vivo Injection injection to abdominal cavity or 
tail vein, concentrations 0-
225mg/kg/bw. Sacrifice +96h 
Si NP deposition identified in testes, glands and interstitial cells 
(Kim et al., 2006) Si NP 50nm Male IRC Mice Fertility in vivo Injection intraperitoneal injection, 
10,25,50,100mg/kg, 4 wks, 
sacrifice @ designated times 
Small amount of Si NP found in testicle, gland and interstitial cells, no 
pathological changes in testes. No acute tox or mortality @ high 
concentrations. No apparent abnormalities in subsequent generations 
(Yamashita et 
al., 2011) 
Si NP 70 nm 
(nSP70), 300 nm 
(nSP300) and 
1,000 nm 
(mSP1000), TiO2 
& fullerene NP 
65, 322, 1,140, 
217 and 143 nm 
Pregnant mice Fertility - F1 in vivo Injection To determine distribution, 
injection at GD16 and 
fluorescent examination 24h 
afterwards. To determine 
fetotoxicity, injection (100 µl, 0.8 
mg per mouse) into pregnant 
mice at GD16 and GD17 
Si NPs with <100 nm and nano-TiO2 35 nm induce resorption of embryos 
and foetal growth restriction. Maternal body weight ↓ SP70 & TiO2, but 
SP300, SP1000 and fullerenes did not show any changes. Modifying the 
surface of Si NPs from –OH to –COOH or –NH2 functional groups can 
prevent these complications.  
(Durnev et al., 
2010) 
Si NP 2-5nm male F(1)(CBAxC57Bl/6) mice or to 
outbred albino rats 
Fertility (mech) in vivo Injection 1-5-mu granules in water 
suspension injected on days 1, 7, 
and 14 of gestation 
A 24-h exposure in a dose of 5 mg/kg increased DNA damage in bone 
marrow cells. Si NPs ↓body weight gain in pregnant rats and new-born rats 
at different stages of the experiment but had no effect on other parameters 
of physical development of rat progeny and caused no teratogenic effects. 
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(Morishita et al., 
2012) 
Amorphous 
silica particles 
(nSP70, 70-nm 
diameter; 
nSP300, 300-nm 
diameter). 
Balb/c mice testis Target organ 
toxicity 
in vivo iv 
injection 
tail 
injected intravenously through 
the tail vein with 100 lL (0.8 mg) 
of nSP70 or nSP300 on two 
consecutive days then TEM used 
to examine distribution 
qualitatively.  
70nm but not 300nm Si were able to enter nuclei of spermatocytes (through 
BTB). This matched previous findings that 70nm Si can pass through blood-
placenta barrier. For histology Mice were given 4 doses of 100 lL (0.4 or 0.8 
mg) nSP70 or saline (control), IV through the tail vein every other day. 
Testes were collected 48 h or 1 week after the last administration. Found no 
histological changes. Did not examine hormone levels. 
(Ren et al., 2016) Si NPs diameter 
57.66nm  
C57 male mice Target organ 
toxicity 
in vivo tracheal 
perfusion  
2mg/kg every 3 days for 45 days 
(so 15x). Some sacrifice at 45days 
others at 75 days post first dose.  
At d45, GC layer was thin, with vacuolisation and exfoliated cells in focal 
points. Claim Si NPs were visible in spermatogenic cells (I can’t see from 
their images). Sperm motility and normality in the epididymis was 
decreased in Si NP treated comp to control at d45. These effects appeared 
to be reversible, with d75 testes and epididymis having normal morphology 
and sperm content.  As with the histological findings, TUNEL apoptosis assay 
showed more apoptotic spermatocytes and spermatoblasts at d45 treated, 
but no change from normal at d75. Ox stress testing at d45 showed 
decreased SOD, but increased MDA and 3-NT. Day 75 SOD and 3-NT were 
no different to control but MDA was higher. Authors suggest possible 
mechanism for Si-NP induced apoptosis. 
(Bara et al., 
2018) 
mesoporous 
silica NPs (no 
size given) 
Swiss albino mice. 28F and 10M Target organ 
toxicity 
in vivo oral Exposed to ZnO NP 50/100mg/kg 
or bulk ZnO 100mg/kg, or MSN 
50/250mg/kg. Oral gavage on 2 
alternate days GD 15-19.  
No histological changes in placenta seen in all treatments. Testes exposed 
to ZnO or high dose MSN prenatally showed changes including prominent 
epithelial vacuolization, decrease in seminiferous tubule diameter, low 
cellular adhesion of epithelia and alterations to spermatogenesis. Low dose 
MSN and bulk Zn groups had no changes. Testosterone increased in high 
bulk ZnO, lowered in high MSN, no changes in ZnO NP or low MSN. In 
female corpus luteum, StaR was decreased in high ZnO and MSN, P450 and 
LHR higher in MSN, No change in ZnO NP group for P450 or LHR. In offspring 
(post pubertal, gestational exposure) – ZnO NP and bulk Star higher, 
P450scc significantly higher in 200mg bulk ZnO, and non-significantly higher 
in ZnO NP. P450c17, 17B-HSD and LHR no change following ZnO NP. MSN 
exposure resulted in increased StaR, decreased P450scc, LHR, 17b-HSD and 
P450c17.  
(Xu et al., 2014) Si NPs male ICR mice (8wks).  Target organ 
toxicity 
in vivo IV 
injection 
tail 
Mice given Si NPs 20mg/kg every 
3 days, 5x over 13-day period. 
Sacrificed at 15/35/60 days after 
1st dose.  
Saw reversible changes to oxidative stress and quality/quantity of 
epididymal sperm (observed at 15/35d but not 60d). No changes to 
acrosome integrity, sperm numbers, spermatogonia numbers or levels of 
Testosterone, LH or FSH. Suggests damage is reversible. 
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Carbon Nanotubes 
Carbon-based ENM have in a wide variety of forms, encompassing carbon allotropes 
such as fullerenes, and cylindrical carbon nanotubes (CNT). CNT are hollow tubes of 
carbon, with a unique molecular structure which affords them extraordinary properties, 
including high tensile strength, high electrical conductivity, high ductility, high heat 
conductivity, and relative chemical inactivity. They hold great promise for applications 
such as targeted drug delivery. However, CNT are a classical example of HARN, bearing 
structural similarities to other fibrous materials such as asbestos. Consequently, there is 
much interest in their potential toxicity to humans and animals, particularly via 
inhalation (Tran et al, 2008; Poland et al, 2008). Five studies were identified reporting 
reproductive and developmental endpoints, of which 1 was in vitro, 1 ex vivo and 3 in 
vivo (Table 5).  
All studies appeared to agree that CNT are toxic to the male reproductive organs, 
however the extent reported once again varies with approach, CNT type and dose 
regimen. The study in vitro used Syrian hamster embryo cells, alongside V79 hamster 
lung cells to compare cytotoxicity and genotoxicity of single- double- and multi-walled 
CNTs (SWCNT, DWCNT, MWCNT). The authors reported that MWCNT were more 
cytotoxic and genotoxic than SWCNT or DWCNT (Darne et al., 2014). However, it is 
notable that the authors used the micronucleus test as part of their assessment, to 
which interference from ENM has previously been highlighted (Kroll et al., 2012). The ex 
vivo study examined developmental endpoints for acute and long-term exposure of 
zebrafish embryos to CNT, highlighted in Table 5 (Cheng et al., 2009). They showed an 
immune response was generated following CNT exposure. While embryos were able to 
produce primordial germ cells and a second generation, the larvae of this generation 
had a lower survival rate than control thus implying a negative effect on reproductive 
potential. 
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Table 5: In vivo and in vitro reproductive and developmental toxicity studies of carbon nanotubes (CNT), outlining key parameters from each study identified, including study type, exposure type and method and 
relevant findings described within the paper. 
Paper ENM Animal/Cell Study Type in vivo/ 
in vitro 
Exposure  Method Outcomes 
(Darne et al., 
2014) 
single and MW 
CNTs (nanocyl)  
Syrian hamster embryo and 
immortalised V79 hamster lung 
cells 
Target organ 
toxicity 
in vitro Incubation examined cytotoxicity and 
genotoxicity endpoints.  
Found MWCNTs more cytotoxic and genotoxic than SWCNT or DWCNTs. 
Notable that this group used the micronucleus test which has reported 
interference for ENM. Used the comet and DCF-DA test for free radical 
generation.  
(Cheng et al., 
2009) 
CNT Zebrafish Embryos Developmental ex vivo Incubation Zebra fish embryos exposed 
to 2 ng of fluorescein 
isothiocyanate (FITC) labelled, 
bovine serum albumin (BSA) 
coated MWCNT at the 1 cell 
stage. Examinations 
conducted at 30 minutes, 24, 
48 and 96 hours post 
microinjection.  
At early stages, the embryos generated an immune response by 
accumulating circulating white blood cells at the trunk region. The embryos 
were able to produce normal primordial germ cells and were able to 
produce a second generation. The larvae of the second generation 
however, had lower survival rates compared to the untreated groups, 
suggesting a negative effect on the reproduction potential. 
(Nirmal et al., 
2017) 
hydroxyl-
functionalised 
MWCNT  
Wistar rat sperm Target organ 
toxicity 
in vivo incubation 6 animals per group, 
0.4mg/kg, 2mg/kg and 
10mg/kg, 15 doses over 30 
days.  
Sperm count, motility and normality showed dose-dep decrease. Viability 
unchanged, acrosome unaffected and DNA quality same. Sperm 
abnormalities inc. curved tails and deformed heads. Histology showed dose 
dependent changes. Vacuolisation, reduced GC layer and oedema 
interstitially with dilated blood vessels. Test levels decreased in 2/10 
treatment groups comp to control. Ox stress markers – SOD and GPx dose 
dep increase, GST and MDA sig increase treated 2/10.  
(Bai et al., 2010) COOH-MWCNTs 
and NH2-
MWCNTs  
mice Target organ 
toxicity 
in vivo injection five repeated intravenous 
injections of COOH-MWCNTs 
and NH2-MWCNTs in mice for 
13 days  
Exposure did not elicit any change in sperm counts, sperm motility and 
sperm morphology. Histological changes seen at d15 following dosing 
(vacuolisation, reduced GC layer etc) recovered after d60/90 washout 
period. 
(Farombi et al., 
2016) 
f-MWCNTs  Wistar rats 50 pubertal (8-week-
old)  
Target organ 
toxicity 
in vivo injection 0.25/0.5/0.75 and 1mng/kg f-
MWCNTs via IP injection for 5 
days. 
Markers of Ox stress increased significantly dose dependent manner in 
testes and sperm (SOD, CAT, GPx up but GST and GSH down). Plasma Test. 
Level significantly decreased with treatment. Histopathology showed 
increasing effects with dose – decreased GC layer, interstitial congestion, 
oedema, tubular degeneration. Similar effect seen in epididymis – 
hyperplasia and loss of sperm in lumen 
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Zinc Oxide  
Zinc oxide (ZnO) ENM are frequently available as powders or dispersions. They exhibit 
antibacterial, anti-corrosive, antifungal and UV filtering properties, and are commonly 
used in the manufacture of rubber, concrete, food products, sunscreens and as coating 
agents by the paint industry. Of the 7 studies identified, 1 was in vitro, 1 ex vivo and 5 
were in vivo (Table 6).  
In vitro, Barkhordari et al (2013) found dose-dependent toxicity of ZnO ENM to human 
sperm samples following incubation for 180minutes (Barkhordari et al., 2013). Ex vivo, 
a study exposing zebrafish embryos to micron-sized ZnO to of zebrafish embryos again 
highlighted the importance of dissolution of ions in toxicity, but interestingly, this time 
the authors reported that a solution of Zn2+ ions was less toxic than ZnO particles, 
suggesting that ROS generated by the ZnO led to its more potent toxicity (Zhu et al., 
2009). 
Of the literature examined in vivo, two studies administered pregnant rats to ZnO ENM 
via differing exposure routes. Zhang et al and Jo et al both examined maternal and F1 
effects of ZnO exposure (Zhang et al., 2008, Jo et al., 2013). Zhang et al (2008) used 
intratracheal instillation, and found lower pregnancy rates in exposed dams, but no 
significant neurological impairment of those pups born. Jo et al (2013) exposed dams by 
oral gavage, observing a reduced number of born/live pups, together with decreased 
birth weight and increased foetal resorption. They also undertook an investigation into 
biodistribution of ZnO ENM following exposure, finding ENM within the mammary tissue 
of dams, and within the liver and kidney of pups (but did not mention the testes).  
In relation to target organ specific effects, two studies exploring oral exposure to ZnO 
ENM reported adverse morphology in the testis post-exposure, with evidence of 
damage to  LC  and developing spermatozoa (Moridian et al., 2015, Talebi et al., 2013). 
The combined observations of lowered circulating testosterone, and lowered numbers 
of LC also emphasises the potential for endocrine disturbance following ZnO ENM 
exposure. 
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Table 6: In vivo and in vitro reproductive and developmental toxicity studies of zinc oxide ENM (ZnO), outlining key parameters from each study identified, including study type, exposure type and method and 
relevant findings described within the paper. 
Paper ENM Animal/Cell Study Type in vivo / 
in vitro?  
Exposure  Method Outcomes 
(Barkhordari et al., 
2013) 
ZnO NPs (no size 
given) 
human sperm Target organ 
toxicity 
in vitro incubation 15 sperm samples exposed to 
10/1000/500 or 1000ug/ml for 
45/90/180 minutes.  
Cell death 20.8,21.2 and 33.2% after 45/90/180mins. Highest concentration 
gave highest tox. 180mins exposure sig worse than all other exposure times 
(Zhu et al., 2009) ZnO NPs Zebrafish Embryos Developmental ex vivo Incubation Zebra fish embryos exposed to 
ZnO. Examined sedimentation 
of nanoscale ZnO in zebrafish 
culture medium and assessed 
the toxicity of settled ZnO NP 
aggregates on developing 
zebrafish embryos and larvae.  
Within 48h micron-sized ZnO NP aggregates formed and settled out of the 
culture medium. These aggregates exerted dose-dependent toxicity to 
zebrafish embryos and larvae, reducing hatching rate and causing 
pericardial oedema. The observed toxicity of the ZnO NP aggregates was 
not likely a result solely of particle dissolution, as soluble Zn2+ alone caused 
much less toxicity to zebrafish embryos than ZnO NP. The combination of 
both ZnO NP and Zn2+ is likely to lead to the embryonic toxicity, possibly by 
increasing reactive oxidative species (ROS) and/or compromising the 
cellular oxidative stress response.  
(Zhang et al., 
2008) 
ZnO NPs Rats Maternal/ F1 in vivo Intratrach
eal 
Instillation 
Pregnant rats exposed via 
intratracheal instillation at the 
dose of 7.5 mg/kg bw once a 
day for 5 days.  
Pregnancy rates in Nano-ZnO group were lower than those of Control. 
Difference of birth numbers between groups was not significant. Body 
weights of young rats in Nano-ZnO group at the day of 4, 7 and 21 were 
higher than those of other groups. Results of water maze experiment 
showed that the Nano-ZnO group did not behave in a significantly altered 
manner to control. There was no statically significant difference between 
particle groups and Control group in experiments of plane righting reflex 
and air righting reflex. 
(Moridian et al., 
2015) 
ZnO NPs (no size 
given) 
32 NMRI mice Target organ 
toxicity 
in vivo oral 5/50/300mg/kg ZnO NPs daily 
for 35 consecutive days 
(sperm cycle in mouse).  
Found sig decrease in serum T levels in M/H dose groups, and slight 
decrease in L group. Same finding for diameter of Sem Tubule in L then 
M/H group. Took into account shrinkage of seminiferous tubules in paraffin 
embedded tissue (21%) – good practise. In M/JH groups total vol of 
seminiferous tubules, interstitial tissue and LC number were sig lower than 
control. Suggested loss of LCs may lead to loss Testosterone. 
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(Talebi et al., 
2013) 
ZnO NPs (no size 
given) 
32 adult male NMRO mice  Target organ 
toxicity 
in vivo Oral 5, 50 or 300mg/kg dose  Sperm count and motility decreased sig compared to control, and abnormal 
sperm numbers increased sig in higher dose groups.  Histomorphology 
analysis showed various findings: low dose had vacuolisation, med dose 
had GC degeneration, loss elongating spermatids, disorganisation of GC and 
sloughing, high dose had all of the above with atrophy and multinucleated 
giant cells present. Johnsen’s score showed sig decrease in med and high 
dose groups. Morphometrics showed ST diameter and seminiferous 
epithelial height dig decreased in med and high doses (but no mention of 
staging here so is this really relevant?). Leydig cell numbers were also 
significantly reduced in low and med dose. No staging of tubules 
undertaken with this paper, nor characterisation of ZnO offered.  
(Jo et al., 2013) ZnO NPs <100nm Rats Maternal / F1 in vivo Oral 
Gavage 
Rats were exposed to 500 
mg/kg bw of ZnO 
nanoparticles, beginning 2 
weeks before mating and 
continuing until postnatal day 
4. 
Rats treated with nano-zinc oxide showed reduced number of born/live 
pups, decreased body weights of pups and increased foetal resorption. Zinc 
oxide nanomaterials were distributed to organs such as mammary tissue of 
dams and liver and kidney of pups.  
(Mohamed and 
Abdelrahman, 
2018) 
ZnO NPs<100nm 
and <40nm 
40 rats Target organ 
toxicity 
in vivo Oral Investigated the possible 
protective role of ZnO NPs on 
testicular and epididymal 
structure and sperm 
parameters in nicotine-treated 
rats. 40 rats, some had 
nicotine 1mg/kg and others 
nicotine+ZnO 40nm for a 
period of 30 days 
Histology showed ZnO supplementation appeared to help prevent nicotine 
related damage (which showed as separation of seminiferous epithelium, 
congested blood vessels and possible pyknotic nuclei etc in ST). Epididymal 
samples showed mucosa around epididymis and congested blood vessels 
with mononuclear infiltration, some of which was reversed with ZnO. Ox 
stress measured via CAT, SOD, GSH and GPx were reduced in NP 
supplemented compared to nicotine alone, MDA levels were also lower in 
this group. Sperm morphology and count same result. StaR and P450scc 
expression significantly decreased in nicotine group, whereas ZnO NP 
supplemented group caused increase in both past control.  
Bryony L Ross PhD 71 
Summary 
 
The foregoing review demonstrates that ENM of various types are able to access 
immunopriviledged areas relating to the reproductive system and influence 
reproduction and development in a number of ways. ENM can cross barriers such as the 
placenta and BTB, having been observed in both male and female reproductive organs. 
Exposure to ENM results in interference with aspects of fertility, including 
spermatogenesis and endocrine function. In addition, a number of ENM have been 
shown to impair embryonic development and to have adverse effects on the 
morphology and later reproductive function of offspring to maternally exposed animals.  
Mechanistically, toxicity from exposure to ENM appears to potentially affect 
reproduction via a number of modes of action. Physico-chemical characteristics of ENM 
are clearly important, and functionalisation of ENM can often alter the toxicity and 
Mechanism of Action (MoA) observed. In addition, secondary release of ions via 
nanoparticle destabilisation appears to be an important consideration, as exemplified 
by some of the studies discussed. Likewise, it is sensible to expect that this will be the 
case for the BTB also, although no published literature is yet available.  
Many ENM have been shown to elicit direct cytotoxicity to cells of the reproductive 
system and developing embryos. One MoA which has received much attention is that of 
oxidative stress, which can threaten germ cell, foetal and placental cells. ENM have also 
been demonstrated to elicit DNA damage via a number of mechanisms, direct and 
indirect. In addition, a role for inflammation in induction of reproductive and 
developmental toxicity has been suggested, and evidence to support this is emerging.  
The literature published to date shows a great diversity in study design, with only one 
study from that reviewed using a test known to be validated (the developmental 
embryonic stem cell test, EST). Reporting varies hugely from study to study, as does 
choice of ENM in terms of its size, surface morphology & functionalization, controls 
used, dose regimens applied, exposure routes selected, and indeed whether such 
important aspects of each study are reported in full by their authors. Furthermore, 
components of studies also differ greatly in terms of model system, species of choice, 
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assays (and whether interference from ENM has been considered in their choice), 
biomarkers considered and end points under investigation. This makes comparison of 
studies difficult, as well as deduction of general rules for testing. To avoid further 
problems with comparison of studies, ideally all future research would include the 
following: i) Clear physico-chemical characterisation for all ENM reported on, ii) The use 
of well-characterised reference materials alongside test materials from which to make 
a comparison, iii) Inclusion of ionic controls for metallic ENM to elaborate further on 
whether any effect seen is ionic or particulate, iv) Consideration of potential for assay 
interference from ENM at every stage (in vitro), and v) where possible, consideration of 
ENM as endocrine disruptors, alongside investigation of their role in eliciting direct 
toxicity to the testis.  
Overall, it is clear that ENM are able to interfere with male and female fertility, 
development and later reproductive success of offspring. However, the sheer 
complexity of the reproductive system, gaps in data and diversity in studies makes it 
hard to draw any solid conclusions or rules from the evidence on mechanisms or 
expected outcomes at the current time. There is therefore a clear need for structured 
testing of ENM developed for industrial or medical purposes to elucidate potential 
adverse effects to reproduction and development. 
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Objectives of the research programme  
 
Based on the clear requirement for development of knowledge on male reproductive 
nanotoxicology, and the concurrent need to reduce, refine or replace the use of animal 
testing in research, the aim of this research is to investigate toxicity of ENM to the male 
reproductive system with a focus on development of non-animal testing approaches in 
line with the 3Rs principle.  
The research will use a panel of commonly used reference engineered nanomaterials, 
alongside some highly relevant commercially available materials, selected as 
representative of the field. These have been well characterised, enabling generation of 
data which is directly comparable to that of other researchers using the same materials. 
During the research, the potential for interference of ENM with the assays will also be 
considered at each stage, as will the involvement in ionic dissolution from particles in 
their toxicity. 
 
The work programme has four main sections:  
1. Making use of established male gonadal cell lines, establishing suitable assays 
to screen ENM for cytotoxicity and the effects of time- and dose- on effect; 
2. Using a sub-panel of ENM, investigation of functional cellular parameters 
relevant to both fertility and endocrine health will be undertaken on the same 
cell lines;  
3. In parallel with 1 & 2, testicular tissues collected from animals exposed in vivo 
through a 28-day sub-chronic oral dosing regimen to two types of silver, three 
types of silica and a silver ionic control will be examined in detail for 
morphological and functional markers of effect; 
4. The results in vitro will then be compared to those generated in vivo. 
Determination of comparability will guide a decision on ability of the in vitro 
tests to predict outcomes in vivo, and form one of the first steps in formation of 
an integrated approach to testing and assessment (IATA) for male DART 
following exposure to nanomaterials.  
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The output of this research will contribute to both building the knowledge base relating 
to male reproductive toxicity from ENM in vitro, and toward forming useful alternative 
models for predicting toxicity from engineered nanomaterials. Thus, the ultimate aim is 
to develop robust, reliable and repeatable in vitro test methods for the prediction of 
engineered nanomaterial (ENM) toxicity in vivo. 
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Chapter 2: Selection, handling and preparation of the Engineered 
Nanomaterial Panel  
 
Introduction  
 
To ensure comparability between tests, the same engineered nanomaterials have been 
used in all experiments in the present study. The ENMs selected were from two 
European Commission Framework 7 projects: MARINA (MAnaging RIsks of 
NAnoparticles, FP7-NMP 263215), and SUN (Sustainable Nanotechnologies, FP7-NMP 
604305). Any additional ENMs used were in support of the materials used within these 
projects. This short chapter outlines the materials used and rationale for their choice, 
together with providing materials and methods on their handling, dispersion and 
preparation for work both in vitro and in vivo.     
 
Figure 6: The four generations of nanotechnology. From (Rocco, 2005) 
 
In the mid-2000s, Mike Rocco of the U.S. National Nanotechnology Initiative described 
4 generations of nanotechnology development as part of a road mapping exercise for 
the future of the field (Fig. 6). These ranged from passive nanostructured materials (1st 
generation products) that may be added to existing products or materials to benefit 
their function e.g. as paint or fuel additives, or for incorporation to polymers and metals 
Bryony L Ross PhD 76 
to improve their performance, through active nanostructures with targeted health or 
structural effects, nanosystems capable of guided assembly and basic robotics, to 4th 
generation molecular systems controlled from the molecular level up, with much more 
complex functions. In order to orientate the work reported within this thesis, it is 
important to recognise that all ENM used are classified as first-generation ‘pristine’ 
nanomaterials; passive nanostructures that have been created and are in their pure, or 
unformulated, state.  
 
Selection of the Nanomaterial Panel  
Within the MARINA project, ENMs were selected based on scientific, regulatory and 
industrial relevance. These materials selected were available from the Nanomaterials 
Repository at the Joint Research Council (JRC). The JRC’s repository was founded to 
provide an independent source of control and reference ENMs in response to a previous 
lack of reference and control samples, which over time had led to a lack of 
harmonisation of procedures used to generate data for risk assessment of ENMs 
(Cotogno et al., 2016). As such, the materials provided were controlled to be from the 
same manufacturer, source and batch, as the degree to which ENMs with the same 
chemical identity but differing sources may be considered to be the “same” material has 
been debated (Motzkus et al., 2014). The materials selected for use have also been 
utilised in occupational health and safety testing within a number of other projects 
worldwide to help establish potential risk from first generation ENM.  
Within the repository, various forms of materials with differing nanoforms but the same 
chemical identity have been made available, to assist with grouping and read-across. 
Within MARINA, 14 principal ENMs were selected for investigation: Titanium Dioxide 
(TiO2 NM-101, 103, 104, 105); Silica Dioxide (SiO2 NM-200, 203); Zinc Oxide (ZnO NM-
110, 111, 112); Multi-walled Carbon Nanotubes (MWCNT NM-400, 401, 403); nano-
Silver (nano-Ag NM-300K). In addition, 5 secondary materials were selected: other SiO2 
(NM-100, 102); cerium dioxide (CeO2 NM-211, 212); and nanoclay (NM-600). Of these 
materials, those in bold were selected for use within the MARINA hazard theme testing 
and are used in the work described in this thesis. Many of these materials overlap with 
materials selected by the OECD Working Party on Manufactured Nanomaterials project 
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on the safety testing of a representative set of manufactured nanomaterials, providing 
additional relevance for their selection and use (OECD, 2010).  
Materials were extensively characterised, both by the JRC and partners within the 
MARINA project (Riego Sintes, 2015, Rasmussen et al., 2013, Rasmussen et al., 2014, 
Comero et al., 2011). Characterisation includes (but is not limited to): Agglomeration/ 
Aggregation; Water Solubility/ Dispersibility; Crystalline phase; Crystallite size; 
Representative Electron Microscopy; Particle size distribution; Specific surface area; 
Zeta potential; Surface chemistry; Photocatalytic activity; Redox potential; Radical 
formation potential; Elemental analysis and Storage stability over time and at different 
temperatures. Consequently, no further characterisation work was undertaken during 
the present study.   
To complement those used in MARINA, some additional ENMs were used in specific 
sections of this doctoral work. These were: pristine Copper Oxide (CuO) ENM from the 
SUN project, selected because of its use in antimicrobial wood coatings (SPA, 2014), and 
synthetic amorphous silica (SAS), selected because of its industrial relevance and used 
in vivo as a comparative material to the reference ENM NM202 (van der Zande et al., 
2014a).  
Physico-chemical information on all ENMs used within the project is provided in Table 
7. All ENMs with the prefix NM were sourced from the Joint Research Council’s reference 
nanomaterial repository, prepared under Good Laboratory Practise (GLP) (Cotogno et 
al., 2016).  
 
Nanomaterial Weighing and Handling  
ENM from the JRC were distributed in vials under argon, all other materials were 
distributed in vials. ENMs were prepared slightly differently depending on whether they 
were provided as powder or dispersion (for example, NM-300). All vials were stored at 
room temperature in the dark. It was advised that materials should be used for a 
maximum of one week once open, however, this was not always practically possible due 
to the time span of the laboratory work and limited quantities of ENM available. It 
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should be noted that ENM used within the low dose Alamar Blue experiments and PCR 
work were all used out with the 1 week recommended timeframe as a result. All ENMs 
were weighed for preparation into dispersion using a 6-place micro balance with laminar 
flow HEPA filter system, situated within a fume hood equipped with air control system 
that was set up specifically for safe handling of ENM, and housed in a specially 
designated ENM weighing and handling room within Edinburgh Napier University. 
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Table 7: Panel of ENMs selected for use within the MARINA project, and the present study. Table includes ENM name and JRC reference number, together with form and basic physico-chemical parameters provided 
by the manufacturer and from literature using the same ENM panel (JRC, 2011, Kermanizadeh et al., 2013, Riego Sintes, 2015, Rasmussen et al., 2013, Rasmussen et al., 2014, Comero et al., 2011, van der Zande et 
al., 2014a, Cefic, 2012). 
ENM JRC ID and source (where available) 
Chemical 
Number (where 
available) 
Type of 
Material FORM 
Mean Primary 
Particle Size (nm)  
Length and 
Diameter 
(nm) 
Particle size 
distribution [nm] 
Specific Surface Area 
[m2/g] 
NM-101 TiO2 JRCNM01001a - 
Titanium 
Dioxide 
Anatase, thermal 
uncoated 5-6 N/A 
<100 = 95%; 
<50 = 77%; 
<10 = 11% 
320 
NM-103 TiO2 - - 
Titanium 
Dioxide 
Thermal 
hydrophobic 186 N/A N/A 60 
NM-104 TiO2 - - 
Titanium 
Dioxide hydrophilic 67 N/A N/A 60 
NM 200 SiO2 JRCNM02000a - 
Silicon 
Dioxide, 
coated 
Precipitated PR-A-02 47 N/A N/A 189 
NM-202 SiO2 - - 
Silicon 
Dioxide, 
uncoated 
Thermal PY-B-01 10-25 N/A N/A 204 
NM-110 ZnO BASF Z-Cote 
1314-13-2, EINECS Zinc Oxide, 
uncoated uncoated 100 N/A N/A 13 215-222-5 
NM-111 ZnO JRCNM01101a BASF Z-Cote HP1 
1314-13-2, 2943-
75-1 EINECS 215-
222-5, 220-941-2 
Zinc Oxide, 
coated 
Coated with 
TriethoxycapryIsilane 
130 
140 N/A N/A 15 
NM-300 RAS GmbH 7440-22-4 Silver 
Colloidal suspension,  
Polyoxylaurat 
Tween-20 capped 
(stabilising agent) 
Ag <20 nm (15 nm 
mean). Nominal 
silver content 
10w/w% 
N/A N/A N/A 
NM-300 DIS RAS GmbH - Silver Dispersant N/A - N/A N/A N/A 
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ENM JRC ID and source (where available) 
Chemical 
Number (where 
available) 
Type of 
Material FORM 
Mean Primary 
Particle Size (nm)  
Length and 
Diameter 
(nm) 
Particle size 
distribution [nm] 
Specific Surface Area 
[m2/g] 
NM-212 CeO2  - 
Cerium 
Dioxide, 
uncoated 
precipitated >10 to 20 N/A N/A 65 
NM-400 CNT JRCNM04000a Nanocyl 
7782-42-5, EINECS MWCNT, 
Short 
entangled 
Multi-walled Carbon 
Nanotubes N/A 
L846nm 
D11nm N/A 11 231-955-3 
NM-401 CNT JRCNM04001a  
7782-42-5, EINECS MWCNT, long 
entangled 
Multi-walled Carbon 
Nanotubes N/A 
L4048nm, 
D67nm N/A 11 231-955-3 
NM-403 CNT JRCNM04003a - MWCNT Multi-walled Carbon Nanotubes N/A 
L443nm, 
D12nm N/A 12 
Pristine CuO - - Copper Oxide Pristine 3-35 (av. 12) N/A N/A  
Nano Amor Industrial silver  Silver PVP coated <15nm N/A <15 = 75% 15-62 = 25%  
AgNO3 - - 
Silver nitrate, 
ionic Ionic silver N/A N/A N/A N/A 
ZnSO4 - - Zinc oxide, ionic Ionic Zinc N/A N/A N/A N/A 
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Once the vial of any ENM had been opened, work to dispense the required weight to a 
separate vial from which to prepare dilutions was carried out quickly, ensuring that the 
stock solution vial was not open for any longer than absolutely necessary. During this 
time, the vial was kept upright to minimize the escape of argon. Clean glassware and 
spatulas were used for each handing of ENM.  
 
Protocol for weighing NM-300 Ag and preparation of stock solution for dispersion 
Vials of NM-300 contained 0.5 g silver in a dispersant composed of 5 ml de-ionised water 
(75%) with ammonium nitrate stabilizing agent (7%) and emulsifiers (8%), comprised of 
4% Polyoxyethylene Glycerol Trioleate and 4% Polyoxyethylene(20) Sorbitan mono-
Laurat (Tween 20). The silver concentration was roughly 10% w/w (100mg/ml), meaning 
that each vial contained 500 mg of silver. As the material was very viscous, weighing was 
recommended for dilution. For example, this meant that if 60mg of NM-300 was 
weighed (representing 6mg NM-300 at 10% w/v), 5.6ml of deionized and autoclaved 
water containing 2% FBS would be added to form the stock dispersion under clean 
conditions in a fume hood within the cell culture lab to produce a 2mg/ml stock solution.  
 
Protocol for weighing materials other than NM-300 & preparation of stock solution for 
dispersion 
For each ENM approximately 5-10mg of particles were weighed, to which 4-6 ml 
dispersion media were added under clean laboratory conditions (in a fume hood within 
the cell culture lab). For NM-110 and 111 (ZnO), an additional pre-wetting step with 0.5 
vol.% ethanol (EtOH) was included, as this was essential to achieve a good suspension 
in the dispersion media. Practically, this meant that for 6mg of ZnO, 30µl of 0.5% ethanol 
would be added drop by drop and the powder mixed by rotating the tube in the hand 
for 30secs-1min. 5.97ml of deionized and autoclaved water containing 2% FBS was then 
added to form a 2mg/ml stock solution. 
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Dispersion Protocols for ENM  
ENM toxicity testing often requires preparation of particle dispersion in liquid. For many 
ENMs, forming a stable dispersion in aqueous media is difficult due to their tendency to 
form agglomerates. Dispersibility may be improved using a number of approaches, from 
adjusting pH or ionic strength of the dispersant, to addition of solvents, or inclusion of 
de-agglomeration steps via mechanical stirring, shaking or ultrasonication (Hartmann et 
al., 2015).  
Selection and application of a suitable protocol for ENM dispersion is important in order 
to provide better control over delivered dose, avoid generation of false positive results 
(via secondary toxicity from dispersants or chemicals added to aid dispersion), and avoid 
undesirable modifications of ENM caused by the dispersion process. In addition, from a 
regulatory point of view, harmonisation and standardisation of protocols and methods 
applied  is vital to provide data which is comparable and reproducible (Hartmann et al., 
2015).  
Within this work, and in line with the agreed approach used by MARINA project 
partners, a dispersion protocol used in the NANOGENOTOX project was adopted (Joint 
Action co-funded by the Executive Agency for Health and Consumers - Grant Agreement 
n°2009 21 01 under the European Union 2nd Health Programme). This was selected as 
a good basis for a harmonized generic protocol for the dispersion of nanomaterials in 
aqueous media for the purposes of mammalian toxicological testing.  
 
Dispersion protocol (in vitro)  
ENM stock solutions were prepared to a concentration of 2 mg/ml in deionized and 
autoclaved water containing 2% FBS, and then sonicated (400W) for 16 minutes in a 
water bath at room temperature to assist dispersion. Water bath sonication was 
selected as it was considered to pose less risk of introducing contaminants or disrupting 
the structure of ENM than other available methods such as probe sonication (Hartmann 
et al., 2015). Working solutions were diluted to 200µg/ml, and from these, serial 
dilutions were prepared as outlined within Chapters 3 and 4.  The described protocol 
ensured stable dispersion for up to 1 hour before considering re-dispersion due to 
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potential onset of agglomeration and/or sedimentation. However, any sedimented 
particles were easily re-dispersed by vortexing the dispersion for 10 seconds. ENM 
dispersions were prepared fresh for each particle treatment undertaken. Following the 
preparation of stock solutions, working concentrations were prepared in complete 
culture media (without FBS). 
 
Dispersion protocol (in vivo)  
Preparation of ENM dispersions and their use within in vivo experiments was 
undertaken at the laboratories of Waginingen University, Netherlands (as part of a 
larger in vivo study within the MARINA project), the testicular tissue from which was 
provided to Edinburgh Napier University for analysis. The team conducting the in vivo 
treatments followed the same dispersion protocol as stated above for NM-300, with 
some small differences. Van der Zande et al reported that “NM-300 particles were 
suspended in LC/MS grade water to a total silver concentration of 27 mg/mL, AgNO3 was 
dissolved in LC/MS grade water to a final silver concentration of 2.7 mg/mL and matrix 
controls were equally diluted”. Pure liquid chromatography/mass spectrometry (LC/MS) 
grade water (Biosolve, Valkenswaard, The Netherlands) served as a matrix control for 
both NM-300 and AgNO3. ENM suspensions/solutions were prepared freshly three times 
a week. As per the protocol used in vitro, suspensions were also sonicated after 
preparation for 20 min at 20°C at 100% output (4W specific ultrasound energy (240 
J/m3) to minimise agglomeration, using a Branson 5510 water bath sonicator (Emerson, 
USA) (van der Zande et al., 2012).  
 
Other preparations of ENM used: ENM feed mixes (in vivo)  
The in vivo animal treatments were undertaken by either oral gavage, or via feed. For 
those which were undertaken by feed (NM202), this was achieved by mixing NM202 
with feed, preparation of which was undertaken at the laboratories of Waginingen 
University, Netherlands. For this, Van der Zande et al summarised that “NM202 was 
mixed with standard feed and chocolate milk was added to increase palatability, which 
was assessed in a pilot experiment. SAS or NM-202 was mixed by hand-stirring to a thick 
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paste with chocolate milk (Chocomel, Nutricia, The Netherlands) and ground standard 
diet pellets (RMH-B, ABDiets, The Netherlands) in a ratio of 1:8:1 respectively, by weight. 
Total intended silica content was 99 mg/g and was fed in different amounts to rats to 
achieve the desired daily dosage” (van der Zande et al., 2014a, van der Zande et al., 
2014b) 
 
Disposal of ENM  
Following use, all unused solutions containing ENM were disposed of in a way which 
avoided their release into the ecosystem (e.g. by being entered into the general 
drainage system) in line with the most recent guidance on the safe handling of 
nanomaterials. In this case, ENM containing solutions were decanted into sealed waste 
containers and stored in the dark at room temperature before specialist waste disposal 
via a third-party company. 
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Chapter 3: In vitro toxicity of a panel of ENM  
 
Introduction 
While the toxicity of various ENM has been demonstrated in numerous publications over 
the last 15 years, as outlined within Chapter 1, there remains a relative scarcity in 
available information and understanding of the effects ENM may have on the male 
reproductive system.  From the available literature, several interesting in vitro focussed 
studies help in both highlighting the need to build knowledge in the area, and provision 
of further justification of the ENM panel selected, described in full within Chapter 2.  
Existing knowledge in vitro  
In two separate studies, Braydich-Stolle et. al. showed that the mouse spermatogonial 
stem cell line C18-4 was adversely affected by metal nanoparticle exposure (Braydich-
Stolle et al., 2005, Braydich-Stolle et al., 2010). Of the metal NP tested, smaller NPs had 
a greater effect and silver elicited the highest toxicity, with evidence of interference with 
cellular kinase interaction and cellular division following exposure. Furthermore, Asare 
et. al. investigated cytotoxic and genotoxic effects of silver (Ag) and titanium dioxide 
(TiO2) NPs to primary testicular cells from C57BL6 mice. They observed that Ag NPs were 
cytotoxic but minimally genotoxic, and that TiO2 NPs did not affect cell number, 
proliferation nor elicit any significant genotoxicity (Asare et al., 2012).  Wiwanitkit et. al. 
demonstrated that gold NPs were able to penetrate sperm heads and tails of a human 
sperm cell sample, causing an increase in immotile cells compared to control (Wiwanitkit 
et al., 2009). Conversely, Makhluf et al. showed that bovine sperm cells incubated with 
a colloid solution of iron oxide NPs showed no adverse effects to motility or their ability 
to undergo the acrosome reaction, showing that the observed responses to ENM 
exposure are not necessarily uniform (Ben-David Makhluf et al., 2006). Such variation in 
outcomes reported following metal nanoparticle exposure highlights the need for 
further investigation, with some concomitant consideration of the role physico-chemical 
characteristics have in determining hazard and thus any associated risk.  
Komatsu et. al. were one of the first groups to set the scene for further investigation of 
toxicity within the Leydig cell line, by examining uptake and toxicity of diesel exhaust 
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particles (DEP), TiO2 and Carbon Black (CB) on the TM3 Leydig cell line. They showed 
that the particles were internalised by the cells, and that following this a number of 
effects were seen, from impairment of cell proliferation and viability, to alterations in 
testosterone production via interference with the steroidogenic acute regulatory (StAR) 
gene (Komatsu et al., 2008). Han et al recently reported that exposure of Leydig and 
Sertoli cell lines (details of exact cell lines used not published) to zinc oxide (ZnO) 
nanoparticles in vitro resulted in internalisation, time- and dose- dependent cytotoxicity 
through induction of apoptosis (Han et al., 2016). Finally, Zhang et al reported that silver 
nanoparticles inhibited viability and proliferation of TM3 Leydig and TM4 Sertoli cell 
lines in a dose- and time- dependent manner, by damaging cell membranes and inducing 
generation of reactive oxygen species (ROS) (Zhang et al., 2015a). They showed that 
toxicity increased with decreasing size of silver particle, and through PCR demonstrated 
that pathways related to apoptotic cell death  (p53, pErk1/2) were upregulated and 
genes encoding receptors and enzymes involved in control of testosterone synthesis and 
action were downregulated (AR, LH-R, CPY11A1, 3bHSD, CYP1Aa1, StaR, amongst 
others).  
This brief section not only outlines findings to date in relation to research carried out in 
vitro on male somatic cell lines into the hazard of ENM, but also highlights the relative 
scarcity of such information. As such, it serves to emphasise the need to broaden the 
knowledge base in the area by developing methodology and undertaking further 
research in vitro.  
 
Existing approaches to DART and the need for development of in vitro approaches 
The studies presented so far highlight not only evidence for direct reproductive toxicity, 
but also a potential endocrine disrupting role for ENMs, as it is clear that may interfere 
with enzymes, proteins and receptors involved in endocrine regulation of 
steroidogenesis and thus function of the Hypothalamus-Pituitary-Gonadal axis. 
Consequently, testing for reproductive and endocrine endpoints is likely to be required 
to build a full hazard profile for ENMs.  
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As summarised in Chapter 1, current approaches to establishing the Developmental And 
Reproductive Toxicity (DART) of chemicals, agrochemicals and pharmaceuticals are very 
much reliant on in vivo methods. The animal burden associated with reproductive 
endpoints remains high both in the risk assessment of chemicals and development of 
medicines and medical devices, with the average number of animals required to fulfil a 
single DART test undertaken being between 560 and 2,450 (Beekhuijzen, 2017).  Some 
attempts have been made to refine testing approaches to reduce the number of animals 
required; for example, by the replacement of OECD TG416 ‘Two generation 
reproductive toxicity test’ with OECD TG443 ‘Extended one-generation reproductive 
toxicity study (EOGRTS)’ where possible within the REACH Chemical Regulations 
(Beekhuijzen, 2017). However, to date there have been no stand-alone in vitro system 
or model developed in place of traditional reproductive toxicity, and currently there 
remain very few, if any, validated in vitro tests which may be used to contribute to 
building a hazard profile for a given chemical/pharmaceutical. 
 
The challenge of building validated in vitro tests for reproductive endpoints is further 
complicated by complexity of the reproductive system and its reliance on and 
interaction with the rest of the body (via endocrine, neurological and immunological 
systems, amongst others), which made it incredibly difficult to develop validated in vitro 
tests that are representative of what may be achieved in vivo. 
Currently, OECD TG443 ‘Extended one generation reproductive toxicity study’ for 
chemicals, and the OPPTS 870.3800 ‘Reproduction and Fertility effects’ test for 
agrochemicals are perhaps the most equipped of the standard in vivo reproductive 
toxicity tests to examine potential reproductive toxicity and endocrine disruption 
endpoints. Despite this, and the fact that on average they use over 1,000 animals each, 
the OECD recognise that information on mechanism of action for endocrine disruption 
probably still “needs to be obtained from in vitro EATS assays (Endocrine, Androgen, 
Thyroid, Steroidogenesis) or [other] in vivo lower tier tests” (OECD, 2018b). This 
highlights that while in vivo testing is still considered the gold standard in ensuring 
reproductive safety, the importance of in vitro testing in understanding in vivo outcomes 
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cannot be denied. It is further corroborated by the latest guidance on hazard testing of 
nanomaterials under REACH, which states that prior consideration of all available non-
animal information should be made before any in vivo test is conducted, and that 
“relevant and reproducible in vitro test systems may be used” to contribute to hazard 
assessment (ECHA, 2017).  
Finally, the rapid ongoing evolution of nanotechnologies means that the number of 
nanomaterials under development is growing exponentially. While many of these may 
share the same chemical identity, their varied physico-chemical modifications and 
functionalisation mean that it is not possible to simply assume hazard profile based on 
testing undertaken on pristine nanomaterials, yet the use grouping and read-across in 
hazard testing is not without limits. This further highlights the need for robust, high-
throughput in vitro assays that allow for a rapid screening of the vast number of existing 
and newly developed nanomaterial variants. Such in vitro testing systems could be used 
as an early warning system to better reduce the number of in vivo studies required, in 
line with the 3Rs principle of reduction, refinement and replacement of animal testing 
(Russel and Burch, 1959).  
 
Initial steps toward developing in vitro methods to appraise reproductive toxicity of 
ENM  
In order to minimise the animal burden of reproductive toxicity testing, it is important 
to develop reliable, reproducible in vitro methods and models by which to gain insight. 
As nanotoxicology is a relatively young field of research, development of such tests 
remains very much within its infancy. The initial step in establishing the usefulness of in 
vitro testing in predicting the potential for ENM to cause harm to the male reproductive 
system in vivo is to investigate cytotoxicity within a pre-defined testicular cell line.  
Leydig cells are polyhedral cells present within the testicular interstitium. They hold key 
developmental, reproductive and immune system roles, and are responsible for 
production of androgens which act on both local and systemic targets. Locally, 
androgens produced by Leydig cells stimulate Sertoli cells, the ‘nurse’ cells which control 
the blood-testis-barrier (BTB) and manage the process of spermatogenesis inside 
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seminiferous tubules of the testis. For in vitro testing, the mouse Leydig cell line TM3 
which was originally isolated from the BALB/C mouse was selected for use (Mather, 
1980, Mather et al., 1982). The successful use of TM3 cells has been previously reported 
both in more general reproductive toxicity studies (Engeli et al., 2018, Yin et al., 2017), 
and in those using ENM (Komatsu et al., 2008, Talebi et al., 2013). TM3 cells are also 
complementary to the TM4 Sertoli cell line, having been isolated at same age and using 
the same methodology, thus presenting potential for investigation of more complex in 
vitro models through co-culture work. TM3 was therefore considered a good choice as 
an initial cell line representative of the Leydig cell.  
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Objectives  
 
The objective of this chapter was to identify whether a key cell found within the testes, 
the Leydig cell, would be adversely affected following ENM exposure, with the aim of 
developing a reliable in vitro initial hazard screen test. The toxicity tests will determine 
an LC50 (intermediate concentration for a 50% reduction in viability) in a Leydig cell line 
(TM3) following exposure to a range of ENM doses and exposure times, in order to guide 
development of further research to determine whether ENM alter normal cell function 
when at sub-lethal doses. To ascertain the impact of ENM physico-chemical properties 
the cells were exposed to a panel of ENM, with varying properties, to help identify 
potential commonality or differences in cell response.  
 
The research questions to be addressed were therefore:  
1) Using a basic assay for cytotoxicity, which ENM from a pre-established panel (if 
any) have adverse effects on TM3 cell viability?  
2) For those ENM found to affect viability, can a timecourse assay using Alamar Blue 
help to establish the effect of time- and dose- on toxicity? 
3) Through analysis of the results, is it possible to identify a sub-lethal 
concentration range and recommended exposure time for future investigation 
into the functional effects of ENM on TM3 cells?  
4) Taking into account prior reports of ENM interference with assays in vitro, are 
the WST-1 and Alamar Blue assays suitable to assess cytotoxicity to TM3 Leydig 
cells from ENM? 
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Materials and Methods 
 
The Nanomaterial Panel and its preparation 
The panel of ENMs selected for analysis, methods for their handling, dispersion and 
preparation of serial dilutions are described in Chapter 2.  
Expression of dose for in vitro work 
Expression of dose in nanotoxicology presents a complex problem. Basic pharmalogical 
principles dictate that response is proportional to the concentration of the affecter at 
its site of action. Historically, dose was therefore expressed in terms of mass per volume 
of diluent prepared (e.g. µg/µl). However, this makes the assumption that any material 
prepared for testing in suspension has clearly defined physico-chemical properties that 
remain unchanged during the dosing process. In reality however, it has been shown that 
the moment ENM make contact with any biological media, they become altered, for 
example via agglomeration, aggregation or the formation of protein coronae (Lundqvist 
et al., 2008, Lynch and Dawson, 2008, Bouwmeester et al., 2011). It also fails to take into 
account the difference between dose administered, and the dose which reaches the site 
of action (in this case cell monolayer surface). Dosimetry for nanoparticles can be 
affected by numerous factors, including shape, size, density, agglomeration, surface 
charge (zeta potential), as well as media properties such as density and viscosity, and 
other factors including gravitational settling from suspension or surface area of the test 
environment (Teeguarden et al., 2007).  
In order to allow for the fact that in vitro testing was undertaken on a cellular monolayer 
within a fixed area, it is important as a bare minimum to take into account surface area. 
Therefore, although dose preparations were calculated in µg/ml, the final results are 
represented as µg/cm2, as this provides a more realistic representation of the dose of 
ENM which is in contact with the surface area of the cells within a 2-D model. Table 8 
outlines the conversion between the two dose modalities for the range of doses applied 
to cells.  
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Table 8: Dose conversions between µg/ml and µg/cm2 used for cytotoxicity studies 
Initial Dose range, 96 well plate: 
µg/ml 0.125 1.25 12.5 25 50 100 200 
µg/cm2 0.037 0.37 3.76 7.53 15.06 30.12 60.24 
Low Dose Range, 96 well plate: 
µg/ml 0.075 0.75 1.5 3 6 12  
µg/cm2 0.023 0.23 0.47 0.94 1.875 3.75  
 
Selection and establishment of optimal growth conditions for the TM3 Leydig cell line  
The TM3 mouse Leydig cell line (ATCC CRL-1714Ô) was successfully cultured within a 
sterile environment using Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 
Ham 500ml with L-glutamine, 15mM HEPES, and sodium bicarbonate (DMEM), together 
with 10% foetal bovine serum (GibcoÒ FBS) and penicillin/streptomycin. Quality 
assurance work was undertaken to ensure a good working knowledge of both TM3 and 
TM4 cell lines.  
As these cells are semi-immortalised, they do not behave exactly as a fully immortalised 
cell line and have required some additional time within the project to determine and 
implement optimum growth parameters (Fulton and Hutchison, 2012). Because of this, 
all work undertaken within this research was controlled for passage number (passage 3-
9) and replicated at least 5 times to ensure statistical power in calculating results. 
Normal behaviour in culture and doubling time, together with determination of 
optimum seeding density within assay plates was investigated. Cells were seeded into 
T25 culture flask (with a 25cm2 growth area) at a density of 1x106 cells/10mls media, 
and counts taken daily over 4 days in order to calculate their doubling time (Fig. 7). 
Viable cells were identified via Trypan Blue or Nigrosin exclusion, and cell counts 
undertaken using a Haemocytometer (Neubauer counting chamber). Throughout each 
count, % viability remained high (>96%), and by day 4, 7.52x106 cells were counted. 
Doubling time was calculated using the following equation:  
!"#$%&'(	*&+, = Duration	x	log(2)log(<&'=%	>"'>,'?@=?&"') − log	(&'&?&=%	>"'>,'?@=?&"') 
Doubling time for TM3 cells between passage 3 and 9 was calculated to be 32.96 hours.  
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Figure 7: Doubling time of TM3 cells, seeded in a T25 flask at a density 1x106 cells in 10mls media. n=1. Viable cells identified via 
Trypan Blue exclusion; counts undertaken with Neubauer counting chamber. 
 
Control for hormone interference in assays in vitro 
Charcoal stripping of FBS is used routinely for cell culture in endocrine studies, and 
involves its absorption with activated carbon, with the aim of minimising non-polar 
material such as lipophilic (lipid-related) materials (virus, certain growth factors, 
hormones and cytokines) regardless of molecular weight but has little effect on salts, 
glucose, amino acids, etc. without nonspecific loss of other serum components 
(ThermoFisher-Scientific, 2019a). 
To ensure that cell growth and viability were not affected by use of charcoal stripped 
serum, a comparison of growth and assay performance of TM3 cells using both standard 
FBS and charcoal stripped FBS (c/s FBS) at two concentrations within medium (5% and 
10%) was undertaken. Addition of 10% c/s FBS led to slower doubling times in TM3 cells, 
but addition of 5% c/s FBS resulted in no change in cell growth or behaviour (data not 
shown). Addition of Charcoal stripped FBS at 5% (GibcoÒ One ShotÔ charcoal stripped 
Foetal Bovine Serum, USDA Approved) was therefore selected for use with the TM3 cell 
line in all investigations.   
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Cytotoxicity Assessment 
 
WST-1 assay  
The WST-1 assay is a colourimetric assay, used to measure the activity of cellular 
enzymes in reducing the soluble tetrazolium dye WST-1 (4-[3-(4-Iodophenyl)-2-(4-nitro- 
phenyl)-2H-5-tetrazolio]-1,3-benzene disulphonate) to insoluble formazan (Fig. 8). This 
bioreduction is undertaken by oxidoreductase enzymes in the cytosol of cells, 
dependent on glycolytic NADPH production by mitochondria. Reduction of WST-1 
therefore increases with cellular metabolic activity, due the elevation of NADPH, thus, 
formazan production directly correlates to the number of metabolically active cells in 
the culture, measured by a scanning multiwell spectrophotometer (ELISA reader).  
 
Figure 8: The reduction of the tetrazolium salt WST-1 to insoluble Formazan in metabolically active cells. EC=electron coupling 
agent, RS=mitochondrial succinate-tetrazolium-reductase system. From (Roche, 2011).  
Initially, experiments to identify the optimal seeding density for TM3 cells to give the 2 
days of growth in wells required to undertake the assay, without cells becoming over-
confluent were undertaken. This was important for TM3 cells, as over confluence leads 
to cell growth up around the edges of the plate, creating an almost ‘pancake-like’ folding 
of the cell monolayer which would interfere with absorbance readings. TM3 Leydig cells 
were seeded in a 96 well plate at a density of 5x104 cells/well and allowed to incubate 
for 24h, until a confluent cellular monolayer had formed. ENM stock solutions were 
prepared to a stock concentration of 2mg/ml and sonicated to assist dispersion, 
described in detail within Chapter 2. Working solutions were diluted to an equivalent 
on-plate dose of 60.2μg/cm2 from which serial dilutions were prepared down to 
0.037μg/cm2. Cells were exposed to ENM for a period of 24hrs according to the plate 
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plan in Appendix. 2. This allowed for every cell treatment to be made in triplicate, except 
the ‘no cells’ controls which were in duplicate.  
After the incubation period, the old medium was discarded from the wells which were 
then rinsed with fresh medium before adding further media to a final volume of 100μl 
per well. 10μl of WST-1, cell proliferation reagent, was then added to each well and the 
96 well plate incubated again for 2 hours at 37°C in a 5% CO2 atmosphere. Following 
incubation, cell viability was estimated by measuring absorbance on a plate reader at 
450nm. In total, a minimum of 5 replicates of the assay were carried out for each ENM.  
The experimental design built in a number of controls, which are outlined below and 
noted on relevant wells of Appendix 2 in superscript:  
1. Cells in medium without ENM + WST-1: negative control to show endogenous 
levels of WST-1 reduction from cells. 
2. Cells + Triton X-100 + WST-1: positive control for loss of viability with no ENM 
Exposure. 
3. Medium without cells + WST-1: negative control to ensure media does not 
interfere in the assay. 
4. Nanoparticles in medium without cells + WST1: control to identify any 
interference with/inhibition of the assay from ENM.  
5. Cells + Triton X-100 + ENM + WST-1: positive control for loss of viability following 
ENM Exposure. 
6. Cells + nanoparticles +NO WST-1: negative control to show that ENM do not 
interfere in the assay. 
 
Alamar Blue (AB) Assay 
In addition to assessing cell viability using the WST-1 assay, the Alamar Blue assay was 
also used during exposure over a 24-hour timecourse. This used the same experimental 
and control setup as outlined for WST-1 to ensure that the source of any assay 
interference was identifiable. In this assay, viable cells reduce the non-fluorescent, 
membrane permeable blue compound Alamar Blue (resazurin) into a fluorescent pink 
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dye (resorufin), which is extruded into the medium. Alamar Blue (AB) is stable and water 
soluble so can be used for timecourse assays such as this. Successful reduction takes 
place only in metabolically active cells; thus fluorescence provides an indication of cell 
metabolic viability.  
There is an overlap between the absorbance spectra of resazurin and resorufin. If test 
wells are fully reacted and there is no oxidised substrate present, then determination of 
the amount of reduced AB is Absorbance570nm – Absorbance600nm. However, during a 
time course assay this is not often the case, especially at earlier time points, and so using 
this calculation alone leads to generation of negative absorbance readings. Thus, to 
correct for the contribution of oxidised substrate, the following procedure was used to 
derive the amount of reduced AB at the prescribed reading filter (570nm): 
1. Subtract absorbance of media only from AB in media to give Absorbance at the 
lower wavelength of 570nm (AOLW) and the higher wavelength of 600nm (AOHW)   
2. Use these values to calculate a correction factor (R0): 
R0 = AOLW / AOHW 
3. The % reduced AB is then given by:  
ARLW = ALW – (AHW x RO) x 100 
Thus, the following equation provides a corrected value for % difference in reduction:  
 
The Alamar Blue assay was carried out in triplicate for ENMs identified as being of 
interest – i.e. those with positive results for cytotoxicity – NM-110 and 111 (ZnO), NM-
300 (Ag), and NM-101 (TiO2) as a reference material. Silver dispersant (NM-300DIS) was 
also examined in a single experiment as a cross check for interference or reactivity of 
the dispersant with AB.  
Preparation of cells and dispersion of ENMs followed the same initial protocol as for 
cells exposed to ENM and then assessed using WST-1. At the time of exposure to ENMs, 
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Alamar blue was added to each well and fluorescence was then measured at 570nm 
using a plate reader at 2, 4, 6 and 24 hours in order to track changes in viability 
(reference absorbance 600nm). Plates were maintained in an incubator between 
readings. The values of viability were corrected using the equation above, as well as 
against endogenous (blank) expression.  
In order to provide a direct comparison to results from the WST-1 assay, a full dose 
response was conducted using the original dose range (0.037-60.24µg/cm2). A second 
lower dose range of 0.023-3.75µg/cm2 was then investigated to identify sub-lethal 
concentrations that could be used for further assessment of cell impacts at non-lethal 
doses. 
 
Statistical Analysis  
Absorbance readings for both tests were initially processed using Microsoft Excel. As 
pilot data confirmed that some of the ENM interfered with absorbance in the assay, 
following input of raw data, all readings were corrected by subtracting absorbance of 
the ENM control wells (containing nanoparticles + WST-1) from the test wells 
(containing nanoparticles + cells + WST-1). Mean absorbance and standard deviation 
were calculated, and results were expressed as a % viability relative to untreated 
(endogenous) control cells.  
Results were then imported to Graphpad Prism v7.0, and the data analysed using 
descriptive statistics, together with a Shapiro-Wilk test for normality (selected due to 
the lower experimental replicate number). To deduce whether treatment led to 
significant changes in cellular viability relative to untreated control, a one-way analysis 
of variance (ANOVA) was conducted, with a post-hoc Tukey or Dunnett’s multiple 
comparison test to provide comparison between individual doses of ENM, and ENM 
doses and control; P<0.05 *, P< 0.01 ** P<0.001 ***. For comparisons with more than 
one contributing factor (e.g. charcoal stripped medium vs standard FBS, and nano-silver 
vs ionic silver) a 2-way ANOVA was used, with a post-hoc Dunnett’s test for multiple 
comparisons between treatments and control.   
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Data was plotted as box and whiskers and scatter plots, to show the range in readings 
and identify where there was high variation. Where a potential dose-response 
relationship was identified, further analysis was undertaken using non-linear 
log(inhibitor) vs. response (three parameter) curve. The data output was tested for 
normality using both the D’Agostino-Pearson omnibus normality test and the Shapiro-
Wilk normality test, residuals were plotted, and outliers counted using the ROUT 
coefficient.   
Results 
 
Comparison of cell viability in Charcoal-stripped and Standard FBS  
Before carrying out cytotoxicity testing for all ENM, a comparison of viability between 
cells cultured in normal FBS and those cultured in charcoal stripped FBS was undertaken, 
by exposing cells to uncoated and coated ZnO (M110 and 111) at doses from 0.037-
60.24µg/cm2 (n=3). Exposure to both ENM resulted in a clear dose-dependent toxicity, 
with no apparent difference in result between the two serum types, despite some 
variability around the point at which cells appeared to be losing viability (Fig. 9).  
 
Figure 9: Comparison for serum type – standard FBS vs Charcoal Stripped FBS. Viability of cells following 24h exposure to Zinc 
Oxide (NM-110 & 111) using the WST-1 cytotoxicity assay. All values corrected for WST-1 interference with assay. Doses from 
0.037-60.24µg/cm2. N=3. 
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To confirm that serum type did not influence cellular response to a toxic challenge, a 2-
way ANOVA was undertaken. The results of this confirmed that serum type had no effect 
on result (n/s) whereas dose effect was significant (**** p<0.0001) for NM-110. Cells 
exposed to NM-111 also showed a significant reduction in viability compared to dose 
(**** p<0.0001). In this case, ANOVA also suggested influence of media on viability 
(P=0.0015**). However, this was due to wide variation around the onset of cellular 
toxicity (0.37 and 3.76ug/cm2), which skewed the data and led to significance in the 
findings. In support of this, when a 2-way ANOVA was repeated excluding these doses, 
any significance associated with serum type was nullified, while dose effect remained 
significant (p<0.0001****). As a result, all future cell culture work was undertaken using 
5% c/s FBS, selected as being optimal for cell culture.   
Toxicological assessment of ENM Panel: cell proliferation assays 
Assay Interference Testing  
Examination of the controls outlined within the materials & methods section revealed 
the control wells (WST-1 & media) showed a marginal interference in absorbance 
reading caused by the dye; all results were therefore corrected for WST-1. For silver 
(NM-300, NM-300dis and AgNO3), marginal interference from the ENM was also 
identified. To ensure this did not skew the results, an additional correction for silver 
particles was made for these materials.  
Titanium Dioxide (NM-101, 103 & 104) 
Fig. 10 shows the cytotoxicity assessment of TM3 cells exposed to three forms of 
titanium dioxide, NM-101 (anatase), NM-103 (hydrophilic) and NM-104 (hydrophobic) 
(n=6) across a range of doses from 0.037μg/cm2 to 60.24μg/cm2. These are expressed 
as % cell viability relative to that in a healthy endogenous control (also reported as box 
and whiskers plots in Fig. 11).  
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Figure 10: Viability of TM3 cells exposed to Titanium dioxide ENM: NM-101, 103 & 104 for 24h assessed using the WST-1 
cytotoxicity assay (n=5). Viability expressed as % relative to untreated (endogenous) control. Doses 0.037-60.24µg/cm2. All values 
corrected for WST-1 interference with assay. 
 
 
 
 
Figure 11: Box and Whiskers representation of viability of TM3 cells cultured in charcoal stripped serum, following 24h exposure to 
Titanium Dioxide (NM-101, NM-103 and NM-104) using the WST-1 cytotoxicity assay (n=6). Doses 0.037-60.24µg/cm2. All values 
corrected for WST-1 interference with assay. Dose 0 is untreated (negative) control. Where a statistically significant loss in viability 
of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** 
p=0.0001). 
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For NM-101, very little change in viability of cells was observed across the dose range, 
although the standard deviation on some doses was high. Statistical analysis of the 
results by ANOVA showed there was no significant difference between the readings 
(P>0.05).  
For NM-103, little change in viability of cells was observed from 0.037-60.24μg/cm2, 
however at 60.24μg/cm2 mean viability decreased to 73%. Statistical analysis of the 
results showed that this decrease in viability was not statistically significant (P >0.05). 
Cells exposed to NM-104, showed little notable alteration in viability across the range 
of doses tested, albeit there was some variance in the results at higher doses reported. 
ANOVA confirmed no significant effect on viability with nanomaterial dose (P>0.05). 
 
Zinc Oxide (NM-110, 111 & ionic control)  
The cytotoxicity assessment conducted in parallel for the uncoated (NM-110) and 
coated (NM-111) forms of ZnO, together with ionic ZnSO4 as a control material is 
summarised in Figures 12 & 13.  
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Figure 12: Viability of cells cultured in charcoal stripped serum, following 24h exposure to Zinc Oxide (NM-110 & 111) or zinc ions (ZnSO4), 
assessed using the WST-1 cytotoxicity assay. Viability expressed as % relative to untreated (endogenous) control. Doses from 0.037-
60.24µg/cm2. N=5 for NM-110 & NM-111, N=3 for ZnSO4. All values corrected for WST-1 interference with assay. 
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Figure 13: Box and Whiskers representation of viability of TM3 cells cultured in charcoal stripped serum, following 24h exposure to 
Zinc ENM and ionic Zinc (NM-110, NM-111 and ZnSO4) using the WST-1 cytotoxicity assay (n=6). Doses 0.037-60.24µg/cm2. All 
values corrected for WST-1 interference with assay. Dose 0 is untreated (negative) control. All values corrected for WST-1 
interference with assay. N=5 for NM-110 & NM-111, N=3 for ZnSO4. . Where a statistically significant loss in viability of cells was 
identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001). 
The results show a clear dose-response toxicity, cell viability decreasing with increasing 
dose for both ENMs and ZnSO4 ions. To further understand the nature of the dose-
response observed, a non-linear curve was fitted to the results of NM-110 and NM-111 
cell exposures in order to identify the nature of the relationship and understand the 
influence of potential outliers in the data. Figure 14 shows the raw data fitted to a 
log(inhibitor) vs. response (three parameter) curve.  
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Figure 14: Non-linear curve showing toxicity of NM-110 to TM3 cells. Doses 0.037-60.24µg/cm2. N=5. The data output was tested 
for normality using both the D’Agostino-Pearson omnibus normality test and the Shapiro-Wilk normality test, residuals plotted, 
and outliers counted using the ROUT coefficient. Outliers identified are highlighted in red. The LC50 value was identified to be 
3.813µg/cm2. 
Results of the curve fit for NM-110 gave an R2 value of 0.8197 and revealed that the data 
did not appear to be normally distributed (p=0.0020** D’agostino-Pearson, 
p<0.0001**** Shapiro-Wilk). ROUT analysis identified key outliers within the 3.76 and 
7.53μg/cm2 doses, where the greatest variation was reported for this ENM (shown in 
red within Fig. 14). To further characterise the dose-response curve, the doses with high 
variation were removed and the data re-plotted to test whether the outliers were 
responsible for the lack of normality in distribution found via the D’Agostino-Pearson 
test. Results of this curve fit showed a much-improved fit (R2= 0.9843), found that the 
data was normally distributed without inclusion of outliers, and that there were no 
further outliers in the data. From this regression, it was possible to calculate an LC50 
value (concentration at which 50% of viability is lost) of 3.813μg/cm2. 
Results of the curve fit for NM-111 showed an R2 value of 0.9662, that the data was 
normally distributed (n/s D’agostino-Pearson and Shapiro-Wilk), and ROUT analysis did 
not identify any outliers. The LC50 value reported was 6.052μg/cm2 (Fig. 15).  
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Figure 15: Non-linear curve showing toxicity of NM-111 to TM3 cells. Doses 0.037-60.24µg/cm2. N=5. The data output was tested 
for normality using both the D’Agostino-Pearson omnibus normality test and the Shapiro-Wilk normality test, residuals were 
plotted, and outliers counted using the ROUT coefficient.  Outliers are highlighted in red where present. The LC50 value was 
identified to be 6.052µg/cm2. 
Significance of the dose-response toxicity was confirmed by one-way ANOVA, which 
showed a significant effect for NM-110 (p<0.001***), NM-111 (P<0.0001****) and 
ZnSO4 (P=0.003***). Dunnett’s multiple comparisons showed that this effect was 
significant from 3.76µg/cm2 for both NM-110 (p<0.001***), 7.53µg/cm2 for NM-111 
(p<0.0001****) and ZnSO4 (p<0.005** increasing to p<0.0001**** from 7.53ug/cm2).  
Cells exposed to NM-110 showed a high degree of variance in % viability between assay 
replicates at 3.76μg/cm2 (Fig 13), the dose level at which a significant onset of toxicity 
was observed. In this case, the variation in response was so great that the effect of ENM 
exposure on viability was not statistically significant at any dose under 7.53μg/cm2 
(P<0.01**). Cells exposed to NM-111 also recorded wide variation in % viability between 
replicates at 0.37μg/cm2. ANOVA confirmed a significant reduction in viability compared 
to control from 3.76μg/cm2 (P<0.0001****). Data collected from ionic zinc (ZnSO4) 
exposures revealed a similar dose response correlation with decreased cell viability with 
cells exposed NM-110 and 111, with a clear dose-dependent decrease in cell viability 
from 3.76μg/cm2 upwards. A two-way ANOVA comparing NM-110 NM-111 and ZnSO4 
was undertaken to confirm results; this found no significant interaction between 
0.01 0.1 1 10 100
0
50
100
150
Dose (µg/cm2)
%
 V
ia
bi
lit
y 
re
la
tiv
e 
to
 c
on
tro
l
Bryony L Ross PhD 105 
treatments, but that viability was altered significantly with increasing dose 
(p<0.0001****).  
Silica Dioxide (NM 200 & 203) 
Cytotoxicity assessments for two forms of silica dioxide (NM-200 and NM-203) are 
shown in Figures 16 and 17.  
 
Figure 16: Viability of cells cultured in charcoal stripped serum, following 24h exposure to silica dioxide (NM-200 & 203), assessed 
using the WST-1 cytotoxicity assay (n=6). Viability expressed as % relative to untreated (endogenous) control. Doses from 0.037-
60.24µg/cm2. All values corrected for WST-1 interference with assay. 
The results indicate that there appears to be little effect on cell viability from NM-200, 
but NM-203 shows a decrease in cell viability at highest doses (Fig. 16). Little variation 
between replicates was observed, especially in comparison to other ENM tested. 
Statistical analysis confirmed that for NM-200 there was a small but statistically 
significant change in viability with increasing dose (p=0.0223*), which Dunnett’s 
multiple comparisons confirmed was significant from 0.37μg/cm2 (p<0.05*). This was 
likely due to the fact that there was very little variation across replicates, as shown in 
Fig. 17.  
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Figure 17: Box and Whiskers representation of viability of TM3 cells cultured in charcoal stripped serum, following 24h exposure to 
silica dioxide ENM (NM-200 & 203) using the WST-1 cytotoxicity assay (n=6). Doses 0.037-60.24µg/cm2. Dose 0 is untreated 
(negative) control. All values corrected for WST-1 interference with assay. Where a statistically significant loss in viability of cells 
was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001). 
 
The observed decrease in viability at the higher doses in cells exposed to NM-203 was 
found to be significant (P<0.001***), and multiple comparison analysis revealed that 
this effect became significant at a dose of 3.76μg/cm2 (p<0.05*).  
Silver, Silver Dispersant and Silver ions (NM-300, 300Dis and AgNO3) 
Cytotoxicity assessment was next undertaken for colloidal silver nanoparticles (NM-300) 
and a silver ionic control (AgNO3). As silver was the only ENM provided in suspension as 
a colloid, its dispersant (NM-300dis) was also provided for testing to ensure that any 
effect observed following NM-300 exposure was independent of its dispersant. As 
previously outlined, all results displayed were corrected for WST-1 interference. In this 
case, results were also corrected for ENM, as the ENM control wells (ENM + WST-1) 
showed a marginal interference in absorbance reading. The results are summarised in 
Figs. 18 and 19. 
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Figure 18: Viability of cells cultured in charcoal stripped serum, following 24h exposure to Silver, Silver Dispersant and ionic Silver 
(NM-300, NM-300DIS and AgNO3), assessed using the WST-1 cytotoxicity assay (n=6). Viability expressed as % relative to 
untreated (endogenous) control. Doses from 0.037-60.24µg/cm2. All values corrected for ENM and WST-1 interference with assay. 
  
 
 
Figure 19: Box and Whiskers representation of viability of TM3 cells cultured in charcoal stripped serum, following 24h exposure to 
Silver (NM-300), Silver dispersant (NM-300Dis) and ionic Silver (AgNO3) using the WST-1 cytotoxicity assay (n=6). Doses 0.037-
60.24µg/cm2. All values corrected for ENM and WST-1interference with assay. Dose 0 is untreated (negative) control. All values 
corrected for WST-1 interference with assay. Where a statistically significant loss in viability of cells was identified compared to 
control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001). 
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 There was clear dose-response effect of silver ENM and ion exposure on TM3 cell 
viability, but no effect on viability from silver dispersant. To further understand the 
nature of the dose-response observed and the influence of potential outliers on the 
data, a non-linear (log(inhibitor) vs. response (three parameter)) curve was fitted to the 
results of NM-300 (Fig. 20).  
The curve fit for NM-300 gave an R2 value of 0.7826 and reported that the data did not 
appear to be normally distributed (n/s D’agostino-Pearson, p=0021** Shapiro-Wilk). 
ROUT analysis identified key outliers within the 3.76 and 7.53μg/cm2 doses, where the 
greatest variation was reported for this NM (shown in red within Fig. 20). To further 
characterise the dose-response curve, the 2 doses with high variation were removed 
and the data re-plotted. Results of this curve fit showed a much-improved curve fit (R2 
= 0.9802), normal distribution of the data and identified no further outliers. The 
regression gave an LC50 value of 7.885μg/cm2 for NM-300. 
Figure 20: Non-linear curve showing toxicity of NM-300 to TM3 cells. Doses 0.037-60.24µg/cm2. N=6. The data output was tested 
for normality using both the D’Agostino-Pearson omnibus normality test and the Shapiro-Wilk normality test, residuals were 
plotted, and outliers counted using the ROUT coefficient.  Outliers are highlighted in red. The LC50 value was identified to be 
7.885μg/cm2. 
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 Results of the curve fit for AgNO3 showed an R2 value of 0.9398, and that the data was 
not normally distributed (n/s D’agostino-Pearson, p=0.0433* Shapiro-Wilk). ROUT 
analysis identified one outlier value at the 0.370µg/cm2 dose (Fig. 21). To further 
characterise the dose-response curve, the doses with high variation were removed and 
the data re-plotted. Results of this curve fit revealed an improved R2 value of 0.9802, 
and that there were no further outliers in the data. Regression analysis produced an LC50 
value of 0.282μg/cm2 for AgNO3.  
Toxicity of NM-300 and AgNO3 was confirmed by one-way ANOVA, which showed a 
significant effect for NM-300 (p<0.001***) and AgNO3 (p=0.0055**). For NM-300, 
results show a high degree of variance between replicates of the assay at 3.76µg/cm2 
and 7.53µg/cm2, the dose around which a significant drop in viability was observed (Fig. 
19). As such, toxicity was not statistically significant until 15.06µg/cm2 (P<0.001***). 
The linear regression confirmed an LC50 value of 7.85µg/cm2.  
ANOVA of NM-300Dis also showed significance in viability changes across the dose 
range (p=0.027*). A Dunnett’s multiple comparison test suggested that there was 
significant change in viability following exposure for doses in the middle of the range of 
exposures (3.76 and 15.06µg/cm2, P<0.05*).  
Figure 21: Non-linear curve showing toxicity of AgNO3 to TM3 cells. Doses 0.037-60.24µg/cm2. N=6. The data output was tested 
for normality using both the D’Agostino-Pearson omnibus normality test and the Shapiro-Wilk normality test, residuals were 
plotted, and outliers counted using the ROUT coefficient.  Outliers are highlighted in red. The LC50 value was identified to be 
6.052µg/cm2.   
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For ionic silver (AgNO3), significance in dose-response toxicity established by one-way 
ANOVA (p=0.055**). Multiple comparisons confirmed that this change was significant 
from 3.76µg/cm2.  
 
WST-1 Analysis – Carbon Nanotubes (NM-400, 401 and 403) 
Cytotoxicity appraisal for three CNT of varying length and diameter (NM-400, 401 and 
403) is summarised in Fig. 22 and 23.  
 
Figure 22: Viability of cells cultured in charcoal stripped serum, following 24h exposure to carbon nanotubes (NM-400, 401 & 403), 
assessed using the WST-1 cytotoxicity assay (n=3). Viability expressed as % relative to untreated (endogenous) control. Doses from 
0.037-60.24µg/cm2. All values corrected for WST-1 interference with assay. 
 
Initial appraisal of the graphed results shows limited change in TM3 cell viability 
following exposure to CNTs, except perhaps at the higher doses applied. One-way 
ANOVA indicated no significant change in viability for NM 400 and NM-401. However, a 
significant effect on viability was identified following exposure to NM-403 (p=0.0443*). 
Further investigation confirmed there was no paired change in NM-400 or NM-401 and 
showed that significant differences were observed between untreated and 0.037µg/cm2 
in NM-403 (P=0.0093**).  
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Figure 23: Box and Whiskers representation of viability of TM3 cells cultured in charcoal stripped serum, following 24h exposure to 
Carbon Nanotubes (NM-400, NM-401 & NM-403) using the WST-1 cytotoxicity assay (n=3). Doses 0.037-60.24µg/cm2. All values 
corrected for WST-1 and interference with assay. Dose 0 is untreated (negative) control. Where a statistically significant loss in 
viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** 
p=0.0001). 
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WST-1 Analysis – Pristine Copper Oxide Nanotubes (CuO) 
Cytotoxicity assessment following exposure of TM3 cells to pristine copper oxide ENM 
is shown in Fig. 24. 
 
Figure 24: Box and Whiskers representation of viability of TM3 cells cultured in charcoal stripped serum, following 24h exposure to 
pristine copper oxide using the WST-1 cytotoxicity assay (n=3). Doses 0.037-60.24µg/cm2. All values corrected for WST-1 
interference with assay. Dose 0 is untreated (negative) control. Where a statistically significant loss in viability of cells was 
identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001). 
 
Exposure to CuO resulted in dose-response toxicity, with viability decreasing as dose 
increased. One-way ANOVA confirmed significance of this change (p=0.0150*), and 
Dunnett’s multiple comparison confirmed showed that significant differences between 
untreated and 0.037, 30.12 and 60.24µg/cm2 in NM-400. To further investigate the 
nature of this dose-response relationship, a non-linear curve was fitted to the results. 
Figure 25 shows the raw data fitted to a log(inhibitor) vs. response (three parameter) 
curve. The R2 value of the line was 0.8591, with data reporting as normal in both tests 
undertaken, and no outliers identified. This allowed identification of an LC50 value of 
7.752µg/cm2 for pristine CuO. 
0
0.0
37 0.3
7
3.7
6
7.5
3
15
.06
30
.12
60
.24
0
20
40
60
80
100
120
Dose (µg/cm2)
%
 V
ia
bi
lit
y 
re
la
tiv
e 
to
 c
on
tro
l
CuO
*
*** **
Bryony L Ross PhD 113 
 
Figure 25: Non-linear curve showing toxicity of pristine CuO to TM3 cells. Doses 0.037-60.24µg/cm2. N=3. The data output was 
tested for normality using both the D’Agostino-Pearson omnibus normality test and the Shapiro-Wilk normality test, residuals 
were plotted, and outliers counted using the ROUT coefficient.  Outliers are highlighted in red. The LC50 value was identified to be 
7.752μg/cm2.  
 
Time Course Appraisal of Cytotoxicity 
Following identification of nanomaterials that had a negative impact on cell viability and 
associated LC50 values, it was appropriate to identify the impact of time on this response. 
Timecourse studies were undertaken for ENM of interest, namely titanium dioxide NM-
101 (used as a control as WST-1 revealed no toxicity following exposure), both uncoated 
(NM-110) and coated (NM-111) zinc oxide, and silver (NM-300).  
The study was conducted using the standard dose range (0.037μg/cm2 to 60.24μg/cm2) 
and a lower dose range (0.023 – 3.75μg/cm2) informed by the results of cytotoxicity 
evaluation using the WST-1 assay, with the aim of identifying sub-lethal doses which 
could be used to guide analysis of functional changes within the cells following ENM 
exposure. 
All results underwent a correction for interference from ENM, as it was noted from ‘no 
ENM’ controls in initial assays that ENM appeared to interfere marginally in readings. It 
was also noted that for all ENM tested, there were seemingly erroneous readings and 
huge variance in results at t=24h, leading to questions around suitability of this 
timepoint for measurement of viability using the Alamar Blue assay.    
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TM3 Timecourse study - Titanium Dioxide (NM-101): High dose range  
Following NM-101 treatment, analysis shows a dose- and time- response dependent 
effect on viability (Fig. 26). At 24h the variation in results is large and shows a decrease 
in toxicity at higher doses compared to earlier timepoints. As the results at the 24hour 
timepoint were such a departure from the pattern observable through the other times, 
the ANOVA was repeated without the 24hr time data. This showed time (p=0.0065**) 
and dose (p<0.0001****) were still significant.  
 
       
      
Figure 26: Timecourse assay following exposure to TiO2 (NM-101) at the high dose range 0.037μg/cm2 to 60.24μg/cm2 in the 
presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Where a statistically significant loss in 
viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** 
p=0.0001). 
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TM3 Timecourse study - Titanium Dioxide (NM-101): Low dose range  
At the low dose range of 0.023 – 3.75μg/cm2, NM-101 had little effect on the viability of 
cells except at the highest doses (Fig 27). Statistical analysis indicates that while there 
was no change in response with time, there was a significant effect from dose 
(p=0.014**) on cells’ ability to reduce Alamar blue. However, a Dunnett’s test did not 
show any significant departure from control in any of the treatments at any timepoint, 
therefore it is likely that the findings of the ANOVA are influenced by the huge variance 
in readings at higher doses, which could quite easily skew results given ANOVA is based 
on the assumption of equal variance within all samples.  Interestingly at the 24-hour 
measurement, higher doses of NM-101 seem to increase cell ability to reduce Alamar 
blue, before dropping off sharply at the highest dose. 
 
      
      
Figure 27: Timecourse assay following exposure to TiO2 (NM-101) at the low dose range 0.037μg/cm2 to 60.24μg/cm2 in the 
presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Where a statistically significant loss in 
viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** 
p=0.0001). 
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TM3 Timecourse study – Zinc Oxide (NM-110): High dose range  
For NM-110, a decrease in viability with increasing dose was present, which appeared 
to increase with time (Fig. 28). A clear reduction in viability of cells appears at a low dose 
(3.76μg/cm2) for 2h, 4h and 6h timepoints. Again, at 24h the variation in results is such 
that it is difficult to identify a clear pattern at first examination. 2-way ANOVA of the 
results revealed no interaction between time and dose, but was significant for time and 
dose effects individually (p<0.0001****). As previously, removal of the 24h timepoint 
from the analysis altered the outcome considerably, this time showing no significant 
effect of time on the result, but a significant decrease in cells’ ability to reduce AB with 
increasing dose (P<0.0001****). Multiple comparisons showed no significant difference 
between data compared to control for the 2h timepoint, however at 4h and 6h the 
highest dose was found to be significantly different to control (p<0.001*** and 
p<0.01** respectively).  
   
   
Figure 28: Timecourse assay following exposure to uncoated ZnO (NM-110) at the high dose range 0.037μg/cm2 to 60.24μg/cm2 in 
the presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Where a statistically significant loss 
in viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & 
**** p=0.0001). 
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TM3 Timecourse study - Zinc Oxide (NM-110): Low dose range  
At the lower dose range, NM-110 treated cells appeared to show a clear decrease in 
viability in cells exposed to doses of 1.875μg/cm2 and above at 2h, 4h and 6h timepoints, 
becoming more pronounced as time progressed (Fig. 29). As with previous tests, the 
results at 24hours show an apparent increase in cellular activity, followed by sharp 
decrease at the highest dose, but with such heavy variation it was not immediately clear 
if this was a meaningful response. 2-way ANOVA using all datasets gives a significant 
outcome for both dose (p=0.001**) and time (p=0.0002***). However, it was clear that 
the 24hour timepoint results were skewing the statistical analysis. This was confirmed 
by ANOVA, which reported a significant effect of dose on reduction of Alamar blue 
(p<0.0001****) but no effect of time on the outcome after removal of the 24h readings.  
   
   
Figure 29: Timecourse assay following exposure to uncoated ZnO (NM-110) at the low dose range 0.037μg/cm2 to 60.24μg/cm2 in 
the presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h.Note the adjusted Y axis on (D) to 
incorporate increased variability in readings. Where a statistically significant loss in viability of cells was identified compared to 
control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001).  
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TM3 Timecourse study - Zinc Oxide (NM-111): High dose range  
NM-111 showed a dose-response toxicity over the high dose range, with loss of cell 
viability >3.76μg/cm2 at t2h, t4h and t6h timepoints (Fig. 30). Again, at t24h the variation 
in results makes it difficult to interpret the outcome. 2-way ANOVA showed no 
interaction between time and dose on the result, but gave a significant outcome for 
effect of time and dose separately on the result (<=p<0.0001****). The 24hour 
timepoint appeared to be skewing the statistical analysis, and its removal revealed 
significance of time on ability of cells to reduce Alamar Blue (p=0.0218*) whilst 
maintaining significance in relation to dose effect (p<0.0001****).  For all timepoints, 
multiple comparisons showed a significant change in cells’ ability to reduce AB at doses 
of 3.76ug/cm2 and above, with assigned significance of p<0.001*** at 2hours, and 
p<0.0001**** at 4 and 6 hours.  
    
   
Figure 30: Timecourse assay following exposure to coated ZnO (NM-111) at the high dose range 0.037μg/cm2 to 60.24μg/cm2 in 
the presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Where a statistically significant loss 
in viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & 
**** p=0.0001).  
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TM3 Timecourse study - Zinc Oxide (NM-111): Low dose range  
At a low dose range, NM-111 treated cells showed a decrease in viability at doses of 
0.94μg/cm2 and above at 2, 4 & 6h readings, which seemed to become more marked as 
time progressed (Fig. 31). 2-way ANOVA of the full dataset reported a significant effect 
of time on results (p=0.0001***) but no significant effect of dose on the outcome. As 
with previous materials, large variance in results at the 24h timepoint appeared to be 
sufficient to skew statistical analysis. As the results at the three earlier timepoints 
appear to show a clear dose-response effect, the ANOVA was repeated without the 24h 
data, and this confirmed a significant effect of dose on outcome (p<0.0001****) but 
time-driven effect. Further examination of the data post-hoc using multiple comparisons 
showed that the effect of dose was significant from 1.875μg/cm2 at 2h (p=0.0231*), 
0.094μg/cm2 at 4h (p=0.0277*) and 1.875μg/cm2 at 6h (p<0.0001****).  
   
  
Figure 31: Timecourse assay following exposure to coated ZnO (NM-111) at the low dose range 0.037μg/cm2 to 60.24μg/cm2 in the 
presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Note the y axis scale on (D) is increased 
to incorporate variance in readings. Where a statistically significant loss in viability of cells was identified compared to control, 
asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001). 
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TM3 Timecourse study - Silver (NM-300): High dose range  
For NM-300, results show a wide range of viability with large variation and there is no 
observable pattern in the results (Fig 32). 2-way ANOVA confirmed that variance in the 
dataset meant that neither dose nor time had a significant effect on cells’ ability to 
reduce Alamar blue.  
 
  
  
Figure 32: Timecourse assay following exposure to silver (NM-300) at the high dose range 0.037μg/cm2 to 60.24μg/cm2 in the 
presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Where a statistically significant loss in 
viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** 
p=0.0001). 
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TM3 Timecourse study - Silver (NM-300): Low dose range  
At the low dose range, the NM-300 treated cells appear to show a slight increase in 
cellular reduction of Alamar blue followed by a decrease when compared to endogenous 
from 1.875μg/cm2 and above at the 2h timepoint (Fig 33). At 4h, this decrease appears 
to begin at a lower dose of 0.94μg/cm2. However, the 6h and 24h timepoints appear to 
show an initial increase in reduction of Alamar blue, followed by a decrease at the 
highest doses, albeit with large variance in data recorded around the mean. 2-way 
ANOVA of the full dataset showed a significant effect from both time (p=0.023**) and 
dose (p=0.0001***) on the results.  Multiple comparisons seem to show a significant 
dose response within only the mid doses of 2h and 4h readings (the highest readings).  
 
  
   
Figure 33: Timecourse assay following exposure to silver (NM-300) at the low dose range 0.037μg/cm2 to 60.24μg/cm2 in the 
presence of Alamar Blue (n=3). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Note the y axis scale on (C & D) is 
increased to incorporate variance in readings. Where a statistically significant loss in viability of cells was identified compared to 
control, asterisks depict level of significance (* p=0.05, ** p=0.01, *** p=0.001 & **** p=0.0001).  
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TM3 Timecourse study – Silver dispersant (NM-300dis): Control testing 
A single replicate AB assay was undertaken for NM-300dis (dispersant liquid only), to 
examine whether the dispersant could contribute to any observed toxicity. Appraisal of 
results indicates that dispersant alone had no effect on overall cell viability (Fig. 34). No 
statistical analysis was undertaken as this experiment was carried out as a single 
replicate.   
 
 
 
 
 
 
 
Figure 34: Timecourse assay following exposure to silver dispersant (NM-300dis)) at the high dose range 0.037μg/cm2 to 
60.24μg/cm2 in the presence of Alamar Blue (n=1). Timepoints represented: A = t2h, B = t4h, C = t6h, D = t24h. Where a 
statistically significant loss in viability of cells was identified compared to control, asterisks depict level of significance (* p=0.05, ** 
p=0.01, *** p=0.001 & **** p=0.0001). 
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Discussion 
 
To begin work toward developing suitable in vitro methods by which to study 
nanotoxicity in the male reproductive system, basic toxicity testing was undertaken 
using an established panel of reference ENM and the mouse Leydig cell line, TM3. 
Following this, the influence of time- and dose- on response was investigated, and 
where possible an LC50 was identified to guide development of further investigation into 
whether ENM alter normal cell function at sub-lethal doses. In parallel with this, the 
suitability of WST-1 and Alamar Blue assays for investigation of ENM toxicity in vitro was 
also considered.  
Optimisation of protocols: assay interference and future endocrine work  
The FBS used routinely in cell culture contains a number of growth factors and hormones 
involved in cell growth promotion. Because later work in this thesis aimed to examine 
endpoints relating to steroidogenesis and local function of receptors, enzymes and 
proteins related to the HPG axis, it was important to minimise interference in any results 
from such exogenous steroid, peptide and thyroid hormones, growth factors and other 
lipophilic materials via use of charcoal-stripped FBS.   
Exploration of the impact of serum type on findings via the WST-1 assay revealed no 
major difference in results between charcoal-stripped FBS and standard FBS used 
alongside medium comprised of Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture 
F-12 Ham 500ml with L-glutamine, 15mM HEPES, and sodium bicarbonate. This meant 
that all following experiments outlined within this thesis were undertaken using 
charcoal-stripped FBS, giving a higher confidence in the outcome of further work to 
establish the functional basis of any toxicity observed on endocrine endpoints.  
It must be recognised that some ENM have been shown to absorb proteins and form a 
protein corona which may influence their uptake and fate (Kermanizadeh et al., 2013). 
However, it remains relevant to expose cells in medium containing some serum, as any 
ENM reaching the testis following exposure in vivo would be exposed to a multitude of 
proteins along the way. Therefore, we feel use of charcoal-stripped serum is a good 
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compromise between stunted cell growth in serum-free system and potentially dubious 
results to the outcome of planned endocrine endpoints via addition of traditional FBS.  
The setup of the WST-1 cell proliferation and Alamar Blue timecourse assay was such 
that it was easy to identify any source of interference. Before analysis, each set of results 
was therefore examined for potential interference from ENM or other sources. In all 
WST-1 assays, the ‘cells + WST-1’ control showed that WST-1 dye had a marginal 
interference in readings, leading to small increases in % viability of cells relative to 
control.  On this basis, all outputs were corrected for WST-1 during final analysis to 
ensure that results were not skewed. Interestingly, in those assays using NM-300 or 
AgNO3, interference from ENM was also noted, as such, an additional correction for this 
interference was put in place. In all of the Alamar Blue assays undertaken, a low level of 
interference from ENM but no interference of Alamar blue was observed on the 
absorbance readings taken. Based on this, all results were corrected for ENM to ensure 
this did not skew results.  
Interference of ENM with in vitro toxicity assays is a relatively commonly reported 
occurrence, especially where optical detection methods are used. In 2012, Kroll et al 
recommended that in each in vitro test system, evaluation for each single nanoparticle 
type should be undertaken, as ENM may interfere in classic cytotoxicity assays (such as 
the lactate dehydrogenase or MTT assays) in concentration- particle- and assay- specific 
manner (Kroll et al., 2012). Despite this, many studies published still make little attempt 
to include consideration of this potential effect, making its inclusion here was especially 
important. From these results it can be concluded that the assays produced a 
reproducible assessment of toxicity for the cell line and materials in question. 
Cytotoxicity and time- and dose- dependent effects 
A variety of ENM-specific outcomes were identified. For ease of consideration, these 
are reported per nanomaterial.  
Titanium dioxide (NM-101, 103 & 104) 
The first ENM tested were TiO2 NM-101 (anatase), NM-103 (hydrophobic) and NM-104 
(hydrophilic). Exposure to NM-101 showed no change in viability of cells, with little 
variation. Exposure to NM-103 and 104 showed a small decrease in viability to 73% at 
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the highest dose applied for NM-103 and no change to viability for NM-104. However, 
there was much greater variability in results recorded for these ENM, which most likely 
accounted for the decrease in average viability reported. This finding is in agreement 
with those reported for 8 other cell lines from 6 other systems/organs in the body as 
part of a major screening study published from this work in 2015, allowing the 
conclusion to be reached that the TiO2 ENM tested were not cytotoxic (Farcal et al., 
2015). Because results for NM-101 showed the least variation and greatest 
comparability to other organs/systems reported, it was selected as a control material 
for timecourse assays reported here, and future investigation of changes to TM3 cells at 
the functional level, reported in Chapter 4.  
The Alamar Blue results for titanium dioxide NM-101 showed that of the two dose 
ranges tested, a significant effect on cells’ ability to reduce AB was only observed for the 
highest two doses in the high dose range (30.12 and 60.24μg/cm2) from 2 hours 
onwards. Consultation of the literature suggests this toxicity may be linked to the 
materials’ catalytic properties, which are in turn linked to its crystalline structure. TiO2 
comes in two main forms, anatase (as with NM-101) and rutile. It has been shown that 
as particles become smaller, their toxicity appears to increase, with anatase being more 
biologically active than rutile for the endpoints of cytotoxicity or oxidative DNA damage 
(Auffman et al., 2009). Therefore, although statistically significant, it is most likely that 
the findings are because of the enormous amount of TiO2 added to the cells rather than 
because of any specific toxicity. Indeed, TiO2 ENM are used within many consumer 
products such as sunscreens with no reported adverse effects to health. 
Silica dioxide (NM-200 & 203) 
Silica dioxide (NM-200 & 203) reported little change in viability of cells compared to 
control, except for NM-203 at the highest doses. The finding of a significant decrease in 
viability from control reported for NM-203 was likely due to the low standard deviation 
across replicates, which meant that any small variation in mean viability produced a 
significant result. As such, neither NM-200 nor NM-203 were considered to impact 
viability sufficiently to warrant their progression to subsequent sub-lethal toxicity 
studies, at least initially. Interestingly, a recently published study investigating the 
influence of mesoporous silica ENM on the WST-1 assay indicated that it occasionally 
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underestimated toxicity, leading to viabilities exceeding 100%. However, no such effect 
was identified here, suggesting that this may be either an ENM- or cell line- specific 
effect (Braun et al., 2018). 
It is interesting that method of manufacture appears to have an effect on the toxicity, 
as precipitated SiO2 (NM-200) did not decrease cell viability whereas thermally 
produced SiO2. This result is comparable to that of Barkalina et al, who found no effect 
of mesoporous silica on the functions of mammalian boar sperm in vitro (Barkalina et 
al., 2014). Interestingly, when compared to other cell types from different organ 
systems, the effect of SiO2 appears to be organ-dependent, as toxicity was identified to 
the MH-S alveolar macrophage cell line, and the mES embryonic stem cell line (Farcal et 
al., 2015).  
Outcomes from in vivo studies report similar variation in findings, which appear to be 
dependent on the characteristics of ENM used, dose and exposure route. For example, 
Morishita et al found no adverse effects to testicular tissues following intravenous 
injection of 0.8mg 70nm or 300nm silica particles, and Bara et al found mesoporous 
silica nanoparticles (MSN) to be comparatively safer than zinc oxide ENM in swiss albino 
dams and pups following oral exposure to 50 or 250mg/kg does during gestation days 
15-19 (Morishita et al., 2012, Bara et al., 2018). Conversely, Ren et al identified evidence 
of oxidative stress and adverse effects to sperm motility and normality following 
exposure of C57 mice to 57nm silica nanoparticles via tracheal perfusion. However, 
these effects appeared to be reversible, with animals recovering after a period of wash-
out post dosing (Ren et al., 2016). Given this information, and with more time and 
resources, it would be interesting to investigate the potential for silica ENM to effect 
changes to TM3 cell line at a functional level in future.  
Carbon nanotubes (NM-400, 401 and 403)  
Appraisal of cytotoxicity for CNT showed no significant alteration in TM3 cell viability for 
NM-401, but a significant effect of ENM exposure for NM-400 and 403. Although 
absorbance readings did not suggest notable interference from CNTs to the assay 
outcome, it was noted that both NM-400 and 403 did not disperse well using the 
protocol applied, and that they appeared to settle out of suspension to form a visible 
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layer on top of cells when applied to the 96 well plate, that was hard to wash off before 
application of WST-1. To add to this, conflicting outcomes following use of the WST-1 
assay have been previously reported in the literature, suggesting some interaction with 
the test dye (Gormley and Ghandehari, 2009). For this reason, it is hard to be confident 
that the reported effects are a direct effect of the ENM on TM3 cells; it can be speculated 
that significance in findings is more likely due to sedimentation of CNTs onto the cellular 
monolayer interfering with readings rather than through interaction of ENM with the 
cells themselves.  
Converse to our findings in vitro, in vivo exposure of rodents to CNTs reports clear 
findings of testicular toxicity. For example, Nirmal et al exposed Wistar rats to 0.4, 2 or 
10mg/kg hydroxyl-functionalised MWCNT (multi-walled CNT, diameter 10-20µm, length 
10-30µm) for 15 does over 30 days, reporting adverse outcomes to the testis via 
histological analysis, an increase in oxidative stress and sperm abnormalities without a 
decrease in sperm viability, a finding that was echoed by Farombi et al following 
intraperitoneal injection of functionalised MWCNTs to mice (Nirmal et al., 2017, 
Farombi et al., 2016). Furthermore, it is suggested that the wide range of length, 
diameter and functionalisation used for investigation of CNTs driving the variety of 
outcomes reported, corroborated by the finding of differential toxicity between single-
walled, double-walled and multi-walled CNTs in Syrian hamster embryo and lung cells 
(Darne et al., 2014).  
Due to this discrepancy in findings between our work in vitro and that reported in vivo, 
further consideration of dispersion protocol for CNTs, and methods by which to wash 
them from cells before reading absorbance using any optical reading detection system 
is advisable. 
Copper Oxide  
Exposure of TM3 cells to pristine copper oxide resulted in a clear dose-response toxicity, 
and following non-linear regression, an LC50 value of 7.752µg/cm2 was identified. This 
material was provided by partners in the SUN project, and their findings both in vitro 
and in vivo reflect this finding of toxicity. Ivask et al reported dose-response toxicity to 
the human T-lymphocyte cell line Jurkat following exposure to CuO (Ivask et al., 2017). 
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Gosens et al reported pulmonary toxicity following a short-term inhalation exposure 
protocol (5 days) at 6h equivalent concentration of 0, 0.6, 2.4, 3.3, 6.3, and 13.2 mg/m3, 
which showed signs of recovery following a 22day wash-out period post exposure 
(Gosens et al., 2016). Given additional time, it would be very interesting to investigate 
further the potential mechanism of toxicity from CuO to TM3 cells, and compare this to 
histological findings from the testis of animals exposed in the study of Gosens et al, 
which were kindly provided to our group for future investigation and comparison.  
Zinc Oxide (NM-110, 111 and ZnSO4) 
TM3 cells showed clear dose-response toxicity following exposure to both NM-110 and 
111. Timecourse appraisal showed that for both ENM, this effect was dose- but not time-
dependent, with a significant reduction in viability of TM3 cells identified at doses of 
3.76μg/cm2 (NM-110) and 1.88μg/cm2 (NM-111) and above at 2,4 and 6h timepoints. 
Via non-linear regression, and subsequent exclusion of outliers it was possible to identify 
an LC50 of 3.813μg/cm2 for NM-110 and 6.052μg/cm2 for NM-111. Further analysis of 
the data makes it highly likely that the results of the 2-way ANOVA were influenced by 
the outliers identified, and thus the difference in toxicity reported for NM-110 and 111 
to that of the regression analysis. Using the LC50 value calculated, and Dunnett’s multiple 
comparison test as guidance, future investigation of the effects of NM-110 and 111 on 
functionality of TM3 cells will use sub-lethal doses of <3.76µg/cm2.  
Comparison of these results with those for similar assays undertaken on cell lines from 
other organs and tissues shows a similar toxicity to cells of the immune system (Raw 
264.7 and MH-S Macrophage cell lines) and respiratory system (16HBE human bronchial 
cells). However, no toxicity was identified in HMDM monocyte-derived macrophages or 
Calu-3 lung cancer cells, implying potential for differing effects on cell types within each 
organ (Farcal et al., 2015). To support this, Vecchione et al published a study on 
developmental toxicity endpoints which highlighted differences in toxicity to murine 
fibroblasts (NIH3T3, representing differentiated tissue) and murine embryonic stem 
cells (mES, representing embryonic tissue) following exposure to NM-110 and 111. They 
reported that while mES cells lost viability following exposure to NM-110/111 at doses 
of above 10µg/ml, the viability of NIH3T3 was unaffected, supporting the idea that ENM 
may affect animals during development differently (Vecchione et al., 2013).   
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Interestingly, our results mirror those for the 16-HBE cell line, which indicate a slightly 
lower toxicity from NM-111 than NM-110. It would be worth considering whether this 
difference in toxicity could be due to a protective role for the triethoxycaprylsilane 
coating applied to NM-111. Unfortunately, of the available studies, none were identified 
which included other types of ZnO, nor that reported in detail the characteristics of the 
ENM used.  
Silver (NM-300, NM-300dis & AgNO3) 
TM3 cells showed clear dose-response toxicity following exposure to both NM-300 and 
AgNO3. 2-way ANOVA was unable to identify any clear link between either dose or time 
and response for the higher dose range, but a clear effect of time- and dose- was 
observed at the low dose range, with significant loss of viability in TM3 observed at 
1.88μg/cm2 and above at 2 hours, and 0.94μg/cm2 at 4 hours. Due to aberrant readings 
in both the high dose range, and 6/24h timepoints of the low dose range, it may be 
suggested that NM-300 interferes with the assay at high doses. These findings were 
identical to those reported for the TM4 cell line, adding weight to this suggestion (Fulton 
and Hutchison, 2013). It may also be that the results are subject to interference by silver 
ions released from the NM-300 colloidal solution (discussed below). It is notable that 
the results at 4hours for NM300 differed significantly for the same dose (3.76 ug/cm2) 
between high- and low- dose ranges using the Alamar Blue assay. When comparing 
these to WST-1 results, which were undertaken at n=6 rather than n=3, it is clear that 
this dose is one which generally produced large fluctuations in response regardless of 
number of experimental replicates. This is most likely because this dose is around the 
point at which viability in cells began to drop drastically. Via non-linear regression, and 
subsequent exclusion of outliers it was possible to identify an LC50 of 7.885 ug/cm2 for 
NM-300, and 0.282 ug/cm2 for AgNO3. Based on these results, a maximum dose 
3.75µg/cm2 was planned for future work ensuring a sub-lethal dose was applied to cells. 
Our findings are in agreement with those of Zhang et al, who saw a dose-dependent 
decrease in viability of both TM3 and TM4 cells, and an increase in reactive oxygen 
species formation following exposure to 10 and 20nm silver nanoparticles (Zhang et al., 
2015a).  
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Interestingly, initial analysis of the data for NM-300dis indicated a significant loss of 
viability to cells following exposure, which required further investigation to understand. 
The Dunnett’s multiple comparison test suggested a significant change in viability across 
doses in the middle of the range of exposures. Examining distribution of data at these 
vs the other doses revealed these doses exhibited less variation than the others tested, 
thus leading to a false indication that there was a significant departure from the 
untreated control. To check this hypothesis, these dose points were removed and the 
ANOVA re-run, this time reporting a finding or non-significance. As cells appeared 
healthy under the microscope and were not affected by the higher doses applied, it was 
concluded that dispersant did not influence toxicity of silver ENM.  
Ionic influences on toxicity of metal ENM  
Auffman et al previously reviewed the chemical stability of metallic NPs, highlighting 
direct release of metals in solution (dissolution) as one of three key ways ENM may 
effect toxicity (Auffman et al., 2009). Thus, another important point for consideration is 
whether toxicity observed from metallic ENM is a particulate or ionic effect; for this 
reason ionic controls were implemented for zinc oxide and silver ENM.  
It has previously been shown that ionic silver is toxic to development and has greater 
adverse effect than its particulate counterpart (Li et al., 2010, Bar-Ilan et al., 2009). 
Toxicity studies on the freshwater alga Pseudokirneriella subcapitata have shown 
comparable toxicity between 30nm ZnO and dissolved ZnCl2 salts (Franklin et al., 2007). 
The high surface area of metal-based ENM increases potential for metal ion release, and 
toxicity observed can be linked to the ionic content (Beer et al., 2012). This is thought to 
be responsible for the antibiotic and antibacterial properties of silver, as these are linked 
to the release of Ag+ ions in solution, and subsequent binding of their surface atoms to 
electron donor groups containing sulphur, oxygen or nitrogen (Auffman et al., 2009).  
It is possible based on this to suggest that toxicity of metal oxide NPs such as NM-110, 
111, 300 and CuO could be attributed to dissolution of ions in solution. However, as zinc- 
and copper-based ENM were provided in powder form and the silver in a colloidal 
solution, the implications of this need to be considered slightly differently as any 
dissolution of Zn+ or Cu2+ ions could only happen once in the prepared ENM dispersion, 
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whereas the silver colloid may have been releasing ions throughout its storage post 
manufacture.  
It has been reported that ZnO ENM undergo fast dissolution, with evidence to suggest 
that 50-60% of NM-110 and 111 may be dissolved in cell medium after 24h 
(Kermanizadeh et al., 2013). This makes an ionic influence on observed toxicity possible, 
which certainly matches the similarity of decreased viability and LC50 observed between 
ZnO ENM and its ionic control. Similarly, there is evidence to suggest that dissolution of 
CuO in cell culture medium is up to 40% (Ivask et al., 2017). Importantly, Ivask & 
colleagues reported that the dissolution of CuO applied at a concentration of 2μg/ml 
was similar to that of CuSO4, suggesting strongly that the pristine CuO used in this 
research also underwent dissolution. They go on to suggest that dissolution and any 
subsequent transformation of ZnO and CuO ENM during testing may  influence strongly 
the toxicities recorded (Ivask et al., 2017). Conversely, Kermanizadeh et al reported that 
less than 1% of NM-300 dissolved in medium following 24h (Kermanizadeh et al., 2013). 
This makes it less likely that the toxicity observed from NM-300 is due to the release of 
ions and may account in part for why the LC50 values for AgNO3 was much lower than 
that for NM-300.   
Another important point to consider is that the toxicity of silver NPs increases during 
storage, due to slow dissolution. Kittler et al demonstrated that aged silver 
nanoparticles (after 1 month and 6 months of storage) caused complete cell death 
within primary human mesenchymal stem cells when compared to silver NPs only 3 days 
in age (Kittler et al., 2010). However, they also noted that their silver NPs were stored 
in an aqueous dispersion without any stabilising agents present, emphasising the 
importance of the inclusion of the stabilizing agents included in NM-300dis.  
Investigation into ion release from NM-300 into its matrix has been demonstrated under 
storage conditions to be <0.01w/w%, but ion concentration was stable over the 12 
month period of testing (Comero et al., 2011). This suggests it would be possible that 
the toxicity profile of NM-300 to change with increasing time in storage and thus greater 
dissolution of ions into solution. In addition, Comero et al also mention that there will 
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be some evaporation of the solution over time, meaning that the content of the solution 
becomes more potent over time.  
During this period of research, logistical issues meant that NM-300 was stored for longer 
than recommended within the literature above. In combination with the knowledge 
about dissolution of Ag+ ions presented, this may mean that while the ionic contribution 
to NM-300 toxicity was less pronounced, latter results (timecourse assay) could be 
influenced by increased potency of the NM-300 solution. In future, it would be useful to 
re-run the timecourse assay with ‘fresh’ NN300, in order to appraise whether storage 
time did have any effect on outcome, which may explain potential differences in LC50 
values.  
Issues encountered with Timecourse assays 
Interestingly, the variation in findings at the 24hour timepoint for all four ENM tested 
was massive compared to the other timepoints in all three replicates, leading to a 
question over what may have caused this. Alamar Blue measures a change in cellular 
reduction capability, which could be due to cell death, cell cycle impairment, or decrease 
in cellular metabolism, the measured reduction of blue resazurin to red resorufin being 
undertaken via agents like NADH which are readily produced within viable cells. One 
paper which provides some insight into the possible reasoning for this is that of O’Brien 
et. al. (2000).   
O’Brien et al tested primary rat hepatocytes, alongside HeLa and HepG2 cell lines using 
AB. They found that resazurin to resorufin reduction can go on to create a third highly 
reduced product – hydroresarufin. This final product is non-coloured and therefore 
doesn’t give absorbance reading. Reduction of Resorufin to hydroresorufin could lead 
to aberrant results in tests as living cells which fully reduce resazurin will give a weaker 
signal than dying/dead cells which can’t reduce the dye fully. They tested this using a 
HepG2 liver cell line and found that with a t1/2 of 10 hours, measurements with a 26hour 
lag gave higher absorbance than that expected from a strict correlation between time 
and absorbance. To further investigate this, primary Hepatocytes were treated with 
control or the known toxicant sodium azide (NaN3) with viability investigated using AB 
at a 2, 10 or 20% preparation. Absorbance readings showed that a lesser concentration 
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of AB dye led to a rapid shift to colourless in untreated cells. Thus, at a 2h timepoint, 
NaN3 treated cells showed lower viability than untreated cells, but after 20 hours NaN3 
treated cells appeared to show a higher viability than untreated (especially at lower 
AB%). This was repeated for cells exposed to CuSO4 as a point of comparison, and the 
same results were found (O’Brien et al., 2000).  
Based on this, it is very possible that the pattern observed for NM-110, 111 and 300 of 
lower viability within untreated cells was due to complete reduction of dye to 
hydroresorufin, whereas the higher readings from treated cells was due to cell 
death/reduction in ability to metabolise the dye, and thus more partly reduced product 
being present in the media. In contrast, the WST-1 results, which followed an identical 
24-hour exposure, gave an accurate representation of cell viability. Based on this it is 
plausible to conclude that Alamar Blue is not the ideal method by which to measure 
changes in viability over a longer period of exposure, and that the 24hour exposure point 
measured by WST-1 is suitable for further testing when combined with the lower dose 
range explored by the Alamar Blue assay. Ideally, it would be useful to repeat some of 
the shorter exposure times using WST-1 to provide a point of comparison for all 
timepoints measured and explore whether a 4 or 6h exposure would be most suitable 
for further testing of functional markers.  
Conclusions and Future Development  
In summary, two in vitro toxicity assays were optimised for investigation of an 
endocrine-active cell type via use of charcoal stripped serum, and it was found that once 
optimised the assays produced a reproducible assessment of toxicity for the cell line and 
ENM panel. Viability of TM3 cells following a 24-hour exposure to a panel of ENM gave 
a variety of results. Titanium dioxide (NM-101 Anatase, NM-103 hydrophilic & NM-104 
hydrophobic), Silver dispersant (NM330Dis) and Multi-walled Carbon Nanotubes (NM-
400, 401 and 403) were not found to be toxic to cells. Zinc Oxide (NM-110 coated & NM-
111 uncoated), Silica Dioxide (NM-200 & 203), Silver (NM-300) and Copper Oxide were 
shown to impact upon cell viability at relatively low doses. For NM-110, 111, ZnSO4, NM-
300, AgNO3 and copper oxide, a non-linear log(inhibitor) vs response curve was plotted 
to identify an LC50 value to guide selection of dose for future sub-lethal functional 
studies. Consideration was given to the potential role of dissolution of ions from metallic 
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ENM in their observed toxicity. Recognition must also be offered to the role that 
differences in physico-chemical characteristics (hydrophobicity/philicity, size, coating, 
charge, production method etc.) may have in driving differential toxicities from 
materials with the same chemical identity.  
As the same investigation was carried out in parallel for the TM4 Sertoli cell line within 
Edinburgh Napier University (Fulton and Hutchison, 2013), it is possible to present 
findings by WST-1 and Alamar Blue for both cell lines for comparison (Table 9). 
As mentioned in this discussion, results for both TM3 and TM4 cells for NM-103 & 104 
(TiO2), NM-200 & 203 (SiO2), and NM-110 and 111 (ZnO) have been published in a 
summary paper, bringing together evaluation of in vitro cytotoxicity of the ENM panel 
to 12 cellular models, representing 6 different target organs/systems: immune, 
respiratory, gastrointestinal, reproductive, hepatic systems and embryonic tissues 
(Farcal et al., 2015). The toxicity assessment was undertaken using 10 different assays 
for cytotoxicity, embryotoxicity, epithelial integrity, cytokine secretion and oxidative 
stress. To our knowledge, this is the first time that thorough physico-chemical 
characterisation ENM was combined with a standardised approach to dispersion, 
consideration of ENM behaviour in biological media, potential interference with assays 
and cell- and ENM- specific responses was reported in the published literature for such 
a large group of ENM, target organs/systems and endpoints.     
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Table 9: Summary of findings from WST-1 and Alamar Blue on Leydig (TM3) and Sertoli (TM4) cells. Results are reported as ‘-‘ 
where no toxicity was identified, ‘(-)’ where toxicity was identified only at the highest possible dose in vitro, and ‘+’ where clear 
toxicity was seen. Where possible, the dose over which a significant decrease in viability was seen is reported, and for those ENM 
eliciting a clear dose-response toxicity to TM3 cells, and LC50 value is given. 
 
To date, cytotoxicity assays for a panel of ENM have been successfully set up, optimised 
and tested for interference from ENM. This has produced data on Leydig cell viability 
Nanomaterial 
Cytotoxicity 
TM3 
Timecourse TM3 
Cytotoxicity 
TM4 
Timecourse TM4 
Titanium 
Dioxide 
NM-101 - - - - 
NM-103 - N/A - N/A 
NM-104 - N/A - N/A 
Silica Dioxide 
NM-200 (-) N/A (-) N/A 
NM-203 (-) N/A (-) N/A 
Zinc Oxide 
NM-110 + 
>1.875μg/cm2, 4h 
LC50 3.813μg/cm2 
+ >3.75μg/cm2, 4h 
NM-111 + 
>0.94μg/cm2, 4h 
LC50 6.052µg/cm2 
+ >3.75μg/ccm2, 4h 
ZnSO4 + N/A   
Silver 
NM-300 + 
>0.94μg/cm2, 4h 
LC50 7.885 µg/cm2 
+ >1.875μg/cm2, 4h 
 
NM-300Dis - - - - 
AgNO3 
+ 
LC50   
0.282µg/cm2 
N/A   
Copper Oxide Pristine CuO 
+ 
LC50 
7.752µg/cm2 
N/A N/A N/A 
MWCNT 
NM-400 (-) N/A N/A N/A 
NM-401 (-) N/A N/A N/A 
NM-403 (-) N/A N/A N/A 
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following exposure to ENM across a range of timepoints and highlighted a number of 
ENM for which it could be expected that exposure to the testis  would result in a 
reduction in viable Leydig cell population, with resulting effects on androgen 
production, the regulation of spermatogenesis and even possibly adverse effects on BTB 
integrity. These assays allowed identification of a sub-lethal dose range in which to 
investigate functional changes in cells. There are a number of key functional and 
metabolic pathways within the Leydig Cell which could be affected following ENM 
exposure and lead to the observed reduced viability, as well as potential changes in the 
cells’ key function – production of steroid hormones. Establishing these is the next step 
in establishing suitable in vitro models by which to appraise male reproductive 
nanotoxicology, and the subject of the next chapter.  
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Chapter 4: Functional changes to Leydig Cell behaviour following 
ENM Exposure  
 
Introduction 
Following examination of results from the WST-1 and Alamar Blue assays, three ENM 
were identified as being of interest for further examination of functional cellular 
responses; uncoated zinc oxide, coated zinc oxide and silver (NM-110, 111 and 300). For 
this, a No Observed Effects Limit (NOEL) was identified, and expression of several key 
proteins, receptors and enzymes in steroidogenesis were examined following treatment 
of TM3 cells with doses of ENM under the NOAL. This was initially undertaken by looking 
for alteration in expression of mRNA via RT-qPCR, and then by looking for any changes 
in cellular protein expression via Western blot. Results could then be compared to those 
from histological analysis on testicular samples from male Sprague-Dawley rats 
undertaken concurrently (reported within Chapter 5) to look for comparability between 
findings in vitro and in vivo.  
A number of potential proteins, enzymes and receptors of interest were identified based 
on prior knowledge of the Leydig cell, steroidogenesis, and endocrine system regulation 
of male reproductive function (much of which is outlined within Chapter 1). These 
aligned with some of the key proteins investigated histologically, so that direct 
comparison of results could be made. To provide full rationalisation for the selection of 
each, the steroidogenic pathway within the Leydig cells of the testis is outlined in detail, 
together with commentary on available information relevant to ENM currently 
published.  
Steroidogenesis & Selection of targets for measurement  
They Leydig cell is the only testicular cell expressing all of the necessary enzymes for 
conversion of cholesterol to testosterone, these being cholesterol side chain cleavage 
(CYP11A1), 17a-hydroxylase/C17-20 lyase (CYP17A1), 3b-hydroxysteroid 
dehydrogenase/D5-4 isomerase (HSDB3), and 17b-hydroxysteroid dehydrogenase type 
3 (HSD17B3)  (Payne, 2007, O’Shaughnessy, 2017). Consequently, it is the sole site for 
conversion of 27-carbon cholesterol to 19-carbon steroid hormones such as 
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testosterone in this organ (O’Shaughnessy, 2017). As previously outlined, the production 
of testosterone is completely dependent on stimulation of LCs by luteinising hormone 
(LH). LH binds to high-affinity LH-receptors (LH-R) on the surface of LCs, activating a 
series of events which ultimately lead to the production of testosterone, which 
stimulates reproductive organ activity, controls actions in the periphery and maintains 
the male phenotype (Dufau and Tsai-Morris, 2007). As such, the LH-R is required for: i) 
normal function of the Hypothalamus-Pituitary-Gonad (HPG) axis via endocrine 
signalling, ii) management of paracrine interaction between Leydig and Sertoli cells, as 
well as iii) autocrine management of steroidogenesis and metabolic processes within 
the Leydig cells themselves.  
The effects of ENM exposure on circulating LH levels and LH receptor expression are not 
extensively reported, nor does the literature reach any decisive conclusion. In relation 
to circulating LH levels, Kong et al reported no change to LH levels in male rats following 
nickel ENM exposure during a one generation reproductive toxicity test (Kong et al., 
2014). Reyhani et al observed a dose-dependent decrease in LH levels following 
intraperitoneal injection of silver ENM (0.5-5mg/kg/day for 25 days), whereas no change 
in serum LH levels was detected by Mathias et al following silver ENM exposure of Wistar 
rats via oral gavage at 15 or 30µg/kg for 46 days, or by Garcia et al following exposure 
of CD1 mice to 1mg/kg silver NPs over 5 doses intravenously at 1mg/kg (Rezazadeh-
Reyhani et al., 2015, Mathias et al., 2015). In relation to LH-R expression, only 1 study 
was identified: Bara et al (2018) reported an increase in LH-R expression following oral 
exposure to silica ENM in swiss albino mice, but not following zinc oxide ENM exposure 
via the same route (Bara et al., 2018).  
Because of the both limited and contrasting information available from the existing 
literature, and as the initiator for the effects of LH on testosterone production, the first 
target selected was the luteinizing hormone (LH) receptor. A G-coupled transmembrane 
receptor (GCPR), the LH-R is found in abundance on the surface of Leydig cells (Chen et 
al., 2007). LH-R is within the superfamily of GCPRs with 7 membrane-spanning guanine 
nucleotide-binding domains and belongs to a sub-class which includes other receptors 
for pituitary hormones (Dufau, 1998). The LH-R is heterodimeric, and at the monomeric 
level contains a and b subunits; the 92 amino acid a subunit being common to the LH-
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R, and other hormones including the human chorionic gonadotropin receptor, thyroid 
stimulating hormone receptor and the follicle-stimulating hormone receptor. 
Transcription of the 121 amino acid b subunit is therefore responsible for its unique 
functions and high receptor-binding capacity for LH (Choi and Smitz, 2014).  
LH-R cDNA encodes a 75kDa glycoprotein, composed of two functional units: a heavily 
glycosylated extracellular (EC) hormone-binding domain which binds LH with high 
affinity, and the 7 membrane transmembrane/cytoplasmic module which anchors the 
receptor and transduces the signal initiated in the EC domain by coupling to G proteins 
(Jiang et al., 2014). The mature receptor is 80-90kDa in size, of which around 15kDa are 
made up of carbohydrate chains located at potential glycosylation sites on the EC 
domain (Dufau and Tsai-Morris, 2007).  
Binding of LH to the LH-R induces binding of its cytosolic domain to a membrane-bound 
G protein, inducing exchange of bound guanosine 5’-diphosphate for guanosine 5’-
triphosphate. In turn, this activates the a subunit of the G Protein to dissociate from its 
dimeric b-g subunit and interact with Adenylyl cyclase to convert Adenosine 
Triphosphate (ATP) to cAMP, after which it re-associates with the b-g subunit, restarting 
the cycle (Dufau and Tsai-Morris, 2007).  
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Cyclic adenosine monophosphate (cAMP) is the primary second messenger for LH-R in 
steroidogenic signal transduction, with the phospholipid-specific phospholipase C (PLC) 
and extracellular signal-regulated kinase (ERK) pathways also playing major roles (Fig. 
35) (Choi and Smitz, 2014). This activation of cAMP is considered key to activation of 
steroidogenesis in temporally distinct manners, either acutely over minutes (via StaR 
activation and transfer of cholesterol to the inner mitochondrial membrane), or 
chronically over hours (via an increase in gene transcription for the enzymes p450scc, 
P450c17, 3β-HSD and 17b-HSD) (Kotula-Balak et al., 2012). TM3 cells have been shown 
to increase cAMP production in response to stimulation with LH, therefore it is 
considered that these cells possess active LH-Rs (Mather, 1980). Because of this LH-R 
expression was investigated for both RNA and protein-based work.  
cAMP activates both protein kinase A (PKA) and B (AKT). Phosphorylation of proteins 
such as peripheral-type benzodiazepine receptor (PBR) and steroidogenic acute 
regulatory protein (StaR) via PKA is a key regulatory step in hormone-stimulated steroid 
Figure 35: Luteinizing Hormone Receptor and its common second messenger pathways. LH = luteinizing hormone, G = G protein, 
AC = Adenylyl cyclase, ATP = Adenosine Triphosphate, cAMP = cyclic adenosine monophosphate, PKA= protein kinase A, PLC = 
phospholipid-specific phospholipase C, ERK 1/2= extracellular signal-regulated kinase, PKC = protein kinase C, AKT =protein kinase 
B. From (Choi and Smitz, 2014). 
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production. Both PBR and StaR have been implicated as holding important roles in 
translocation of cholesterol to the inner mitochondrial membrane, a constant supply of 
which is needed as a substrate for steroid hormone synthesis.  
The primary source of cholesterol in all steroidogenic cells is cholesterol esters within 
lipid droplets. When this is depleted, cholesterol may be sourced from de novo synthesis 
or from exogenous lipoproteins (Fig. 36) (Chen et al., 2007). By comparison with adrenal 
cortex cells which use plasma lipoproteins as the major source of cholesterol, Leydig 
cells produce most of their own testosterone from lipid droplets, or de novo from 
acetate (the rate limiting enzyme in this process being 3-hydroxy-3-methylglutaryl-
coenzyme (HMG CoA)). Carboxyesterase (ES-10) and hormone sensitive lipase (HSL) are 
also considered to play significant roles in mobilisation of cholesterol synthesised de 
novo. The Leydig cell may also import exogenous cholesterol from blood lipoproteins via 
the scavenger receptor class B type 1 (SR-B1), a receptor which is also stimulated by LH 
(Reaven et al., 2000).  
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Figure 36: Location and role of selected key players in steroidogenesis within the Leydig cell. Regulatory and Steroidogenic pathways 
in the Leydig Cell. Highlighted are receptors, enzymes and molecules of interest which have been selected for further analysis via 
functional assays. LH-R: LH receptor, G: G protein, AC: Adenyl Cyclase, PKA: Protein Kinase A, StaR: Steroidogenic acute regulatory 
protein, PBR: Peripheral benzodiazepine receptor, Sr-BI: Scavenger receptor class B type 1, ES-10: Carboxyesterase, HS-lipase: 
hormone sensitive lipase, NCE: Neutral Cholesterol esterase. Image adapted from (Chen et al., 2007). 
As cholesterol is hydrophobic and cannot simply diffuse across the aqueous 
intermembrane space of mitochondria, it is thought that StaR and PBR play coordinated 
roles in transport of cholesterol across the mitochondrial membrane (Chen et al., 2007). 
Discovered in the 1980s by Orme-Johnson & Pon, and later described in detail by Stocco 
et al, the 30kDa mitochondrial phosphoprotein StaR is considered to be the true rate 
limiter in steroidogenesis, controlling transport of cholesterol from the outer to the 
inner mitochondrial membrane (Clark and Stocco, 1996, Pon and Orme-Johnson, 1986). 
StaR is rapidly synthesised in response to stimulation of the cell to produce steroid by 
luteinising hormone, possibly via cAMP induced ERK pathway activity (Gyles et al., 2001). 
It was shown to be essential to steroidogenesis, as mutations in the StaR gene were 
shown to results in congenital lipoid adrenal hyperplasia (lipoid CAH), in which affected 
individuals are unable to produce adequate levels of steroids and suffered excessive 
cholesterol levels (Stocco, 2007). As such, StaR was selected as the second key target of 
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interest for investigation of the effects of ENM on steroid synthesis and function of the 
Leydig cell.  
Whilst the exact mechanism of action for StaR remains debated, it is considered to be 
likely that it interacts with other mitochondrial outer membrane proteins such as StaR-
binding protein and the Peripheral Benzodiazepine Receptor (PBR) to facilitate 
cholesterol transfer. The PBR receptor (more recently known as translocator protein 
TSPO) is a high affinity cholesterol binding protein present in high levels on the outer 
mitochondrial membrane, most likely acting as a channel for cholesterol transport 
(Papadopoulos et al., 2006). Stimulation with LH causes an increase in PBR ligand 
binding, which may be blocked by inhibition of PKA, suggesting cAMP induced 
phosphorylation may be involved (Chen et al., 2007).  
It is proposed that StaR and PBR work in coordination, with StaR being a ‘gatekeeper’ 
managing and initiating transport of cholesterol, and PBR acting as the ‘gate’ through 
which it enters the mitochondria. However, with evidence both in support of and 
opposition to this proposal, it remains subject to much debate and certainly requires 
further investigation (Stocco, 2007). Previous studies have shown that StaR is expressed 
within TM3 cells and is affected by alterations in cellular environment as well as 
exposure to ENM  (Zhang et al., 2015a). With such an important part in the steroidogenic 
pathway, StaR was examined both via RNA and protein work. 
Once within the mitochondria, the first step in production of steroid hormones from 
cholesterol is its conversion to pregnenolone. This is catalysed by cholesterol side-chain 
cleavage enzyme (P450scc). P450scc is a member of the cytochrome P450 haem 
containing superfamily of enzymes (family 11, subfamily A, polypeptide 1), encoded by 
the gene CYP11A1. It is expressed on the inner mitochondrial membranes of Leydig cells, 
its synthesis being promoted in part by cAMP via LH stimulation. P450scc holds an 
important role as the rate-limiting enzymatic step in conversion of cholesterol to 
pregnenolone, and as such was selected as the third target of interest for investigation 
of ENM effects on Leydig cell function (Payne, 2007). It does this in the presence of 
NADPH and oxygen via a series of three monooxygenase reactions, which include 2 
hydroxylations of cholesterol side chains, then cleavage of the bond between two 
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specific carbons, producing from 27-carbon cholesterol 21-carbon pregnenolone and 
isocapraldehyde (Fig. 37).  P450scc was investigated at the molecular level via RNA 
expression.  
 
Figure 37: Conversion of cholesterol to pregnenolone by P450scc. 
The literature reports few studies including investigation of StaR and P450scc following 
ENM exposure, and those available indicate that effect may be ENM dependent. One 
such study reported significant increases in expression of CYP11A1 mRNA but no change 
in Star mRNA following intravenous injection of silver ENM in mice (Garcia et al., 2014). 
In another study, Mohamed et al aimed to investigate whether zinc oxide (ZnO) ENM 
may be protective to testicular function in animals exposed to nicotine. The group 
observed a decrease in both StaR and CYP11A1 following nicotine treatment, that was 
potentiated past control with the addition of ZnO ENM. This indicates that ZnO ENM 
exposure may increase expression in both StaR and P450scc converse to the changes 
seen with silver exposure.  A second paper from Bara et al (2018) includes measurement 
of StaR and CYP11A1 expression following silica and zinc oxide ENM. This reports that in 
adult swiss albino mice exposed to zinc oxide and silica ENM gestationally (from 
gestational day 15-19), StaR expression was increased following both ZnO and silica 
exposure, while CYP11A1 expression was increased following ZnO but decreased 
following silica exposure.  
Pregnenolone diffuses from the mitochondria and moves to the smooth endoplasmic 
reticulum (SER) of LCs via methods which are largely unexplored to date (Sewer and Li, 
2008). Once in the SER, pregnenolone is converted to 21-carbon progesterone by the 
hydroxysteroid dehydrogenase enzyme 3β-hydroxysteroid (3b-HSD). 3β-HSD is a 
membrane-bound enzyme present in mitochondrial and microsomal membranes, of 
which there are multiple isoforms; in total 6 have been isolated and characterised to 
date (Kotula-Balak et al., 2012). Within rodent Leydig cells, variant 1 of 3β-HSD catalyses 
one step in the biosynthesis of testosterone from pregnenolone, by converting the ∆5-
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3ß-hydroxysteroid pregnenolone to the ∆5-3-ketosteroid progesterone in the presence 
of NADPH. Its human counterpart is 3β-HSD variant 2. Zhang et al reported significant 
downregulation of 3β-HSD in male somatic and spermatogonial stem cells following 
exposure to silver ENM (Zhang et al., 2015a). 
 
Figure 38: Key steroid biosynthetic pathways in Leydig cells. Enzymes examined using protein and RNA work are highlighted in red. 
P450scc = side chain cleavage enzyme; 3β-HSD = 3β-hydroxysteroid. Reproduced from Payne (2007). 
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To complete synthesis of testosterone (T), 21-carbon progesterone is converted to 19-
carbon androstenedione via catalysis with CYP17, and finally to the 19-carbon T via 
catalysis with 17β- hydroxysteroid (17b-HSD). T may be further metabolised by 5a-
reductase (S5A) to dihydrotestosterone (DHT), or the enzyme CYP19A1 (encoding 
aromatase enzyme) to oestradiol (Fig. 38). For the purposes of this work, testosterone 
and dihydrotestosterone are considered to be the most important hormones in sexual 
maturation and maintenance of the male phenotype (Payne, 2007).  
The literature reports that CD1 mice exposed to silver ENM at 1mg/kg via intravenous 
injection showed significant upregulation of 3β-HSD (Hsd3b1) expression (Garcia et al., 
2014). Conversely, Jia et al (2014) reported no change in 3β-HSD expression following 
oral exposure of pubertal Kunming mice despite observing clear adverse effects on 
testicular morphology and a decrease in expression of 17b-HSD. To help fill a clear gap 
in the data, and as a key step in the final synthesis of testosterone (T) within Leydig cells, 
3β-HSD v1 was investigated at the molecular level via RNA expression. 
Upon synthesis within the Leydig cell, T can act both locally and systemically. 
Systemically, T contributes to negative feedback within the HPG axis, controlling 
reproductive function. It is also involved with the HPA (Hypothalamic Pituitary Adrenal) 
axis, influences sexual activity, promotes muscle growth and helps to manage platelet 
aggregation in the blood. Locally, T has an important role in managing spermatogenesis 
via its paracrine action on Sertoli cells within testicular seminiferous tubules. In addition, 
adult LCs have been shown to express Androgen Receptors (AR) at variable levels in both 
rodents and humans, and so can be responsive to autocrine androgen signalling from T 
(Eacker and Braun, 2007). This may be for a number of reasons, including controlling LC 
number and steroidogenic enzyme production (O'Hara et al., 2015). Within target 
tissues both systemically and locally, T can act directly to mediate changes by binding to 
the Androgen receptor, or it may act indirectly following conversion to other active 
steroid hormones.  
Also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), the AR is 
activated by binding androgenic hormones, testosterone or dihydrotestosterone in the 
cytoplasm. Once bound, a conformational change in the receptor causes dissociation of 
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heat shock proteins which transport from the cytosol into the cell nucleus and then 
dimerize, before binding to its hormone response element on DNA, causing an up- or 
down-regulation of specific gene transcription. As such, its primary role is as a DNA-
binding transcription factor that regulates gene expression. In addition, AR has also been 
shown to have a second mode of action, which is independent of interaction with DNA. 
This involves interaction with signal transduction proteins in the cytoplasm, causing 
rapid changes in cell function such as alteration in ion transport, or indirect secondary 
changes to gene transcription for example via phosphorylation of other transcription 
factors (Fig. 39).  
 
Within the literature, only one study examining the effects of ENM on AR expression 
was identified. Jia et al (2014) reported no change to AR mRNA expression in pubertal 
Kunming mice exposed to TiO2 orally at various doses (Jia et al., 2014). In vitro, Kang et 
al recently reported that exposing human prostate cells to silver ENM disrupted AR 
transactivation (triggering of gene expression via signalling cascades following AR 
Figure 39: Androgen Receptor genomic and non-genomic mechanisms of action. From (Silva et 
al., 2015) 
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binding of T or DHT). The mechanism of action suggested was that silver ENM may bind 
to dihydrotestosterone, thus inhibiting its ability to bind to the AR (Kang and Park, 2018).  
It is also known that endocrine disrupting chemicals such as brominated flame-
retardants are capable of altering AR expression, therefore investigation of AR 
expression following ENM exposure appears both valid and needed (Kharlyngdoh et al., 
2018). TM3 cells are able to produce testosterone, therefore examining whether they 
possess AR is relevant (Musa et al., 2000). As it wasn’t clear from the literature whether 
TM3 cells have active ARs, it was decided that AR would be examined via protein analysis 
to establish whether it was present. 
Objectives 
In order to build on results from the basic cytotoxicity assays undertaken within Chapter 
3, it was necessary to investigate the functional effects of ENM exposure on TM3 cells 
in vitro. The outcomes of this could then be compared to those recorded following 
exposure of animals in vivo (Chapter 5).  
Research questions to be addressed were:  
1. Does exposure to zinc oxide and silver ENM lead to changes in mRNA expression 
encoding for a number of key markers of endocrine function in TM3 cells (LH-R, 
StaR, P450scc & 3b-HSD)?  
2. Does exposure to zinc oxide and silver ENM lead to changes in protein expression 
for a number of key markers of endocrine function in TM3 cells (LH-R, StaR & 
AR)?  
The aim of the work was therefore to elucidate whether TM3 exposure to zinc or silver 
based ENM caused changes in RNA or protein expression for key markers of 
reproductive function in vitro that could be compared to results gathered from 
concurrent analysis being undertaken on testicular samples from animals exposed in 
vivo (chapter 5).   
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Materials and Methods 
 
RNA Expression via RP-qPCR 
To examine RNA expression, Reverse Transcriptase quantitative Polymerase Chain 
Reaction (RT-qPCR) was used. RT-qPCR using an intercalating dye such as SYBR® Green 
is an attractive prospect for pilot experiments such as this, as it is fast, inexpensive and 
the technique is relatively easy to master. SYBR® Green is an asymmetrical cyanine dye, 
which fluoresces when intercalated with double stranded cDNA. The cDNA-dye complex 
absorbs blue light (λmax = 497 nm) and emits green light (λmax = 520 nm). RT-qPCR was 
undertaken according to the guidelines for minimum information for publication of 
quantitative RT-PCR experiments (MIQE) (Taylor, 2010).  For RNA work, primers were 
designed based on available published literature and through NCBI-NIH Primer-BLAST.  
RNA Extraction  
Preparation of RNA for PCR was undertaken using TM3 cells exposed to NM-110, NM-
111 and NM-300 as follows. Cells were cultured for 24 hours in 6 well plates at a density 
of 2.75x105 cells/well. This resulted in a final cell number which was sufficient for 
extraction of RNA using the Qiagen RNeasy kit, which requires a maximum of 1x107 cells 
as a pellet. Cells were treated with ENM at sub-lethal doses (0,4 and 8μg/ml, or 0, 1.26 
and 2.52µg/cm2 as determined in Chapter 3) and incubated for a further 24 hours. It 
should be noted that these ENM were used out with the 1 week recommended opening 
time, due to the limited availability of materials and the time it took to carry out 
experimentation. To disrupt and homogenise the cells, 350μl Buffer RLT from the kit 
(guanidine-isothiocyanate containing lysis buffer which disrupts cell membrane, 
linearizes nucleic acids and destabilises RNAses) was added to wells after removal of the 
medium, and the lysate transferred to an Eppendorf tube. A further 350µl of 70% 
ethanol was then added and mixed well, before 700µl of sample (including precipitate) 
was transferred to an RNeasy spin column placed in a 2ml collection tube, and 
centrifuged in an Eppendorf 5415R centrifuge for 15 seconds at 8161 xg to bind total 
RNA to the column and wash off buffer RLT. Flow through was discarded.  
On-column DNAse digestion was undertaken using a Qiagen DNase On-Column 
Digestion kit. Initially, 350µl of buffer RW1 was added to the column. Buffer RW1 
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contains a guanidine salt, as well as ethanol, and is used as a stringent washing buffer 
that efficiently removes biomolecules such as carbohydrates, proteins, fatty acids etc., 
that are non-specifically bound to the silica membrane. At the same time, RNA 
molecules larger than 200 bases remain bound to the column. Once added, the column 
was centrifuged for 15s at 8161 xg and flow-through discarded. DNase incubation mix 
was prepared by suspending 10μl DNase I stock solution to 70μl Buffer RDD in mini 
Eppendorf. The mixture was applied directly to the spin column membrane and 
incubated at room temperature for 15min. 350μl of buffer RPE – a mild washing buffer 
which removes traces of salts present on the column from earlier buffers - was added 
to the column which was centrifuged for 15s at 8161 xg and the flow-through discarded. 
Two further washes with buffer RPE were then undertaken as above, before the column 
was placed into a new 2ml collection tube and centrifuged at full speed for 1 minute to 
dry the membrane.  
The RNeasy column was placed into a new 1.5ml collection tube, before 30-50µl of 
RNase-free water was added to the column membrane. The column was then 
centrifuged for 1minute at 8161 xg to elute the RNA into a collection tube, before 
quantification and storage at -20˚C.  
RNA Quantification and Quality check  
Following collection of RNA, basic quantification was done via photometric analysis 
using a Thermo Fisher Nanodrop 2000 spectrophotometer. In short, 2μl of RNase-free 
water was added to the instrument measuring platform to provide a blank, followed by 
2μl of purified RNA. Quantity was determined by absorbance at 260nm, and purity as a 
ratio between absorbance readings at 260 and 280nm (pure RNA having a ratio of 
between 1.9 and 2.1).  
Additional quantification and integrity readings were undertaken via chip-based gel 
electrophoresis using the Agilent Bioanalyzer 2100. Chip-based electrophoresis uses the 
chip as an integrated electrical circuit, with each electrode from the machine’s cartridge 
providing independent power. The system drives charged molecules, such as RNA, along 
a voltage gradient which pushes them through a sieving polymer matrix, separating 
molecules by size, with the smaller ones migrating faster than the larger ones. Detection 
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is by laser-induced fluorescence (LIF), with dye molecules intercalating with RNA 
strands. The resulting gel image and details from the electropherogram (plot of 
fluorescence intensity vs size/migration) can then be compared to a ladder containing 
components with known sizes to determine molecule size. Quantification is achieved by 
comparing the area under the upper marker (markers are internal standards) to the 
sample peak areas. As the concentration of the upper marker is known, sample 
concentration can be calculated. Integrity of the RNA sample is achieved by determining 
ribosomal ratio, and the presence/absence of degradation products.   
To prepare samples for the bioanalyzer, 2μl of each sample was pipetted into small 
Eppendorf tubes. For those samples with an indicated concentration of >500ng/μl, 
samples were diluted 1:1 with RNase free water to ensure accurate readings (1.5μl 
sample:1.5μl RNase free water). Samples were then heat denatured for 2minutes at 
70˚C. 65μl of Agilent RNA 6000 nanogel matrix was vortexed for 10 seconds, before 1μl 
of RNA 6000 nanodye concentrate was added. The gel-dye matrix was then vortexed to 
mix further, before being spun in a centrifuge for 10 minutes at 15996 xg. A 16-pin 
bayonet electrode cartridge was loaded into a priming station, and 9μl of gel-Dye matrix 
placed into the bottom of the relevant well, before being syringe pressurised for 30 
seconds. 9μl of gel-dye matrix was then loaded to two other wells, alongside a further 
well containing 5μl of the RNA 6000 nanomarker to complete chip preparation. Once 
the chip was ready, 1μl of sample was pipetted into the base of each well, and 1μl of 
ladder added to a final well, as per a pre-prepared chip layout plan. The chip was placed 
on an IKA Vortex mixer and well contents mixed for 1min at 2400rpm before reading 
was undertaken on the Bioanalyzer. The resulting output provided graphed marker and 
2 ribosomal peaks (18s and 28s), together with RNA concentration (ng/μl), rRNA ratio 
(28s:18s) and RNA Integrity number (on a scale of 1-10).  
Reverse Transcription 
To perform PCR using RNA as a template, RNA must first be reverse-transcribed to 
complementary DNA (cDNA) in a reverse transcription (RT) reaction. This was carried 
out as a 1-step RT-PCR reaction using PrimerDesign Reverse transcriptase premix-2Ô, 
and RT negative control premix for controls. A final concentration of 5ng/μl was required 
for the PCR reaction. Therefore, in order to prepare enough cDNA to perform all PCR 
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using samples that were reverse-transcribed in the same reaction, the volume required 
to undertake full analysis was calculated (including 10% extra in case of pipetting or 
other user errors) using results from the RNA quantification, and the RT reaction 
planned based on this (Appendix 3).  
For the RT reaction, the work area was prepared by decontaminating with RNase Zap™, 
and nuclease-free pipettes and plastics used in all handling and transfer. The pre-
calculated volume of RNA sample was added to 20µl of RT premix 2 into 0.2μl thin wall 
reaction tubes, including RNase-free water where required to balance the reaction 
volume (volume can be varied without affecting the efficiency of the RT reaction). 
Samples were then incubated in a thermal cycler at 42˚C for 20 minutes for the RT 
reaction to occur, then 72˚C for 10 minutes to heat inactivate any other products. Based 
on the calculations, the resultant cDNA was finally diluted with RNase-free water in 
order to adjust it to 5ng/µl concentration required for PCR, before being stored at -20˚C 
until required.  
geNorm Pilot Experiment for Reference Gene Selection 
Use of multiple stable housekeeping (stable reference) genes (HKG) is the method of 
choice for RT-qPCR (Vandesompele et al., 2002). In order to select the most appropriate 
reference genes for use during PCR, a geNorm reference gene selection kit containing a 
12 gene panel was used. geNorm is a recognised gold standard in the industry for 
selection of reference genes from which to normalise experimental data. The gene panel 
provided for mus musculus cell lines is:  
• Mus musculus actin, beta, cytoplasmic (ACTB), mRNA; 
• Mus musculus glyceraldehyde-3-phosphate dehydrogenase (GAPDH), mRNA; 
• Mus musculus ubiquitin C (UBC), mRNA; 
• Mus musculus beta-2 microglobulin (B2M), mRNA; 
• Mus musculus phospholipase A2 (YWHAZ), mRNA; 
• Mus musculus ribosomal protein L13a (RPL13A), mRNA; 
• Mus musculus calnexin (CANX), mRNA; 
• Mus musculus cytochrome c-1 (CYC1), mRNA; 
• Mus musculus succinate dehydrogenase complex, subunit A (SDHA), mRNA; 
• Mus musculus 18S rRNA gene; 
• Mus musculus eukaryotic translation initiation factor 4A2 (EIF4A2), mRNA; and 
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• Mus musculus ATP synthase subunit (ATP5B), mRNA. 
 
The PCR laminar flow hood was 
prepared by cleaning with RNase 
Zap™, and the area, plus all plastics 
and pipettes further sterilized 
using UV light before work 
commenced. To prepare the 
primers, they were first pulse spun 
to ensure that dry primer mix was at the base of the Eppendorf tube, then re-suspended 
using 200µl primer mix contained in the kit. PCR reaction mix was prepared using Primer 
design 2x PrecisionPLUS™ qPCR Mastermix with SYBR green (Table 10). Once the 
reaction mix was prepared, 15µl was pipetted into each well on a Primer Design 
BrightWhite qPCR plate. Following this, 5ul of diluted cDNA at 5ng/μl concentration was 
added to each well according to a pre-prepared plate plan. The plate was sealed with an 
optical seal and centrifuged for 1 minute at 19 xg to mix well contents, before being 
transferred to a StepOneä qPCR system, and run according to the thermal cycling 
conditions outlined within figure 40.  During this, three main steps are undertaken 
repeatedly: i) denaturation; heating of samples to 95°C to denature template DNA, 
disrupting hydrogen bonds and interactions holding base pairs together, ii)  annealing; 
cooling to around 60°C to allow primers to base pair (anneal) to complementary regions 
on the template, and iii) extension; where temperature is  increased to allow the 
polymerase to extend the primer to form a nascent DNA strand.  After completion of 40 
cycles, the cycler holds temperature between 4°C and 10°C to maintain integrity of the 
products.  
 
Table 10: PCR Reaction mix preparation (per well) as provided by 
PrimerDesign. *working concentration of primers = 300nM in a 20µl 
reaction. 
Component  Vol. for 1 reaction 
Resuspended primer mix 1µl* 
PrimerDesign 2x PrecisionPLUSä 
Mastermix 
10µl 
RNAse/DNAse free water 4µl 
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Figure 40: Amplification conditions for PCR 
 
Results were then analysed using qbasePLUS software, a programme based on Microsoft 
Excel which incorporates data quality controls and uses an advanced relative 
quantification model with efficiency correction, multiple reference gene normalization, 
inter-run calibration and error propagation along each step of the calculations 
(Hellemans et al., 2007). This ranked housekeeper genes (HKG) in order of stability of 
expression, providing reference values for acceptable gene stability (geNorm M value), 
and the results were used to dictate reference genes used for later PCR. 
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 Primer Design & Efficiency testing 
 Following an extensive literature search, primers were designed based on published 
literature and via cross-reference to NCBI-NIH Primer-BLAST, a free-to-use online 
offering which helps users make primers that are specific to the intended PCR target. 
Primer-BLAST uses algorithms to help with primer choice, and screens these against a 
database which helps to avoid selection of non-specific amplifications (Ye et al., 2012).  
The final primer designs were procured from Eurofins genomics (Table 11). Primers were 
provided as separate Forward and 
Reverse preparations. Upon arrival, 
primer tubes were first pulse spun to 
ensure that dry primer mix was at the 
base of the Eppendorf tube. They were 
then re-suspended a volume of 
RNAse/DNase free water, calculated to 
provide a starting concentration of 
100pMol/µl. To ensure complete 
Component 1 Reaction 
Resuspended Eurofins primer mix 
@6pMol/ul (F+R) 
2ul 
PrimerDesign 2x PrecisionPLUS™ 
Mastermix 
10ul 
RNase/DNase free water 3ul 
Template (25ng) 5ul @5ng/μl 
Final volume 15ul 
Primer Identity Amplicon characteristics 
Name Variant Accession 
Number 
Primer Sequence Size (base 
pairs) 
Tm (˚C) GC 
content 
(%) 
LH-R - NM_013582 F: CTCGCCCGACTATCTCTCAC 
R: ACGACCTCATTAAGTCCCCTG 
20 
21 
61.4 
59.8 
60 
StaR - NM_011485 F: GCAGCAGGCAACCTGGTG 
R: TGATTGTCTTCGGCAGCC 
18 
18 
60.5 
56.0 
66.7 
CYP11A1 Subfamily A, 
Polypeptide 1, 
Transcript 
Variant 1 
NM_019779 F: 
ACATGGCCAAGATGGTACAGTTG 
R: ACGAAGCACCAGGTCATTCAC 
23 
21 
60.6 
59.8 
47.8 
3ß-HSD Transcript 
variant 1 
NM_008293 F: TTCCCAGGCAGACCATCCTA 
R: TCTGTTCCTCGTGGCCATTC 
20 
20 
59.4 
59.4 
55 
Table 12: User-supplied PCR reaction mix preparation/well 
Table 11: Primers designed for PCR work 
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resuspension, each tube was vortexed, then allowed to stand for 5mintes before being 
vortexed again and stored at -20˚C when not in use. Primer Design required 6pMol of 
forward and 6pMol of reverse primer for a PCR reaction mix using Primer Design 
Mastermix, therefore a 6pMol/µl solution was prepared, and F and R primers were 
mixed just prior to addition to the mix (Table 12).  
For the calculation of gene expression via the delta delta Ct method used (ΔΔCт), it is 
assumed that PCR primer efficiencies are comparable between the gene of interest 
(GOI) and the housekeeper gene(s) (HKG). In order to ensure that this assumption is 
valid, primer efficiencies were calculated using a standard curve.  Ideal primer efficiency 
is between 90-110%. To prepare the standard curve, a sample of untreated cDNA was 
diluted in RNase-free water according to table 13.  
 
 
 
 
 
 
 
 
RT-qPCR was performed under the same conditions as the GENORM analysis (Figure 40), 
with each sample in technical and biological triplicate per GOI, and results were analysed 
within Microsoft Excel.  
In addition, a further set of custom-designed primers was obtained from Primer Design 
(Table 14). These primers have guaranteed efficiency of >90% and are suitable for use 
with the delta Ct method without need for mathematical correction. To prepare the 
primers, they were first pulse spun to ensure that dry primer mix was at the base of the 
Eppendorf tube, then re-suspended in 660µl RNAse/DNase free water contained in the 
Tube Sample Volume sample Volume RNAse-free 
water 
A Stock cDNA 85ul 0µl 
B 1/10 dilution 8.5ul tube A 76.5µl 
C 1/100 dilution 8.5ul tube B 76.5µl 
D 1/1000 dilution 8.5ul tube C 76.5µl 
E 1/10,000 dilution 8.5ul tube D 76.5µl 
Table 13: Serial Dilutions of untreated cDNA to generate standard curve 
for primer efficiency determination 
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kit. To ensure complete resuspension, each tube was vortexed, then allowed to stand 
for 5mintes before being vortexed again and stored at -20˚C when not in use. 
 
Table 14: Primer Design Custom-designed primers 
 
PCR  
Once all preparatory work had been completed and the process optimised, the final 
experimental PCR was carried out for the GENORM panel analysis for both the Primer 
Design GOI primer set, as well as GAPDH ACTB and YWHAZ HKGs. Each PCR reaction was 
prepared according to Table 15. A standard plate setup was adhered to for each gene, 
which included each treatment in triplicate, each sample in biological triplicate, as well 
as no template controls (NTC) using RNase-free water, and no reverse transcriptase 
control (NRT) using RNA samples which underwent thermal cycling in the absence of 
Primer Identity  Amplicon characteristics 
Name Variant Accession 
Number 
Primer Sequence Size 
(base 
pairs
) 
Amplico
n Length 
Tm 
(˚C) 
GC 
conten
t (%) 
LH
-R
 
- NM_013582 F: TTCACCCAAGACACTCCAATG 
R: AGCCAAATCAACACCCTAAGG 
21 
21 
96 56.
4 
56.
4 
47.6 
St
aR
 
- NM_011485.
5 
F: TGGCTGCTCAGTATTGACCTG 
R: AGGTGGTTGGCGAACTCTATC 
21 
21 
92 52.
4 
52.
4 
52.4 
CY
P1
1 A
1 
Subfamily 
A, 
Polypeptid
e 1, 
Transcript 
Variant 1 
NM_019779 F: TGCTGTCTACCAGATGTTCCAC 
R: CCTTCCAGGTCTTAGTTCTGAGG 
22 
23 
89 57.
5 
57.
5 
50 
3ß
-H
SD
 
Transcript 
variant 1 
NM_008293 F: CCCCTGCTCAGAGACAAACATA 
R:AAGGCAAGATATGATTTAGGAC
T 
TGAA 
22 
27 
125 57.
2 
57.
3 
50 
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reverse transcriptase (Primer Design noRT). Once 
the reaction mix was prepared, 15µl was 
pipetted into each well on a Primer Design 
BrightWhite qPCR plate. Following this, 5ul of 
diluted cDNA at 5ng/μl concentration was added 
to each well according to the plate setup plan 
(Table 15). The plate was sealed with an optical 
seal and centrifuged for 1 minute at 19 xg to mix 
well contents, before being transferred to a 
StepOne qPCR system and run according to the 
amplification conditions outlined within Fig. 40. 
Results were then analysed using Microsoft Excel 
and Graphpad Prism.  
 
Protein Expression via Western Blot  
To investigate protein expression, SDS-PAGE gel electrophoresis followed by Western 
Blot was undertaken, using both fluorescent and horseradish peroxidase conjugated 
secondary antibodies. For the protein work, antibodies were selected that matched to 
some of those used for histological analysis of animal tissues following ENM exposure in 
vivo and procured from Santa Cruz biotechnology.   
Protein Extraction 
Preparation of protein samples for Western blotting was undertaken for ENM-110, 111 
and 300 as follows. TM3 cells were cultured for 24 hours in a 6 well plate at a density of 
2.75x105 cells/well, either with or without addition of testosterone to allow 
determination of whether the cells were stimulated in any way following hormone 
exposure. This was done by adding 3μl of 1nM T or ethanol vehicle to each well to give 
final concentration of 9nM in each well of the plate.  Cells were treated with ENM at 
sub-lethal doses (0,1,2,4,6 and 8μg/ml, equating to 0, 0.32, 0.63, 1.26, 1.89 and 2.52 
μg/cm2) and incubated for a further 24 hours. Following this, plates were washed with 
1ml phosphate buffered saline (PBS) on ice twice, scraped and transferred to ice cold 
tubes. Tubes were centrifuged at 146 xg for 5 minutes at 4 C̊. PBS was removed, and the 
Table 15: PCR reaction mix, prepared according 
to protocol from PrimerDesign. 
Components Vol. for 1 
reaction 
PrecisionPLUS 10µl 
Primer/Probe mix 1µl 
Template (25ng) 5µl 
RNAse/DNAse free 
water 
4µl 
Final Volume 20µl 
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pellet re-suspended in 3x its own volume of lysis buffer containing HALT protein inhibitor 
cocktail (Thermo Scientific #87786), before being incubated on ice for 20 minutes. 
Following incubation, tubes were centrifuged at 13,793 xg at 4˚C for 5 minutes. The 
supernatant was then removed, and a Bradford assay performed to determine protein 
content before storing samples at -80˚C.  
The Bradford assay 
The Bradford assay is a colorimetric protein assay, based on the shift in absorbance of 
Coomassie Brilliant Blue dye. Under acidic conditions the red form of the dye is 
converted into its bluer form to bind to the protein being assayed. When protein binds 
to the dye, it stabilizes the blue form of the Coomassie dye. Consequently, the amount 
of the dye-protein complex present in solution is a measure of the protein concentration 
and can be estimated by measuring its absorbance at 600nm. Reference standards were 
prepared from 0 - 1500μg/ml protein. 5μl standards and protein extract samples (diluted 
1:5) were added to a 96 well plate, followed by 250μl Bradford reagent. After 5 minutes 
of incubation at room temperature, the plate was read at 600nm and the absorbance of 
samples vs standards was used to determine the protein concentration of each sample. 
All readings were adjusted against the absorbance of a zero standard.  
Western Blot 
Western blotting is a technique in which gel electrophoresis is used to separate 
macromolecules such as proteins in a sample by size (kDa). Introduced in 1979 by 
Towbin et al, blotting involves the transfer of proteins from gel to a nitrocellulose or 
polyvinylidene difluoride (PVDF) membrane and blocking to prevent nonspecific binding 
(Towbin et al., 1979). The membrane is then probed with primary antibodies specific to 
the target protein of interest, and a secondary antibody specific to the host species of 
the primary in order to produce a detectable signal. Detection may be undertaken via a 
number of established methods, including colourimetric reactions, fluorescence and 
chemiluminescence (ThermoFisher-Scientific, 2019b).  
Fluorescence Detection via LiCor 
Fluorescence-based systems for detection of proteins are based on conjugation of 
fluorophores (fluorescent molecules) to secondary antibodies, which attach to the 
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primary antibody on the protein of interest (Fig. 43, right). Within the detection system, 
a light source emits high energy photons and excites the fluorophore, allowing it to leave 
ground state (S0) and enter a higher energy state (S‘1). Some of this energy dissipates 
allowing the fluorophore will enter a relaxed state (S1). Finally, a photon of light at a 
slightly lower energy and longer wavelength than the light source itself is emitted (due 
to the energy dissipation that has already occurred), returning the fluorophore to 
ground state again (S0). The emitted light signal is captured by a camera to produce the 
final image.  
For fluorescent detection, 0.75mm thickness gels were prepared in the lab following an 
in-house protocol (Frazer, 2014). Later these were later replaced by mini-PROTEAN® 
TGX™ pre-cast gels, purchased from BioRad in order to reduce preparation time on each 
blot. Protein samples were prepared at 1μg/ml (sufficient for 10μg protein/lane) in 
loading sample buffer and boiled for 5 minutes at 95 C̊ for 5 minutes. 10μl of sample was 
then loaded to each lane of the gel, with a final lane containing 4ul PageRuler™ Plus pre-
stained Protein ladder (10-250kDa). Electrophoresis was run at 100V for 90minutes (or 
until the protein ladder reached the end of the gel). Gels were then removed, and 
transfer to nitrocellulose membrane was undertaken for 1 hour at 100V with the tank 
on ice.  
Once transfer was complete, the nitrocellulose membrane was blocked in Odyssey 
Blocking Buffer diluted 1:1 with PBS for 1-2 hours at room temperature. Odyssey 
blocking buffer is a mammalian protein-free blocker in PBS, which helps to prevent non-
specific protein binding as the membranes have a high affinity for proteins. Following 
blocking, the primary antibody of interest and reference antibody (Actin) were prepared 
according to the dilutions outlined within Table 16 (page 163). 
The membrane was cut in half, and the Ab of interest added to one membrane, while 
the reference Ab was added to the other. Incubation took place overnight at 4 C̊ on a 
laboratory rocker to ensure distribution of the antibodies across the membranes. The 
following morning, the membrane was rinsed for 4 cycles of 5 minutes with 1x PBS-
Tween (PBS-T) on a rocker at room temperature, before incubation with a fluorescent 
secondary antibody (Odyssey antibody prepared in Odyssey blocking buffer with 0.1% 
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Tween) at room temperature for 1 hour in the dark with shaking. Following a further 
rinse cycle with PBS-T, a final rinse with PBS was undertaken before reading the 
membranes on an Odyssey infrared imaging system (Li-Cor) in both 700 and 800 channel 
settings and undertaking further analysis using Image Studio Lite software. 
Enhanced Chemiluminescence (ECL) Detection via GBox 
Chemiluminescent Western blotting was used for some blots, as it is a highly sensitive 
detection system for looking at single proteins and issues were encountered with 
detection on the fluorescent LiCor system. The selected system is luminol-based, using 
horseradish peroxidase (HRP) conjugated secondary antibodies. In the presence of HRP 
and peroxidase buffer, the luminol in the reaction mix applied oxidises to an excited-
state product called 3-aminopthalate which emits light as it decays. (Fig. 43).  
Sample preparation and electrophoresis was identical to that used for LiCor fluorescent 
detection. However, gels were prepared according to a plan which allowed one 
membrane to be stained for all 4 antibodies (Fig. 42 and 43).  
Once the gel was run, PVDF membrane was activated in 100% methanol for 5 minutes, 
then rinsed in blotting buffer. Transfer was undertaken at 100V for 60minutes with the 
tank on ice. Once transfer was complete, the PVDF membrane was blocked in a solution 
of PBS-tween containing 10% Marvel (milk powder containing the phosphoprotein 
casein which binds to unoccupied sites on the membrane) for 1-2 hours at room 
temperature. Primary antibodies were prepared as in Table 16, membranes were cut 
down the centre of each ladder, and incubated with separate primary antibodies 
overnight at 4˚C on a rocker.   
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The following day, the membrane was rinsed with PBS-tween (0.05%tween) and washed 
for 4x5 minutes (applying fresh buffer each time). The secondary antibodies were 
prepared (in PBS-Tween 0.05% with 5% marvel) and incubated with the membrane for 
1 hour at room temperature with shaking. As these secondary antibodies were 
horseradish peroxidase conjugated, this incubation did not need to be in the dark. 
Following a further rinse cycle with PBS-T (rinse, followed by 4x5minute wash), the 
membrane was rinsed with PBS to remove residual tween.  
Amersham ECL Prime Western Blotting Reagents were prepared according to 
manufacturer’s specification (GE Healthcare Life Sciences), with aliquots of both luminol 
and peroxidase solution being allowed to warm to room temperature before use 
(luminol solution was kept in the dark until application to the membrane). ECL reagents 
were mixed just prior to use, then carefully pipetted onto the membrane laid on a clear 
plastic surface in preparation for imaging.  Imaging was undertaken using the GBox 
Chemi Gel Doc using GeneSys software for automatic optimization of the sensitive image 
capture step. Subsequent analysis was undertaken using Image J software.  
 
Figure 41: Example ECL Actin stain (NM-110 & 
NM-111 n=1). 0,4 and 8μg/µl represent doses 
of 0, 1.26 and 2.52µg/cm2 
Figure 42:  Gel/Membrane layout for staining against 4 antibodies and analysis by 
ECL. 0, 4 and 8μg/µl represent doses 0f 0, 1,26 and 2.52µg/cm2. 
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Figure 43: Western Blot detection methods. LHS is enhanced chemiluminescence as used with the GBox system, the 
equation representing the chemical change required to produce light. RHS is fluorescence as used with the LiCor 
system, the lower portion of the image representing excitation of a fluorophore bound to a secondary antibody  and its 
subsequent release of light. Image compiled from resources provided by BioRad and GE Life Sciences. 
Bryony L Ross PhD 164 
 
Table 16: Antibody Preparation for Western Blotting analysis. Detailed is primary antibody and its preparation for detection in either fluorescent (LiCor) or ECL (GBox) based systems, along with secondary antibodies 
and their respective preparation for each detection method.  
1˚ 
ANTIBODY 
RAISED 
IN 
MOLECULAR 
WEIGHT (kDa) 
Preparation 
(Fluorescent) 
Preparation 
(ECL) 
2˚ ANTIBODY 
(Fluorescent) 
Preparation 
(Fluorescent) 
2˚ ANTIBODY 
(ECL) 
Preparation 
(ECL) 
Actin 
(Santa 
Cruz) 
Goat 
Polyclonal 42kDa 
1:10,000 
2ul in 10ml 
Odyssey BB 
+0.1%Tween 
1:10,000 
2ul in 10mll 
PBS-T with 
10% Marvel 
Alexa-Fluor 
Donkey α Goat 
1:10,000 
1ul in 10ml 
Odyssey BB 
+0.1%Tween 
Dako 
Rabbit α Goat 
1:5000 
2ul in 10ml PBS 
0.05%tween + 
5% Marvel 
LH-R 
(Santa 
Cruz) 
Rabbit 
Polyclonal 85kDa 
1:200 
50ul in 10ml 
Odyssey BB 
+0.1%Tween 
1:200 
50ul in 10ml 
PBS-T with 
10% Marvel 
Alexa-Fluor 
Goat α Rabbit 
1:10,000 
1ul in 10ml 
Odyssey BB 
+0.1%Tween 
Dako 
Goat α Rabbit 
1:5000 
2ul in 10ml PBS 
0.05%tween + 
5% Marvel 
AR 
(Santa 
Cruz) 
Rabbit 
Polyclonal 110kDa 
1:100 
50ul in 5ml 
Odyssey BB 
+0.1%Tween 
1:100 
50ul in 5ml 
TBS-T 
w.10% 
Marvel 
Alexa-Fluor 
Goat α Rabbit 
1:10,000 
1ul in 10ml 
Odyssey BB 
+0.1%Tween 
Dako 
Goat α Rabbit 
1:5000 
2ul in 10ml PBS 
0.05%tween + 
5% Marvel 
StaR 
(Santa 
Cruz) 
Goat 
Polyclonal 30kDa 
1:100 
50ul in 5ml 
Odyssey BB 
+0.1%Tween 
1:100 
50ul in 5ml 
TBS-T 
w.10% 
Marvel 
Alexa-Fluor 
Donkey α Goat 
1:10,000 
1ul in 10ml 
Odyssey BB 
+0.1%Tween 
Dako 
Rabbit α Goat 
1:5000 
2ul in 10ml PBS 
0.05%tween + 
5% Marvel 
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Statistical Analysis  
Calculations to determine components for PCR reactions based on RNA concentration 
measurements were undertaken in Microsoft Excel.  
geNorm pilot experiment data was inputted to qbase+ software, which uses the full 
dataset for all 12 potential HKGs to calculate the gene expression stability measure ‘M’ 
for a reference gene as the average pairwise variation ‘V’ for that gene with all other 
tested reference genes. Stepwise exclusion of the gene with the highest M value allows 
ranking of the tested genes according to their expression stability, based on the 
principles and calculations described previously by Vandesompele et al. (Vandesompele 
et al., 2002). 
Calculation of Primer efficiency was undertaken in Microsoft Excel by calculating 
average Ct values for each serial dilution of primer, alongside the log of each sample 
dilution, then using this to produce an R2 value for the slope of the regression between 
the two. Primer efficiency was then calculated as a percentage value using the following 
equation:  
!"#$%"	'((#)#%*)+(%) = 0103 456789 − 1; ∗ 100  
PCR analysis produced data files within StepOne software, which were exported to 
Microsoft Excel. These files contained comprehensive raw information and readings on 
melt temperatures, multicomponent data, amplification data and cycle thresholds (Ct). 
From this, Ct values for each sample in triplicate were used to calculate a mean Ct value 
per sample. These values were used to calculate relative changes in gene expression via 
the ΔΔCт method (Hellemans et al., 2007, Livak and Schmittgen, 2001). 
In order to calculate fold change in expression, a geometric mean Ct value for each RNA 
sample was calculated from the mean Ct values across the three HKGs. This was then 
subtracted from the mean Ct value of the corresponding GOI, to produce a ΔCт value. 
ΔΔCт was then calculated by subtracting the ΔCт of the experimental control from the 
ΔCт of the treated sample. This was converted into a fold difference in gene expression 
using the following equation (Livak and Schmittgen, 2001):  =>?@	A#((%"%*)%	#*	B%*%	%CD"%EE#>* = 23(GGHт).  
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The fold difference was then logged to the base 2 in order to normalise the fold change 
for display as either positive or negative according to whether expression increased or 
decreased. Once ΔCт and log fold change were derived, these were transferred to 
Graphpad Prism v7; ΔCт values were used for 1-way ANOVA with post-hoc Tukey’s test 
used to determine statistical significance of any changes observed, and log fold change 
values were used to plot the outcomes graphically.  
Densitometry plots from Western Blots were analysed for fluorescent detection via 
Image Studio Lite (LI-COR Biotechnology), and for ECL via Image J. In short, the blot 
image was adjusted so that bands were clearly visible on the image. The area around 
each band was then selected, background intensity subtracted, and the intensity of the 
selected bands imported to Microsoft Excel and Graphpad Prism for further analysis and 
graphing.  
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Results 
RNA Quantification and Integrity 
Initial analysis of RNA quantity was undertaken via spectrophotometric analysis using a 
Thermo-Fisher Nanodrop 2000 spectrophotometer. This was used to guide sample 
preparation for more accurate analysis using chip-based electrophoresis on the Agilent 
Bioanalyzer 2100. The bioanalyzer uses laser-induced fluorescence detection to produce 
both densitometry plots (Fig. 44) and electropherograms which are used to calculate 
RNA quantity (concentration: ng/μl) and RNA integrity number (RIN).  
Quantification was undertaken by 2100 Expert software, which uses a ladder containing 
components of known sizes to plot a standard curve of migration time vs. molecule size, 
alongside data from the internal standard ‘RNA 6000 nanomarker’ to align the ladder 
data and correct for drift effects over the course of each chip run. These known values 
are then used to quantify the concentration of each RNA sample on the chip in ng/μl. 
The RNA Integrity Number (RIN), a measure of integrity of total RNA samples is also 
produced, using Agilent Biotechnologies’ proprietary method which appraises the entire 
electrophoretic trace of the sample, including presence or absence of degradation 
products. Generally, it is considered that an RIN of >7 indicates good quality RNA.  
The results (Appendix 4) show that whilst the Nanodrop is a useful initial indication on 
presence or absence of RNA in an extracted sample and its purity, concentration 
reported tended in many cases to be a lower estimate of RNA content than those 
Figure 44: Densitometry plot of chip-based electrophoresis for RNA samples from cells treated with NNM-110 and NM-
111 Zin Oxide nanoparticles. 
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obtained when the sample underwent detailed quantification using the Bioanalyzer. 
RNA concentrations were found to be sufficient to proceed with PCR in 24/27 samples, 
and consistently high RNA integrity scores (RIN) indicated that RNA extraction had been 
successfully undertaken to the required standard. For cell treated with NM-300 at 
2.52μg/cm2 aberrant readings were recorded, indicating that the cells and their RNA 
content were potentially degraded. This finding was in line with the results discussed 
within chapter 3, which indicated that although 2.52μg/cm2 was considered to be a sub-
lethal dose of NM-300, the nature of the NM preparation meant that over time, ionic 
silver was released from the nanoparticles, leading to an increase in potency with 
storage which in turn reduces the threshold for loss of cell viability.  
 
GENORM 12 Gene Panel Analysis 
geNorm analysis on 18 representative samples against 12 target genes was completed 
using qbase+ software. Analysis confirmed the run layout was correct, with all samples 
measured in the same run against a given reference target. Results of the analysis 
showed that the optimal number of reference targets in this experimental situation is 3, 
as geNorm average pairwise variation V < 0.15 when comparing a normalization factor 
based on the 3 or 4 most stable targets (Fig. 45). As such, the optimal normalization 
factor can be calculated as the geometric mean of reference targets GAPDH, ACTB and 
YWHAZ. High reference target stability was observed (average geNorm M ≤ 0.5). This is 
typically seen when evaluating candidate reference targets on a homogeneous set of 
samples (e.g. untreated cultured cells, or blood from normal individuals). Fig. 46 & 47 
show the stable expression and behaviour of all three selected housekeeper genes.  
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Figure 45: geNorm pairwise variation across 12 potential reference genes. Optimal number of targets confirmed to be 3, with 
V<0.15 for this number (sample n=18). 
 
 
 
Figure 46: geNorm M values for 12 panel kit. GAPDH, ACTB and YWHAZ were confirmed as having the most stable expression 
across all samples tested (sample n=18) 
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Figure 47: Melt Curves for GAPDH, YWHAZ and ACTB (L to R) as selected using geNorm analysis. 
 
Primer Efficiency testing  
Efficiency testing was undertaken for each of the primers designed based on published 
literature and using NBCI – NIH Primer –BLAST was undertaken. If primer efficiency is 
100% then Ct values in 10-fold dilutions will be 3.3 cycles apart, representing a 2-fold 
change for each change in Ct. Desirable primer efficiencies lie between 90% and 110%. 
However, initial analysis of the amplification plots and melt curves generated indicated 
that there may be issues with the primers, as all except StaR showed late and unevenly 
distributed cycle amplification, and melt curves were not clean in appearance (Fig. 48).  
Further analysis of the Ct values showed that primer efficiency was poor, with calculated 
efficiencies varying hugely between primers and all indicating R2 values far lower than 
the desired >0.90 (Table 17).  
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Figure 48: Melt curves generated during primer efficiency testing. 
 
  
LH-R CYP11A1 
3β-HSD StaR 
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Because of the issues encountered despite extensive research and planning and use of 
primers which were mostly already published in the 
literature, the decision was made to move to using 
custom-designed primers from PrimerDesign.  
PCR 
Analysis of the output from RT-qPCR using 
PrimerDesign custom primers revealed several 
interesting findings. Initial analysis of the 
Amplification Plots and Melt Curves confirmed that 
the primers were behaving as predicted, with 
amplification plots showing reliable cycle threshold 
(Ct), and clear single-peak melt curves, indicating 
the primers were working well and with good 
Primer Slope R Squared Plot 
LH-R -0.51 0.69 
 
CYP11A1 -0.15 0.28 
 
3ß-HSD -0.23 0.31 
 
StaR 0.06 0.59 
 
33
33.5
34
34.5
35
35.5
36
36.5
-5 -4 -3 -2 -1 0 1
Ct
Log	(sample	quantity)
35
35.2
35.4
35.6
35.8
36
36.2
36.4
-5 -4 -3 -2 -1 0 1
Ct
Log	(sample	quantity)
33.8
34
34.2
34.4
34.6
34.8
35
35.2
35.4
35.6
-5 -4 -3 -2 -1 0 1
Ct
Log	(sample	quantity)
33.8
33.85
33.9
33.95
34
34.05
34.1
34.15
34.2
34.25
-5 -4 -3 -2 -1 0 1
Ct
Log	(sample	quantity)
Table 17: Efficiency testing of Primers sourced from Literature and Primer-BLAST searching 
Figure 49: Example melt curve for PrimerDesign custom 
primer. Curve shown is for StaR. Blue region at base is 
no template control data. 
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efficiency (Fig.49). Ct values were converted to fold-change in gene expression, and 
results graphed. The change in gene expression is shown as the log to the base 2 of fold 
difference in expression order to allow display as either positive or negative according 
to whether expression increased or decreased. 
 
For NM-110 uncoated zinc oxide, it appeared that there was a small reduction in 
expression of 3ß-HSD, LH-R and CYP11A1. There was little to no change recorded in 
expression for StaR recorded (Fig. 50). Statistical analysis of these results showed that 
no changes were significant when tested using 1-way ANOVA (Table 18, p175) implying 
that overall for this sample size there is little evidence for a change in expression from 
any of the genes tested. 0,4 and 8μg/µl represent doses of 0, 1.26 and 2.52µg/cm2.  
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Figure 50: mRNA expression from TM3 cells exposed to NM-110 shown as log(2) ratio fold difference compared to vehicle 
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For NM-111 uncoated zinc oxide, visual analysis of the graphed data appeared to show 
an increase in expression for all genes with increasing dose of nanomaterial applied 
(Fig.51). This was further investigated by ANOVA and Tukey’s post-hoc analysis (Table 
18), which showed that for StaR the change in expression was significant from 
1.26µg/cm2, and for CYP11A1 the change in expression was significant from 2.52µg/cm2. 
However, for LH-R and 3ß-HSD, no significant change in expression was found. It was 
notable that for 3b -HSD the probability of a difference in expression was 0.085, which 
indicates a 90% confidence level in changed expression compared to vehicle.   
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Figure 51: mRNA expression from TM3 cells exposed to NM-111 shown as log(2) ratio fold difference compared to vehicle 
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For NM-300 silver, all genes appeared to show an increase in expression in treated cells 
compared to control (Fig. 52). However, despite the trend in the data, none were shown 
to be significant by one-way ANOVA (Table 18). However, it was notable that for StaR 
and 3b -HSD the probabilities of a difference in expression were 0.096 and 0.077 
respectively, which indicates a 90% confidence level in changed expression compared 
to vehicle. For this dataset, no Tukey’s multiple comparison test was undertaken due to 
the lack of RNA for TM3 cells treated with 2.52µg/cm2 NM-300.  
  
Figure 52: mRNA expression from TM3 cells exposed to NM-300 shown as log(2) ratio fold difference compared to vehicle. 
Graphs show only lower dose (4µg/µl or 1.26µg/cm2) data because cells treated with 8µg/µl (2.52µg/cm2) did not yield any RNA. 
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Table 18: Statistical analysis of RT-qPCR for 4 GOI in TM3 cells treated with NM-110, NM-111 and NM-300. It is worth noting that 
as little RNA was detected in samples treated with 8µg/µl NM-300, no Tukey’s multiple comparisons test was completed. 
 
NM-110 NM-111 NM-300 
GOI 
ANOVA 
Result 
Tukey Result 
ANOVA 
Result 
Tukey Result 
ANOVA 
Result 
StaR p=0.096 
0v4 p=0.9787 
0v8 p=0.1153 
4v8 p=0.1484 
Sig**** 
p<0.0001 
Significant* 
0v4 p=0.2863 
0v8 
p<0.0001**** 
4v8 
p<0.0001**** 
n/s 
p=0.0966 
LH-R p=0.260 
0v4 p=0.2374 
0v8 p=0.5585 
4v8 p=0.7430 
n/s 
p>0.070 
n/s 
0v4 p=0.2241 
0v8 p=0.0909 
4v8 p=0.7666 
n/s 
p=0.303 
CYP11A1 p=0.676 
0v4 p=0.7681 
0v8 p=0.9881 
4v8 p=0.6854 
Sig** 
p=0.004 
Significant* 
0v4 p=0.2704 
0v8 p=0.0036** 
4v8 p=0.0211* 
n/s 
p=0.4718 
3b-HSD-
1 
p=0.285 
0v4 p=0.2774 
0v8 p=0.4733 
4v8 p=0.8898 
n/s 
p=0.091 
n/s 
0v4 p=0.2316 
0v8 p=0.0858 
4v8 p=0.7266 
n/s 
p=0.077 
 
Western Blotting   
The standards against which protein quantity was estimated showed accuracy in 
preparation, with a linear regression R2 fit of 0.9849 (Fig. 53). Protein concentration 
readings were used to prepare 200μl ‘Western-ready’ sample aliquots at a 
concentration of 10μg in a 10μl volume, complete with loading sample buffer and 10% 
DTT. 
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Figure 53: Standards for derivation of protein concentration from prepared samples obtained via Bradford assay. Linear regression 
R2 fit of 0.9849.  
 
The first antibody examined was the LH receptor, with Actin as the reference antibody 
using the LiCor fluorescent system. TM3 cells treated with NM-110 were selected as the 
first for examination by Western blot. The initial gels for NM-110 exposed cells n1, n2 
and n3 which were supplemented with testosterone are shown in Fig. 54. Interestingly, 
two rows of clearer bands were present around 85kDa for LH-R.  
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Figure 54: Western blot analysis for expression of Actin (LHS of membrane) and LH-R (RHS of membrane) recorded on LiCor 
using fluorescent secondary antibodies. A) NM-110 n1 +T, B) NM-110 n2 +T, C) NM-110 n3 +T. 0,1,2,4,6 and 8μg/ml represent 
0, 0.32, 0.63, 1.26, 1.89 and 2.52 μg/cm2 doses. 
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Whilst initial Western blots using this system were promising, further runs examining 
LH-R Expression and using different Antibodies (AR, StaR) revealed a lack of reliability 
for LH-R and sensitivity issues with detection for AR and StaR (Fig. 55).  
Due to the sensitivity problems on the LiCor system, an alternative detection method 
was attempted using enhanced chemiluminescence (ECL). In order to ensure that pilot 
experiments for all antibodies were tested using this system, a simplified treatment 
protocol was used, which examined only control, 1.26µg/cm2 and 2.52µg/cm2 
treatments and did not include any testosterone treatment of cells. Results showed that 
Actin expression was reliable, indicating that gel preparation, electrophoresis, transfer, 
antibody incubation and ECL reaction had been undertaken to a satisfactory standard. 
ECL allowed reliable detection of Androgen Receptor (AR) expression across all samples. 
However, LH-R and StaR were not detectable using this method (Fig. 56).   
 
Figure 55: Example of Western blot for NM-110 n3 +T, originally probed for LH-R and Actin, which was unsuccessfully re-probed for 
Androgen Receptor and StaR. Locations where these antibodies should have been are shown on the image for illustration. 0,1,2,4,6 and 
8μg/ml represent 0, 0.32, 0.63, 1.26, 1.89 and 2.52 μg/cm2 doses. 
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For Androgen receptor, ImageJ was used to obtain densitometry readings for all 
samples, and these were normalised as a % of Actin expression. Initial examination of 
the data suggested that there may be a dose-dependent decrease in AR expression 
following exposure to all three ENM tested (Fig. 57). However, variation was high, and 
analysis via ANOVA confirmed that there was no significance in the findings because of 
this (NM-110, p=0.8603, NM-111 p=0.2365, NM-300 p=0.7550). In order to understand 
this trend further, additional Westerns would be required to reduce variation and 
improve the statistical power of the ANOVA. 
  
Figure 57: Mean expression of AR in TM3 cells treated with NM-110, 111 and 300 as a % of Actin expression in the same sample. n=3. 
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Figure 56: Representative ECL capture of antibody stains. L to R: Actin, AR, LH-R & StaR. 0,4 and 8μg/ml 
represent 0, 1.26 and 2.52 μg/cm2 doses 
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Discussion 
 
Within this chapter, TM3 cells were exposed to sub-lethal doses of two zinc oxide (NM-
110 and 111) and one silver (NM-300) ENM. There were 2 research questions to be 
addressed: i) Does exposure to zinc oxide and silver ENM lead to changes in RNA 
expression for a number of key markers of endocrine function in TM3 cells (LH-R, StaR, 
P450scc & 3b-HSD)?, and ii) Does exposure to zinc oxide and silver ENM lead to changes 
in protein expression for a number of key markers of function in TM3 cells (LH-R, StaR & 
AR)? Through these questions, the overall aim was to understand further whether ENM 
exposure caused changes in RNA or protein expression for key markers of reproductive 
function in vitro, and to compare these results to those gathered from concurrent 
analysis being undertaken on testicular samples from animals exposed in vivo (chapter 
5). PCR and Western blot analysis revealed a number of findings, which are summarised 
in Table 19.  
Table 19: Summary of findings from PCR and Western analysis of RNA and Protein expression in TM3 cells 
Marker Nanomaterial RNA Expression Protein Expression 
LH Receptor 
(Lhr) 
NM-110 ↓ ? 
NM-111 ↑ ? 
NM-300 ↑ ? 
Androgen 
Receptor 
NM-110 N/A ↓ 
NM-111 N/A ↓ 
NM-300 N/A ↓ 
StaR 
(Star) 
NM-110 ↑ ? 
NM-111 ↑ ? 
NM-300 ↑ ? 
CYP11A1 
(Cyp11a1) 
NM-110 ↓ N/A 
NM-111 ↑ N/A 
NM-300 ↑ N/A 
3β-HSD 
(Hsd3b1) 
NM-110 ↓ N/A 
NM-111 ↑ N/A 
NM-300 ↑ N/A 
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PCR analysis for RNA expression  
Due to sample size and associated variation, analysis of RNA expression via PCR did not 
produce any statistically significant outcomes for the genes tested. However, some 
interesting trends were apparent. For NM-110, it appeared that there was a decrease in 
expression of LH-R, CYP11A1 and 3β-HSD, and an increase in StaR. For NM-111 and NM-
300, an increase was seen across all GOIs tested. From a biological perspective, this 
indicates the potential for alterations to steroidogenesis within TM3 cells.  
LH-R expression  
LH-R expression was decreased following NM-110 exposure but increased following 
NM-111 and NM-300 exposure. Both downregulation and upregulation of the LH-R can 
lead to decreases in fertility levels (Narayan, 2015). Downregulation may lead to low 
testosterone levels, associated detrimental effects to Sertoli cell function and ultimately 
spermatogenesis.  In addition, a lack of negative feedback to the HPG axis by 
testosterone may result in unimpeded production of GnRH, in itself leading to excess 
production of LH and FSH at the adenohypophysis and later downregulation of the 
whole system over time. Unregulated upregulation is also associated with detrimental 
effects; activating mutations in the LH-R having been associated with Leydig cell 
hyperplasia and high circulating levels of LH (Narayan, 2015).   
From the available literature, only one study was identified that recorded LH-R 
expression following ENM exposure, and like our work, it reported varied findings.  Bara 
et al exposed pregnant swiss albino mice to mesoporous silica and zinc oxide (ZnO) ENM 
at doses between 50 and 250mg/kg via oral gavage on gestational day 15-18 and 
examined both dams and their offspring (at 6 months age). In dams, they saw increased 
LH-R expression in mesoporous silica nanoparticle (MSN) exposed animals, but no 
change in ZnO exposed. In their offspring, LH-R levels were again unchanged by ZnO 
exposure, but this time were decreased following MSN exposure compared to control 
(Bara et al., 2018). The authors did not offer speculation on why LH-R expression was 
altered differently between dams and offspring. However, it is clear that ENM interfered 
with the normal LH-R expression in all animals tested. 
Based on the data available to date, it would be unfitting to try and draw any conclusions 
over these potential changes in LH-R expression. However, it is important to recognise 
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that there is a potential here for ENM exposure to cause alterations in LH-R expression 
independent of trophic drive.  In order to investigate this further, it would be interesting 
to repeat the study with a greater replicate number, elucidate via Western blot whether 
these changes were translated into final production of LH-R and examine the 
mechanism of action responsible. Comparison of the changes in LH-R to the work 
undertaken in vivo is also important in order to see whether findings in vitro reflect those 
in vivo.  
Should repeated studies confirm changed expression of LH-R, one possibility for next 
steps could be to examine expression of both LH-R and the peptide hormone insulin-like 
peptide 3 (INSL-3) in primary Leydig cells. INSL-3 is secreted by Leydig cells but is not 
directly influenced by the pulsatile action of the HPG axis nor acutely regulated by LH or 
cAMP in adult animals (its responsiveness to HPG axis and Leydig cell events in immature 
or old animals is different) (Ivell et al., 2014). It acts on specific receptors on the Leydig 
cell to modulate steroidogenesis (RXFP2 receptors) and appears to be part of a feed-
forward mechanism to ‘buffer’ the production of steroids following LH-R stimulation, 
and seems to act in a similar way in ovarian follicular theca cells (the female equivalent 
of Leydig cells) (Ivell et al., 2014). As INSL-3 appears not to fluctuate as much androgens, 
and it’s role in the gonads is in part to buffer fluctuations in output from the HPG axis, 
examining this alongside LH-R in primary cells could give an interesting picture of the 
effect of ENM exposure on both, and whether (at least acutely) INSL-3 may act to help 
‘level out’ any impact on the HPG axis and spermatogenesis via LH-R up- or down-
regulation.  
StaR expression 
All ENM treatments led to a potential increase in expression of StaR, the key rate limiting 
protein in cholesterol transport for testosterone production. Zhang et al reported a 
downregulation in expression of TM3 and TM4 cells to StaR following exposure to silver 
nanoparticles (Zhang et al., 2015a). However, three in vivo studies suggest that changes 
to StaR expression following ENM exposure may vary. The first described StaR 
expression in TM3 cells following treatment with nano TiO2, diesel exhaust particles 
(DEP) or carbon black (CB) (Komatsu et al., 2008). They reported no change in expression 
of Star following treatment with 10 or 30 µg/ml TiO2, but an increase in expression 
Bryony L Ross PhD 184 
compared to control following treatment with DEP or CB. Bara et al also evaluated StaR 
expression following oral exposure to ZnO or MSN (see above for detailed outline of the 
experiment), and found a decrease in StaR expression in dams following ENM exposure, 
but an increase in their male pups (Bara et al., 2018). Garcia et al reported no change in 
StaR expression following exposure of CD1 mice to a series of 5 injections of citrate 
coated silver ENM (10nm) at 1mg/kg (Garcia et al., 2014).  
Again, it appears that response to ENM exposure varies dependent on the ENM used, 
and that there is variation in the available literature in terms of ENM used, dose applied, 
and exposure route selected. Had additional time been available, it would have been 
useful to undertake additional TM3 cell treatments and harvest additional RNA to 
hopefully add more power to the outcome found for this (and other) genes of interest.  
CYP11A1 expression  
CYP11A1 is the gene encoding for P450scc, the enzymatic rate limiter in steroidogenesis 
responsible for conversion of cholesterol to progesterone within the mitochondria of 
Leydig cells. A number of other studies have reported changes in CYP11A1 expression 
following ENM exposure. Jia et al reported no change in CYP11A1 expression following 
oral exposure of pubertal Kunming mice to titanium dioxide nanoparticles at between 
10 and 250mg/kg doses, a finding in agreement with Zhang et al, who reported no 
change in CYP11A1 expression of TM3 cells following exposure to silver ENM at a pre-
determined LC50 concentration (Zhang et al., 2015a). However, Garcia et al reported an 
increase in CYP11A1 expression following exposure of CD1 mice to citrate coated nano-
silver (10nm) via a series of 5 injections at 1mg/kg, (Garcia et al., 2014). Similarly Zhang 
et al reported an increased expression in CYP11A1 following exposure of neonatal ICR 
mice to silver nanoparticles post-natal days 8 – 21 and a period of wash-out period of 
up to  80 days (Zhang et al., 2015b).  
Whilst our findings and those from studies examining the effects of silver ENM in vitro 
differ, they are in agreement with the outcomes of studies reported in vivo, making this 
pilot data potentially promising. To build this dataset, the next logical step would be to 
undertake further testing with an appropriate antibody for CYP11A1 in vitro on TM3 
cells via Western blot, and in vivo on tissue from animals exposed to the same ENM via 
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immunohistochemistry to see whether this increase in CYP11A1 expression resulted in 
a higher production of P450scc. Should CYP11A1 be upregulated and resultant P450scc 
levels higher, this would indicate a potential for disruption of steroid hormone synthesis 
following NM-300 exposure. It would also be relevant to consider testing other types of 
silver ENM on the same tissue, to try and determine why our results differed from those 
of Zhang et al.  
3b-HSD Expression  
3b-HSD is responsible for conversion of pregnenolone to progesterone within the 
smooth endoplasmic reticulum of Leydig Cells. Following a similar pattern to CYP11A1, 
expression of 3b-HSD was decreased following exposure to NM-110 but increased 
following exposure to NM-111 and NM-300. The published literature reports varied 
outcomes for expression of 3b-HSD following ENM exposure, although in vitro 
mechanistic studies are scarce. Garcia et al (outlined above) reported an increase in 3b-
HSD following intravenous exposure to silver ENM, whereas Jia et al (also outlined 
above) reported no change in 3b-HSD following oral exposure of mice to nano-TiO2 (Jia 
et al., 2014, Garcia et al., 2014). As with the other genes of interest reported here, the 
effect of ENM exposure appears to be nanomaterial-specific. However, dysregulation of 
3b-HSD regardless of whether via upregulation or downregulation indicates a potential 
for disruption of normal steroidogenesis. It would be useful to investigate this further, 
via PCR, Western blot for protein analysis and immunohistochemistry for detection of 
the enzyme in tissues exposed to ENM (provided in chapter 5). 
Another interesting avenue of research would be to examine expression of 17b-HSD 
expression, as the final step in production of testosterone from androstenedione. 
However, this would require use of primary Leydig cells as there is not yet a cell line 
(TM3, MA-10, Mltc-1 etc.) known to express 17b-HSD, and therefore suitable for 
investigation of the later steps of spermatogenesis (Engeli et al., 2018).  
The importance of ENM coating in understanding response to zinc oxide exposure  
The differences in changes to expression of genes encoding LH-R, P450scc and 3b-HSD 
following exposure to NM-110 and 111 (uncoated and coated zinc oxide) is interesting, 
as it highlights the importance differing physico-chemical properties may play in 
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creating different outcomes for hazard testing in materials with the same chemical 
identity. As reported within Chapter 2, NM-110 is uncoated zinc oxide, with an average 
primary particle size of 100nm. In contrast, NM-111 is coated with 
triethoxycaprylylsilane, a silicone-based material that gives it a hydrophobic coating.  
Generally speaking, coating an ENM is used to either functionalise the materials in some 
way (for example to help with even dispersion), or to attempt to reduce their relative 
toxicity.   
Whist no other published work was found relating to NM-110 or 111 exposure and 
reproductive toxicity, a few relevant studies were identified which considered the role 
of ZnO coatings in toxicity. Following exposure of mice to a single dose of NM-110 and 
111 via intratracheal instillation, Gosens et al reported differing outcomes for lung and 
liver endpoints depending on ENM (Gosens et al., 2015). NM-111 coated ZnO resulted 
in greater inflammatory responses than NM-110, which the authors suggested could be 
via release of triethoxycaprylylsilane from the ENM over time or due to the fact that 
NM-111 was more stable allowing for longer persistence in the body and increased 
inflammation by comparison to NM-110.  
Interestingly, another study undertaken by Osmond-McLeod and colleagues reported 
exposure of human hepatic stellate cells to 30µg/ml NM-110 or 111 for 24 hours 
(Osmond McLeod, 2014). NM-110 exposure resulted modulation of multiple cell stress 
signalling pathways known to regulate cellular responses to abiotic stresses, 
mechanisms responsible for control of cell survival or apoptosis and senescence, 
together with a loss of cell viability. In contrast, exposure to NM-111 and ionic zinc 
control (ZnSO4) had little to no effect on the cells. The authors suggested that in this 
instance, the triethoxycaprylylsilane of NM-111 was protective against ZnO toxicity to 
this cell line in vitro.  Following application of silica coating, Chia & Leong also reported 
a reduction in toxicity of Zinc oxide nanoparticles (which had been pre-processed in 
various synthetic gastrointestinal fluids at acidic pH) to two types of gastrointestinal cell 
lines (Chia and Leong, 2016).   
The authors postulated that silica coating of ZnO may be protective against toxicity from 
ZnO particles or Zn ions released via dissolution. Gosens et al also noted the importance 
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of pH in the solubility and subsequent dissolution of zinc ions from ZnO ENM. They 
suggest that in their study, much of the NM-110 and 111 underwent almost complete 
dissolution and therefore the increased toxicity from NM-110 exposure may be an ionic 
effect rather than particulate. This hypothesis does seem to agree with the results seen 
from these studies, despite the fact that neither Gosens nor Chia reported use of a pre-
wetting step in preparation of ZnO solutions for treatment of cells, bringing into 
question the actual dose of ZnO reaching cells, given its relatively low solubility in water 
alone.   
In relation to the present research, there is insufficient evidence to allow a conclusion 
to be reached on the exact reason for the difference in RNA expression between the two 
types of ZnO ENM. Given the evidence above, an obvious next step would be to examine 
the rate of dissolution of zinc ions from NM-110 and 111 in the cell culture medium used 
for TM3 cells, in order to understand extent to which dissolution of ions may contribute 
to observed changes in RNA expression and subsequent cellular toxicity. To elucidate 
further events at the cellular level, it would also be interesting to undertake assays on 
TM3 cells examining endpoints relating to cellular stress and death (such as NFκB, 
ATM/ATR, mTOR, AKT, and MAPK signalling pathways), or generation of reactive oxygen 
species.  
Technical Challenges with PCR 
PCR also generated a number of problems and technical questions. The first of these 
was the notable observation that cells treated with 2.52μg/cm2 NM-300 did not produce 
any useable RNA. This finding was in line with the results discussed in Chapter 3, which 
indicated that although 2.52μg/cm2 was considered to be a sub-lethal dose of NM-300, 
the nature of the NM preparation meant that over time, ionic silver was released from 
the nanoparticles, leading to an increase in potency with storage which in turn reduces 
the threshold for loss of cell viability. The nature of the work involved in this thesis 
meant that the PCR analysis was undertaken some time after the original cytotoxicity 
assays, and as availability of ENM was limited, stock vials of NM-300 therefore had to be 
used that had been open for longer than was advised within the protocol for their 
handling and use (outlined in Chapter 2). Therefore, it is likely that this increased toxicity 
was due to an increase in potency over time.  
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The original Primers designed from a review of the literature and cross-check in Primer-
BLAST were not deemed to be suitable for use following efficiency testing. Consideration 
of why this may have happened led to a number of possibilities. The first was that 
sample preparation and pipetting were inaccurate. However, a second run of the 
efficiency experiment yielded identical results where all other PCR experiments were 
successful, therefore operator error was unlikely to be the problem.  
Secondly, RNA that contains PCR inhibitory compounds such as sample preparation 
reagents, or excessive protein can lead to partial or complete inhibition of PCR. 
However, as RNA was analysed by both Nanodrop and Bioanalyzer and quality found to 
be high, it is unlikely that this was the case. gDNA contamination can produce 
unexpected amplicons and interfere with expected efficiency. However, no-RT controls 
showed zero amplification, therefore gDNA contamination was ruled out.  
The fourth was that the primer design was not optimal, despite using BLAST to identify 
a unique sequence and cross check those primers which had been sourced from the 
literature. All primers were within the optimal length of 18-22 bases, which allows 
adequate specificity but is short enough for primers to anneal to template at the 
annealing temperature. Optimal amplicon length is 100-150bp; the longest primer, Star, 
was 247bp in length which may have contributed to the sub-optimal results. Fifth, in 
relation to GC content, ideal content is between 40% and 60%. Again, Star had a slightly 
high GC content of 66% which may have had some influence. Sixth, both LH-R and 3b-
HSD had some repeats and runs of single bases which may be contributing factors to 
misprimes. The biggest indicator that mis-primes or primer-dimers are causative of 
issues is from examination of melt curve plots. Normally, melt curves will show a single 
distinct peak in the plot of the negative derivative of fluorescence vs. temperature (as 
shown for the housekeeper genes). However, for these primers multiple peaks were 
present, indicating off-amplicon products were present. Finally, further examination of 
the Tm for each primer (the temperature at which one-half of the primer DNA duplex 
will dissociate to become single stranded) showed that melting temperature was slightly 
lower (2-3°C) than the low temperature range set on the StepOneä default cycle. This 
could also have been a contributing factor to the erratic amplification observed, 
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although it was not an inhibitory factor for the Primer Design primer set, so is unlikely 
to be the single reason for failure of the original primer set.  
Western Blot Analysis  
Initial Western blot analysis using fluorescent detection methods proved problematic. 
As cells were not passaged more than 10 times in their preparation for protein 
extraction, and all protein was extracted from passage-matched cell populations, this is 
not likely to be due to accumulated differences in cell protein expression profiles. 
However, it may be that modified subtypes of the protein were present. Following a 
time-consuming re-appraisal of the methods used with no improvement, the decision 
to move from Fluorescent to ECL based Western detection was made as it is considered 
to be a more sensitive detection system for weakly expressed antibodies. However, 
despite clean electrophoresis and clear detection of housekeeper genes & AR, there 
were still issues with detection of LH-R and StaR. There are three possible reasons for 
this: i) that the proteins selected are not expressed within the TM3 cell line, ii) that 
despite careful selection, the specific antibodies used for this experiment were not 
suitable for detecting the isoform of protein expressed, or iii) that the specific antibodies 
used were not suitable for a Western endpoint, or for the cell line. As detection of LH-R 
was possible via the fluorescent detection system, it is more likely that issues with the 
particular antibody purchased are responsible than a lack of expression in this case. As 
it was not possible to detect StaR using either fluorescent or chemiluminescent 
secondary antibodies, it was concluded that this antibody was not suitable for Western 
blot analysis, despite having been sold as such. It would therefore be appropriate to 
repeat the Western study protocol with fresh antibodies from a different supplier to see 
whether better results could be gathered.  
Whilst the Western based protein work was problematic, initial findings from ECL 
detection of AR showed what appeared to be a decrease in expression following 
exposure to ENM. Interestingly, work undertaken at Edinburgh Napier University in 
parallel with this research also generated Western blots for AR using protein extracted 
from TM4 Sertoli cells with some success. Figures 58 and 59 show expression of AR 
following exposure to NM-110 & 111 (n=3), and NM-300 (n=1) (Young et al., 2014).  
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All three graphs show a downward trend in AR expression with increasing dose of NM-
110, 111 and 300. For zinc oxide (NM-110 and 111), the original measurements provided 
were used to undertake statistical analysis. Neither NM-110 nor NM-111 were found to 
be significantly different to control at any dose via one-way ANOVA (NM-110 p=0.2053; 
NM-111 p= 0.051). This was most likely due to the large variation recorded in results. To 
understand this further, it would be useful to repeat Western analysis for all three ENM 
in order to build a more powerful set of data on which to undertake statistical analysis 
for significance of ENM effect on AR expression.  
There is little to no published literature against which to compare or contrast these 
findings. As Androgen Receptor is important in the development and progression of 
prostate cancer, some papers are available which describe research into the potential 
role of functionalised ENM as constructs onto which to build AR inhibitors as targeted 
medication in prostate cancer patients (Reznikov et al., 2015). Interestingly, one cancer 
therapy focussed study of the LNCaP prostate cancer cell line reports suppression of 
prostate cancer cell growth following exposure to selenium nanoparticles. The authors 
suggest that this is mediated via AR and the Akt/Mdm2 (apoptotic) pathways (Kong, 
2012).  
As investigation of the effects of ENM exposure on the expression of androgen receptors 
appears to remain a little investigated avenue of research. It would be relevant to pursue 
this avenue further in vitro, perhaps using alternative cell lines (Mltc-1 or MA-10) as 
comparison or expanding the work to primary Leydig and Sertoli cells. In any case, it 
would be useful to consider use of an alternative antibody for AR in any future work, as 
following issues with immunohistochemical analysis of tissues exposed to ENM in vivo it 
was suspected that the quality of this antibody quality was questionable.  
Based on this scarcity of published work, to our knowledge this downward trend in AR 
expression seen following exposure to two types of zinc oxide ENM (NM-110 and 111) 
on TM4 Sertoli cells, and silver ENM (NM-300) on TM3 Leydig and TM4 Sertoli cells is 
being shown for the first time. Despite being pilot data, and a clear need to build a larger 
dataset to provide sufficient power to the data for good statistical analysis, this is an 
Bryony L Ross PhD 191 
interesting outcome, with clear implications for spermatogenesis, regulation of the HPG 
axis and male fertility if confirmed.  
 
Figure 58: Androgen Receptor expression in TM4 cells treated with NM-110 and NM-111 (uncoated and coated) Zinc Oxide at 
doses of 0, 1, 2, 4, 6 and 8µg/ml, equivalent to 0, 0.32, 0.63, 1.26, 1.89 and 2.52µg/cm2 in the presence of testosterone 
stimulation. Receptor expression is expressed as a % of b-Actin expression in control sample to which testosterone stimulus has 
been added (Control+T). AR expression is overlaid with cell viability (% relative to control) following 24 hours of exposure to ENM, 
recorded using the Alamar Blue assay. N=3. (Young & Fulton, 2014). 
Bryony L Ross PhD 192 
 
Figure 59: Androgen Receptor expression in TM4 cells treated with silver ENM (NM-300) at doses of 0, 1, 2, 4, 6 and 8µg/ml, 
equivalent to 0, 0.32, 0.63, 1.26, 1.89 and 2.52µg/cm2 in the presence of testosterone stimulation. Receptor expression is 
expressed as a % of b-Actin expression in control sample to which testosterone stimulus has been added (Control+T). N=1. (Young 
& Fulton, 2014). 
 
Final conclusions and Next steps   
Analysis of RNA and protein expression for the receptor mediating pituitary release of 
LH and thus stimulation of reproductive function (LH-R), rate limiting proteins and 
enzymes in conversion of cholesterol to testosterone (StaR, CYP11A1 and 3b-HSD), and 
the receptor mediating the effects of testosterone directly on spermatogenesis within 
seminiferous tubules and on Leydig cells via autocrine action (AR) revealed some 
interesting preliminary results. These imply that ENM may alter Leydig cell function at 
sub-lethal concentrations, potentially impacting spermatogenesis, the HPG axis and 
fertility. There is also evidence to suggest effects may be nanomaterial specific, 
reinforcing important questions for the risk assessment community around the role of 
physico-chemical characteristics in altering sub-lethal changes to cell function in 
materials that would be classed as the same chemically. Whilst none of the results from 
these pilot tests are sufficiently powerful to make any definite claims about changes to 
the function of TM3 Leydig cells, a potential effect has been demonstrated and further 
research to expand on this is clearly warranted.  
0
20
40
60
80
100
120
Control Control+T 5ug/ml 12.5ug/ml 25ug/ml 37.5ug/ml 50ug/ml
%
 A
nd
ro
ge
n 
Re
ce
to
r E
xp
re
ss
io
n
Dose (µg/ml
Androgen Receptor Expression in TM4 cells 
treated with Silver (NM300)
Bryony L Ross PhD 193 
Various specific avenues of research have been outlined earlier; however, one obvious 
next step would be to repeat ENM exposure on primary Leydig cells and perform a 
testosterone assay on cell supernatants. This is not possible with TM3 cells due to their 
aforementioned inability to convert androstenedione to testosterone, however, it may 
be possible that measurement of androstenedione could be used as an alternative.  
Accurate measurement of testosterone could be achieved using mass spectroscopy and 
as the endpoint in steroidogenesis, would offer a definitive answer to whether Leydig 
cells were functioning normally following ENM exposure. Results could then be directly 
compared to results of a similar assay in vivo. Unfortunately, time and resource 
constraints meant that this was not possible within the duration of this research.  
A further potential line of investigation could be to conduct a series of experiments 
comparing the effects of ENM exposure on Leydig, follicular theca cells and adrenal 
cortical cells. Theca cells are the equivalent of Leydig cells within the female 
reproductive system, and adrenal cortical cells are responsible for steroid, 
mineraolcorticoid and glucocorticoid synthesis within the adrenal glands. As all three 
cell types are responsible for production of steroids essential for endocrine system 
function, any potential disruption to this process could have important systemic effects.  
The results of in vitro assessment give hope that this could be used as a predictor of in 
vivo endpoint measurements, as presented in this discussion. There is more work to be 
done, and there is a need to be a check on the best and most appropriate cell line to 
work up as a potential OECD TG of the future. These mechanistic studies do not stand 
alone but can help toxicologists identify target cells that may influence endocrine 
function. 
Results in vitro can now be compared to those generated from analysis of tissues taken 
from animals exposed to the same panel of ENM to identify whether the in vitro work is 
a suitable substitute or guide for predicting hazard in vivo.   
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Chapter 5: Histological analysis of changes to rat testis following 
exposure to ENM   
 
Introduction 
In addition to understanding of the effects of engineered nanomaterials (ENM) on 
animal cell lines in vitro, it is important to understand effects in vivo, in order to form a 
comparison between the two and establish suitability of in vitro testing for predicting 
effect in vivo.  To allow this, animals were exposed to some of the same ENM in vivo by 
MARINA project partners in the Netherlands, and testicular tissue from these animals 
provided to Edinburgh Napier University for histological analysis.  
Following fixation and processing, testicular tissue samples from Sprague-Dawley rats 
exposed to a panel of silver and silica ENM via oral gavage were shipped from RIKILT, 
Waginingen, Netherlands to Edinburgh Napier University. After sectioning, tissues were 
stained using haematoxylin and eosin and examined in detail for morphological and 
stereological changes, as well undergoing immunohistochemical stains to determine 
activity in various receptors and enzymes considered to play important roles in 
spermatogenesis.  
In order to establish whether exposure to ENM caused any morphological or functional 
changes, it is first important to have a more detailed understanding of normal testicular 
morphology and the spermatogenic cycle. Although basic testicular morphology is 
explained within the introductory chapter of this thesis, testicular toxicity most often 
manifests as subtle changes in the detail of its morphology. Changes in testicular 
morphology may be examined via various histological techniques. Histology has proven 
indispensable in furthering understanding of both general biology and pathology, and 
histopathology allows examination of tissue post mortem for changes due to chemical 
or environmental exposure through an animals’ life. 
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Testicular Morphology in detail  
As previously outlined, the testis is a complex structure, composed of convoluted 
seminiferous tubules separated by interstitial tissue (Fig. 60). It has been reported from 
detailed morphological analysis that 82.4% of the volume is occupied by seminiferous 
tubules, 15.7% by interstitial tissue, and 1.9% by the capsule (Mori, 1980).   
The interstitium is formed from populations of Leydig cells, testicular macrophages, 
fibroblasts, mast cells, blood vessels, nerves, lymphatic vessels and connective tissue. 
Leydig cells are polyhedral cells, which tend to cluster together around blood capillaries. 
They make up around 2.7% of testicular volume, and represent around 17% of the 
interstitial tissue in rats, although this percentage varies from species to species (Creasy 
and Chapin, 2013, Mori, 1980). As the major site for synthesis of testosterone they are 
a key component in the HPG axis, responsible for regulation of reproductive function 
(Fig. 60).  
 
Figure 60: Generalised morphology of the testes. The interstitial compartment contains Leydig Cells, Blood vessels and capillaries, 
as well as lymphatic vessels and testicular macrophages (not visible). The seminiferous tubules, lined by peritubular myoid cells, are 
composed of two compartments – the basal and adluminal compartments. Within these, germ cells develop through 
spermatogenesis, a process which is managed by Sertoli cells, before being shed into the central lumen at spermiation.   
Testicular macrophages are the principle immune cells within the testis, but in addition 
to response to infection are also involved in regulation of spermatogenesis, 
steroidogenesis and other homeostatic functions of the testis (Winnall and Hedger, 
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2013). They are a distinct subset of mononuclear phagocytes and are made up of two 
populations. The first are of embryonic origin, present from the beginning of life and 
associated mainly with Leydig cells. The second have their origins in bone marrow, and 
are found on the surface of seminiferous tubules, appearing around puberty 
(Mossadegh-Keller et al., 2017). 
Intertubular and peritubular capillaries run parallel to or around seminiferous tubules, 
supplying oxygen, nutrients and important endocrine messengers. The lymphatic 
channels between Leydig and peritubular cells on the seminiferous tubules are 
responsible for removal of interstitial fluid containing waste from tissues, and also form 
an accessory return route for blood plasma. Importantly, they also play a vital role in the 
immune system, being the primary site for cells relating to adaptive immunity (e.g. T 
cells and B cells). Relatively free equilibration occurs between the interstitial tissue, 
lymph and blood vessels, but penetration through the seminiferous tubule wall into its 
basal compartment is limited, and the barrier between the basal and adluminal 
compartments (within which sperm develop) is tightly controlled by the Blood Testis 
Barrier (BTB). 
The seminiferous tubules themselves are surrounded by peritubular myoid cells (PTM). 
These have various functions, including forming a loose part of the BTB, and having 
paracrine regulatory interactions with Sertoli and Leydig cells. They also contain actin 
filaments which are thought to contract in order to create peristaltic waves that help 
move developing spermatozoa and testicular fluids during spermatogenesis (Creasy and 
Chapin, 2013). Between the PTM cells and the internal cell populations of each tubule 
lies a basement membrane. 
Sertoli cells (SC) rest on the basement membrane of tubules, attached by hemi-
desmosomes. They are large euchromatic cells which are irregular but columnar in 
shape, with thin cytoplasmic ‘arms’ which protrude toward the tubule lumen at various 
distances depending on the stage of spermatogenesis ongoing in that particular locale 
(Fig. 61). Sertoli cells have a multitude of functions, including:  
i) Maintenance of homeostasis within stem cell populations, and transport of 
micronutrients to developing sperm. Germ cells are completely reliant on 
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Sertoli cells for nutrients, being unable to produce their own. SC provide 
lactate and/or pyruvate to spermatocytes and spermatids, and a-keto acids 
to germ cells. 
ii) Establishing germ cell adhesions and communication via ectoplasmic 
specializations called tubulobulbular complexes. SC are also responsible for 
‘moving’ developing sperm through the seminiferous tubule (detailed 
further below). 
iii) Phagocytosing the waste products of spermatogenesis from seminiferous 
tubules. As well as losing many of its organelles, the cytoplasmic volume of a 
spermatid is reduced around 70% during its development. This is left behind 
in tubules in residual bodies (which may be seen as dark coloured autophagic 
vacuoles under a light microscope). SCs phagocytose and digest these.  
iv) Initiation and response to endocrine signals. SC are targets for FSH and 
testosterone, transducing those endocrine signals and other cellular cues 
into paracrine regulation of germ cells, and forming an important part of the 
HPG axis by themselves producing activin and inhibin which feedback to 
control androgen and FSH release.  
v) Initiation and regulation of the cycle of the seminiferous epithelium (see 
below). 
vi) Maintaining the Blood-Testis Barrier (see below). 
vii) Inhibiting autoimmune reactions to autoimmunogenic sperm and 
maintaining immune privilege in the testis via the Blood-Testis barrier.  
These roles are summarised within Fig. 61. Disturbance of any of these is likely to impair 
spermatogenesis, and potentially affect fertility. 
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Spermatozoa themselves develop within the adluminal compartment of tubules, 
separated from the rest of the testis by the blood-testis-barrier (BTB). This develops fully 
during puberty and is formed by a series of 4 different cell junctions which encircle each 
Sertoli cell – gap junctions (GJ), tight junctions (TJ), ectoplasmic specialisations, and 
desmosomes (Fig. 62). TJs are the most important component of the BTB, acting in a 
‘gate and fence’ function; the gate preventing passage of water, solutes and larger 
molecules, and the fence controlling movement of proteins and lipids (Mruk and Cheng, 
2015). Their regulation is multifaceted, involving hormones, cytokines, the presence of 
germ cells and a number of key proteins. Prelepotene and Lepotene spermatocytes pass 
through these TJs at the commencement of the seminiferous tubule cycle (as explained 
Figure 61: Illustration of Sertoli cell morphology via immunofluorescent microscopy (IF) (left) and schematic representation of its 
interaction with germ cells at different stages during spermatogenesis together with other key functions (right). The IF image shows 
a Sertoli cell isolated in vitro (with attached elongating spermatids). Cell is labelled for filamentous actin (red) and somatic cell-
specific tubulin (green). The cytoplasmic arms wrap germ cells with thin processes which nurture cells through their differentiation. 
They do this via specialised cell-cell junctions between sertoli cells and germ cells (or other sertoli cells) called ectoplasmic 
specializations, labelled red around the spermatid heads. Bar = 10µm. The image showing sertoli cell interaction and functions details 
the many functions it serves: (1) transport of micronutrients across the junctional complex; (2) management of waste and recycled 
leftover cytoplasm during germ cell development; (3) maintenance of the blood–testis barrier (BTB); (4) establishment of germ cell 
adhesions and communication; (5) inhibition of immune reactions and maintenance of immune privilege; (6) initiation and response 
to endocrine signalling pathways; (7) initiation and regulation of the cycle of the seminiferous epithelium; and (8) maintenance of 
stem cell homeostasis. The autoimmunogenic germ cells remain sequestered within the adluminal compartment behind the BTB, 
surrounded by Sertoli cells which secrete immunoregulatory factors (5) to modify any immune response. Treg = T cells, M2 = 
macrophages. Images reproduced from Franca et. al. (2016). 
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within spermatogenesis subsection). Sertoli-Sertoli and Sertoli-Germ cell attachments 
are facilitated by ectoplasmic specialisations, the basal part of which also helps to form 
the BTB. Desmosomes are cell-cell junctions that help to ensure adhesion of adjacent 
cells, whereas GJs are cell-cell channels that allow passage of metabolites, ions, second 
messengers and other small molecules (Mruk and Cheng, 2015, Creasy and Chapin, 
2013).  
 
Figure 62: Illustration of the different kinds of cellular junction in the epithelium of rat seminiferous tubules.4 types of junction are 
represented: tight junctions, ectoplasmic specialisations, desmosomes, and gap junctions. Each plays a crucial but slightly different 
role in maintenance of the BTB. Image reproduced from Mruk & Cheng (2015).  
 
The BTB is important for two main reasons. First, it acts to maintain seminiferous tubules 
as an immune-privileged area of the body by stopping developing sperm from leaking 
out into the surrounding space. This is important because sperm themselves are 
autoimmunogenic, i.e. capable of eliciting an immune response which can generate 
antispermatozoal antibodies or developing autoimmune reactions such as autoallergic 
orchiditis, both of which result in reduced fertility. Second, the BTB separates the 
intratubular and intertubular fluids, allowing spermatogenesis to occur in a chemically 
controlled microenvironment (Johnson and Everitt, 2000).  
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Spermatogenesis  
Spermatogenesis is a cyclical process by which diploid germ cells gradually transform 
into mature haploid spermatozoa within seminiferous tubules. Its etymology is within 
the Greek language, ‘sperma’ meaning seed, ‘kytos’ meaning cell, and ‘genesis’ meaning 
production. It initiates on postnatal day 5 in the rat and broadly speaking, occurs in three 
main phases: i) mitotic proliferation of cells, ii) meiotic division of cells to generate 
genetic diversity and halve chromosome number, and iii) cytodifferentiation which 
packages haploid chromosomes for delivery to the oocyte (Johnson and Everitt, 2000, 
Mruk and Cheng, 2015). This is summarised within Fig. 63 and outlined in more detail 
below. 
i) The basement membrane of seminiferous tubules is lined with spermatogonial stem 
cells, which form a reservoir of self-regenerating stem cells and support continual sperm 
production through the majority of male life (Oatley and Brinster, 2006). At intervals, 
groups of cells called A1 spermatogonia emerge, marking the beginning of a 
spermatogenic cycle. These undergo mitotic divisions at around 42-hour intervals, 
producing clones. In the rat there are 6 mitotic divisions, leading to a maximum clone 
size of 64 cells (although cell death means this may be much lower). This pool of cells 
may be sub-classified into A-4 spermatogonia (1st three mitotic divisions), Intermediate 
after the 4th mitosis, and B after the 5th division. Type B spermatogonia then form resting 
primary spermatocytes (prelepotene spermatocytes) after a final 6th division. Whilst 
complete karyokinesis ensures that nuclear division is complete in each of these mitotic 
divisions, cytokinesis is incomplete, therefore all primary spermatocytes derived from 
one A1 spermatogonium are linked by thin cytoplasmic bridges, forming a large 
syncytium. This remains in place throughout the meiotic divisions that follow, and 
individual cells are only released as mature spermatozoa.  
ii) During the second phase, resting prelepotene spermatocytes are found lining the 
basal intratubular compartment of the seminiferous tubules. These move into the 
adluminal intratubular compartment by disrupting the tight junctions between adjacent 
Sertoli cells. They then enter a prolonged meiotic prophase, moving through leptotene, 
zygotene, pachytene and diplotene stages, with characteristic morphologies depicting 
the state of their chromatin. At this point, their genetic material is shuffled, and they 
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become particularly sensitive to damage (especially during pachytene). At the first of 
two meiotic divisions, homologous chromosomes separate to opposite ends of the cells, 
then cytokinesis yields two haploid secondary spermatocytes. A second meiotic division 
then yields early round spermatids. At this stage, the cells remain linked syncytially via 
cytoplasmic bridges.  
 
iii) During the final phase, spermatids undergo the 19-step process of spermiogenesis 
(Fig. 63). This involves major cytoplasmic remodelling of the spermatid to take it from a 
round to elongated state. The resulting spermatozoa have elongated tails containing 
mitochondria to allow propulsion. The head of the spermatozoa, containing compacted 
haploid chromosomes, also has an acrosome which acts as an ‘enzymatic knife’ to aid 
PROLIFERATION 
MEIOSIS 
SPERMIOGENESIS 
Me1 
Me2 
Figure 63: Germ cell development through spermatogenesis in the rat. The Proliferation phase includes 6 mitotic divisions from 
A1-A4 type spermatogonia, Intermediate (I), B type (B) and finally prelepotene spermatocytes (PL). Meiosis begins with small 
Lepotene spermatocytes (L) entering prophase, cell enlarging through Zygotene (Z), early- mid- and late Pachytene (EP, MP, LP) 
spermatocytes. Diplotene spermatocytes (D) then undergo the first meiotic division (Me1) to produce Secondary Spermatocytes 
(SS). After the second meiotic division (Me2), haploid cells begin to differentiate by forming round spermatids (RS) which 
represent steps 1-7 of spermatid development. RS become Elongating Spermatids from step 8 when the tail of the spermatozoa 
starts to form, continuing to differentiate until step 19 where they are considered to be mature spermatozoa and ready for 
release. Image adapted from Creasy, 1997.   
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passage toward an oocyte. When spermatozoa are completely formed, the cytoplasmic 
bridges between them break, and they are released in to the lumen at spermiation. The 
residual bodies left behind at this stage are in effect dustbins for residue of cytoplasm 
that is superfluous to requirements; these are phagocytosed by Sertoli cells after sperm 
are released.  
Structural support and movement of germ cells is imperative to successful 
spermatogenesis. Sertoli cells play a critical role in managing this process, disassembling 
the junctional complexes on the luminal side and forming new ones on the basal side of 
the germ cell, effectively ‘moving’ it into the adluminal compartment. This dynamic 
mobilisation can be thought of like hospital theatre doors – to maintain a safe 
environment, when one set of doors are open, the others must be closed. The process 
is repeated as these germ cells develop, with germ cells moving down the adluminal 
compartment to the luminal edge midway through development, then back toward the 
sertoli cell nucleus, before elongation and final release as spermatozoa (Creasy and 
Chapin, 2013, Mruk and Cheng, 2015).  
 
The spermatogenic cycle in the rat  
Within the rat, the spermatogenic cycle is generally broken down into 14 identifiable 
stages based on morphological markers, as first described by Leblond and Clermont in 
1952 (Leblond and Clermont, 1952). Each stage contains a set population of developing 
spermatogonia, spermatocytes, round and elongating spermatids (Fig. 64). Although 
division into 14 stages is arbitrary, the cycle of spermatogenesis is a specifically timed 
developmental process; it takes 12.9 days in the Sprague-Dawley rat (10 days in humans) 
to see all 14 stages at any one location in a seminiferous tubule.  
The actual time taken for the complete process of spermatogenesis whereby basal 
spermatogonia reach the final stage of spermatid development represents 4.5 
spermatogenic cycles, which is 56 days in Sprague-Dawley rats (Creasy, 1997) or around 
74 days in man, although it has been reported that spermatozoa may start to be shed 
as early as postnatal day 42 in the rat (Creasy and Chapin, 2013). Because seminiferous 
tubules are folded repeatedly within the testis, any section of testicular tissue typically 
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reveals hundreds of tubule cross-sections, all at one of the 14 stages of 
spermatogenesis.  
 
Based on a thorough understanding of testicular morphology and the spermatogenic 
cycle, the available literature was consulted for evidence of adverse testicular effects 
following ENM exposure. A number of studies examining the potential effects of ENM 
on male reproductive health using histological techniques have been published, 
reporting a variety of exposure routes, analysis techniques and outcomes. From the 
growing body of literature, studies using an experimental approach similar to that 
employed within the current chapter (oral exposure, silica or silver based ENM) are the 
focus of this section.  
Effects of ENM on male reproductive health following Oral Exposure 
Several authors report distribution of nanoparticles to the testis and subsequent 
detrimental effects to the testis following oral exposure regimes within rodents. (Jia et 
al., 2014) examined the effect of pubertal TiO2 ENM exposure on testosterone synthesis 
and spermatogenesis in 60 Kunming mice. TiO2 NPs 25nm in size were given orally to 
groups of mice at doses of either 10, 50 or 250mg/kg for 42 days from post-natal day 
28-70. Abnormalities measured in epididymal sperm were much higher in exposed 
animal. The authors also reported a loss of developing spermatogonia within the 
seminiferous tubule germ cell layer at the highest dose, and the presence of vacuoles at 
all doses. 
Figure 64: Stages of the spermatogenic cycle within the rat. To show the transitional characteristics, cell nuclei are depicted. 
Stages are identifiable by roman numerals. Steps of development from round spermatids to mature spermatozoa are labelled 
using letters and numbers. Round spermatids are seen within steps 1-8 of sperm development, and elongating spermatids from 
step 9-19. Mitosis is indicated by ‘M’ and meiosis by ‘Me1’ or ‘Me2’. Spermatogonia are depicted as A, I or B type. Spermatocytes 
are depicted as prelepotene (PL), Lepotene (L), Zygotene (Z), Pachytene (P), Diplotene (Di) and Secondary (SS). Image 
reproduced from Hess (1990). 
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(Hong et al., 2015) exposed ICR mice aged 5 weeks to either 2.5, 5 or 10mg/kg 
bodyweight TiO2 ENM 5-6nm in size (equivalent to around 0.15-0.7g of TiO2 in humans 
60-70kg bodyweight) daily via oral gavage for 60 days. Histopathology revealed lesions 
in the testis and epididymis, with reduction in sperm motility, quantity and increases in 
abnormal sperm recorded. Within the testis, seminiferous tubule germ cell layer was 
seen to be depleted, with reduced numbers of Leydig cells and mature sperm, and 
presence of pyknotic nuclei, spermatolysis and severe disorganisation of the tissue. 
(Moridian et al., 2015) exposed 32 NMRI mice aged 6-8 weeks orally to either 5, 50 or 
300mg/kg ZnO NPs daily for 35 consecutive days (equal to one sperm cycle in mouse). 
They reported significant decreases in serum testosterone levels in the 50 & 300 mg/kg 
dose groups, and a slight decrease in the 5mg/kg group. The diameter of seminiferous 
tubules was measured; a small decrease in size was reported for 5mg/kg alongside a 
significant reduction in size compared to control in the 50/300mg/kg group. In the 
50/300 mg/kg groups, the total volume of seminiferous tubules, interstitial tissue and 
Leydig cell number were also significantly lower than control. The authors suggested the 
decrease in serum testosterone could be due to the loss of Leydig Cells  
Silica NPs 
Studies specifically examining silica ENM report mixed findings in relation to whether 
silica either accumulates within the testis or causes detrimental effects. In relation to 
distribution of silica nanoparticles to the testis, the findings of an der Zande et al are 
key, as they concern the same animals from which tissue samples were used in this 
chapter of research (van der Zande et al., 2014a).  Silica nanoparticle treatments (28-
day oral exposure to 100, 500 or 1000mg/kg bodyweight NM202 or 100, 1000 or 2500 
mg/kg bodyweight SAS silica nanoparticles) did not reveal any significant accumulation 
in the testis compared to control. However, this does not mean that the tissues were 
not exposed to nanoparticulate silica during the experimental regime, rather it confirms 
that there was no accumulation of silica in the organ. 
Of those studies published that included morphological evaluation of the testis without 
finding any histological changes, notable is that of (Morishita et al., 2012) who examined 
distribution and histologic effects of amorphous nanosilica (nSi) in Balb/c mice testis. An 
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initial protocol established that nano silica were able to enter the testis (being detected 
via TEM in the nuclei of spermatocytes). Following this, ENM were injected with either 
0.4mg or 0.8mg 70nm nano silica (nSP70) via the tail vein every other day for 4 doses in 
total. The testes were collected 48 hours or 1 week after the last administration, and 
histological examination revealed no changes compared to control. Likewise, a study 
undertaken by Kim et al in 2006 revealed no histological findings following exposure of 
mice to magnetic silica nanoparticles via intraperitoneal injection (Kim et al., 2006). 
Some studies have reported reversible effects, with histological and biochemical 
markers of toxicity returning to normal after a recovery period. Xu and colleagues 
investigated intravenous exposure of ICR mice (8 weeks old) to 65nm nSi ENM at a dose 
of 20mg/kg every 3 days, a total of 5 times over 13-day period. Animals were sacrificed 
at 15, 35 or 60 days after the 1st dose. The authors reported reversible negative changes 
to oxidative stress markers and quality/quantity of epididymal sperm, observed at 15/35 
days, but not 60 days. They found no changes to acrosome integrity, sperm number, 
spermatogonia number or levels of testosterone, LH or FSH. These findings led them to 
the conclusion that damage following nSi exposure is transient and reversible (Xu et al., 
2014). 
Similar to Xu, Ren et al reported reversible damage to the testis in C57 mice exposed to 
57nm Si ENM by tracheal perfusion over 15 doses (2mg/kg every 3 days for 45 days). 
Animals sacrificed at the end of the dosing regimen showed focal areas of seminiferous 
tubules with a thin germ cell layer, vacuolisation and exfoliation or sloughing of cells into 
the lumen. At this time point, sperm motility and normality in the epididymis was 
decreased compared to control, an increased number of spermatocytes were found to 
be undergoing apoptosis, and there were raised levels of markers related to oxidative 
stress (MDA and 3-NT). Conversely, animals sacrificed following a 1-month wash-out 
period were not different to control (Ren et al., 2016).  
Although most studies concerning exposure to silica nanoparticles in pubertal or adult 
rodents reported either no adverse outcome, or reversible adverse effects, a recent 
study suggests that prenatal exposure to nano silica may lead to negative reproductive 
outcomes in pups. Bara et al investigated reported negative outcomes relating to 
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testicular morphology and hormone levels within 6-month old swiss albino mice 
exposed to mesoporous silica ENM in utero. Dams were exposed via oral gavage at 
either 50 or 250mg/kg bodyweight between gestational days 15 and 19. The high dose 
group showed changes in testicular morphology, with prominent epithelial 
vacuolization, decrease in seminiferous tubule diameter and alterations to the 
spermatogenic process visible. Testosterone levels were measured as decreased in this 
group compared to control, however StaR expression was increased, and P450scc, LH-
R, 17b-HSD and P450c17 expression decreased. No changes were measured within the 
low-dose group, indicating a threshold of effect between the two (Bara et al., 2018). 
Silver NPs 
The literature concerning the effects of silver nanoparticle exposure is far wider than 
that for silica, and it appears to be more widely accepted that silver nanoparticles 
generally result in adverse effects to male reproductive organs following short, medium 
or long-term exposure.  
Of primary importance are the findings of Van der Zande et al, as tissue samples from 
their study are used within this chapter of research (van der Zande et al., 2012). By 
contrast to their findings for silica, their evaluation of the distribution, elimination and 
toxicity of <20nm silver nanoparticles within Sprague-Dawley rats following 28 days of 
oral exposure (at 90mg/kg daily) reported distribution to and accumulation within the 
testis of silver nanoparticles. It is important to note that silver concentrations were 
highly corelated to the amount of Ag+ ion present in the silver nanoparticle suspension, 
further analysis on which suggested that silver ion distribution was far greater than silver 
nanoparticle. Nonetheless, Ag nanoparticles were also present, and interestingly, not 
cleared from the testis after an 8-week period of wash-out.  
Research published by Kim et al in 2008 further substantiates the findings of Van der 
Zande. Following 28-day oral exposure of Sprague-Dawley rats to 30, 300 or 1000 mg/kg 
bodyweight silver nanoparticles (50-70nm) according to OECD TG407, all tissues from 
exposed groups showed a statistically significant (p=<0.1) dose-dependent increase in 
silver concentration (Kim et al., 2008). Additionally, in 2010, Kim et al tested oral toxicity 
of 56nm silver nanoparticles over a sub-chronic 90-day period, according to OECD 
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TG408. Following daily exposure of 5-week-old specific-pathogen free (SPF) Fisher 344 
rats to 30, 125 or 500mg/kg silver, a dose-dependent accumulation of particles was seen 
in all tissues examined, including the testis (Kim et al., 2010). Finally, Lee and colleagues 
went on to demonstrate that not only were silver nanoparticles able to accumulate in 
the testis, it was likely that their biopersistence was greater than seen by van der Zande 
et al. Following 28 days’ oral exposure in Sprague-Dawley rats, the group allowed 
animals to recover for up to 4 months before testing for silver content in their organs. 
They saw accumulation and persistence of Ag nanoparticles in the brain and testis of the 
animals with no sign of clearance. This was contrary to all other organs tested, which 
showed a gradual decrease over the 4-month recovery period (Lee et al., 2013).  
Based on these studies, it can be assumed with relative confidence that silver 
nanoparticles are able to enter and accumulate within the testis following oral exposure, 
potentially affecting homeostasis and leading to adverse effects. This outcome is 
mirrored within studies examining exposure via alternative routes, with silver 
distribution to the testis of rats and mice reported following intravenous administration 
(Dziendzikowska et al., 2012, Garcia et al., 2014, Wang et al., 2013), intraperitoneal 
administration (Wang et al., 2013), and transdermal uptake (Pfurtscheller et al., 2014). 
Of the many available studies, a few specifically concern effects of Ag NPs following oral 
exposure. Miresmaeili et al evaluated the effects of Ag NPs on the acrosomal reaction 
and spermatogenic cells in rats following oral gavage exposure every 12 hours over one 
cycle of spermatogenesis (48 days). Rats were exposed to either 25, 50, 100 or 200 
mg/mg bodyweight. A triple stain for the acrosome reaction showed a significant 
difference between control and treated animals in relation to live vs dead sperm 
quantities and to the ability of sperm to undergo the acrosome reaction (key for 
fertilization of oocytes). No change in Sertoli cell number was seen, and a reduction in 
spermatogonia cells was only observed in the highest dose group. However, animals 
receiving doses from 50-200mg/kg all showed significant reduction in number of 
primary spermatocytes and spermatids and spermatozoa (Miresmaeili et al., 2013).   
In relation to longer-term exposures, Thakur et al administered 10-12-week-old Wistar 
rats Ag NPs at 20ug/kg daily for 90days. Histological examination of testicular tissue 
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revealed disorganisation and atrophy of seminiferous tubule germinal epithelia, loss of 
spermatogenic cells (especially spermatocytes and spermatids) and exfoliation of germ 
cells into the lumen. Some Sertoli Cell Only (SCO) tubules were present, and very few 
mature spermatozoa were seen. TEM analysis showed damage to tubular basement 
membrane, and apoptotic germ cells, with separation from basal laminae. Sertoli cells 
showed dissociation of nuclei from the basal portion, vacuoles in the cytoplasm and 
presence of silver NPs and lysosomal bodies. Spermatogonia, round spermatids, 
elongating and plus mature spermatids were all noted to be adversely affected (Thakur 
et al., 2014) 
Two studies examining pre-pubertal effects of Ag NP exposure in male Wistar rats 
reported similar findings to those in adult animals. Sleiman et al exposed pre-pubertal 
Wistar rats via oral gavage to 60nm Ag NPs at either 50 or 15ug/kg bodyweight from 
post-natal day (PND) 23-53, sacrificing at the end of exposure or after 5 weeks of wash-
out at PND90. Exposure delayed puberty onset in both treatment groups compared to 
control. A reduction in total and daily sperm production was seen at PND53 for the high 
dose group, and both groups at PND90. Morphometric analysis showed disorganisation 
of the seminiferous tubule epithelium, sloughing of germ cells and debris into the lumen. 
However, no significant difference in epithelial height or lumen/tubule diameter was 
recorded, and no change in serum testosterone or oestradiol concentrations from 
control observed at either PND53 or 90 (Sleiman et al., 2013).  
Mathias et al examined a slightly longer period of exposure to Ag NPs during prepubertal 
development. 30 Wistar rats were dosed orally with 60nm Ag NPs at either 15 or 
30ug/kg/day from PND12 to PND58, with sacrifice after 44 days of wash-out at PND102. 
Like Sleiman et al, they observed that onset of puberty was delayed in treated animals. 
Acrosomal integrity and sperm plasma membrane integrity (measured by eosin-y and 
nigrosin staining) decreased in a dose dependent manner, while the number of sperm 
abnormalities increased. Again, no change on serum hormone levels (testosterone, LH, 
FSH and oestradiol) was recorded (Mathias et al., 2015). 
Several other studies concerning alternative routes of exposure have also reported 
relevant histological outcomes. Rezazadeh-Reyhani et al found alterations in 
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seminiferous tubular diameter and spermiogenesis index compared to control in 
animals exposed intraperitoneally to 50-60nm silver nanoparticles at doses from 0.5-
5mg/kg daily for 25 days (Rezazadeh-Reyhani et al., 2015). Similarly, a 2014 paper from 
Garcia et al described various changes in seminiferous epithelial morphology, including 
germ cell apoptosis and a reduction in Leydig cell numbers following intravenous 
injection of 1mg/kg 10nm silver NPs to CD1 mice for 12 days (Garcia et al., 2014). 
Interestingly, Castellini et al reported no adverse morphological observations following 
a single intravenous injection of 0.6mg/kg bodyweight silver nanoparticles (40nm), 
despite finding damage to sperm. Conversely, (Fathi et al., 2018) observed a significant 
reduction in number of spermatogonia, Sertoli and Leydig cells in Wistar rats exposed 
via a single intraperitoneal injection (Castellini et al., 2014).  
In summary, it is clear that both Si and Ag NPs are able to reach the testis following oral 
exposure, with multiple sources reporting testicular accumulation of Ag NPs with little 
clearance over time. Mixed outcomes reported following silica exposure indicate a 
potential for adverse morphological and functional effects, which may be resolved over 
time. Conversely, almost all studies on silver ENM indicate it is likely to cause adverse 
effects on both testicular morphology and function.  
Based on the available literature, it is clear that thorough histopathological analysis is 
able to form a cornerstone in establishing effect (where present) of ENM on the testis. 
Some studies also attempted to use stereological methods to produce a semi-
quantitative evaluation of either epididymal sperm or the seminiferous tubule and its 
contents. Additionally, numerous studies have examined sperm morphology, motility 
and abnormalities as the end product of spermatogenesis. To compliment this, serum, 
blood or homogenized tissue samples are often used to determine hormone level 
changes, or expression of RNA or proteins indicative of changes in steroidogenesis, 
components of the HPG axis or important proteins, enzymes and receptors for 
maintaining testicular homeostasis during spermatogenesis. Additionally, 
immunohistochemical staining of tissues for key proteins, enzymes and receptors to the 
functioning of the testis forms another useful and commonly applied route of 
investigation to further understand functional aspects of testicular biology following 
ENM exposure.  
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Objectives  
In order to build further understanding of the potential adverse effects of engineered 
nanomaterial exposure on male reproduction, processed paraffin-embedded testis from 
Sprague-Dawley rats exposed to one of 2 types of silica dioxide, 2 types of silver ENM, 
silver ions or vehicle were procured from animals following a 28-day oral exposure 
protocol. 
The research questions to be addressed were:  
1. Does exposure to silver and silica ENM lead to morphological changes in the 
testes of treated animals? 
2. Could semi-quantitative, systematic, stereological analysis of tissue reveal any 
measurable changes to the cycle of the seminiferous epithelium indicative of 
altered function following ENM exposure? 
3. Could exposure to silver and silica ENM lead to any functional changes in the 
steroidogenic pathway or other key elements of the HPG axis within the testis? 
4. Were any identified changes in tissues from animals exposed in vivo comparable 
to findings from previous work undertaken in vitro?  
The aims for analysis were therefore twofold:  
i) to undertake a qualitative analysis of testicular morphology, together with 
an evaluation of stain intensity for various receptors, proteins and enzymes 
involved in steroidogenesis and its regulation, and  
ii) to further build understanding of morphological changes using a semi-
quantitative, stereological analysis of the tissue.  
A two-pronged qualitative analysis was developed, consisting of a detailed 
morphological analysis to uncover any changes (subtle or gross) to the testicular 
structure which may indicate toxicity. This was followed by immunohistochemical 
investigation of key receptors, proteins and enzymes to provide an indication on 
whether functional aspects of steroidogenesis and the HPG axis were altered following 
exposure. In order to provide a semi-quantitative appraisal of any effects, a stereological 
analysis was also designed.  
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Materials and Methods 
 
Testicular tissues from rats used in two in vivo studies on the effects of ENM were 
provided by RIKILT, Netherlands. The testes were one of a number of major organs that 
were collected during a wider study, other organs included brain, liver, kidneys, spleen 
and sections of the intestine. This work was undertaken in accordance with the national 
guidelines for the care and use of laboratory animals under approval of the Dutch 
welfare committee. Of the organs collected, Edinburgh Napier University received a 
selection of paraffin embedded samples of kidney, liver, testis, brain and spleen. In this 
thesis, only testicular samples were considered. Exact details of the in vivo protocols for 
animal treatment, organ collection and preparation for histology is outlined below. 
Animal study I: Silver nanoparticle treatments  
The first study concerned exposure to three types of silver based ENM: NM-300, a JRC 
standardised nanoparticle used within the MARINA project; Nano Amor, an industrially 
available silver nanoparticle; and silver nitrate ions (AgNO3) used as an ionic control. 
Details of all nanoparticles used are outlined within Table 20. Six-week old male 
Sprague-Dawley rats weighing ~245g each at the start of experimental work were 
purchased from Harlan (Horst, the Netherlands). Animals were housed in polycarbonate 
cages and acclimatised to a 12h light/dark reversed cycle for 2 weeks. Room 
temperature was ~20°C with a relative humidity of ~55%. Food and water was provided 
ad libitum except for a 2hr fasting period before each treatment. Rats were randomly 
divided into 5 groups of 5 for treatment:  
1. NM-300 Ag < 20; 90 mg/kg bw  
2. Nano Amor Ag < 15-PVP; 90 mg/kg bw,  
3. AgNO3 9 mg/kg bw,  
4. Ctrl-Ag < 20, and  
5. Ctrl-Ag < 15-PVP / AgNO3.  
In addition, the remaining rats were randomly divided into 3 groups (n = 5) to study the 
wash-out until day 36, and into another 3 groups (n = 5) to study the wash-out until day 
84. These wash-out groups for day 36 and 84 received equal treatments as group 1-3. 
All animals were exposed daily for 28 days by oral gavage, at a dosing volume of 3.3ml/kg 
bodyweight. The suspensions and solutions were directly administered to the lower 
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oesophagus after 2 hours of fasting to prevent a reflux reaction.  At day 29 the first 5 
groups were euthanised by CO2/O2 inhalation and the organs excised aseptically, 
weighed and placed on ice. The washout groups were sacrificed at day 84 and organs 
collected using the same protocol. Animals were provided to Edinburgh Napier 
university after fixation in 10% neutral-buffered formalin, and subsequent dehydration 
in a series of ethanol and embedding in paraffin. 
Table 20: Nanomaterials used in animal treatments 
ENM Type of Material Form Primary particle 
size and specific 
surface area 
Additional info 
JRC NM-
300k 
Coated Silver NPs from JRC 
representative manufactured 
nanomaterial panel 
Suspension <20nm Dispersed in matrix of 
stabilizing agents 
polyoxyethylene glycerol 
trioleate (4%) and Tween 
20 (4%) in H2O. 
Nano Amor Commercially available coated 
nanosilver from 
Nanostructured & Amorphous 
Materials Inc. 
Dry powder <15nm 75% PVP. Final 
concentration 27mg/ml 
suspended in LC/MS grade 
water. 
AgNO3 Ionic silver control, Sigma 
Aldrich 
Dry powder - Final concentration 
2.7mg/ml suspended in 
LC/MS grade water. 
SAS Synthetic Amorphous Silica  Dry Powder  Primary particle 
size: 7nm 
SSA: 380m2/ga 
Hydrophilic pyrogenic  
At least 89% of the 
material was >100nm in 
SEM analysis 
NM202 Silica Dioxide Dry Powder Primary particle 
size: 10-25nm 
SSA: 200m2/ga 
Hydrophilic pyrogenic  
At least 78% of the 
material was >100nm in 
SEM analysis 
 
Animal study II: silica nanoparticle treatments  
The second animal study concerned exposure to two types of silica nanoparticulates: 
NM202, a JRC standardised nanomaterial used within the MARINA project; and SAS, a 
synthetic silica nanoparticle which is industrially available. Six-week-old male rats 
purchased from Harlan (Horst, the Netherlands) were housed individually in 
polycarbonate cages to allow control over feed. Animals were acclimatised to a 12h 
light/dark reversed cycle for 3 weeks prior to experiment at a room temperature of 
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~20°C with a relative humidity of ~55%. Feed and water were given ad libitum, except 
for a 2-hour fasting period before the prepared feed was offered to the animals, and the 
following exposure period. 
Animals were an average bodyweight of ~280g at commencement of the experiment. 
They were randomly divided into 10 groups (n=5), made up of seven groups to be fed 
SAS or NM-202 in different dosages or vehicle for 28 days, and 3 groups which were fed 
either vehicle control or the highest doses SAS or NM-202 for 84 days. The groups for 
28-day exposure were: 1) SAS; 100 mg/kg bw/day, 2) SAS; 1000 mg/kg bw/day, 3) SAS; 
2500 mg/kg bw/day, 4) NM-202; 100 mg/kg bw/day; 5) NM-202; 500 mg/kg bw/day; 6) 
NM-202; 1000 mg/kg bw/day and 7) control. For the 84-day exposure, the groups were 
divided into: 8) SAS; 2500 mg/kg bw/day, 9) NM-202; 1000 mg/kg/day and 10) control. 
The dosages selected were chosen to reflect previously observed LOAEL of 1500 mg/kg 
bw/day for SAS (van der Zande et al., 2014a) The medium and high doses of NM202 
were chosen to be lower than those of SAS, because the material characterization 
showed a higher fraction of silica in the nano-size range in the feed matrix for NM-202. 
All treatments were offered prepared food with SAS, NM202 or vehicle.  
Rats were allowed to consume all feed prepared with either vehicle, NM202 or SAS, and 
thereafter were immediately offered standard feed pellets again. During the course of 
the study, it was noted by the technical staff undertaking the experiment that the rats 
ate all silica containing food mixtures or vehicle mixtures within the exposure period of 
two hours. 
One day after the last exposure (day 29) animals in groups 1-7 were euthanized by 
CO2/O2 inhalation and organs were excised aseptically, weighed and placed on ice. 
Animal testes were provided to Edinburgh Napier university after fixation in 10% 
neutral-buffered formalin, and subsequent dehydration in a series of ethanol and 
embedding in paraffin. Animals from groups 8-10 underwent an 84-day exposure. 
However, the testes of these groups were not made available to Edinburgh Napier 
University for further analysis.  
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Selection of Tissue and its Preparation  
Upon arrival at Edinburgh Napier University, tissue samples were organised and 
catalogued (Table 21). The tissue samples selected for analysis were control animals, 
along with those treated with silver ENM, and those treated with silica NM202. These 
were chosen as they provided a direct comparison between the in vitro testing already 
completed and the in vivo work which had been undertaken. Whilst analysis of the full 
complement of tissues provided would have been ideal, time constraints meant that a 
focussed set needed to be chosen. 
Table 21: Tissue Samples selected for analysis from those provided by RIKILT. 
Treatment Animal # Dose Washout 
Y/N 
Sacrifice Day 
CONTROL J13 Vehicle only Y 85 
CONTROL J20 Vehicle only Y 85 
CONTROL J22 Vehicle only Y 85 
CONTROL J28 Vehicle only Y 85 
CONTROL J44 Vehicle only Y 85 
NM-300K G31 90 mg/kg bw/day Y 78 
NM-300K G32 90 mg/kg bw/day Y 78 
NM-300K G33 90 mg/kg bw/day Y 78 
NM-300K G34 90 mg/kg bw/day Y 78 
NM-300K G35 90 mg/kg bw/day Y 78 
Nano Amor I41 90 mg/kg bw/day Y 78 
Nano Amor I42 90 mg/kg bw/day Y 78 
Nano Amor I43 90 mg/kg bw/day Y 78 
Nano Amor I44 90 mg/kg bw/day Y 78 
Nano Amor I45 90 mg/kg bw/day Y 78 
AgNO3 K51 09 mg/kg bw/day Y 78 
AgNO3 K52 09 mg/kg bw/day Y 78 
AgNO3 K53 09 mg/kg bw/day Y 78 
AgNO3 K54 09 mg/kg bw/day Y 78 
AgNO3 K55 09 mg/kg bw/day Y 78 
CONTROL G16 Vehicle only N 29 
CONTROL G31 Vehicle only N 29 
CONTROL G36 Vehicle only N 29 
CONTROL G38 Vehicle only N 29 
CONTROL G40 Vehicle only N 29 
202 LOW D24 100mg/kg bw/day N 29 
202 LOW D33 100mg/kg bw/day N 29 
202 LOW D35 100mg/kg bw/day N 29 
202 LOW D41 100mg/kg bw/day N 29 
202 LOW D47 100mg/kg bw/day N 29 
202 MEDIUM E7 500mg/kg bw/day N 29 
202 MEDIUM E9 500mg/kg bw/day N 29 
202 MEDIUM E26 500mg/kg bw/day N 29 
202 MEDIUM E27 500mg/kg bw/day N 29 
202 MEDIUM E34 500mg/kg bw/day N 29 
202 HIGH F4 1000mg/kg/bw/day N 29 
202 HIGH F5 1000mg/kg/bw/day N 29 
202 HIGH F10 1000mg/kg/bw/day N 29 
202 HIGH F29 1000mg/kg/bw/day N 29 
202 HIGH F46 1000mg/kg/bw/day N 29 
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202 HIGH F4 1000mg/kg/bw/day N 29 
202 HIGH F5 1000mg/kg/bw/day N 29 
202 HIGH F10 1000mg/kg/bw/day N 29 
202 HIGH F29 1000mg/kg/bw/day N 29 
202 HIGH F46 1000mg/kg/bw/day N 29 
202 HIGH I1 1000mg/kg/bw/day Y 85 
202 HIGH I8 1000mg/kg/bw/day Y 85 
202 HIGH I23 1000mg/kg/bw/day Y 85 
202 HIGH I42 1000mg/kg/bw/day Y 85 
202 HIGH I45 1000mg/kg/bw/day Y 85 
 
To prepare tissues for analysis, 15 non-consecutive sagittal 5µm sections from the testis 
of each animal were cut from each paraffin embedded block using a Leica RM2125RT 
rotary microtome, floated onto ThermoFisher Superfrost™ glass slides using a water 
bath set to 42°C (which electro-statically attract tissue to reduce loss during staining) 
before being dried in an oven overnight at 60°C.  
Tissues were then examined for morphological and functional markers of change using 
qualitative morphological and stain intensity analyses and semi-quantitative 
stereological analysis, to allow a validation of results obtained from in vitro studies. This 
was completed using first Haematoxylin and Eosin staining and then 
Immunohistochemical stains for antibodies identified to be of interest. 
 
Haematoxylin and Eosin (H&E) staining 
H&E staining involves application of haematoxylin (a basic dye) and eosin (an acidic dye) 
to prepared tissue samples in order to stain cellular structures and make them easily 
viewable for analysis down a microscope. Haematoxylin is comprised of hemalum (a 
complex formed from aluminium ions and hematein). Hematein is an oxidation product 
of haematoxylin. When tissue is exposed to haematoxylin, it stains acidic (basophilic) 
structures such as the nucleus purple. Eosin is a fluorescent acidic dye which acts as a 
counterstain to haematoxylin by binding to basic (eosinophilic) structures like proteins 
within the cytoplasm and staining them shades of red to pink. The end result is a clear 
stain of intracellular structures which shows nuclei as blue to blue/black, cytoplasm in 
deep pink, and red blood cells and eosinophilic granules in bright orange/red. 
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Haematoxylin and Eosin staining protocol 
To stain tissues using H&E, slides were first brought to a hydrated state through xylene 
and diminishing grades of alcohol to water. This ensures removal of all paraffin as this is 
hydrophobic and prevents staining with aqueous reagents such as H&E. Slides were 
stained with haematoxylin (Mayer's Haematoxylin, Cellpath UK) for 5 minutes in a bath 
on a laboratory rocker, then washed with tap water for 30secs-1min, before being 
dipped in 1% acid alcohol solution to remove any background staining and washed in 
water again. If necessary, they were then ‘blued up’ in warm Scott’s tap water substitute 
(Cellpath UK) – a weakly alkaline solution which assists in bringing out the blue staining 
on the nuclei. An eosin Y based counterstain (mixture of 8-parts 1% Aqueous Eosin and 
1-part Putt’s Eosin, both from Cellpath UK) was then applied as a bath for 5 minutes, 
slides were washed in water for 30sec-1minute to remove all Eosin, and then 
dehydrated through alcohol and xylene baths before applying pertex mounting glue and 
coverslips. The staining protocol including times for immersion of slides in each solution 
is summarised within Table 22. 
Table 22: Haematoxylin and Eosin staining protocol 
1. Rehydration 2. H & E Stain 3. Dehydration 
Solution Time Solution Time Solution Time 
Xylene (de-wax 1) 3min Mayer’s Haematoxylin 5min Methylated spirit 1min 
Xylene (de-wax 2) 2min Water wash 30sec-1min Ethanol 2 (70%) 2min 
Ethanol 1 (90%) 2min 1% acid alcohol 1-3 quick dips Ethanol 3 (90%) 1min 
Methylated spirit 1min Water wash 30sec-1min Xylene (clearing) 1min 
Water 30sec-
1min 
Scott’s tap water 
substitute 
1min Xylene (coverslip) 5min 
  Water wash 30sec-1min   
  Eosin 5min   
  Water wash 30sec-1min   
 
Immunohistochemistry 
Immunohistochemistry (IHC) is based on the interaction of target antigens with specific 
antibodies tagged with a visible label and this enables the visual localization of specific 
cellular components within tissue. For this endpoint, the peroxidase enzyme based-
system making use of biotin labelling and formation of an avidin-biotin complex was 
selected. This system therefore allows sensitive visualisation of the cellular target 
(antigen) via 4 key steps (outlined in Fig. 65):  
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1. Binding of the primary antibody of interest to the protein/receptor of interest 
on the tissue, 
2. Binding of a biotinylated secondary antibody to the primary antibody, 
3. Binding of an avidin-biotinylated peroxidase enzyme complex (ABC) to the biotin 
attached to the secondary antibody to increase signal, and finally 
4. Addition of an enzyme substrate (DAB) in order to label the antigen, in this case 
via development of a colorimetric reaction from clear to brown.  
A panel of antibodies were selected for investigation to compliment the functional 
analysis carried out in vitro, and the optimal dilution determined for the tissue samples. 
These are outlined within Table 23. 
 
 
  
 
Figure 65: Biotin labelled immunohistochemistry. Source: Vector Labs 
(VectorLaboratories, 2018). 
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Table 23: Panel of Antibodies selected for examination of tissues collected by immunohistochemistry. 
ANTIBODY DETECTS PRODUCER RAISED IN 1ºAb 
Dilution 
SECONDARY 
ANTIBODY 
Luteinising 
Hormone 
Receptor 
(LH-R) 
Luteinising 
hormone 
receptor, 
indicative of 
Leydig Cell 
function 
Santa Cruz Rabbit 
Polyclonal 
1:50 Vector Labs: biotinylated 
universal anti-
mouse/rabbit IgG 
secondary antibody 
Androgen 
Receptor 
(AR) 
Androgen 
receptor, 
abundant within 
healthy Sertoli 
Cells 
Santa Cruz Rabbit 
Polyclonal 
1:50 Vector Labs: biotinylated 
universal anti-
mouse/rabbit IgG 
secondary antibody 
Steroidogenic 
acute Regulatory 
Protein 
(StaR) 
Regulation of 
steroid hormone 
synthesis by 
Leydig Cells 
Santa Cruz Goat 
Polyclonal 
1:50 Vector Labs: Biotinylated 
Universal Pan-Specific 
Antibody (Horse Anti-
Mouse/Rabbit/Goat IgG) 
3-β-
hydroxysteroid 
dehydrogenase 
(3β-HSD) 
Regulation of 
steroid hormone 
synthesis by 
Leydig Cells 
Santa Cruz Goat 
Polyclonal 
1:50 Vector Labs: Biotinylated 
Universal Pan-Specific 
Antibody (Horse Anti-
Mouse/Rabbit/Goat IgG) 
Deleted in 
AZoospermia-
like protein 
(DAZL) 
Present within 
Germ cells and 
crucial to 
achievement and 
maintenance of 
spermatogenesis 
Santa Cruz Goat 
Polyclonal 
1:250 Vector Labs: Biotinylated 
Universal Pan-Specific 
Antibody (Horse Anti-
Mouse/Rabbit/Goat IgG) 
Mouse Anti-Rat 
Granulocytes 
RP-1 
Reacts with rat 
peritoneal and 
peripheral blood 
neutrophils if 
present 
BD 
Biosciences 
Mouse 
monoclonal 
1:50 Vector Labs: biotinylated 
universal anti-
mouse/rabbit IgG 
secondary antibody 
 
It is notable that two new antibodies were introduced in addition to those already used 
within the in vitro work, namely Dazl and RP-1. Dazl was used to measure germ cell 
development within the spermatogenic cycle (something which was not possible in the 
individual cell lines used in vitro), and RP-1 was employed to investigate whether 
inflammatory effects observed within the testicular interstitium were due to immune 
system response. To undertake immunohistochemical staining for each of the above, 
slides were taken through the four key steps of immunohistochemical staining as 
follows:  
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1. Dehydration, antigen retrieval and peroxidase blocking  
Slides were first dewaxed and hydrated using xylene and graded alcohols to water as 
per the hydration steps employed for H&E staining (Table 22). They were then 
microwaved in citrate buffer to allow antigen retrieval whereby cross-linking of proteins 
which occurs during the fixing steps of sample preparation is reversed in order to 
unmask the epitope of interest. Following this, they were blocked in 3% peroxidase 
solution for 20 minutes to suppress endogenous peroxidase activity, which would cleave 
the substrate and lead to background staining caused by non-specific binding of the 
antibody.  
2. Serum blocking and antiserum binding  
A Tris-Buffered Saline wash (a solution which is close to physiological pH of 7.4) was 
prepared by diluting 0.1M Tris (10x) with water and sodium chloride. Following a wash 
with TBS, a further 30-minute block for non-specific binding was undertaken using 
normal horse serum (2.5%, Vector labs). A PAP pen was then used to seal the space 
around tissue on each slide, the primary antibody selected was diluted appropriately in 
normal horse serum and applied before slides were incubated in a humidified chamber 
overnight at 4 C̊.  
3. Binding of Secondary antibody and ABC complex 
The following day, primary antibody was washed from slides using PBS-Tween (0.1%). 
Negative controls were washed separately to avoid any cross-reaction with primary 
Antibody. Slides were then incubated with an appropriate secondary Antibody (Table 
23) for 60 minutes at room temperature. A further wash was undertaken with TBS 
before incubation with Avidin-Biotin Complex (ABC complex, Vector Labs) for 60 
minutes to enable substrate binding (Fig. 20).  
4. Addition of DAB substrate and colorimetric reaction to visualise results 
DAB staining Following a final 5-minute TBS wash, DAB substrate (3,3'-
Diaminobenzidine, Vector Labs) was prepared and applied to the slides to determine 
antibody localisation. When colour development was deemed sufficient, the colour 
reaction was stopped by rinsing slides in water for 5 minutes. They were then 
counterstained with haematoxylin and then dehydrated through graded alcohols to 
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xylene for final mounting using Pertex mounting medium (Cellpath UK). Sections for all 
control and treated animals were run for each antibody at the same time and under the 
same conditions to ensure comparability. 
Image Capture 
Once slides were prepared, a Zeiss slide scanner (Axio Scan.Z1, accessed at Institute of 
Aquaculture, Stirling University) was used to digitise all specimens. The scanner uses an 
automated process to create high quality virtual slides in a reliable, reproducible way. 
The slide library was then catalogued in preparation for morphological and stereological 
analysis using the software packages Zeiss Zen Blue v2.3 for morphological analysis, and 
ImagePro Premier v8 (Media Cybernetics) for stereological measurements.  
 
Virtual slide preparation for Morphological Analysis  
Qualitative morphological analysis to identify treatment effects was undertaken on H&E 
stained slides. Every virtual slide prepared was scanned within Zen blue software to 
appraise general appearance, and 2-4 representative images at varying magnifications 
taken of each in preparation for analysis. 
Virtual slide preparation for Stereological analysis I: basic analysis 
Five snapshot images were taken from H&E stained 
slides at 50x magnification using Zen Blue to 
produce five subset virtual slides saved as Carl Zeiss 
Image (czi) files, which unlike many other image 
formats, retain metadata that allow the user to 
zoom into much higher magnifications in order to 
undertake detailed analysis at a later time. To 
ensure that analysis was as consistent and 
unbiased as possible, these were taken as subset 
images from each pole of the slide, plus the centre 
(Fig. 66). Images were then white balanced to 
remove unrealistic colour casts from the light 
source at imaging using pre-sets within Zen, and a scale bar was applied to each for 
Figure 66: Subset image preparation from tissue 
sections within Zen. A 50x magnification was 
applied, then 5 subset images were captured from 
the 4 poles of the section plus the middle. 
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reference. At this stage the virtual subsets of slides were blinded by a person uninvolved 
in the work to minimise bias in analysis.  
Virtual slide preparation for Stereological analysis II: staging and related measurements 
Subsequently, a second stereological analysis of slides was undertaken (rationale 
outlined below) which included staging of tubules on each virtual slide before 
measurement of key parameters. To enable this, a similar protocol was followed as for 
analysis I, but using Dazl antibody stained slides to assist in identification of tubule stage.  
 
Morphological analysis of tissues 
One virtual slide per animal in each treatment or control group was analysed for general 
appearance, structure and morphology of the seminiferous tubules, Leydig and 
interstitial cells. Commentary was prepared based on observations and any 
morphological changes of note. This was then used to guide subsequent 
immunohistochemical and quantitative analysis.  
 
Immunohistochemical Analysis:  
Virtual slides were evaluated subjectively but systematically. Initially the intensity of 
immunostaining was noted for each animal on a scale from negative through weakly, 
moderate to strongly positive, and overstained. Although staining intensity was noted, 
it was not considered to be a quantitative measure of immunostaining, as the 
colourimetric reaction seen with DAB does not represent a linear relationship between 
concentration of compound and absorbance. This is because DAB does not follow the 
Beer-Lambert law as it is not a true absorber of light, but rather scatters it with a broad, 
featureless spectrum (van der Loos, 2008). Thus, darkness of DAB stain is not directly 
related to amount of reaction product. Based on this, intensity of staining was used as a 
qualitative indicator only and any inferences on potential alteration in steroidogenic 
potential were made in conjunction with those from the western blot and RNA analysis 
(Chapter 4).  
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Stereological analysis of tubules I: basic measurements  
Initially, blinded H&E images were imported to ImagePro Premier software and the scale 
bar used to calibrate measurements. On each image, all tubules that were fully visible 
within the screen were then measured for diameter across the shortest point of the 
cross-section, and germ cell layer thickness from the edge of the tubule to the inner 
edge of the germ cell layer. Measurements were exported to Microsoft Excel and 
compiled before transfer to Graphpad Prism v7 for statistical analysis.  
 
Stereological analysis of tubules II: staging and related measurements 
Following processing of initial results, it was clear that the stage of the seminiferous 
epithelium at which each tubule was played a major role in the tubule diameter, lumen 
volume and germ cell layer thickness observed. Therefore, a second analysis was carried 
out which took into account stage, following guidance set out by Creasy et. al. (Creasy, 
1997). As this analysis was far more detailed, only silver treated animals and controls 
were analysed, with plans to include animals from the silica study at a later date. The 
analysis required several key steps in order to be successful: 
1. Tubule staging, assisted by  
2. Dazl immunostaining intensity measurement, then 
3. Measurement of tubule diameter and lumen volume,  
4. Measurement of additional relevant parameters, including internal luminal 
volume (where cell sloughing into the lumen was present), and allocation a 
shape class (round, elliptical or elongated).   
Each step is outlined in full within the sub-sections below.  
1. Staging of tubules 
Identification of tubule stage was undertaken within Zen Blue software, and 
systematically labelled within this programme before export to Image Pro Premier for 
measurement. Staging of tubules was supported by development of a decision key to 
assist with accuracy and consistency. This was adapted from several sources, initially 
referencing Leblond’s seminal paper defining the stages of the cycle of the seminiferous 
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epithelium in the rat (Leblond and Clermont, 1952), and then using work from Hess 
which provided a detailed overview of each stage and its characteristics (Hess, 1990, 
Meistrich and Hess, 2013), alongside OECD prepared guidance on the histopathological 
evaluation of the male reproductive system (OECD, accessed 2017). The final decision 
key and supporting data are outlined within Tables 24 and 25. It is important to note 
that because of previously recognised challenges with assigning stages I-IV using 
classical histology methods such as paraffin sectioning, these stages were grouped 
together for this analysis.  
2. Dazl immunohistochemical stain intensity 
To assist staging, analysis of the staining intensity of Dazl protein was also undertaken 
for each tubule on each virtual slide. Dazl is a crucial factor for achievement and 
maintenance of spermatogenesis, and its expression is known to vary within germ cell 
populations in the testis. Rocchietti-March et al reported weak but specific Dazl staining 
in in the cytoplasm of intermediate and B Spermatogonia, primary spermatocytes during 
Prelepotene to Zygotene stages, and in the acrosomal region and around elongating 
spermatids. They also observed strong specific staining in the cytoplasm of primary 
spermatocytes, which was lost in Diplotene spermatocytes (Rocchietti-March et al., 
2000). It was hoped that this stage-specific Dazl staining would provide a further support 
to ensuring accuracy in staging of tubules for stereological analysis. Expected Dazl stain 
intensity was therefore outlined alongside key germ cell populations within Table 25, to 
be used alongside the primary decision key (Table 24) to support staging of tubules.  
Tubules on each virtual slide were evaluated subjectively but systematically so that the 
intensity of immunostaining was appraised for each animal on a scale from negative (0) 
through weakly (1), moderate (2) to strongly (3) positive, and (4) overstained. Results 
were then exported to excel for initial analysis, before being imported to Graphpad 
Prism v7 for final analysis and graphing. The final graphed result for Dazl stain was 
overlaid onto each graph produced of measured tubule diameter and lumen volume per 
treatment to illustrate the supportive relationship between Dazl stain and tubule stage. 
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Table 24: Key cell populations, distinguishing features, morphological and stereological identifiers present at each stage of the seminiferous tubule cycle used in staging tubules for morphological and stereological 
analysis. 
Initial Question:  Are 2 steps of spermatids present (round and elongating)? YES: stages I – VIII / NO: stage IX - XIV 
If YES to question 1: Are elongated spermatids located near lumen? NO: late I-V / YES: Late VI-VIII 
   
Stage in 
Cycle 
Spermatid 
Step 
Spermatid populations 
present 
SPERMATID Step Distinguishing 
Features Germ cell types Present Morphology Notes Stereological analysis Notes 
I 1, 15 Round + Elongating Spermatids 
15: Pronounced curve of nuclear 
apex and bulge in caudal region, 
located midway between lumen 
and basal membrane 
A1 Spermatogonia 
Pachytene spermatocytes 
Earlier P spermatocytes are 
closer to basement 
membrane and darker in 
appearance 
Tubule diameter ↑stages I-IV 
Germ Cell Epithelium Volume ↑ stages 
XIV-V of next cycle 
II 2,16 Round + Elongating Spermatids 
16: located midway between 
lumen and basal membrane 
A1 Spermatogonia 
Intermediate Spermatogonia 
Pachytene spermatocytes 
Earlier P spermatocytes are 
closer to basement 
membrane and darker in 
appearance 
Tubule diameter ↑stages I-IV 
Germ Cell Epithelium Volume ↑ stages 
XIV-V of next cycle 
III 3, 16 Round + Elongating Spermatids 
16: located midway between 
lumen and basal membrane 
A1 Spermatogonia 
Intermediate Spermatogonia 
Pachytene spermatocytes 
Earlier P spermatocytes are 
closer to basement 
membrane and darker in 
appearance 
Tubule diameter ↑stages I-IV 
Germ Cell Epithelium Volume ↑ stages 
XIV-V of next cycle 
IV 4, 17 Round + Elongating Spermatids 
17: located midway between 
lumen and basal membrane 
A1 Spermatogonia 
Intermediate Spermatogonia 
B Spermatogonia 
Pachytene spermatocytes 
Earlier P spermatocytes are 
closer to basement 
membrane and darker in 
appearance 
Tubule diameter ↑stages I-IV 
Germ Cell Epithelium Volume ↑ stages 
XIV-V of next cycle 
V 5, 17 Round + Elongating Spermatids 
5: Slightly curved head cap from 
acrosomic system (Ac) 
17: located midway between 
lumen and basal membrane 
A1 Spermatogonia 
Intermediate Spermatogonia 
B Spermatogonia 
Pachytene spermatocytes 
B type Spermatogonia 
present against basement 
membrane 
Lumen volume ↑stages V-VIII 
Germ Cell Epithelium Volume ↑ stages 
XIV-V of next cycle 
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VI 6, 18 Round + Elongating Spermatids 
Presence of mitotic figures 
Step 18 spermatids 
A1 Spermatogonia 
B Spermatogonia 
Prelepotene spermatocytes 
Pachytene spermatocytes 
PL spermatocytes are 
squashed and have ‘dots’ in 
them 
Lumen volume ↑stages V-VIII 
Germ Cell Epithelium volume ↓ stages 
V-VII 
VII 7, 19 Round + Elongating Spermatids 
Elongating spermatids line luminal 
border 
Step 19 spermatids 
A1 Spermatogonia 
Prelepotene spermatocytes 
Pachytene spermatocytes 
Later P spermatocytes are 
larger and move toward 
lumen 
Basophilic granules present 
in cytoplasm 
Tubule diameter ↑stages VII-VIII 
Lumen volume ↑stages V-VIII 
Germ Cell Epithelium volume ↓ stages 
V-VII 
VIII 8 Round Spermatids Step 19 spermatids Line luminal border 
A1 Spermatogonia 
Prelepotene spermatocytes 
Residual bodies present 
around lumen 
Tubule diameter ↑stages VII-VIII 
Lumen volume ↑stages V-VIII 
IX 9 Elongating Spermatids No late spermatids present 9: spermatids all appear round 
Lepotene Spermatocytes 
Possibly some residual prelepotene 
spermatocytes 
More Lepotene than 
prelepotene 
Residual bodies in 
epithelium 
Tubule diameter ↓stage VIII-IX 
Lumen volume ↓ stage VIII-IX 
X 10 Elongating Spermatids 
No late spermatids present 
10: slight elongation starting to 
show 
Lepotene Spermatocytes 
Residual bodies have 
disappeared 
 
 
XI 11 Elongating Spermatids 11: Ac hooks off at angle and spermatids present in clumps Lepotene Spermatocytes 
Distinct bundles of 
elongating spermatids 
present 
 
XII 12 Elongating Spermatids 12: more elongated and narrow than (11) 
Zygotene spermatocytes 
Pachytene spermatocytes 
Some Diplotene 
spermatocytes may be 
present 
 
XIII 13 Elongating Spermatids 13: bulge of spermatid head now present 
Zygotene spermatocytes 
Diplotene Spermatocytes 
Large number of Diplotene 
spermatocytes present  
XIV 14 Elongating Spermatids 14: spermatids appear more ‘hooked’ than (13) 
Pachytene spermatocytes 
2ndary Spermatocytes 
Meiosis Occurring  
Meiotic figures present 
Some secondary 
spermatocytes may be 
visible 
Germ Cell Epithelium Volume ↑ stages 
XIV-V of next cycle 
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Table 25: Key cell populations present at each stage the seminiferous cycle in tubules to support decision key outlined within table 24 for staging of tubules for morphological and stereological analysis. Relative 
expected Dazl protein immunohistochemical stain is also noted at the base of the table, based on Rocchietti-March et. al. (2000). Images reproduced from Hess (Hess, 1990). 
Germ cell type Present in stage? Y/N 
Name Morphology I II III IV V VI VII VIII IX X XI XII XIII XIV 
Intermediate 
Spermatogonia  
 Y Y Y Y          
B Spermatogonia 
 
   Y Y Y         
Prelepotene 
 
     Y Y Y       
Lepotene 
 
        Y Y Y    
Zygotene 
 
           Y Y  
Pachytene: 
LHS early 
RHS late  
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Early 
Y 
Late 
Y 
Late 
Y 
Late  
Y 
Early 
Diplotene 
 
           Y Y  
Meiotic 
 
             Y 
Secondary 
Spermatocytes 
 
             Y (in some) 
Expected Dazl Stain Intensity - - - - + ++ +++ +++ ++ + + - - - 
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3. Stereological Measurements within Image Pro Premier  
Once virtual slides including annotation for tubule stage were imported to Image Pro 
Premier, the scale bar was used to calibrate measurements. Each tubule was then 
systematically measured for diameter and lumen volume. Diameter was measured 
across the shortest point of the tubule cross-section, and luminal volume measured by 
drawing a region of interest (ROI) around the edge of the luminal space, from which 
Image Pro Premier calculated volume in µm/cm2 (Fig. 67).  
4. Measurement of additional parameters and classification of tubule shape 
In some of the treated animals, sloughing of cells into the central lumen of the tubule 
was observed (Fig. 68). Where this occurred, an internal diameter was taken and used 
to generate a second set of volumes, corrected for internal sloughing of cells. This 
second set of measurements were later used within the statistical analysis to elucidate 
whether taking into account cells sloughed into the lumen altered any outcomes 
observed.  
Finally, all tubules were annotated as to whether they were round, elliptical, or 
elongated in shape, in order to later check whether tubule shape influenced outcomes 
relating to the lumen volume measured (Fig. 69). All measurements were then exported 
Figure 67: Example of annotation and measurement process for stage, 
tubule diameter and lumen volume applied to all sample images. Tubules 
were staged and marked sequentially with "number.stage" in Zen Blue, 
before being exported to ImagePro Premier. Tubule diameter was then 
measured across the shortest transverse cross-section of tubule, and 
lumen volume calculated by drawing an ROI around the edge of the 
lumen space in each tubule. Representative image is from animal I43 
within the Nano Amor treatment group, taken from the west pole of the 
slide. 
Figure 68: Representative image of tubule 
containing cells that have sloughed into the centre 
of the lumen. Where this was present, both the 
overall luminal volume and the inner luminal 
volume were calculated within Image Pro Premier, 
in order to provide aid analysis of whether taking 
into account cell sloughing altered any outcomes 
observed relating to treatment. 
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to Microsoft Excel and compiled before transfer to Graphpad Prism v7 and SAS for 
statistical analysis.  
Statistical Analysis  
 
Statistical analysis for this chapter was initially 
begun in Graphpad prism v7, and all of the 
statistical findings reported within the initial 
stereological analysis (stereological analysis I) 
were calculated within this programme. 
However, due to limitations discovered in 
dealing with uneven numbers of replicates such 
as those generated from observational 
recordings during the second part of the 
stereological analysis (which linked tubule stage 
to treatment, tubule shape and presence/lack 
of sloughed cells alongside measured 
outcomes), analysis was switched from Prism 
into SAS. To complete the analysis, Statistical 
Analysis Software (SAS) version 9.4 was used for 
the statistical outputs, while graphical 
representations of datasets were prepared in Graphpad prism. 
Analysis within SAS was completed using a mixed model for repeated measures data. 
Mixed models are a type of linear regression model that take into consideration 
variation that is not generalizable to the independent (fixed) variables (such as 
treatment, tubule stage etc). These are enhancements on classical linear regression 
models that accommodate the fact that animal responses are not completely without 
variance, and as such contain both fixed and random effects, allowing for a more flexible 
approach to correlated data (Seltman, 2018). They also allow for uneven numbers of 
data within each dataset, which meant it is possible to analyse a dataset generated from 
observations and containing uneven numbers of observed tubule diameters and lumen 
volumes per stage and per animal.   
Figure 69: Representative image captured from a 
control animal to illustrate the differences in tubule 
shape captured on each section or virtual slide. Red = 
round tubule cut exactly perpendicular to the direction 
it is running in, green = elliptical tubule, cut at an 
oblique angle to the direction of the tubule, blue = 
elongated tube, cut on a sagittal plane to the direction 
of the tube. 
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Within this model animal was the random effect, tubule stage, treatment, shape etc. 
were fixed effects, and the response was lumen volume or tubule diameter. Having 
animal as the random effect accounts for the fact that this inherently contains variation 
i.e. each animal will respond slightly differently to treatment, something that would 
generally result in errors forbidden by the assumptions of a standard ANOVA or 
regression model. Inclusion of fixed and random effects therefore partitions the 
variability in a regression approach for observations that are correlated. Allowing for 
these allows the correlated variability of animal response to be ‘soaked up’. This means 
the remaining variability is classed as heteroscedastic, uncorrelated and normal error, 
which allows the use of least squared regression techniques to finish the estimation of 
result (Barter, 2018).  
In short, for each outcome of interest, the model calculates a resulting coefficient or 
estimate (which is similar to an average but takes into account assumptions made by 
the model), by fitting a regression line to each factor (e.g. stage or treatment) within 
each level (animal), then averaging the regression to obtain an overall effect of 
treatment on result. For example, when comparing tubule diameters between the d29 
and d85 control animals, the model examining the effect of treatment and stage 
(factors) on tubule diameter (result) would be:  !"#"$%	'()*%+%, = .+)/%	(11	23..(#$%) + +,%)+*%6+	(2	23..(#$%) 
For each of the possible choices with each factor (stage or treatment), the estimate is 
the intercept of the model’s fit plus the estimate of factor 1 (stage) plus the estimate of 
factor 2 (treatment). Thus, if the average tubule diameter calculated within the model 
was 257.21µm, the estimate of stage I-IV was -5.439µm and the estimate of treatment 
d29 was -27.026µm, then the calculated Tubule Diameter estimate for stage I-IV within 
control d29 animals would be:  
Tubule diameter stage I-IV d29 = 257.21 + -5.439 + -27.026 
    = 224.745µm 
At this stage, the model would make a final adjustment for the proportional amount of 
observations that have contributed to each factor vs the overall dataset size, and thus 
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the final ‘weighted average’ produced would account for smaller numbers of 
observations against certain factors.  
 
Results 
 
Morphological analysis of control tissues 
An initial examination of slides from control animals prepared with H&E stain revealed 
tissue with regularly shaped seminiferous tubules at various stages of spermatogenesis, 
interspersed with interstitial Leydig cells, capillaries and blood vessels. 
As depicted within Fig. 70, the seminiferous tubules had a well-defined outer tunica 
propria, with tubular myoid cells lining the basal lamina of the tubules. The epithelium 
was comprised of Sertoli cells and a developing germ cell layer containing sperm at 
various stages of maturation. Within these images, which depict a stage VII tubule (A) 
and a stage VIII tubule (B), the least mature primary spermatogonia (A, intermediate 
and B type – Fig. 71 contains a clear view of an A type spermatogonia) were present at 
the basement membrane, with spermatocytes alongside them in varying stages of 
development from primary to secondary (prelepotene and pachytene visible within Fig. 
70). Round and elongating spermatids were situated midway between basement 
membrane and lumen, and mature spermatids when present passaged toward the 
central lumen before being released at stage VIII of the tubule’s cycle (spermiation). 
Image B shows the migration of Sertoli cells toward the central lumen, which occurs at 
stage VIII. 
The interstitial cell population of Leydig cells, capillaries and blood vessels all appeared 
to be healthy. Fig.71 shows the polyhedral layout of Leydig cells around both capillaries 
and blood vessels in the interstitial space. Adult Leydig cells are not exclusively arranged 
in clusters but do tend to stay in close association a blood supply, as shown within the 
image.  
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Figure 70:  Representative morphology of healthy rat testis, taken from control animal (H&E stained). A: general layout of round 
seminiferous tubules, interspersed with polyhedral Leydig cells and blood vessels/capillaries. The tubule in the centre of the image 
is at stage VII. Scale bar represents 50µm. B: higher magnification representation of the same image. Scale bar represents 20µm.  C 
= capillary; LC = Leydig Cell; GC = Germ Cell layer; L = Lumen; Rb = Residual Bodies; S = Sertoli cell; M = Peritubular Myoid Cell; P = 
Pachytene spermatocyte; PL = Prelepotene Spermatocyte; RS = Round Spermatid; ES = Elongating Spermatid; Sp = mature 
Spermatozoa. 
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Figure 71: Generalised morphology of healthy rat testis with focus on interstitial cell populations. A: adult Leydig cell populations 
surrounding a capillary. B: adult Leydig cells lying in close association to a larger blood vessel containing red blood cells. Scale bar 
represents 20µm.  C = capillary; BV = blood vessel; LC = Leydig Cell; S = Sertoli cell; M = Peritubular Myoid Cell; A= type A 
spermatogonia; P = Pachytene spermatocyte; PL = Prelepotene Spermatocyte; D = Diplotene spermatocyte; RS = Round Spermatid; 
ES = Elongating Spermatid; Sp = mature Spermatozoa. 
 
Morphological analysis of treated tissues 
 
Silica dioxide treated animals (NM202) 
Analysis of tissue from animals treated with silica dioxide - NM202 - at low, medium and 
high doses revealed no obvious morphological changes compared to control tissue. The 
layout of the testis was well structured, with seminiferous tubules at various stages of 
the seminiferous epithelium cycle, and the polyhedral collections of Leydig cells and 
other interstitial contents appeared normal (Fig. 72).  
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Figure 72: Generalised morphology of rat testis from animals treated with NM202 silica dioxide. Morphology appears unaltered 
when compared to control, indicating no major structural disturbances to the testis of these animal following treatment at any 
dose level. A) NM202 low dose; B) NM202 medium dose; C) NM202 high dose. Scale bar represents 100µm. 
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Silver treated animals (NM-300) 
Animals treated with NM-300 silver showed focal areas of generalised dysmorphism 
across the testicular sections. Examination of these areas revealed the presence of 
generalised disorganisation within tubule germ cells, with partial degeneration/atrophy 
of germ cells being visible (Fig. 73). In many tubules, this was accompanied by the 
presence of pyknotic nuclei which are very dark in appearance and indicate the cell is 
undergoing apoptosis (Fig. 73).  
In some tubules, there was a complete loss of lumen and general tubular architecture 
present (Fig. 74). In places, this was accompanied by an accumulation of disorganised 
cells out with the tubules themselves. Although it was not possible to undertake 
examination and further testing to prove the presence of immune cell infiltration, these 
interstitial changes did appear similar to those seen with inflammation (Fig. 75). This 
effect was exclusively within the interstitium, and not observed within the tubules.  
In a few stage IX and X tubules, mature step 19 spermatids could be seen at the 
basement membrane of the tubule (Fig. 76). Retention of step 19 spermatids is 
recognised as a sensitive marker of toxicity within stage XI and X tubules. Within a few 
distinct tubules, appearance of much larger cells which could be developing 
multinucleated giant cells was noted (Fig. 77).  
In tubules which maintained a more structured architecture, exfoliation of germ cells 
into the central lumen (considered a sensitive indicator of spermatogenic disturbance) 
was a widespread observation (Fig. 74). In mature rats there are normally very few 
sloughed cells, therefore this is considered a sensitive indicator of spermatogenic 
disturbance in the testis (Creasy et al., 2012).  
It is important to note that where tubules appeared to be normal, organisation of germ 
cells was unaffected, and tubules from stage I-XIV were present, including stage VIII 
tubules at spermiation and stage XIV tubules with active meiosis underway. This is 
further supported by the observation from one animal where epididymal tissue was 
present on the slide, ducts appeared healthy and contained mature spermatozoa.  
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Figure 73: Image captured from an animal treated with NM-300 silver nanoparticles. A) generalised loss of tubular architecture in 
some tubules and maintenance of normal architecture in others (left- and right-hand side of image). Within this image, round 
spermatids appear to be degenerating, as illustrated by their patchy appearance. B) presence of pyknotic nuclei (very dark cells 
where chromatin in the nucleus is condensed and undergoing apoptosis). Scale bar represents 50µm in A, and 20µm in B. 
 
 
Figure 74: Image captured from an animal treated with NM-300, illustrating area of focal dysmorphism in tubules, alongside 
tubules which appear to be healthy and showing normal germ cell populations and architecture (red asterisks). Scale bar 
represents 100µm. 
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Figure 75: Image captured from an animal treated with NM-300 silver nanoparticles, illustrating generalised loss of tubular 
architecture accompanied by inflammation within the interstitium. Image B offers a higher magnification view on both tubule and 
interstitium contents. Scale bar represents 100µm in A, and 50µm in B. 
 
 
 
 
Figure 76: Images captured from an animal treated with NM-300 silver nanoparticles, showing retention of mature step 19 
spermatids in stage IX (A) and X (B) tubules (red arrows). Retention of mature spermatids after spermiation at stage VIII is a 
sensitive indicator of toxicity. Scale bar represents 20µm. 
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Figure 77: Images from an animal treated with NM-300 silver nanoparticles, showing what could be development of 
multinucleated giant cells within morphologically degenerative tubules (red circles). Scale bar represents 50µm. 
 
 
Silver treated animals (AgNO3) 
As with NM-300 treated animals, those exposed to AgNO3 silver showed focal areas of 
generalised dysmorphism across testicular sections, including a complete loss of lumen 
and general tubular architecture and presence of pyknotic nuclei (Fig. 78). The 
dysmorphism seen within AgNO3 exposed animals was on the whole more widespread 
than in those exposed to NM-300 or Nano Amor, morphologically abnormal tubules 
often being much higher in number than those that were normal in appearance.  
Evidence of hyperplasia within Leydig cells of the tubular interstitium was found in some 
animals and was associated almost exclusively with tubules which had completely lost 
their internal architecture (Fig. 79). It manifested in a focal manner, as a collection of 
Leydig cells with a diameter equal to or more than half of an average seminiferous 
tubule, with no compression of the surrounding tissue, as per the agreed criteria for 
Leydig Cell hyperplasia from the Society of Toxicologic Pathologists (McConnell et al., 
1992).   
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There was no evidence of mature spermatid retention in stage IX and X tubules or giant 
cell formation. However, a very few distinct tubules were noted to be almost completely 
lacking in germ cells, being lined primarily by Sertoli cells (fig. 80). Again, in those tubules 
which maintained a more structured architecture, exfoliation of germ cells into the 
central lumen was a widespread observation Fig. 81). Where tubules appeared to be 
normal, organisation of germ cells was unaffected, and tubules from stage I-XIV were 
present.  
 
 
Figure 78: Representative image of focal dysmorphism within AgNO3 exposed animal. Generalised loss of cellular architecture, and 
presence of pyknotic nuclei (very dark cells where chromatin in the nucleus is condensed and undergoing apoptosis) may be seen 
throughout the tubule. Scale bar represents 50µm. 
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Figure 79: Representative image of morphologically abnormal tubules with LC hyperplasia in the interstitium within AgNO3 
exposed animal (highlighted with star). Scale bar represents 100µm. 
 
Figure 80: Tubule observed within AgNO3 exposed animal containing almost no germ cells, those cells left lining the basement 
membrane are primarily sertoli cells. Scale bar represents 50µm. 
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Figure 81: Sloughing of tubular contents into central lumen, observed within AgNO3 exposed animals. As with other silver 
treatments, morphologically disturbed tubules were often seen alongside tubules which were healthy in appearance (star). Scale 
bar represents 50µm. 
Silver treated animals (Nano Amor) 
As with the other silver treatments, animals exposed to Nano Amor silver showed focal 
areas of generalised dysmorphism across testicular sections. This included complete loss 
of lumen, general tubular architecture and presence of pyknotic nuclei (Fig. 82). 
Additionally, some tubules appeared to show dilation of the lumen, having a thinner 
epithelium containing a normal compliment of germ cells (Fig. 83). Tubules at stages IX 
to XIV generally have a much smaller lumen volume than those at earlier stages of the 
seminiferous epithelial cycle (Wing and Christensen, 1982). As the tubules within Fig. 83 
are stages X and XII (left and right-hand side of image B) it is therefore unlikely for the 
lumen to be so large under normal circumstances.  
Focal areas of dysmorphism were more widespread than in NM-300 exposed animals; 
as with AgNO3 treated animals there were some slides where morphologically abnormal 
tissue was more prevalent than normal. There was no evidence of inflammation or 
Leydig cell hyperplasia within the interstitium, mature spermatid retention in stage IX 
and X tubules or giant cell formation. However, potential arrest of germ cell 
development was noted, namely by the presence of step 12 spermatids within a stage 
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XIV tubule in which step 14 spermatids would be expected (Fig. 84). In those tubules 
which maintained a more structured architecture, exfoliation of germ cells into the 
central lumen was a widespread observation (Fig. 83). Where tubules appeared to be 
normal, organisation of germ cells was unaffected, and tubules from stage I-XIV were 
present.  
 
Figure 82: Representative images of focal dysmorphism within Nano Amor exposed animal. Generalised loss of cellular 
architecture is observable within both tubules, these again being situated adjacent to other tubules which appear to be 
morphologically normal. A number of pyknotic nuclei, identifiable as very dark cells where chromatin in the nucleus is condensed 
and undergoing apoptosis are also visible on image A. Scale bar represents 50µm. 
 
 
Figure 83: Representative images of Nano Amor treated animals where dilated tubule lumens are present. A) tubules with dilated 
lumen may be seen alongside other tubules with sloughing of germ cell contents into the central lumen, or complete obliteration 
of lumen and tubular architecture. B) Higher magnification view of tubules at multiple stages with dilated lumens, and some 
moderate sloughing of germ cell contents. Germ cell layer around the tubule edge appears to be otherwise normal in appearance. 
Scale bar represents 200µm in image A, and 50µm in image B. 
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Figure 84: Tubule observed within animal exposed to Nano Amor which appeared to have retention of step 11 elongating 
spermatids within the lumen of a stage XIV tubule. Tubule stage is identifiable by presence of meiotic bodies in top portion. Step 
11 spermatids may be seen in the very centre of the cells sloughed into the lumen, identifiable as being step 11 due to the 
protrusion of the acrosome and apex at a sharp angle from the caudal portion of the nucleus. Spermatids seen from step 13 to 15 
have a more hooked appearance, with highly condensed (appearing darker) and pointed nuclei.  
 
Immunohistochemical analysis of tissues 
To further elucidate possible mechanisms of toxicity following silver nanoparticle 
exposure, immunohistochemical staining of tubules was undertaken. Preliminary work 
was carried out to optimise the IHC protocol for AR, LH-R, 3β-HSD, Dazl StaR and RP-1 
antibodies. Following this initial work, a full complement of IHC on all animals was 
completed for LH-R, AR, Dazl and StaR. 
3b-HSD 
Staining for 3β-HSD was carried out as part of a preliminary screen of antibodies to give 
an indication of overall tissue health and steroidogenic capability. Moderate 3β-HSD 
expression was found within all interstitial cells (Leydig cells) of all sections sampled (red 
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arrows, Fig. 85), indicating that this enzyme was present within all tissues and 
unaffected by any silver NP treatment.  
 
 
Figure 85: Representative images of immunohistochemical staining for 3b-HSD within rat testis tissue following 3-4 minutes of DAB 
exposure and colorimetric reaction development. Scale bar represents 100µm. A) AgNO3, B) Nano Amor, C) NM-300 & D) Control. 
Red arrows show staining localised to Leydig cells in the interstitium. Asterisks and red circle denote background staining within 
AgNO3 and Nano Amor treated animals that was visible throughout many of the sections analysed.  
 
There was some inconsistency in DAB staining across the samples and some suspected 
overstaining occurring in AgNO3 and NM-300 treated animals, as evidenced by the spill-
over staining onto the peritubular myoid cells, basement membrane and Sertoli cells 
within these tissue sections (red circle Fig. 85 outlines tubule with basal lamina staining 
on an AgNO3 animal slide, and asterisks denote Sertoli cell staining on animal treated 
with Nano Amor). On the whole this gave the slides the appearance of being more 
intensely stained on these treatments than on NM-300 treated or control animal. In 
reality however, this disparity in staining was present across all slides analysed and was 
likely due to a sub-optimal primary antibody.  For this reason, and because StaR worked 
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well one optimised, 3β-HSD staining was not undertaken in a full complement of tissue 
samples. 
LH-R 
Examination of the IHC for Luteinising hormone receptor showed a clear Leydig cell 
specific staining, localised to the Leydig cell cytoplasm, within the interstitium 
surrounding seminiferous tubules across both control and treated animals (red arrows, 
Fig. 86). Following optimisation of the protocol, background or non-specific staining was 
minimised. It appeared that as staining intensity was relatively comparable at a 
moderate to intense level across control, Nano Amor and AgNO3 treated animals, with 
a slightly lesser intensity being present on NM-300 treated samples. It is worth noting 
that staining for LH-R was unaffected in those animals exhibiting focal areas of 
dysmorphism within testicular tissue. As such, although morphologically abnormal, it 
may be considered that LH receptors within the Leydig cells surrounding affected 
tubules were unaffected (Fig. 87).  
 
Figure 86: Representative images of immunohistochemical staining for LH-R within rat testis tissue following 3-4 minutes of DAB 
exposure and colorimetric reaction development. Scale bar represents 100µm. A) AgNO3, B) Nano Amor, C) NM-300 & D) Control. 
Red arrows show staining localised to Leydig cells located within in the interstitium between seminiferous tubules. 
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Figure 87: Representative images of LH-R stained tissue captured from animals treated with nanoparticulate silver. Images A & B 
are both captured from one animal (I44) treated with Nano Amor; A shows a healthy area of testicular tissue; image B shows an 
area of focal dysmorphism within the same slide (red asterisks). Image C shows a stage XII seminiferous tubule from an NM-300 
treated animal which clearly has degenerating tissue sloughing into the lumen, while image D shows meiotic divisions of a stage XIV 
tubule an animal treated with AgNO3. It is notable that LH-R specific staining is comparable and localised to the Leydig cells of all 
images. Scale bar represents 100µm in A & B, and 50µm in C & D. 
 
AR 
Representative images of the completed immunohistochemical stains for androgen 
receptor are depicted within Fig. 88. It was possible to identify some intense Sertoli cell 
specific staining in areas of the control tissue, with moderate to intense nuclear staining 
being seen in silver treated animals, indicating that androgen receptors were present on 
the cells and able to bind substrate.  
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Figure 88: Representative images of immunohistochemical staining for AR within rat testis tissue following 9 minutes of DAB 
exposure and colorimetric reaction development. AR positive Sertoli cell staining is visible as ‘rings’ of dots around the outer edge 
of the seminiferous epithelium in tubules. Some clear background staining of tissue is visible within the NM-300 treated image, this 
was present through many of the slides. Scale bar represents 100µm. A) AgNO3, B) Nano Amor, C) NM-300 & D) Control.  
Closer observation of the androgen receptor immunostaining shows that although 
patchy, the AR stain clearly extends not only to Sertoli cells, but also Leydig and 
peritubular myoid cells, a finding reported widely in the literature (Fig. 89). Again, similar 
staining was present in both control and silver treated animals despite high background 
stain on some slides.  
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Figure 89: A close magnification view of tissue from an A) Silver treated (Nano Amor, I43) and b) control (J20) animal following IHC 
staining for AR. Both show clear staining for AR across a number of cell types. M = peritubular myoid cell (long and thin in shape), S 
= Sertoli cell (round in shape), L = Leydig cell, Asterisk = capillary. Scale bars show 20µm (LHS) and 50µm (RHS) respectively. 
Figure 90 shows in further detail the Sertoli cell staining on an NM-300 treated animal. 
Image A shows clear moderate to intense AR staining in a healthy stage VIII tubule, 
where Sertoli cell nuclei are seen to migrate from the basement membrane toward the 
central lumen to support release of mature spermatids. Image B depicts moderate stain 
for AR within an unhealthy stage VII tubule, found in another area of the same slide. In 
this image, sloughing of cells into the central lumen of the tubule can clearly be seen, 
along with clear positive staining of Sertoli cells for AR (at the basement membrane pre-
migration).  
 
Figure 90: Two images captured from an animal treated with NM-300, following IHC staining for AR. Image A shows a healthy 
stage VIII tubule, with red asterisks indicating staining of Sertoli cells that have migrated toward the central lumen to assist in 
release of mature spermatids at Spermiation. Image B shows an unhealthy stage VII tubule within a focal area of dysmorphism 
from the same slide. Despite the tubule appearing to be abnormal, it is notable that positive AR staining is still present around the 
basement membrane of the tubule (red asterisks).  
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StaR 
A clear cytoplasmic stain for StaR was present within Leydig cell populations of all 
animals, both treated and control, although some issues were encountered with 
background staining (visible within A & C, Fig. 91). It appeared that this staining was of 
a higher intensity in silver treated animals than in control. 
 
Figure 91: Representative images of immunohistochemical staining for StaR within rat testis tissue following 3 minutes of DAB 
exposure and colorimetric reaction development. Scale bar represents 100µm. A) AgNO3, B) Nano Amor, C) NM-300 & D) Control. 
Areas of generalised over-staining are visible on the right-hand side of image A and the bottom right corner of image C.  
 
Within AgNO3 treated tissues, StaR appeared to stain the acrosomal cap region of 
developing round spermatids in some areas (Fig. 92). This may be due to a generalised 
over-staining in areas of the tissue sections, but nonetheless is worth noting.  
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Figure 92: Two images captured from animals treated with AgNO3, and following IHC staining for StaR. Image A shows a healthy 
stage V-VI tubule, with red dashes outlining the area in which round spermatid acrosomal caps have been stained (animal K52). 
Image B shows a closer view of this staining in a different animal (K54). Scale bar represents 50µm on A and 20µm on B.  
Dazl 
Dazl protein stains with varied localisation and intensity dependent on the stage of 
spermatogenesis at which each tubule is captured, and therefore staining is not 
expected to be uniform across the whole tissue sample at the target cells of interest. As 
predicted, staining was not regular across the slide but was definitely positive. Figure 93 
illustrates this variation in staining intensity, which appeared to be linked to tubule 
stage, with tubules around Spermiation (stage VIII) showing the most intense staining. 
Moderate intensity staining was observed in tubules pre- or post- spermiation (stages 
VI-VII or IX-XI), and no stain was seen in either early (stage I-V) or late (stage XIII-XIV) 
tubules.  
To check whether the areas of focal dysmorphism present in treated animals altered 
Dazl staining, slides with clear disruption present were examined for Dazl stain to see 
whether it was altered in any way from tubules with a normal morphological 
appearance. Despite very clear morphological changes being present, Dazl stain on 
affected and unaffected tubules was comparable (Fig. 94).  Dazl provided differential 
staining according to stage that was not changed within tubules with major 
morphological disruption. As a result, Dazl stain intensity can be used to support tubule 
stage identification for further stereological analysis. and was used to assist with staging 
and stereological analysis of tubules. 
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Figure 93: Representative images of immunohistochemical staining for Dazl within rat testis tissue following 3.5 minutes of DAB 
exposure and colorimetric reaction development. Scale bar represents 100µm. Tubules are marked to indicate i) heavily stained 
tubules undergoing Spermiation at stage VII (red stars), ii) moderately stained tubules pre- or post- Spermiation at stages VI-VII or 
IX-XI (orange pentagons), or iii) unstained tubules at the start (stage I-V) or end (stage XII-XIV) of the cycle of the seminiferous 
epithelium (blue triangles).  A) AgNO3, B) Nano Amor, C) NM-300 & D) Control. 
 
Figure 94: Two images captured from animals treated with NM-300 (left) AgNO3 (right) following IHC staining for Dazl Scale bar 
represents 100µm. Both images show clear focal areas of dysmorphism within testicular sections. It is notable that Dazl staining was 
not affected by morphological disturbance, unless germ cells were completely absent from tubules. Thus, it was possible to use Dazl 
staining to assist with staging of damaged tubules. 
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RP-1 
A granulocyte specific antibody (RP-1) was used to explore the possibility of neutrophil 
involvement around damaged tubules. Figure 95 shows representative images of tissues 
stained for RP-1 containing clear areas of morphological dysmorphism. Although some 
of the sloughed cell populations stained intensely with haematoxylin, no DAB positive 
stain for RP-1 was present.  
 
 
Figure 95: Representative images of immunohistochemical staining for RP-1 within rat testis tissue following 3.5 minutes of DAB 
exposure and colorimetric reaction development. Scale bar represents 50µm. Images were selected as they show tubules which 
include cells either sloughed into the central lumen, or cells which have invaded that tubular lumen which would stain positively for 
RP-1 should they be neutrophils. A) AgNO3, B) Nano Amor, C) NM-300 & D) Control. 
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Stereological analysis of tubules I: semi-quantitative analysis  
 
Count data  
Within the first analysis of samples, a total of 2,054 tubules were measured for diameter 
and germ cell thickness. Of these, 915 were control, 193 were NM-300 treated, 186 were 
AgNO3 treated, 203 were Nano Amor treated, 178 were low dose NM202, 199 were 
medium dose NM202 and 180 were high dose NM202.  
Comparison of Control data  
Control data fell into two animal groups: group G animal were sacrificed at 29 days on 
completion of dosing, and group J at 85 days following a 6-week wash-out period. As the 
control animals were sacrificed at more than one time, initial analysis was completed to 
check that tubule diameter and germ cell layer thickness measurements were 
comparable across the two sets of results. An unpaired t-test on the data revealed that 
there was a significant difference between the two groups for tubule diameter P-value 
of <0.0001****  (confidence interval 34.41 to 47.25) but not for germ cell layer thickness 
(P-value 0.9291) (Fig. 96). 
  
Figure 96: Summary of Control datasets for animals sacrificed at day 29 and day 85. Left: Tubule Diameter. Right: Germ Cell Layer 
Thickness. A significant difference was found between the two groups for tubule diameter (P<0.0001) but not germ cell layer 
thickness. 
As a result, the two control datasets were separated for further comparison to the 
treatment data. For completeness of analysis all animals were compared to both control 
groups.  
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Initial Measurement results: tubule diameter 
Results of the data collected on tubule diameter for each animal was graphed per 
treatment (Fig. 97). Initial appraisal of the graphed data did not reveal any particular 
patterns of measured diameter with treatment, other than the observation that control 
animals sacrificed at day 85 (control J) appeared to have a higher tubule diameter than 
those sacrificed at day 29 (control G), and that NM202 medium dose had apparently low 
variability in the tubule diameters recorded, with its box and whiskers plot showing a 
short box and minimal whiskers (Fig. 97 plot h).  
A one-way ANOVA on all treatments compared to d29 control (group G) showed no 
significant difference (p=0.4880). A subsequent Dunnett’s multiple comparisons test 
showed statistical difference between control G and Nano Amor (p=0.0481*), control G 
and NM202 Low dose (p=0.0361*), and control G and NM202 High dose (p=0.0381*).  
The finding of significant differences in tubule diameter between control animals 
sacrificed at the same timepoint to those treated with NM202 (day 29) suggests that 
there may be some effect of treatment here. However, this finding was not replicated 
in NM202 treated animals receiving medium or high doses, and it is possible to speculate 
that this is the case because on the whole measurements collected from animals treated 
with NM202 medium held far less variation than the other treatments (Fig. 97 plot h). 
There were no significant differences in tubule diameter between all treatments and 
controls (d29 control p=0.5682 and d85 p=0.8112).  
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Figure 97: Tubule Diameter measurements (+/- SEM) from all treatments Each treatment had 5 animals except control for which 
there were 8 animals. From Top to bottom: a) AgNO3 (tubules measured n=186), b) NM-300 (tubules measured n=193), c) Nano 
Amor (tubules measured n=203), d) NM202 low dose (tubules measured n=178), e) NM202 medium dose (tubules measured 
n=199), f) NM202 high dose (tubules measured n=180), g) Control (tubules measured n=915), and h) all treatments compared to 
control shown as a box and whiskers plot illustrating minimum to maximum values and median for each group. 
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Initial measurement results: germ cell layer thickness  
Results of the data collected on tubule diameter for each animal is presented in Fig. 98. 
The graphed data did not reveal any particular patterns of germ cell layer thickness 
according to treatment, other than the identification of a possible outlier in the 
observation that one animal (I44) treated with Nano Amor appeared to have unusually 
higher germ cell layer thickness measurements compared to other animals in this group.  
There were no significant differences in tubule diameter between all treatments and 
controls (d29 control p=0.5682 and d85 p=0.8112). The lack of significance when 
comparing silver treated animals sacrificed to controls sacrificed at a similar timepoint 
(day 78 treated and day 85 control) shows that there was no change in tubule diameter 
compared to control at this timepoint and in these treatment groups. 
As morphological and immunohistochemical analysis (undertaken concomitantly with 
the initial stereological analysis) had highlighted significant changes in tubule diameter, 
germ cell layer and central lumen structure, a second stereological analysis was 
undertaken to elucidate whether taking into account seminiferous epithelium stage 
influenced findings.   
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Figure 98: Germ Cell layer thickness measurements (+/- SEM) from all treatments Each treatment had 5 animals except control for 
which there were 8 animals. From Top to bottom: a) AgNO3 (tubules measured n=186), b) NM-300 (tubules measured n=193), c) 
Nano Amor (tubules measured n=203), d) NM202 low dose (tubules measured n=178), e) NM202 medium dose (tubules measured 
n=199), f) NM202 high dose (tubules measured n=180), g) Control (tubules measured n=915), and h) all treatments compared to 
control shown as a box and whiskers plot illustrating minimum to maximum values and median for each group. 
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Stereological analysis of tubules II: staging and related measurements 
 
Identification of Tubule Stage 
Using the decision key adapted from Hess, representative photographs of tubules across 
the 14 stages of seminiferous epithelium in the rat were identified (Hess, 1990). 
Representative photographs of key stages identified in the cycle of the seminiferous 
epithelium of the rat (I-XIV), viewed in paraffin embedded sections were prepared (Fig. 
99).  
Stage I-IV  
Stage I, II, III and IV tubules are almost impossible to differentiate in paraffin sections as 
staging is dependent on a clear view of the golgi apparatus in early round spermatids, 
something which it has been recognised is difficult to identify in paraffin sections (Hess, 
1990). As a result, for this analysis, tubules were grouped into stages I-IV. Generally, 
tubules within this group contain both round and elongated spermatids, the elongated 
spermatids being late in appearance (step 15-17). Pachytene spermatocytes appear 
smaller in size than later stages, and populations of A, I and B type Spermatogonia are 
visible in places.  
Stage V 
In stage V tubules, clusters of late spermatid nuclei may be seen deep in the tubular 
epithelium close or adjacent to Sertoli cell nuclei. Most Spermatogonia present are type 
B rather than A or I.  
Stage VI 
In stage VI tubules, late spermatids are no longer at the epithelium adjacent to Sertoli 
cells but are instead moved closer to the central lumen and often seen in clusters.  
Stage VII 
When tubules reach stage VII, late spermatid nuclei line up around the luminal border, 
and large basophilic granules become visible around the nuclei. On the epithelial border 
of the tubule, B type Spermatogonia have been replaced by Prelepotene spermatocytes.  
 
Bryony L Ross PhD 258 
Stage VIII 
To differentiate stage VII from VIII, two key observations were utilised: i) release of some 
spermatids into the lumen, ii) Sertoli nucleus orientated perpendicular to the epithelial 
border and extended toward the central lumen of the tubule.  
Stage IX 
Within stage IX tubules, mature spermatids are missing entirely from the luminal border, 
bar perhaps a few step 19 spermatids still visible within the centre of the lumen. This 
gives the lumen an ‘empty’ appearance. Large residual bodies are present throughout 
the epithelium, and Lepotene spermatocytes are more prominent as a population than 
prelepotene.  
Stage X 
Stage X tubules are distinguishable from stage IX as the round spermatids present start 
to elongate at this point. Close inspection shows that the cap of the elongating 
spermatids deviates at a sharp angle to the nucleus, with a blunted appearance at the 
tip. Pachytene spermatocytes at this stage start to enlarge in size.  
Stage XI 
In stage XI tubules, the head cap of the elongating spermatid forms a much narrower 
tubular protrusion at an angle to the nucleus, and spermatids are present in distinctive 
bundles. Pachytene spermatocytes continue to appear enlarged and more granular in 
appearance.   
Stage XII 
At stage XII, the tail of the elongating spermatid is longer, narrow and slightly curved. 
Both enlarged late Pachytene spermatocytes, and Diplotene spermatocytes are visible 
within the epithelium, alongside symmetrical round, dark Zygotene spermatocytes.  
Stage XIII 
By stage XIII, large numbers of Diplotene spermatocytes are present with large nuclei 
with dispersed clumps of chromatin. Elongating spermatids in stage XIII tubules are now 
very thin.  
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Stage XIV  
Stage XIV tubules are easily identifiable by the presence of meiotic figures where the 
Diplotene spermatocytes were previously.  
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V 
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Figure 99: Illustrative examples of tubule staging from I – XIV, according to decision key and criteria specified within the literature. 
Scale bar represents 50µm on left-hand side images and 10µm on the right-hand side.  S (Sertoli cell nucleus); A (type-A 
spermatogonia); I (intermediate spermatogonia); B (type-B spermatogonia); PL (preleptotene spermatocyte); P (pachytene 
spermatocyte); L (leptotene spermatocyte); Z (zygotene spermatocyte); D (diplotene spermatocyte); SS (secondary spermatocyte); 
Nu (Nucleus); ES (Elongating Spermatid); RS (Round Spermatid).  
Stage XII
V 
Stage XIII
V 
Stage XIV
V 
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Number of observations 
In total 718 tubules were measured across all samples using a randomised approach; 
167 were control tubules (23.25%), 171 were AgNO3 treated (23.8%), 192 were NM-300 
treated (26.8%) and 188 were Nano Amor treated (26.2%). %).  A breakdown of tubule 
counts per stage, per group is included in Table 26.   
Table 26: Count data for tubule observations made per stage of spermatogenesis assigned across i) all data pooled, and ii) each 
treatment group 
Stage Number of tubules counted 
Total 
population 
Control NM-300 AgNO3 Nano Amor 
I-IV 80 25 (15.0) 18 (9.4) 20 (11.7) 17 (9.0) 
V 47 9 (5.4) 7 (3.6) 16 (9.4) 15 (8.0) 
VI 71 16 (9.6) 15 (7.8) 20 (11.7) 20 (10.6) 
VII 100 22 (13.2) 35 (18.2) 18 (10.5) 25 (13.3) 
VIII 129 28 (16.8) 38 (19.8) 30 (17.5) 33 (17.6) 
IX 83 23 (13.8) 21 (10.9) 21 (12.3) 18 (9.6) 
X 25 7 (4.2) 5 (2.6) 6 (3.5) 7 (3.7) 
XI 51 11 (6.6) 15 (7.8) 11 (6.4) 14 (7.4) 
XII 58 9 (5.4) 23 (12.0) 10 (5.8) 16 (8.5) 
XIII 38 11 (6.6) 5 (2.6) 13 (7.6) 9 (4.8) 
XIV 36 6 (3.6) 10 (5.2) 6 (3.5) 14 (7.4) 
TOTAL 718 167 192 171 188 
 
Dazl staining intensity and tubule stage  
In order to assist with accurate staging of tubules, a sample from each animal underwent 
immunohistochemical staining using the Dazl antibody. As Dazl stains the germ cell layer 
differentially depending on the cell populations within each tubule and thus its stage in 
the spermatogenic cycle, it was expected that intensity of the resulting DAB stain would 
alter with stage of tubule. If this was the case, the stain intensity observed would assist 
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in the identification of tubule stage and later analysis. Initial examination of staged 
tubules according to Dazl stain showed what appears to be a clear pattern of increasing 
then decreasing stain intensity as the tubules move through the cycle of the 
seminiferous epithelium (Fig. 100).  
Figure 101 shows DAB stain intensity for Dazl as a % of the total number of tubules 
identified for each stage of the spermatogenic cycle in control animals (n=5). The stage-
specific Dazl stain increased in intensity from stage V-VIII, decreased from stage IX-XII 
and showed no DAB stain from stage XIII-IV, matching findings from Nicholas et. al. and 
Rochhietti-March et. al. on Dazl expression in rodent testicular seminiferous epithelium 
(Nicholas et al., 2009, Rocchietti-March et al., 2000) Dazl immunostaining was therefore 
confirmed to be a useful measure to assist with accurate staging, and subsequent 
morphological and semi-quantitative analysis of tubules. 
    
    
   
 
Figure 100: Development of Dazl staining according to tubule stage (shown in red). Intensity of Dazl stain increases from stage V-
VII, peaks at stage VIII, then decreases from stage IX-XI, and is not present through stages XIII-IV of the next cycle. It is a useful 
stain to aid accuracy of staging tubules. Scale bar represents 50µm. 
I-IV V VI VII 
VIII IX X XI 
XII XIII XIV 
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Evaluation of control data  
As the control animals were sacrificed at more than one time, initial statistics focussed 
on whether tubule diameter and lumen volume measurements were comparable across 
the two times. Testing of the hypothesis that control data was the same regardless of 
sacrifice date resulted in P-values of 0.3407 for tubule diameter, and 0.6083 for lumen 
volume, with all 95% confidence intervals crossing zero, confirming that there was no 
statistical difference between the two groups (Tables 28 and 29).  
 
Figure 101: DAB stain intensity for Dazl antibody as % of total counts according to stage of tubule in control animals (n=5).  
Table 27: comparison of control data from animals harvested at day 29 compared to day 85 for tubule diameter, generated using a 
mixed-model where animal is the random effect and stage and day are fixed effects. Estimates reported by the model for day29 
and 85 are shown in the first two rows of the table, with the difference between these and associated p-value reported in the 
bottom row. N= 167.  
Sample Estimate (SD) (SD) 95% CI P-value 
C d29 225.49 (15.554) [175.99, 274.99]  
C d85 253.19 (19.075) [192.49, 313.90]  
C d29 - d85 -27.70 (24.623) [-106.06, 50.66] 0.3424 
 
Table 28: comparison of control data from animals harvested at day 29 compared to day 85 for lumen volume, generated using a 
mixed-model where animal is the random effect and stage and day are fixed effects. Estimates reported by the model for day29 
and 85 are shown in the first two rows of the table, with the difference between these and associated p-value reported in the 
bottom row. N=167. 
Sample Estimate (SD) 95% CI P-value 
C d29 12799.68 (1936.8) [6635.94, 18963.43]  
C d85 14581.94 (2380.6) [7005.86, 22158.01]  
C d29 - d85 -1782.25 (3072.4) [-11559.89, 7995.38] 0.6026 
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Cross-evaluation of control data with published data to determine reliability  
Once it was established that control samples were not statistically different, tubule 
diameter and lumen volume measurements from control animals were pooled and 
plotted according to stage (Fig. 102). The graphed measurements are clearly comparable 
with data previously published by Wing & Christensen, also using Sprague-Dawley rats 
(Fig. 103) (Wing and Christensen, 1982).   
 
 
 
 
 
 
 
 
 
 
 
Figure 103: Diameter of the seminiferous tubule and volume of the lumen per unit length of seminiferous tubule at various stages 
of the cycle. Each value represents the mean of four animals (plotted +/- SEM). Wing & Christensen, 1982. NB. lumen volume is 
expressed per unit length of the seminiferous tubule, probably in order to try and correct for shape differences between tubule. 
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Figure 102: Diameter of the seminiferous tubule (squares) and volume of the lumen (circles) at various stages of the seminiferous 
epithelium cycle, superimposed onto the Dazl immunostaining intensity scores recorded. Each value represents the mean of 5 
animals (plotted +/- SEM for comparison to figure 40). NB. lumen volume is expressed directly as recorded (µm/cm2), with the 
influence of tubule shape on volume observed considered later within this analysis. 
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Closer inspection shows that lumen volume changes replicated exactly the pattern in 
Wing & Christensen’s data, with a large rise in mean lumen volume from stage V-VIII, 
and a sharp drop at stage IX following spermiation. Interestingly, Standard Error of the 
Mean (SEM) values reported also followed a very similar pattern, with the lowest 
variation being seen at stage I-IV and IX.  
Tubule diameter changes show a similar pattern to that reported by Wing & Christensen, 
with some small but notable differences. From stage I-IV to V, Wing & Christensen 
reported an increase in tubule diameter, whereas the data collected in this work showed 
a small drop. In addition, the decrease in diameter between stages VIII and IX following 
spermiation was more pronounced in the 1982 paper than in the current work.  
Tubule Diameter Analysis  
Analysis of tubule diameter by treatment produced some interesting findings. Initially, 
tubule diameter was plotted according to stage for all treatments, and overlaid on the 
Dazl stain intensity scores recoreded for each tubule within each treatment (Fig. 104). 
the data showed that the pattern of Dazl expression did not change with treatment. 
However, mean diameter recorded at each stage did not follow the same pattern as 
seen within control animals. However, statistical analysis using a mixed model yielded 
P-values of 0.5025 (AgNO3 – control), 0.7286 (NM-300 – control) and 0.3390 (Nano Amor 
– control), with all 95% confidence intervals crossing zero. Therefore, no significant 
difference was found between treated animals and control (Table 29).  
As stages VII, VIII and IX surround a key event in the seminiferous epithelium cycle 
(representing before, during and immediately after spermiation), further analysis was 
undertaken to investigate these stages in isolation. Comparison of diameter 
measurements from treated animals at stages VII, VIII and IX (together, and then in 
isolation) to control did not change the outcome – no significant difference was seen to 
control in any of the three stages within each treatment (Table 30). 
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Table 29: Comparison of tubule diameter in treated animals to controls generated using a mixed-model where animal is the 
random effect and tubule stage and treatment are fixed effects. Estimates together with their standard deviation and 90% 
confidence interval are reported by the model for each treatment are shown in the first 4 rows of the table; the difference 
between each treatment and control and associated p-value are reported in the bottom 3 rows. 
 Estimate (SD) 95% CI P-value 
AgNO3 243.76 (7.362) [228.15, 259.37]  
Control 236.62 (7.368) [221.00, 252.23]  
NM-300 240.29 (7.335) [224.74, 255.84]  
Nano Amor 246.86 (7.335) [231.32, 262.41]  
AgNO3 - Control 7.14 (10.414) [-14.93, 29.22] 0.5025 
NM-300 - Control 3.67 (10.399) [-18.37, 25.72] 0.7286 
Nano Amor - Control 10.25 (10.399) [-11.80, 32.29] 0.3390 
  
  
Figure 104: Average Seminiferous Tubule Diameter (+/- SEM) overlaid on Dazl staining intensity scores, both according to stage of the 
seminiferous tubule cycle. Dazl staining intensity scores followed the same pattern regardless of whether animals were exposed to 
engineered nanomaterials or not. Tubule diameters recorded showed some alteration from the pattern recorded in control animals. 
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Table 30: Comparison of tubule diameter in treated animals to controls for key stages of the seminiferous epithelium cycle. Results generated using a mixed-model where animal is the random effect and tubule 
stage and treatment are fixed effects. Estimates together with their standard deviation and 90% confidence interval are reported by the model for each treatment are shown in the first 4 rows of the table; the 
difference between each treatment and control and associated p-value are reported in the bottom 3 rows. 
 Stage VII, VIII, IX Stage VII Stage VIII Stage IX 
 
Estimate 
(SD) 
95% CI P-value Estimate 
(SD) 
95% CI P-value Estimate 
(SD) 
95% CI P-value Estimate 
(SD) 
95% CI P-value 
AgNO3 253.53 
(8.256) 
[236.03,     
271.04] 
 
257.46 
(11.162) 
[233.80,     
281.12] 
 
256.58 
(9.880) 
[235.63,     
277.52] 
 
247.55 
(8.433) 
[229.68,     
265.43] 
 
Control 240.66 
(8.225) 
[223.23,     
258.10] 
 
237.90 
(10.712) 
[215.19,     
260.61] 
 
246.18 
(9.931) 
[225.13,     
267.24] 
 
230.63 
(8.286) 
[213.06,     
248.20] 
 
NM-300 243.46 
(8.085) 
[226.32,     
260.60] 
 
247.14 
(9.866) 
[226.22,     
268.06] 
 
242.54 
(9.713) 
[221.95,     
263.13] 
 
240.69 
(8.316) 
[223.07,     
258.32] 
 
Nano Amor 251.91 
(8.209) 
[234.51,     
269.31] 
 
262.55 
(10.313) 
[240.69,     
284.41] 
 
252.22 
(9.846) 
[231.35,     
273.09] 
 
237.88 
(8.754) 
[219.33,     
256.44] 
 
AgNO3 - Control 12.87 
(11.651) 
[-11.83, 
37.57] 
0.2857 19.55 
(15.471) 
[-13.24, 
52.35] 
0.2243 10.39 
(14.009) 
[-19.30, 
40.09] 
0.4689 16.92 
(11.823) 
[-8.14, 
41.99] 
0.1715 
NM-300 - Control 2.79 
(11.536) 
[-21.66, 
27.25] 
0.8117 9.24 
(14.563) 
[-21.64, 
40.11] 
0.5349 -3.64 
(13.891) 
[-33.09, 
25.81] 
0.7965 10.07 
(11.739) 
[-14.82, 
34.95] 
0.4039 
Nano Amor - 
Control 
11.25 
(11.622) 
[-13.39, 
35.89] 
0.3475 24.64 
(14.869) 
[-6.88, 
56.16] 
0.1169 6.03 
(13.985) 
[-23.61, 
35.68] 
0.6719 7.25 
(12.054) 
[-18.30, 
32.81] 
0.5557 
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Lumen Volume by stage analysis:  
Lumen volume was plotted according to stage for all treatments, and overlaid on the 
Dazl stain intensity scores recorded for each tubule within each treatment (Fig. 105). 
The data showed that the general pattern of Dazl expression did not alter with 
treatment. However, mean lumen volume recorded at each stage did not follow the 
same pattern as control animals. Within all treated animals, there appeared to be a small 
drop in lumen volume from stage V to VI, where in control animals lumen volume was 
increasing. The increase in lumen volume between stage VI and VII therefore looked 
much greater by comparison to control. There was also a higher lumen volume at stage 
VII than VIII for NM-300 and Nano Amor treated animals than in control, where stage 
VII and VIII tubules had a similar average volume. In addition, it appeared that maximal 
lumen volume reached at spermiation (stage VIII) was marginally higher in treated 
animals compared to control, and the decrease in volume between stage VIII and IX 
smaller than control in AgNO3 treated animals. 
Statistical analysis using a mixed model where animal was the random effect, and tubule 
stage and treatment fixed effects yielded P-values of 0.5025 (AgNO3 – control), 0.7286 
(NM-300 – control) and 0.3390 (Nano Amor – control) with all 95% confidence intervals 
crossing zero. Thus, despite the differences in graphed data, no significant difference 
was found between treated animals and control (Table 31).  
As stages VII, VIII and IX surround a key event in the seminiferous epithelium cycle 
(representing before, during and immediately after spermiation), and deviation from 
control data was seen in treated animals, further analysis was undertaken to investigate 
whether looking at these stages in isolation revealed any subtle effects taking place. 
Testing of diameter measurements from treated animals at stages VII, VIII and IX as (a 
sub-group) against control did not change the outcome – no significant difference was 
seen to control in any of the three stages within each treatment (Table 32). However, 
testing of stage VII, VIII and IX separately against control showed some differences. 
Within stage VII, Nano Amor treated animals were statistically different to control 
(p=0.0431*), and within stage IX AgNO3 treated animals were statistically different to 
control (p=0.0365*).  
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Figure 105: Average Lumen Volume (+/- SEM) overlaid on Dazl staining intensity scores, both according to stage of the seminiferous 
tubule cycle. Dazl staining intensity scores followed the same pattern regardless of whether animals were exposed to engineered 
nanomaterials or not. Tubule diameters recorded showed some alteration from the pattern recorded in control animals. 
Table 31: Comparison of lumen volume in treated animals to controls generated using a mixed-model where animal is the random 
effect and tubule stage and treatment are fixed effects. Estimates together with their standard deviation and 90% confidence 
interval are reported by the model for each treatment are shown in the first 4 rows of the table; the difference between each 
treatment and control and associated p-value are reported in the bottom 3 rows. 
 Estimate (SD) 95% CI P-value 
AgNO3 21283.18 
(1753.0) 
[ 17566.94, 24999.41]  
Control 16916.95 
(1742.0) 
[13224.09, 20609.81]  
NM-300 19716.64 
(1692.1) 
[16129.49, 23303.80]  
Nano Amor 20746.67 
(1735.7) 
[17067.22, 24426.11]  
AgNO3 - Control 4366.23 
(2470.4) 
[-870.89, 9603.34] 0.0962 
NM-300 - Control 2799.69 
(2429.5) 
[-2350.52, 7949.91] 0.2661 
Nano Amor - Control 3829.72 
(2459.6) 
[-1384.48, 9043.91] 0.1390 
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Table 32: Comparison of lumen volume in treated animals to controls for key stages of the seminiferous epithelium cycle. Results generated using a mixed-model where animal is the random effect and tubule stage 
and treatment are fixed effects. Estimates together with their standard deviation and 90% confidence interval are reported by the model for each treatment are shown in the first 4 rows of the table; the difference 
between each treatment and control and associated p-value are reported in the bottom 3 rows. 
 Stage VII, VIII, IX Stage VII Stage VIII Stage IX 
 
Estimate 
(SD) 
95% CI P-value Estimate 
(SD) 
95% CI P-value Estimate 
(SD) 
95% CI P-value Estimate 
(SD) 
95% CI P-value 
AgNO3 
21283.18 
(1753.0) 
[17566.94,   
24999.41] 
  21370.98 
(2600.7) 
[15857.67,   
26884.29] 
  26062.07 
(2578.7) 
[20595.45,   
31528.70] 
  14173.10 
(1112.1) 
[11815.56,   
16530.65] 
  
Control 
16916.95 
(1742.0) 
[13224.09,   
20609.81] 
  18437.00 
(2418.2) 
[13310.62,   
23563.38] 
  19171.15 
(2592.6) 
[13674.99,   
24667.32] 
  10663.14 
(1062.6) 
[8410.43,   
12915.85] 
  
NM-300 
19716.64 
(1692.1) 
[16129.49,   
23303.80] 
  23154.85 
(2043.7) 
[18822.42,   
27487.29] 
  21211.28 
(2533.0) 
[15841.56,   
26581.00] 
  13007.90 
(1112.1) 
[10650.35,   
15365.44] 
  
Nano Amor 
20746.67 
(1735.7) 
[17067.22,   
24426.11] 
  25716.73 
(2264.1) 
[20917.11,   
30516.34] 
  22084.68 
(2569.0) 
16638.63,   
27530.72] 
  12393.78 
(1201.2) 
[9847.34,   
14940.22] 
  
AgNO3 - Control 
4366.23 
(2470.4) 
[-870.89, 
9603.34] 
0.0962 2933.97 
(3551.3) 
[-4594.40, 
10462.35] 
0.4209 6890.92 
(3656.7) 
[-860.97, 
14642.81] 
0.0778 3509.96 
(1538.2) 
[249.17,    
6770.75] 
0.0365 
NM-300 - Control 
2799.69 
(2429.5) 
[-2350.52, 
7949.91] 
0.2661 4717.85 
(3166.1) 
[-1994.06, 
11429.76] 
0.1556 2040.12 
(3624.6) 
[-5643.74, 
9723.98] 
0.5813 2344.76 
(1538.2) 
[-916.03, 
5605.55] 
0.1469 
Nano Amor - 
Control 
3829.72 
(2459.6) 
[-1384.48, 
9043.91] 
0.139 7279.72 
(3312.7) 
[257.18,   
14302.26] 
0.0431 2913.52 
(3649.9) 
[-4823.87, 
10650.91] 
0.4364 1730.64 
(1603.8) 
[-1669.23, 
5130.50] 
0.2965 
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Whilst staging and measuring tubules, it was observed that some presented with what 
appeared to be populations of sloughed cells within the tubular epithelium. A check of 
the data revealed that of the 718 tubules measured, only 41 had sloughing of cells into 
the lumen (some 6% of the total). Of these, none were measured within control animals, 
leading to the consideration that they were a treatment associated effect. Within 
treated animals, 11.7% of AgNO3 treated tubules, 6% of NM-300 treated tubules, and 
5.6% of Nano Amor treated tubules contained sloughing into the lumen (Table 33). 
Table 33: Count data for tubules measured with and without sloughing of cells into the luminal area. 
Treatment Tubules without 
sloughing 
Tubules with 
sloughing 
% of total tubules 
with sloughing 
Control 167 0 0 
AgNO3 151 20 11.7 
NM-300 181 11 6 
Nano Amor 178 10 5.6 
 
Further examination of the counts to include treatment and stage showed a generalised 
spread of tubules with sloughing across all treated animals, with no observable pattern 
of occurrence (Table 34).   
Table 34: Count data for tubules measured with and without sloughing of cells into the luminal area according to Stage of 
spermatogenesis. + = sloughing present, - = no sloughing 
Stage Sloughing Control AgNO3 NM-300 Nano Amor 
I-IV + 0 4 1 0 
- 25 16 17 17 
V + 0 1 0 1 
- 9 15 7 14 
VI + 0 1 1 0 
- 16 19 14 20 
VII + 0 0 1 1 
- 22 18 34 24 
VIII + 0 1 1 1 
- 28 29 37 32 
IX + 0 0 2 1 
- 23 21 19 17 
X + 0 0 0 0 
- 7 6 5 7 
XI + 0 3 2 3 
- 11 8 13 11 
XII + 0 4 3 1 
- 9 6 20 15 
XIII + 0 6 0 1 
- 11 7 5 8 
XIV + 0 0 0 1 
- 6 6 10 13 
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As it was possible that sloughing of cells into the central lumen of tubules could 
potentially affect the lumen volume recorded, further investigation into the potential 
effect of lumen volume changes on outcome was undertaken. An additional dataset was 
prepared, in which the lumen volume of tubules with sloughing into the central lumen 
was calculated by taking overall volume, then subtracting the inner volume of sloughed 
cells. The dataset was then re-tested against control to establish whether taking into 
account lumen volume adjusted for sloughing affected the outcome. Table 35 outlines 
the outcomes of this test, which confirmed that treated animals were not statistically 
different to control with this adjustment, producing p values of 0.5129 for AgNO3, 
0.8893 for NM-300 and 0.4779 for Nano Amor with all 95% confidence intervals crossing 
zero.  
Table 35: Comparison of lumen volume in treated animals to controls, where lumen volume was corrected for cells sloughed into 
the central lumen. Generated using a mixed-model where animal is the random effect and tubule stage and treatment are fixed 
effects. Estimates together with their standard deviation and 90% confidence interval are reported by the model for each 
treatment are shown in the first 4 rows of the table; the difference between each treatment and control and associated p-value 
are reported in the bottom 3 rows. 
 Estimate (SD) 95% CI P-value 
AgNO3 15061.73 
(1352.4) 
[12194.75, 17928.71]  
Control 13808.58 
(1355.0) 
[10936.12, 16681.05]  
NM-300 14078.35 
(1340.5) 
[11236.58, 16920.12]  
Nano Amor 15194.43 
(1340.6) 
[12352.46, 18036.40]  
AgNO3 - Control 1253.15 (1913.7) [-2803.75, 5310.05] 0.5219 
NM-300 - Control 269.77 (1907.0) [-3772.82, 4312.35] 0.8893 
Nano Amor - 
Control 
1385.85 (1907.1) [-2656.95, 5428.65] 0.4779 
 
The effect of tubule shape on recorded values  
 
As tubule diameter and lumen volume were recorded, tubule shape was also noted in 
order to allow consideration of whether shape affected the values recorded and correct 
for this if necessary. Of the 718 tubules measured, 287 (39.9%) were round, 366 (44.2%) 
were intermediate and 65 (9.01%) were elongated. Table 36 outlines the count data for 
tubule shape according to treatment. The proportional representation of each tubule 
shape was similar across all treatments.  
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Table 36: Count data for shape of tubules measured across all treatments. Round tubules were uniform in shape and diameter, 
Intermediate tubules were more polyhedral than round, with some elongation and difference in diameter dependent on axis 
measured, Elongated tubules were clearly longer than wide with an oval or sausage shaped appearance. Numbers within brackets 
represent % of treatment total (columns), while numbers out with brackets represent % of shape total (rows). 
 Control AgNO3 NM-300 Nano Amor 
Round 91 (53.2) 80 (47.9) 90 (47.9) 105 (54.7) 
Intermediate 59 (34.5) 71 (42.5) 88 (46.8) 69 (35.9) 
Elongated 21 (12.3) 16 (9.6) 10 (5.3) 18 (9.4) 
 
Statistical analysis for Tubule Diameter and Lumen Volume recorded for tubules when 
categorised according to shape is summarised in Table 37. As expected, there was a 
significant shape-dependent difference (p<0.001 or p<0.0001) in both tubule diameter 
and lumen volume dependent on shape of tubule. The only exception was a no 
significant finding for tubule diameter between intermediate and round tubules.  
Table 37: Comparison of shape effects on tubule diameter and luminal volume. Analysis conducted using a mixed model, where 
animal was the random effect and shape was the fixed effect. 
  Estimate (SD) 95% C.I. P-value 
Tu
bu
le
 D
ia
m
et
er
 
Round 237.68 (3.690) [230.44, 244.93]  
Intermediate 233.44 (4.671) [224.27, 242.61]  
Oval 249.20 (3.753) [241.83, 256.57]  
Intermediate-Round 4.25 (3.448) [-2.52, 11.02] 0.2185 
Intermediate-Oval -11.52 (2.009) [-15.46, -7.57] <0.0001 
Oval-Round -15.76 (3.509) [-22.65, -8.87] <0.0001 
Lu
m
en
 V
ol
um
e  
Round 15119.91 (602.12) 13937.69, 16302.14]  
Intermediate 20455.97 (928.98) [18631.99, 22279.96]  
Oval 13717.68 (625.42) [12489.71, 14945.65]  
Intermediate-Round -5336.06 (851.26) [-7007.44, -3664.68] <0.0001 
Intermediate-Oval 1402.23 (496.35) [427.70, 2376.77] 0.0049 
Oval-Round 6738.29 (866.61) [5036.76, 8439.82] <0.0001 
 
Because there was a significant difference between tubule populations when 
categorised according to shape, statistical analysis was re-run for the round and 
intermediate shape groups to investigate whether tubule shape had any effect on 
outcome when comparing  
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Table 38: Re-testing tubule diameter and lumen volume measurements in treated animals to controls for round and intermediate shaped tubules. Results generated using a mixed-model where animal is the random 
effect and tubule stage and treatment are fixed effects. Estimates together with their standard deviation and 90% confidence interval are reported by the model for each treatment are shown in the first 4 rows of 
the; the difference between each treatment and control and associated p-value are reported in the next 3 rows. 
  Round only Intermediate only 
Estimate (SD) 95% CI P-
value 
Estimate (SD) 95% CI P-value 
Tu
bu
le
 D
ia
m
et
er
 
AgNO3 250.84 (7.569) [234.80, 266.89] 
 
240.14 (7.721) [223.77, 256.50] 
 
Control 241.36 (7.357) [225.76, 256.96] 
 
233.03 (7.839) [216.41, 249.65] 
 
NM-300 245.45 (7.373) [229.82, 261.08] 
 
238.95 (7.676) [222.68, 255.23] 
 
Nano Amor 256.60 (7.242) [241.25, 271.96] 
 
238.48 (7.737) [222.08, 254.89] 
 
AgNO3 - Control 9.48 (10.550) [-12.88, 31.85] 0.3821 7.11 (11.004) [-16.22, 30.44] 0.5275 
NM-300 - Control 4.09 (10.425) [-18.01, 26.19] 0.7001 5.92 (10.968) [-17.33, 29.17] 0.5967 
Nano Amor - Control 15.24 (10.341) [-6.68, 37.17] 0.1598 5.45 (11.020) [-17.91, 28.81] 0.6274 
Lu
m
en
 V
ol
um
e 
AgNO3 14095.43 (1257.2) [11430.24, 16760.63] 
 
15873.83 (1179.9) [13372.52, 18375.13] 
 
Control 12579.85 (1189.9) [10057.46, 15102.24] 
 
13438.16 (1215.8) [10860.8, 16015.47] 
 
NM-300 12479.88 (1196.3) [9943.81, 15015.96] 
 
14612.56 (1163.0) [12147.16, 17077.95] 
 
Nano Amor 14351.35 (1144.4) [11925.32, 16777.38] 
 
16397.08 (1185.1) [13884.85,18909.31] 
 
AgNO3 - Control 1515.58 (1728.8) [-2149.24, 5180.41] 0.3936 2435.66 (1694.9) [-1157.40, 6028.73] 0.17 
NM-300 - Control -99.97 (1691.0) [-3684.80, 3484.86] 0.9536 1174.40 (1681.5) [-2390.19, 4738.99] 0.4949 
Nano Amor - Control 1771.50 (1657.9) [-1743.06, 5286.06] 0.3011 2958.92 (1699.8) [-644.56, 6562.39] 0.1009 
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control animals to those treated with silver. Elongated tubules were not tested as the 
sample size was so small.  
Table 38 summarises the results of testing control vs treated for i) round tubules only 
and ii) intermediate tubules only. Tubule diameter testing for round tubules only gave p 
values of 0.3821 (AgNO3), 0.7001 (NM-300) and 0.1598 (Nano Amor), and 0.5275 
(AgNO3), 0.5967 (NM-300) and 0.6274 (Nano Amor) with all 95% confidence intervals 
crossing zero. Lumen volume testing for round tubules only gave p values of 0.3936 
(AgNO3), 0.9536 (NM-300) and 0.3011 (Nano Amor), and 0.17 (AgNO3), 0.4949 (NM-300) 
and 0.1009 (Nano Amor) with all 95% confidence intervals crossing zero. Therefore, 
despite tubule shape having a significant effect on the diameter and volume recorded 
during stereological analysis, consideration of each tubule shape alone did not alter the 
finding of no significance for treatment being different to control. 
 
Discussion 
This chapter examined tissues from animals exposed to one type of silica nanomaterial 
(NM202) and two ENM and silver ions (NM-300, Nano Amor and AgNO3). The research 
questions it addressed were four-fold: i) to establish whether there were morphological 
alterations in ENM treated tissues, ii) to understand whether these could be evaluated 
in a semi-quantitative manner through systematic application of stereological analysis, 
iii) to establish whether exposure to ENM could lead to any changes in functionality of 
steroidogenic pathways or the wider HPG axis in the testis, and iv) to compare results to 
those reported in vitro for comparability and validation.  
Morphological analysis of tissues for changes post-ENM exposure 
Morphological analysis of tissues revealed a variety of findings, including focal 
dysmorphism, degeneration of germ cells, presence of pyknotic nuclei, disorganisation 
and possible hyperplasia of interstitial content, retention of spermatids and sloughing 
of germ cells, many of which were in agreement with the published literature, but some 
which were to our knowledge are being shown for the first time, especially in such detail. 
Table 39 summarises the key findings from morphological examination for ease of 
comparison.  
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Table 39: Summary of morphological changes observed within tissue samples from animals in two studies: i) animals treated with 
low, medium or high dose of NM202 silica nanoparticles; ii) animals treated with one of three different types of silver nanoparticle 
(NM-300, Nano Amor and silver ions AgNO3) 
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Control - - - - - - - - 
NM202 L - - - - - - - - 
NM202 M - - - - - - - - 
NM202 H - - - - - - - - 
Silver Nano 
Amor Y (widespread) Y Y - - Y Y Y 
Silver NM-300 Y (focal) Y Y Y Inflammation-like changes Y - Y 
Silver AgNO3 Y (focal) Y Y - 
Leydig Cell 
Hyperplasia Y Y - 
 
Morphological evaluation of testicular tissue collected following 28-day oral exposure 
to nanoparticulate silica dioxide (NM202) at low, medium and high concentrations did 
not reveal any changes from control. This is similar to the findings of Morishita et al 
(2012) in Balb/c mice following intravenous injection, and Kim et al (2006) who injected 
mice intraperitoneally with 50nm silica nanoparticles (Morishita et al., 2012, Kim et al., 
2006).  
As discussed within the introductory section of this chapter, other published literature 
suggests that there may be a transient adverse reversible effect on the testis following 
oral nano-silica exposure (Xu et al., 2014, Ren et al., 2016). However, this was not seen 
within the current work. As all tissue samples examined in this body of work were taken 
from animals sacrificed at day 29, for completeness (and given time) it could be 
interesting to examine additional stored tissues from NM202 high dose animals 
sacrificed following 6 weeks of wash-out (day 85). However, as no onset of effect was 
observed at d29, it remains unlikely that morphological changes would manifest at a 
later date. 
One key reason for the differences in morphological finding between our work, and 
some of the published literature is that whilst all of the nanomaterials used were 
classified as nano-silica, they were different sizes, prepared using a different synthesis 
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method, which invariably leads to variation in final composition and physico-chemical 
properties. The NM202 used within this research was a standardised representative 
nanomaterial, as selected by the OECD, and had been through extensive 
characterisation both by the Joint Research Centre (who produced the particles), and 
van der Zande et al from whose study tissues were harvested (van der Zande et al., 
2014a, Rasmussen et al., 2013). It is described as a hydrophilic, pyrogenic synthetic 
amorphous silica with a primary particle size between 10 and 25 nm, a specific surface 
area of 200 m2/g, and a purity ≥99.9%. By comparison, the nanoparticles used within 
the published literature are much larger. For example, Morishita et al used silica 
nanoparticles with a reported particle diameter of 300nm, much larger size than those 
meeting the EU definition of a nanomaterial, Kim et al (2006) used 50nm silica-coated 
magnetic nanoparticles, Xu et al (2014) used 65nm silica nanoparticles, while Ren et al 
(2016) used 57nm silica nanoparticles (Morishita et al., 2012, Kim et al., 2006, Xu et al., 
2014, Ren et al., 2016). Without the same nanomaterial from the same production batch 
being used in other published work, it is difficult to draw any firm conclusions around 
true comparability and could certainly lead to differences in histopathological outcome 
following exposure.  
Another potential reason for the difference in both our findings and those in the 
published literature could be related to exposure route: studies reported here used a 
diverse range of exposure routes from direct testicular injection, through 
intraperitoneal injection, oral feeding and tracheal perfusion. Additionally, the 
interaction of nanoparticles with the biological fluids via formation of a ‘protein corona’ 
plays an increasingly recognised role in its Adsorption, Distribution, Metabolism and 
Excretion (ADME) profile, and the protein coronae which form around particles will 
differ greatly depending on what it comes into contact with i.e. blood, intestinal content, 
lung mucosa etc (Lundqvist et al., 2008). It is beyond the scope of this thesis to provide 
further investigation of these effects; however, it is pertinent to recognise their 
importance.  
All animals exposed to nanoparticulate silver exhibited adverse morphological changes, 
but the detail of these changes was material dependent and subtly different between 
each nanoparticle exposure (Table 39). In all silver exposed animals, there were areas of 
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clear focal dysmorphism and disorganisation of tubular content. Tubular degeneration 
(& atrophy) is widely recognised as a common manifestation of toxicological injury in 
the testis, which can be mediated through Germ cell or Sertoli cell injury, hormone 
disruption or vascular effects (Creasy et al., 2012). As in many tubules Sertoli cells 
appeared to be intact and regular in appearance, and there was little further evidence 
of vascular injury, it is possible that this was mediated through hormonal influence.  
Within degenerative tubules, pyknotic nuclei were present, indicating cells undergoing 
rapid cell death over and above the normal cell attrition that is expected during 
spermatogenesis. Apoptosis of germ cells is an important function that acts to limit germ 
cell populations in the testis, with up to 75% of germ cells being discarded through this 
process to ensure that the resultant spermatozoa are viable (Shaha et al., 2010). Germ 
cell apoptosis is regulated via a multitude of proteins and enzymes that induce or inhibit 
the process (Meena et al., 2015). The exact mechanism to trigger apoptosis varies 
between direct toxicity (germ cell injury) and indirect toxicity (Sertoli cell injury). At the 
simplest level, it is initiated through two key pathways; the intrinsic mitochondrial 
pathway which is primarily activated via Mitochondria outer membrane 
permeabilization proteins Bax and Bc-xL, and the extrinsic pathway activated via the 
‘death receptor’ FAS (Lee et al., 1997). Downstream, caspases then act as the final 
executors of apoptosis (Fig. 106). The FAS pathway is utilised by Sertoli cells, activated 
via the FAS ligand FASL acting on Fas, a transmembrane receptor protein expressed by 
germ cells (Lee et al., 1997, Creasy et al., 2012). The Bax or Bcl-xL pathways would 
therefore be routes of apoptotic cell death associated with direct germ cell injury. Yoo 
et al previously reported Fas upregulation and caspase-dependent apoptotic cell death 
in human liver, breast and lung cell lines following exposure to TiO2 ENM (Yoo et al., 
2012). In addition, adding an antioxidant (N-acetyl-L-cysteine) supressed upregulation 
of Fas, activation of Bax and subsequent cell death. Furthermore, Ma et al reported 
activation of apoptotic cell death in a variety of cell types, following exposure to a 
number of ENM (titanium dioxide, copper, silica dioxide, zinc oxide and CNTs). This 
included activation of caspase 3/8/9 in testicular Leydig and Sertoli cells (TM3 and TM4) 
following exposure to silver ENM (Ma and Yang, 2016).  
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As a next step, it would be interesting to investigate the presence of caspases either via 
immunoreactivity or PCR, or changes in expression of FAS/Bax (via western blot or PCR) 
in order to further understand the detail of the effect observed. Nonetheless, the 
presence of pyknotic nuclei in germ cell populations out with those traditionally 
expected during germ cell development is a clear indicator that silver nanomaterials 
have an adverse effect on germ cells in the testis.  
 
Figure 106: Key apoptotic pathways within cells. Adapted from (Igney and Krammer, 2002). 
The presence of sloughing or exfoliation of germ cells in to the central lumen of tubules 
in all animals exposed to nanoparticulate silver, an observation also reported in much 
of the literature (Sleiman et al., 2013, Thakur et al., 2014, Ahmed et al., 2017), is 
considered to be a sensitive indicator of spermatogenic disturbance (Creasy et al., 2012). 
It is acknowledged that in mature animals presence of exfoliated or sloughing of cells 
into the lumen without seminiferous epithelial architectural disorder (or cell debris in 
the epididymis, which unfortunately it was not possible to look for as separate 
epididymal samples were not provided) has been linked to possible handling or fixation 
artefacts in the literature (Foley, 2001, Creasy et al., 2012). However, it is reasonable to 
Bryony L Ross PhD 282 
conclude that this is unlikely to be the case here, as all tissues were fixed simultaneously 
using the same protocol, and this effect is only seen within treated animals.   
Sloughing of cells can be due to a number of processes. Ahmed et al (2018) suggested it 
could be due to effects of silver nanoparticles on filaments of Sertoli cells, leading to 
abnormal development in elongating spermatids. Creasy et al (2012) reflect a similar 
viewpoint, suggesting that in the case of known toxicants like colchicine and 
carbendazim, extensive sloughing of adluminal germ cells is due to effects on 
microtubules that form the Sertoli cell cytoplasm (Creasy et al., 2012). Another 
possibility is disruption to the cytoplasmic syncytium linking developing spermatogonia, 
leading to early release of developing spermatids. To help understand the effect further 
it would be interesting to look further into both the microtubules of Sertoli cells, and 
intercellular bridge formation around developing spermatozoa. A number of possible 
avenues are available to understand further Sertoli cell cytoskeletal integrity, including 
visualisation of occludin, ZO-1 or actin-related proteins responsible for cell-cell junction, 
microtubule and microfilament formation. To investigate intercellular bridge formation 
around developing spermatozoa, it could be interesting to examine expression of testis-
expressed gene 14 (TEX14), which is known to be required for formation of intercellular 
bridges during meiosis, and kinetochore-microtubules attachment during mitosis  (Kim 
et al., 2015). 
Interstitial effects were observed in animals treated with NM-300 and AgNO3, albeit 
slightly different in their manifestation and likely origin. NM-300 treated animals had 
what seemed like inflammatory changes in the tubular interstitium, whilst AgNO3 
treated animals showed evidence of Leydig Cell hyperplasia. Inflammation is typically 
associated with infiltration of immune cells (macrophages, dendritic cells and T cells), 
alongside secretion of pro-inflammatory cytokines, or, if localised to around the vascular 
system it may also be a sign of necrosis. As the changes observed in NM-300 treated 
animals were not associated with the visible vascular system, it is unlikely to be 
associated with any vascular injury or necrotic event. Interestingly, Park et al (2010) 
observed an increase in a panel of inflammatory cytokines following 28 day repeat oral 
dosing of ICR mice to silver (42nm). It has previously been demonstrated that pro-
inflammatory cytokines are able to influence tight junction molecule expression and 
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distribution, thus increasing the permeability of the BTB (Pérez et al., 2013). Thus, 
presence of interstitial inflammation could be considered a ‘warning sign’ of potential 
tubular effects or BTB damage should inflammation be chronic. In this study we have 
identified a possible negative endpoint; it would be interesting to investigate the 
underlying mechanism using a similar cytokine assay on our own tissue to see whether 
these changes are truly inflammatory in nature. 
Occurrence of Leydig cell hyperplasia in AgNO3 treated animals, while relatively common 
in some rat strains such as F344, is less frequent in Sprague-Dawley rats (generally <6% 
of animals), suggesting that this finding was not coincidental (Creasy et al., 2012). 
Hyperplasia observation was focal in nature, with LCs increased in size and number. 
Hyperplasia is seen in response to a range of chemically diverse drugs, and is often 
associated with disruption of the HPG axis, via interference with LC control mechanisms 
at a variety of points (Creasy et al., 2012). In many cases, LC hyperplasia and later 
tumorigenesis is associated with high circulating levels of LH, which causes LC mitosis, 
hyperplasia and eventually adenoma. However, a similar effect may be achieved 
through disruption of intratesticular testosterone or other hormones in the HPG, 
affecting paracrine feedback on LC proliferation (Creasy et al., 2012). To further 
investigate its causality through future study, a measurement of circulating hormones 
in treated animals at the start and end of dosing, and after a 6-week wash-out would be 
required.  
Interestingly, NM-300 was also the only treatment in which multinucleated giant cells 
were identified. Giant cells are usually made up of round spermatids or pachytene 
spermatocytes fused together into a large cell in response to infection or foreign bodies, 
and often alongside more widely observed tubular degeneration. It is believed that 
these form when cytoplasmic bridges between cells in the syncytium of developing germ 
cells are damaged and open, allowing cytoplasmic fusion and a slow form of cell death, 
although they are usually TUNEL negative indicating DNA remains intact within (Creasy 
et al., 2012, Creasy et al., 2014b). Giant cells are often more prevalent in immature 
animals, and as these rats were peri-pubertal it is worth considering whether their 
presence was linked to the animals’ age, although as no such bodies were seen in control 
animals it is likely this could be a treatment effect.  The giant cells observed do not show 
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signs of acrosomal cap adherence, as is often seen when round spermatids are involved 
(Singh and Abe, 1987). Because only 1 testis from each animal was obtained, it is not 
possible to comment on whether this finding is unilateral or bilateral. However, as germ 
cell degeneration was present throughout all sections, this may be seen as a further 
generalised indicator of toxicity to the testis following NM-300 exposure.  
In Nano Amor treated animals, tubules with dilated luminal volume were observed. 
Within affected tubules, a normal but compressed compliment of germ cells was 
present. According to Creasy et al, such dilation may be due to “decreased reabsorption 
of fluid in the efferent ducts, efferent duct blockage, decreased emptying of fluid from 
the seminiferous tubules, or increased production of seminiferous tubule fluid by the 
Sertoli cells” (Creasy et al., 2014a). Creasy et al go on to state that tubular dilation is 
reported in a number of chemicals including the fungicide carbendazim, leukotriene 
inhibitors and endothelin antagonists. Dilation being caused by decreased emptying of 
seminiferous tubules or efferent duct blockage is corroborated by the observation of 
step 11 elongating spermatids sloughed from the germ cell layer being retained in the 
tubular lumen of a stage XIV tubule. Creasy et al (2014a) go on to comment that dilation 
is usually seen as a precursor of complete tubular atrophy, as was observed in AgNO3 
treated animals. Thus, it may be that had examination of Nano Amor treated animals 
been undertaken following a longer period of wash-out, more tubules devoid of a germ 
cell layer would have been observed. 
In AgNO3 treated animals, tubules were visible which had undergone complete germ cell 
layer atrophy, being lined only by Sertoli cells (Sertoli Cell Only or SCO tubules). Although 
SCO tubules can occur as an incidental finding in mice and rats at all ages (Creasy et al., 
2012, Foley, 2001), no SCO tubules were observed in control animals, and it is 
considered an end-stage lesion and has previously been reported as a common outcome 
following exposure to known reproductive toxicants such as phthalates (Hutchison et 
al., 2008). For this reason, it is a notable finding and contributes to the emerging picture 
of silver nanoparticulate toxicity to the testis, especially when considering that the 
dilated tubular lumens seen in Nano Amor treated animals would likely also develop 
into SCO tubules.  
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The final noteworthy finding in silver exposed animals was that of mature spermatid 
(step 19) retention in stage IX and X tubules within animals exposed to NM-300. Under 
normal circumstances, step 19 spermatids are released from the germ cell syncytium 
during stage VIII of the spermatogenic cycle. Retention of spermatids is therefore an 
indicator of some failure in spermiation. Retained spermatids are usually pulled to the 
basal cytoplasm of tubules and phagocytosed by Sertoli cells, therefore retention is 
usually seen as a morphologically subtle but important finding, exactly as reported in 
the findings of the current chapter (Creasy et al., 2014c). Retention may be due to 
disturbances in Sertoli cells, reduced testosterone levels (as spermiation is testosterone 
dependent) or abnormalities in germ cell development (Creasy et al., 2012). It often 
results in reduced epididymal sperm count, increased numbers of sperm abnormalities, 
and potential effects on fertility (Creasy et al., 2014c). From this study we have reported 
spermatid retention as a possible marker of toxicity following an ENM exposure. In 
future studies it would be good to further elucidate the reason for this. Examination of 
Sertoli cell viability, along with hormonal assays would be a preferred approach, should 
blood samples or fresh tissue have been available from the animals exposed.  
It is important to recognise that whilst many of the published papers examining 
histopathology following silver nanoparticle exposure note vacuolisation of the 
seminiferous tubules as an outcome, this was not seen within the present study. 
Vacuolisation often occurs in the Sertoli cell basal cytoplasm as an early indicator of 
morphological injury. Creasy et al (2014) note that this phenomenon is usually seen in 
studies of 28 days or less in duration as a precursor of germ cell degeneration (Creasy et 
al., 2014d). As the animals in this study were subject to a 28-day exposure followed by 
6-week wash out and germ cell degeneration was well established, it is likely that this is 
why vacuolisation was not observed.   
It is notable that some of the morphological changes reported within this chapter are 
similar to those found in tissues from animals exposed to the known endocrine 
disruptors phthalates. It would be interesting to look more closely for similarities 
between the manifestation of their toxicities to see whether any further information or 
lessons could be brought to the hazard assessment of ENM from phthalates. 
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In addition to the work undertaken in this study, some of the testicular tissue was also 
examined for morphological changes at the University of Waginingen using the Johnsen 
score. This system examines at least 100 seminiferous tubules, grading the level of 
sperm maturation between 1 and 10 according to the most advanced germ cell present 
(Table 40). A total score is then determined by dividing the total score by the number of 
tubules evaluated (Dohle et al., 2012).  
Table 40: Johnsen score grading system for testicular morphology 
Score Morphological Identifiers 
10 Full spermatogenesis 
9 Slightly impaired spermatogenesis, many late spermatids, disorganized epithelium 
8 Less than five spermatozoa per tubule, few late spermatids 
7 No spermatozoa, no late spermatids, many early spermatids 
6 No spermatozoa, no late spermatids, few early spermatids 
5 No spermatozoa or spermatids, many spermatocytes 
4 No spermatozoa or spermatids, few spermatocytes 
3 Spermatogonia only 
2 No germinal cells, Sertoli cells only 
1 No seminiferous epithelium 
 
From 100 seminiferous tubules counted, Waginingen University’s Johnsen score 
outcomes are outlined alongside the observed % incidence of cells undergoing apoptosis 
(Table 41) (Bouwmeester, 2014). These results corroborate further our findings, 
showing both a clear effect on spermatogenesis, increased incidence of apoptotic cells 
in animals exposed to nanoparticulate vs control.  
Table 41: Results of Johnsen scores on spermatogenesis in animals exposed to two types of silver ENM, silver ions and vehicle 
control. Unpublished data received via personal communication (Bouwmeester and van der Zande, 2015) 
Treatment Johnson score % of apoptotic cells 
  10 9   
Control 100   0 
NM-300 (20nm) 36.6 63.4 8.2 
Nano Amor (15nm) 25 75 27.6 
AgNO3 92.2 7.8 7.6 
 
Semi-quantitative stereological analysis of tissues 
Establishment of whether stereological analysis could reveal any measurable changes to 
the cycle of the seminiferous epithelium indicative of altered function proved to be 
challenging but ultimately rewarding. Initial analysis of 2,054 measurements of tubule 
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diameter and germ cell layer thickness measurements revealed no true statistical 
difference from control day29 or day85 for any treatment. However, re-examining tissue 
sections from selected treatments (silver only) to take into account tubule stage 
alongside tubular diameter and lumen volume resulted in not only a useful protocol for 
further research into the area, but also a clearer picture on the nuances of any effects.  
As Dazl immunostaining intensity proved to be a useful and accurate indicator of 
seminiferous tubule stage, and as staining was not affected by any treatment, it was 
possible to use this to group tubules according to staining intensity (I-IV and XII-XIV show 
no stain, V, VI, X and XI have a light intensity stain, VII and IX shows a moderate stain 
and VIII a high intensity of staining). From these groupings, a decision key including key 
cell populations, morphological and stereological identifiers was then used to assign 
them to individual stages for stereological analysis. Following initial analysis on 
comparability of control data, measurements collated from 167 tubules for tubule 
diameter and lumen volume in control animals was shown to be directly comparable to 
measurements previously published for Sprague-Dawley rats (Wing and Christensen, 
1982). This comparability offered a high level of confidence in its representation of 
tubule diameter and lumen volume within a healthy population of rats. To our 
knowledge, this is the first time this hybrid method for staging has been implemented 
and reported, as no other evidence for it has been identified from the literature. As such, 
this forms a useful reference methodology by which to undertake future work in the 
area.  
Analysis of tubule diameter using a mixed model revealed no statistical difference 
between control and treated animals for NM-300, Nano Amor or AgNO3. Even when 
analysis was limited to key stages around spermiation (where changes in tubular 
diameter are known to be greater), no change from control was seen. Based on this, it 
is possible to suggest that whilst silver nanoparticle exposure produces varied adverse 
morphological outcomes, there is no change tubule diameter when measured 
stereologically. This observation aligns with the data reporting that dysmorphia was 
seen to be focal, as it may be that this type of gross analysis may not be sensitive enough 
to detect partial changes.  
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Visual analysis of lumen volume initially suggested some changes from control in certain 
treatments, with a decrease in lumen volume from stage V – VI in all treated animals 
that was not present in control, and a higher lumen volume in NM-300 and Nano Amor 
treated animals around stage VII and VIII than in other treatments or control. However, 
statistical analysis of the full dataset using a mixed model resulted in non-significant 
outcomes. More detailed analysis did however reveal some significant stage-specific 
changes in Nano Amor tubules at stage VII and AgNO3 tubules at stage IX when 
compared to control data at the same stage.  
Stage VII tubules are in immediate preparation for spermiation, therefore alteration in 
their stereology at this important point in the spermatogenic cycle could be indicative 
of problems in the tubule.  Interestingly, this finding matches the observation of lumen 
dilation from the morphological examination of tissues, discussed in the previous 
section, and adds weight to the argument that Nano Amor causes adverse effects on 
spermatogenesis in a rodent model.  An increase in stage IX lumen volume compared to 
control in AgNO3 treated animals may be linked to the morphological observation of 
tubular atrophy. It would be interesting to cross-examine the two datasets to see 
whether the observation of tubular atrophy is limited to stage IX tubules in the 
morphological analysis.  
To provide further detail on the observation of germ cell sloughing seen in the initial 
morphological examination, count data on sloughing of cells from the overall population 
of tubules examined was produced. This confirmed sloughing to be treatment-
associated, being present in none of the control tubules, 11% of AgNO3 treated animals, 
and 6% of NM-300 and Nano Amor treated animals. To check that sloughed cells did not 
interfere with the stereological findings for lumen volume, re-analysis of data corrected 
for sloughed cell volume was undertaken, confirming that this was not the case. Thus, it 
is possible to conclude that the germ cell sloughing seen is a focal, treatment-associated 
effect, and that it does not influence the outcome of stereological measurement of 
lumen volume.  
Finally, to provide reassurance that tubule shape did not interfere with findings, analysis 
of results was re-run taking into account tubule shape recorded. This confirmed that 
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although tubule shape was a significant effect, the overall outcome was no different to 
the previous analysis in terms of significance of difference between control and treated 
animals.  
It is interesting to note at this stage that of the published literature which mentioned 
morphometric or stereological measurements as part of its analysis (Sleiman et al., 
2013, Rezazadeh-Reyhani et al., 2015, Bara et al., 2018, Garcia et al., 2014) that none 
appeared to take into consideration tubule stage in interpreting the results. Creasy 
considers that the ability to identify tubular stages to be essential in undertaking a 
sensitive examination of testicular histopathology (Creasy, 1997). Indeed, OECD test 
guidelines 421 and 422 (relating to reproduction/developmental toxicity screening test 
and the combined repeated dose toxicity study with the reproductive/developmental 
toxicity screening test) state that “detailed histological examination should be 
performed on the ovaries, testes and epididymides (with special emphasis on stages of 
spermatogenesis and histopathology of interstitial testicular cell structure) of the 
animals of the highest dose group and the control group”, although tubular staging is 
not mentioned in TG416, the 2 generation reproductive toxicity study, or TG433, the 
extended one-generation reproductive toxicity study (OECD, 1983, OECD, 2015, OECD, 
2001, OECD, 2011). In addition, the ICH S5 for evaluation of DART in pharmaceuticals 
states that “A detailed qualitative microscopic evaluation with awareness of the 
spermatogenic cycle is sufficient to detect effects on spermatogenesis. A quantitative 
analysis of spermatic stages (i.e., staging) is not generally recommended but can be 
useful to further characterize any identified effects.”, but there is a lack of guidance as 
to how to undertake such an evaluation (EMA, 2017). Creasy recommends that as a 
minimum, morphological examination alongside semi-quantitative inspection of tubular 
diameter or cell counts of individual cell populations (with a minimum replicate number 
of 10-15 tubules for tubular diameter or 10 tubules for cell population counts where 
there are 10 rats in a group) should be undertaken (Creasy, 1997).  Based on this, and 
my own findings within this chapter, it would be possible to question the accuracy of 
the outcomes described within much of the literature where stereological analysis was 
reported. Rather though, this serves to highlight the robustness of the analysis 
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undertaken within this study; to our knowledge this is the first time such a detailed 
evaluation has been completed in the area. 
Functional analysis of tissues following ENM exposure via Immunohistochemistry 
To explore the potential for ENM exposure to interfere with the steroidogenic pathway 
or other elements of the HPG axis, immunohistochemical staining for a number of 
important enzymes, receptors and proteins was undertaken. The results are discussed, 
alongside an evaluation against findings in vitro for comparability.  
The first to be examined was 3β-HSD, an enzyme involved in the conversion of 
pregnenolone to testosterone within the smooth endoplasmic reticulum of the Leydig 
cell. Whilst good staining of Leydig cells was observed in all samples, some non-specific 
staining was present in all sections. Such high background staining could be due to a 
number of possible factors, including slide preparation, peroxidase quenching, the 
biotin block applied, the serum block, inadequate washing or indeed the primary and 
secondary antibodies used. As a uniform approach was used to all IHC and almost all 
other tissues were successful, it could be speculated that the primary antibody being 
sub-optimal for this approach is the most likely explanation.  However, the presence of 
relatively uniform moderate staining intensity across Leydig cell populations indicates 
that 3β-HSD was present and therefore that its expression was not hugely affected by 
nanoparticle exposure.  
Luteinising hormone receptor expression appeared to have a comparable moderate to 
intense staining level across control, Nano Amor and AgNO3 treated animals, with a 
lesser intensity of staining being present on NM-300 treated samples. Its expression also 
appeared to be unaffected by dysmorphism following silver exposure, as clear LH-R 
staining was present in Leydig cells surrounding morphologically abnormal tubules. As 
such, it could be considered that luteinising hormone receptor expression was not 
hugely affected by any silver treatment bar NM-300, and that in theory LH stimulation 
from the anterior pituitary would therefore be successful in commencing production of 
androgens. The slightly lowered expression of LH-R within NM-300 exposed animals 
indicates a potential knock-on effect on steroidogenesis and subsequent production of 
viable sperm. In addition, a lack of LH-R would lead to a downstream loss of negative 
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feedback to the pituitary to reduce LH production, potentially interfering with the 
overall HPG axis.  
Bara et al reported no change in LH-R expression of offspring following zinc oxide ENM 
exposure in utero, but a decrease in LH-R expression following exposure to silica under 
the same conditions (Bara et al., 2018). No studies reporting LH-R expression following 
silver ENM exposure were identified. Interestingly, the results of PCR on Leydig cells 
treated with NM-300 in vitro indicated an increase in LH-R expression compared to 
control.  With variability like this reported, it is possible that effects on the LH-R may be 
ENM specific due to differing physico-chemical parameters. In our case, it may also be 
possible that the discrepancy between what we observed in vivo and in vitro is due to 
the isolated nature of TM3 cells in culture. It would be relevant and important to 
investigate ENM effects on Leydig cells as part of a co-culture system in future to see if 
better comparability could be achieved in vitro to in vivo.  
Androgen Receptor immunohistochemistry revealed moderate to intense straining in 
both control and treated animals. In principle, this indicates that treatment with silver 
nanoparticles or ions does not prevent Sertoli cells from responding to testosterone 
released from Leydig cells and thus should be able to support spermatogenesis. The only 
published literature examining AR expression following ENM exposure was that of Jia et 
al, which reported no change in AR expression within male mice following TiO2 exposure 
to 25nm TiO2 at 10, 50 or 250 mg/kg for 42 days spanning puberty (Jia et al., 2014). 
However, this result is for a different ENM, and the results of the western blots used to 
determine protein expression in vitro within chapter 4 indicate a potential increase in 
AR expression on TM3 Leydig cells.  
One potential reason for the disparity in results was that this particular IHC staining 
protocol was one of the hardest to optimise. Despite several attempts with slight 
adjustments to antibody incubation times, washes and blocking, a lengthened DAB 
development time of 9 minutes was required in order to see any Sertoli cell specific 
staining. Unfortunately, this also led to a high level of background stain. As such it is 
reasonable to suggest that the primary antibody used in this instance was not ideal for 
this particular application, despite it being sold as suitable for IHC in rodents in principle. 
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In addition, the issues previously reported with Western Blotting make it difficult to 
reach an informed conclusion on biological reasons for this difference. It would be 
interesting to repeat this work with an alternative AR antibody to see whether more 
conclusive results could be found.  
As a key rate-limiting step in steroidogenesis, immunostaining with StaR reveals much 
about the testis’ ability to convert cholesterol to testosterone (via pregnenolone) within 
Leydig cells. The presence of increased intensity of cytoplasmic staining within Leydig 
cells of all treated animals compared to controls, indicates that StaR was present and 
likely able to mediate the transfer of cholesterol from the outer mitochondrial 
membrane to inner mitochondrial membrane for conversion to pregnenolone. A 
comparable finding of StaR upregulation following silver NM-300 exposure was 
recorded in vitro using PCR analysis (Chapter 4).   
StaR expression is widely accepted as being regulated by the cAMP/PKA signalling 
cascade; however, cAMP/PKA-independent events have also been shown to play a role 
in regulation of StaR. For example, growth factors, macrophage derived factors, chloride 
ions, calcium messenger systems and macrophage-derived factors have all been shown 
to enhance StaR expression independently of cAMP/PKA  (Manna et al., 2016). 
Upregulation of StaR expression has previously been linked to excessive production of 
free radicals and reactive oxygen species, although the exact method of upregulation 
may vary (Manna et al., 2016). Long term potentiation of StaR expression could lead to 
excessive cholesterol transport within cells, almost causing a ‘bottle neck’ for its 
subsequent conversion to pregnenolone by P450scc, or further down the pathway to 
testosterone production.  
PCR analysis within chapter 4 indicated CYP11A1, the gene encoding P450scc may also 
be upregulated by exposure to NM-300 silver ENM, a finding which is echoed within 
published work reporting exposures to neonatal and adult rodents in vivo. For example, 
Garcia et al observed increased an increased in CYP11A1 expression following IV 
injection of 1mg/kg bodyweight silver ENM to CD-1 mice over 12 days (Garcia et al., 
2014). Similarly, following intraperitoneal exposure of neonatal ICR mice from postnatal 
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day 8-15, Zhang et al recorded upregulation of CYP11A1 (Zhang et al., 2015a, Garcia et 
al., 2014). 
A question may then be posed about changes in production of subsequent enzymes 
involved in the conversion of pregnenolone to testosterone, and where a bottle-neck 
would appear should one form. It would be interesting to examine P450scc expression 
within the tissue samples to deduce whether this upregulation in expression seen in 
vitro was mirrored in vivo.  
Interestingly, Garcia et al reported a concomitant increase in CYP11A1 and 3b-HSD 
expression following IV exposure to silver ENM (summarised previously within this 
chapter), but no change in expression of genes involved in cholesterol synthesis from 
intracellular lipids (HMCGR), de novo cholesterol synthesis (HMCGS), cholesterol 
transfer across the mitochondrial border (StaR and Tspo – mitochondrial translator 
protein), or enzymes involved in conversion of cholesterol to testosterone (CYP17A1, 
CYP19A1 and 17b-HSD) (Garcia et al., 2014). This indicates that there may well be a 
bottle-neck in synthesis of testosterone following upregulation of P450scc. As initial IHC 
work undertaken for this thesis indicated 3β-HSD expression did not appear to be 
changed, time and funding permitting, it would also be interesting to re-visit IHC for 3β-
HSD and other key enzymes above involved in testosterone synthesis on the tissues 
available, alongside examining its expression in TM3 cells in vitro using further PCR. The 
only enzyme it would not be possible to examine through TM3 cells is 17β-HSD, as it has 
been shown clearly that this is not expressed within this cell line, or other representative 
cell lines (Engeli et al., 2018).  
Y chromosomal DAZ (deleted in azoospermia) and its autosomal homologue Dazl 
(deleted in azoospermia-like) genes are exclusively expressed in germ cells, and are 
considered to be crucial to achievement and maintenance of spermatogenesis 
(Rocchietti-March et al., 2000). Using Dazl expression to assist with staging of tubules 
was unhampered by morphological changes following nanomaterial exposure, unless 
germ cells were missing altogether from tubules. It is notable that despite Dazl 
expression being seemingly unchanged by silver ENM exposure in this experiment, 
Ahmed et al reported a down-regulation of Dazl in albino rats exposed to silver 
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nanoparticles over 28 days at a dose of 100mg/kg/day (Ahmed et al., 2017). Following 
our observation of sertoli cell only (SCO) tubule formation in AgNO3 treated animals, 
presence of lumen dilation in Nano Amor treated animals, alongside our previous 
comments on the fact that SCO tubules are an end-stage lesion, and knowledge that 
silver ENM are retained in the testis for long periods of time, it would be interesting in 
a future study to look at whether extending the wash-out period of animals post 
exposure before examination would result in i) a higher incidence of SCO tubules, and 
ii) any associated down-regulation of Dazl.  
Following the observation of cell populations within the central lumen of some tubules, 
one explanatory avenue considered was whether any infiltration of immune cells into 
the testicular area had occurred. This was considered as some sloughed cells present 
within the tubular lumen appeared to have masses within them that appeared similar 
to the lobular nuclei seen within mature neutrophils.  
Unlike macrophages, eosinophils and dendritic cells which are found in varying numbers 
in the seminiferous tubule interstitium, granulocytic neutrophils are not found in the 
rodent testis under normal conditions. However, they play an important part in the 
body’s response to infection or damage and their presence would be an indicator that 
the animals’ immune systems were attempting to respond to presence of something 
potentially harmful. As the testicular tubules themselves are an immune privileged site, 
the body’s ‘normal’ immune system cells being kept outside of tubules by the blood-
testis barrier to prevent autoimmune response to the immunogenic spermatids being 
triggered, the presence of any immune cells within tubules themselves would be a sign 
the BTB itself had become compromised in some way. 
IHC for RP-1 showed no specific localisation, indicating that this particular immune cell 
type was not present within the tissue samples, or that the antibody was not optimal 
for this application (indeed, its producer BD Pharmingen suggests a slight variant on the 
antibody that was available to me for optimal immunohistochemical staining). However, 
it may be possible that other immune cells were present, particularly in light of the 
inflammation noted around tubules in NM-300 and AgNO3 treated animals. Alternative 
antibodies would be required to investigate this further. 
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It is worth recognising that despite morphological changes in silver ENM exposed 
animals being widespread, their focal nature could well mean that no drastic change in 
overall expression of proteins, enzymes and hormones related to normal testicular 
physiology would be evident. As much of the dysmorphism observed was interspersed 
with areas of tissue that were completely normal in appearance, it is highly possible that 
this is the case here. It is also worth noting that focal morphological changes are a well-
recognised trait in many reproductive toxicants. For example, known endocrine 
disruptors such as phthalates have been shown to result in a clear pattern of focal 
dysgenesis within testicular tissue, with varying impacts on fertility depending on 
severity and spread of the dysmorphic areas (Hutchison et al., 2008).  
Conclusions, Future thoughts and ideas  
The changes described within tissues from animals exposed in vivo makes a clear case 
for ENM being causative of adverse effects on the testis. There are a number of areas 
for further investigation which would be well worth pursuing.  
Initially, in order to generate a full complement of data for comparison to in vitro work, 
it would be useful to complete IHC analysis on tissues from silica treated animals. A 
further set of testicular tissues procured from animals exposed to nano copper oxide via 
a short-term inhalation protocol were also obtained during the course of this work. In 
order to compare effects in vivo to those generated from exposing cell lines to CuO in 
vitro, morphological, stereological and immunohistochemical analysis of these tissues 
would be required.  
To further understand effects of in vivo ENM exposure on Sertoli and Leydig cell 
structure and function, further IHC could be planned using antibodies as markers of 
cellular integrity, cytostructure and microfilament structure (such as vimentin, occludin, 
ZO-1, actin-related proteins, or testis-expressed gene 14 TEX14, as discussed 
previously). As the inflammation noted in some tissue samples is often associated with 
immune system influx (as discussed previously). Should investigation of cellular integrity 
provide further evidence for injury to the BTB, the risk of autoimmune action on 
developing spermatozoa, or adhesion of antibodies to the sperm surface that prevent it 
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fusing with an oocyte would be much higher. It would therefore be important to in more 
detail at additional IHC markers for components of the immune system. 
The identification of pyknotic nuclei in many of the treated testicular samples indicated 
apoptosis was ongoing. To further understand the extent of apoptotic changes, the 
dead-end TUNEL assay could be used. Further understanding of the mechanism by 
which apoptosis was ongoing could then be considered using caspase assays (via 
confocal microscopy), or further IHC staining for Bax or FAS. Additionally, as much of the 
published work indicates the major role oxidative stress and inflammation hold in 
mediating ENM toxicity at the cellular level, it would be interesting to investigate 
markers of oxidative stress (GSH, GPx, Lipid Peroxidase etc.), and cytokines and 
myeloperoxidase activity as inflammatory biomarkers.  
Working in such a heavily regulated system, it also is important to explore further 
endpoints to see whether the effects at cellular level appear to be from toxicity or 
endocrine disruption. As a fundamental theme throughout this thesis, and being key to 
spermatogenesis and general testicular health, it would be pertinent as a next step to 
explore hormone circulation to look for potential effects on steroid hormones and the 
HPG axis. It is for this reason that many of the published papers in the area focus on 
measuring circulating hormone levels. It is important to note here that the levels of 
testosterone in the testis are often many-fold higher than in the systemic circulation, 
and the two values are not necessarily strictly correlated (Creasy and Chapin, 2013). 
Thus, measuring intratesticular alongside systemic hormone levels would be an optimal 
approach.  
In future work, systemic hormone levels could be measured via serum or blood 
collection, while testicular hormone levels could be undertaken via homogenisation of 
testicular tissue, both of which would be followed by ELISA, Radio Immunoassay or mass 
spectrometry. If it had been possible to influence this aspect of the original animal 
studies used in this chapter of research, collection of both blood and fresh testicular 
tissue from the animals used in this work would have been ideal in order to understand 
clearly the effect of ENM exposure on systemic and local hormone levels. Changes in 
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circulating or local hormone levels would provide a useful indicator as to the 
involvement of endocrine disruption in the effects seen.  
Finally, it is important to recognise that not all mechanistic changes lead to phenotypic 
alterations. For example, sperm number may drop without any change to sperm 
function (leading to almost no change in fertility), conversely sperm number could be 
unaltered, while incidence of abnormalities rises (leading to sub-fertility). For this 
reason, it would be important in future work to include examination of sperm as the 
final endpoint for male reproductive function. The current study used only one testicle 
provided from each animal; any future work could easily include either use of the other 
testicle to examine sperm or use of the epididymis of the same testicle for the same.  
Analysis of epididymal morphology (prepared using Bouins fixative to preserve 
structure) can provide an initial indication of ENM effects on spermatozoa. Investigation 
of sperm motility is possible via simple analysis using a haemocytometer, or more 
comprehensive computer assisted sperm analysis (CASA). Morphology of sperm can be 
examined using Eosin Y staining, and evaluation of DNA fragmentation in sperm heads 
could be achieved using flow cytometry of acridine orange stained samples.  
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Chapter 6: Discussion  
 
The purpose of this thesis was to investigate the toxicity of ENM to the male 
reproductive system with a focus on development of non-animal testing approaches in 
line with the 3Rs principle. Using a panel of commonly used reference engineered 
nanomaterials, alongside some highly relevant commercially available materials, the 
research aimed to: i) establish suitable assays for screening ENM for cytotoxicity and the 
effects of time- and dose- on effect; ii) investigate functional cellular parameters 
relevant to fertility and endocrine health, iii) examine in detail morphological and 
functional markers of effect in tissues from animals exposed to some of the same ENM, 
and iv) compare results generated in vitro to those in vivo to guide a decision on the 
suitability of in vitro testing to predict outcomes in vivo. The overall objective was 
therefore to take initial steps in formation of an integrated approach to testing and 
assessment (IATA) for male DART following exposure to nanomaterials. 
 
Establishing suitable assays for high-throughput screening of ENM cytotoxicity  
The first step in achieving these objectives was to establish reliable and reproducible 
assays by which to screen ENM for toxicity in vitro, including consideration of potential 
for interference from ENM. The cytotoxicity assay (WST-1) was optimised and shown to 
be both reliable and reproducible in this respect for short term exposures, an outcome 
that is in agreement with another recently published appraisal using different ENM 
(Mannerström et al., 2016). The timecourse toxicity assay (Alamar Blue) clearly revealed 
the importance of exposure time in vitro in driving effect and was again shown to be 
suitable for use with ENM for short term exposures with some caveats, including the use 
of robust controls to identify ENM-specific interference. To validate this assay further, it 
would be useful to investigate further the influence of the highly reduced form of 
resazurin on the assay’s output, in order to provide further confidence in results 
generated.  
Following from these findings using TM3 and TM4 cells, it would next be interesting to 
establish relative responses to the same panel of ENM from other available male 
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reproductive cell lines (Mltc-1, MA-10 etc), to check further for reproducibility of the 
assays established, comparability of results, and to open opportunities to identify cells 
that have appropriate endocrine genes for further functional assessment. This would 
help to produce a reliable benchmark against which to compare findings for cytotoxicity 
of other ENM, helping to resolve one aspect of observed variability between studies. 
Importantly, results from the assays established within this research were also 
compared to those from other cell lines from a further nine cellular models 
(representing 6 organs within the body) for six of the ENM tested (Farcal et al., 2015). 
Results from the male testicular cell lines TM3 and TM4 were found to be generally 
comparable with outcomes reported from 7/9 cell lines for TiO2 (NM-103 & 104), 5/6 
cell lines reported for ZnO (NM-110 & 111), and 3/5 cell lines reported for SiO2 (NM-200 
& 203). Any differences in results stemmed from lung macrophage (Raw 264.7 and MH-
S mouse alveolar macrophages) and embryonic cell lines (NIH/3T3 & mES cells), both of 
which appeared to be highly sensitive to challenge from ENM. This further emphasises 
the importance of considering a panel of cell lines of varying sensitivity in future toxicity 
assessments. It also highlights the potential for ENM with varying characteristics 
(manufacturing technique, physical form, coating, size) to generate differing outcomes 
from toxicity tests. This was, to our knowledge, the first time such comparative work 
had been undertaken, and it was very encouraging to see so much general agreement 
amongst datasets.  
A number of important considerations for future in vitro assays contributing to hazard 
assessment of ENM were highlighted through the present study. The first is to establish 
whether ENM may interfere with the assay being used, especially in the case of those 
reliant on optical readings. The second is to elucidate whether the actual dose delivered 
to cells reflects that added to the test system, as highlighted by Cohen et al (2014), and 
from observations on the apparent sedimentation of CNTs on top of cells highlighted in 
the present research (Cohen et al., 2014). Third, for all metallic ENM, the role of ionic 
dissolution and further transformation of ENM in biological media must be considered, 
and relevant ionic controls built into any research planned. Fourth, as highlighted from 
the results of assays using NM-300, consideration of whether transformation of ENM in 
biological media results in altered behaviour is recommended, something which may be 
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directly linked to the question of whether ‘aged’ ENM (later in their life-cycle) behave 
differently to pristine ENM.  At the most basic level, building in robust ionic controls for 
all metallic ENM into future studies is strongly recommended. In addition, use of both 
‘pristine’ and ‘aged’ ENM which have either been in storage (for colloids especially) 
and/or in biological media for some time may be important. Thorough physico-chemical 
characterisation of materials available would assist with many of these issues. At the 
most basic level, for metallic ENM, characterisation of the percentage of dissolution of 
ions within the exposure medium before and during any experiment undertaken would 
be highly useful. This requires a multidisciplinary approach to be applied to hazard 
testing, but such information allows for a fuller understanding of the results from each 
assay.  
Application of these considerations in future work will not only allow for greater 
confidence in results generated, but ultimately also contribute to building robustly 
validated rankings of materials, for example via comparison of the same material with 
differing physico-chemical properties (as reported here), or through comparing the 
same material through stages of its life-cycle.  
 
Evaluation of cellular parameters related to fertility and endocrine function 
Loss of viability in TM3 and TM4 cells was established following exposure to a sub-set of 
the ENM panel. Knowing that metabolic activity was affected, consideration of whether 
ENM exposure led to effects on cell related to fertility and endocrine function was then 
undertaken. At a transcriptional level, it was demonstrated that genes related to Leydig 
Cell function and its important role in steroidogenesis from cholesterol may be 
interrupted or altered. It was possible to identify via measurement of protein expression 
that the TM3 cell expresses androgen receptor, confirming that TM3 is both potentially 
responsive to stimulation with testosterone in vitro. Protein expression work also 
confirmed that exposure to ENM altered both the ability of TM3 and TM4 express AR.  
It is important to recognise that the data reported for RNA and protein expression was 
very much from a time-limited pilot dataset. As a next step, further work to optimise the 
assays used to determine protein expression should be undertaken. In this, it would be 
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important to include a wider panel of protein antibodies, reflective of the genes 
investigated via RNA analysis in future work (using different antibodies where those 
selected previously were shown to be ineffective). Once established, expansion of 
protein expression analysis to a wider panel of testicular Leydig cell lines would not only 
contribute toward development of reliable and reproducible approaches to measuring 
protein expression across the panel, but also enable robust comparison between results 
generated. In line with previous comments, this may also contribute to identification of 
a cell line with additional appropriate genes for a more extensive endocrine assessment. 
Together, these findings are important as they add to previous work which has 
suggested a potential role for ENM as endocrine disruptors, clearly warranting a more 
thorough analysis with a wider panel ENM, genes/proteins and cells. Two potentially 
important genes involved in the management of steroidogenesis to include alongside 
LHR, StaR, CYP11A1 and 3β-HSD could be i) 17β-HSD, as the enzyme responsible for final 
conversion of androstenedione (AD) to testosterone, and ii) INSL-3, a hormone which 
has been identified as a potentially important new diagnostic tool in identifying late-
onset hypogonadism, as it plays an interesting role in modulation of steroidogenesis 
following LHR stimulation but is not directly influenced by the trophic drive of the HPG 
axis (Ivell and Anand-Ivell, 2009, Ivell et al., 2014). In implementing this, it is important 
to note that at the current time, none of the commonly used murine LC lines are capable 
of converting exogenous AD to T, most likely because they do not express the variant of 
17β-HSD required to do so (Engeli et al., 2018).  
It has been reported that both that MA-10 and mLTC-1 LC lines are capable of producing 
progesterone, which accords with observations of high progesterone production in the 
original tumour from which they are derived (Odermatt et al., 2016). This may make it 
possible to measure progesterone as an indicator of whether ENM interfere with the 
initial steps in steroidogenesis by interference with LHR, cAMP and PKA dependent 
signalling, or direct inhibition of StaR, CYP11a1 or 3b-HSD. This would preferably be 
achieved via mass spectrometry (GC-MS/MS or LC-MS/MS), which has been shown to 
be both more sensitive and reliable than RIA- or ELISA- based methods (Stanczyk et al., 
2007). Such interference has already been demonstrated for other ED chemicals such as 
bisphenol-A using MA-10 cells, and the TM3 cell line is frequently used to study the 
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impact of environmental pollutants and EDs such as diethylstilbestrol on 
steroidogenesis (Odermatt et al., 2016). A remaining problem based on the available 
evidence is that evaluation of ENM interference with later stages of steroidogenesis is 
not currently possible. To overcome this issue, it may therefore be necessary to 
undertake future work using primary cells isolated from rodent testicular tissue. If this 
were the case, not only could RNA expression and protein expression be measured, but 
it would be possible to use hormone assays to establish whether exposure to ENM 
altered actual production of Testosterone or Inhibin by LC and SC respectively.  
It would also be possible at this stage to expand the panel of Sertoli cells to provide a 
more complete understanding of the effects of ENM exposure on SC function, via 
measurement of selected genes related to i) endocrine function and ii) cytoskeletal 
integrity and thus BTB function. Endocrine function could be indicated by measurement 
of Inhibin (to investigate ability of the SC to feedback on FSH secretion) and androgen 
binding protein (ABP, which has a role in managing germ cell development). BTB 
integrity could be investigated by measuring ZO-1, Occludin or other actin-related 
proteins. To make analysis of BTB interference more robust, inclusion of measurement 
of transmembrane electrical resistance (TEER), could also be considered, on the basis 
that if TEER is reduced significantly following exposure, the BTB may be compromised.  
Although out with the scope of the current research, in future it would also be important 
to build understanding of the MoA by which ENM may be eliciting effects, for both cell 
lines.  Addition of assay/s measuring endpoints relative to reactive oxygen species 
generation, oxidative stress and apoptotic pathway activation would be relevant and 
justified. This would help in particular with comparison of results in vitro to in vivo.  
With the knowledge that ENM have the potential to disrupt endocrine production and 
signalling, development of biologically-relevant models to establish endocrine 
disruption potential from ENM exposure is important. These could be undertaken 
through a number of different approaches. The most simplistic would be to apply media 
from ENM treated LC (potentially containing signalling molecules released from the 
cells) to TM4 cells, and measurement of relevant gene expression (outlined above). 
Another approach would be to use a 3D co-culture model, incorporating LC and SC 
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alongside germ cells. Development of such co-culture systems has already been 
reported using primary cells isolated from immature rats (Wegner et al., 2013). Some 
researchers have attempted to overcome the obvious requirement for animal sacrifice 
in primary cell culture through co-culturing TM3 LC and TM4 SC lines, alongside the germ 
cell line C18-4, isolated from Balb/c mice (Yin et al., 2017). However, in relation to 
evaluation of endocrine endpoints the obvious limitation of this is the fact that LC are 
unlikely to be able to produce T / DHT, at least via its principal pathway of synthesis.  
Another possible route by which endocrine signalling between cell types could be 
considered is through use of microfluidic ‘endocrine system on a chip’ models. One such 
model, developed by Nguyen et al (2017), used a co-culture microfluidic system 
containing intestinal-pancreatic cells to measure the effect of glucose on production of 
glucagon-like peptide-1 (GLP-1) from the intestinal L-cell line (GLUTag) and insulin from 
the pancreatic β-cell line (INS-1), with the future aim of using the system to screen drugs 
for the treatment of diabetes (Nguyen et al., 2017). Modelling using key cells from the 
male reproductive system and associated organs in the endocrine feedback loops that 
control it (e.g. pituitary & hypothalamic cells) comes with many challenges, the most 
obvious being identification of cell lines which are fully active in terms of hormone 
production and response, identification of a suitable medium that provides appropriate 
nourishment for each organ on the system, and provision of necessary substrates for 
production of signalling molecules by the cells in culture (Eddie et al., 2014).  
An over-arching consideration in interpretation of results (both in vitro and in vivo) is 
the interaction of ENM with the biological environment into which they enter, formation 
of a dynamic biocorona and its subsequent influence on observed effect. Lai et al (2017) 
investigated interaction of gold and silver ENM with human plasma. They identified over 
300 individual proteins on the coronae, of which >80% of which was comprised of the 
20 most abundant biological proteins known (Lai et al., 2017).  Through their analysis, 
they were able to elucidate that differing ENM characteristics such as surface charge 
and core material played a significant role in determining bio-corona composition. 
Likewise, the net charge of protein molecules also influenced their interaction with 
ENM. Such observations imply that it is entirely possible effects of ENM may be altered 
significantly by their bio-coronae. It is unlikely that any biocorona formed in cell culture 
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be the same as that formed in vivo, bringing into question how this influence could 
potentially be managed when comparing results in vitro to those in vivo. 
An alternative consideration relating to the interaction of ENM with their surroundings 
in biological environments is the potential for ENM to interact with biological molecules 
and in turn, interfere with their ability to interact with one another e.g. signalling 
molecules with their receptors, or antibodies with proteins of interest in an assay. 
Noteworthy in consideration of this paradigm is the work of Findlay et al (2017), who 
demonstrated that carbon nanoparticles inhibit the antimicrobial activity of human 
cathelicidin peptide LL-37 even at low concentrations of exposure (Findlay et al., 2017). 
On examination of the underlying MoA, they identified that carbon NP were able to not 
only bind to LL-37 (observed via a change in aerodynamic diameter), but that once 
adsorbed to the surface they caused a change in structure of the peptide and associated 
loss of antimicrobial action. The authors also hypothesised that this NP-peptide 
interaction may have been one of the reasons for a loss of physically detectable peptide 
in some of the assays they conducted, a consideration which could also be applied to 
the protein detection work undertaken in the current research. 
Based on the above, in relation to investigation of endocrine disruption events following 
ENM exposure, it could therefore be hypothesised that ENM-biomolecule interactions 
may either i) interact with proteins at hormone-active sites to influence hormone 
binding, ii) interact directly with hormones to alter them in some way, potentially 
leading to decreased (or increased) activity at their targets, or even iii) attach to 
hormones and other relevant molecules and ‘piggy-back’ around the body, adding 
further complexity to understanding their biokinetics (as from this study it was possible 
to demonstrate that following oral exposure, ENM translocate from the GI tract to testis, 
amongst other organs). As ENM interactions with biological molecules and bio-corona 
formation will no doubt differ in vitro and in vivo, these reflections bring forward a 
multitude of further questions which are not possible to answer at the current time, but 
which must be continually revisited and reconsidered as the field of research develops. 
These considerations not only demonstrate the huge value of in vitro work which may 
be used to establish better understanding of ENM effects and interactions with the male 
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reproductive system, but also highlight the currently remaining requirement for the 
downstream use of animal models in establishing DART for ENM. 
 
Histological appraisal of relevant fertility & endocrine endpoints in animals 
exposed to ENM in vivo  
Detailed examination of morphological and functional markers of effect in tissues from 
animals exposed orally over 28-days to a sub-set of the ENM panel first and foremost 
led to development of a new methodology for staging of testicular tissue in toxicity 
studies. The hybrid technique combined Dazl immunostaining (to quickly allow grouping 
of seminiferous tubule stage) with a decision key (incorporating key cell populations, 
morphological and stereological identifiers) to assign individual stage. This technique 
may be applied easily and ensures a high level of accuracy in determining tubule stage 
without necessarily requiring the many years of experience usually needed to undertake 
such an evaluation. Importantly, this approach allowed consideration of tubule stage to 
be taken into account more readily when undertaking histopathological analysis, 
something which the author and others have found to be key in the correct 
interpretation of stereological and morphological evaluations. It is strongly 
recommended that this robust approach is applied in research pertaining to appraisal of 
testicular histopathology.  
Such considerations are under-recognised in both published nanotoxicology research, 
and within the test guidelines themselves (for all industries). A further major 
recommendation arising from this research is to ensure consideration of tubule stage in 
appraising histopathological endpoints in the testis, and that not only the importance of 
tubule stage be recognised in test guidelines for DART testing in industrial or 
pharmaceutical settings, but that further guidance for its application and interpretation 
be provided. 
A third important outcome of this work was the appraisal of morphological and 
stereological impact of ENM exposure to testicular tissue following a 28-day oral 
exposure regimen, which to our knowledge was achieved a level of detail far greater 
than any previously described.  
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Interestingly, through this evaluation it was possible to demonstrate clearly that those 
animals exposed to silica dioxide showed no unfavourable morphological outcomes, a 
finding that was in agreement with the work in vitro, but not in all published literature 
in vivo. Further examination of the evidence suggested that this was due to a 
combination of factors, including physical characteristics of the ENM reported & the fact 
that many used were not technically ENM at all owing to their larger sizes, the doses 
administered, exposure routes used and associated differences in ADME/toxicokinetic 
profile that followed.  
It was possible to confirm that all animals treated with silver suffered adverse changes 
within their testicular tissue following exposure, which were maintained even after a 6-
week period of wash out, a finding which aligns completely with both that of van der 
Zande et al (2012), who confirmed that silver ENM accumulated in the testis and were 
not excreted following this recovery period, and our own findings in vitro (van der Zande 
et al., 2012). Stereological analysis showed no alteration in tubule diameter with stage 
following exposure to ENM, indicating that at a structural level there was no link 
between tubule diameter and effect observed. However, it was possible to identify 
some very specific changes in lumen volume. These included increases compared to 
control for stage VII tubules in Nano Amor treated animals, and an increase in volume 
for stage IX tubules in treated animals, both of which indicate potential disruption of 
tubules associated with spermiation (stage VIII).  
Whilst the recording of adverse morphological outcomes were consistently recorded in 
all animals treated with silver, there were some differences between the pattern of 
results recorded depending on the type of silver to which animals were exposed, 
allowing the building  of a better picture of how differing physico-chemical 
characteristics may alter biological response and outcomes.  
Effects common to all animals included generalised tubular dysmorphism, presence of 
pyknotic nuclei, degeneration of germ cell populations and sloughing of tubular 
contents into the central lumen, all of which are widely accepted indicators of testicular 
toxicity, and relatively sensitive indicators of a disturbance in spermatogenesis, either 
via direct injury or disturbances in the HPG axis. Sertoli cells are known to be relatively 
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robust, and as many appeared intact, it could be suggested it is more likely these effects 
were mediated via endocrine disturbances. However, further appraisal of key 
parameters in SC and BTB structure, alongside investigation into whether SC cell injury 
would help provide a more complete understanding of these effects and the underlying 
cause.  
One interesting difference in tubular content between silver treatments we highlighted 
was the retention of spermatids identified in testes from NM-300 and Nano Amor 
treated animals, but not in AgNO3 treated animals. Spermatid retention is related to 
problems with spermiation, forming an extremely sensitive indicator of toxicity which 
implicates endocrine disturbance, as spermiation is mediated via testosterone acting on 
SC, adding further weight to the suggestion of endocrine disturbance as a cause for 
observed effects. This finding also allows some conjecture that these effects may be 
primarily mediated via particles not ions, although it would be unwise to draw any 
further inferences from this supposition without further investigation. 
A further specific difference between tubules was the observation of tubule dilation in 
Nano Amor treated animals. This is considered to be a manifestation of problems with 
tubule emptying and is in alignment with the finding of step 11 spermatid retention and 
sloughing of tubule content without its apparent efflux, and that of increased lumen 
volume compared to control in tubules immediately prior to spermiation (stage VII). 
Dilation is also a known precursor of complete tubular atrophy and, as discussed 
previously, it may be that should animals have been sacrificed later an increased 
incidence of this would have been observed. Interestingly, Nano Amor exposed animals 
also presented with germ cell layer atrophy, a precursor of development of SCO tubules. 
As AgNO3 exposure led to identification of SCO tubules, this may suggest that should the 
observed toxicity be mediated by ions rather than particles, more chronic exposure to 
Nano Amor may lead to a similar outcome. In support of this posit, van der Zande et al 
(2012) noted that the soluble silver content to which rats were exposed could 
potentially be up to 4x higher for Nano Amor, owing to its greater dissolution of Ag+ ions 
over the 7 day period tested (45% vs 3% for NM-300) (van der Zande et al., 2012). This 
is further supported by the findings of Kittler et al (2010) who observed that PVP-coated 
silver ENM released more Ag+ ions than citrate capped Ag ENM of the same size (Kittler 
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et al., 2010). Taking into account the fact that NM-300 is citrate-capped, this may offer 
a plausible reason for the lack of tubule dilation or SCO tubules recorded in animals 
exposed to this ENM and suggests that such effects may be mediated by ions rather than 
particles. These observations would require further analysis before any final conclusions 
could be reached.  However, As LC dysfunction (and resultant lowered testosterone 
levels) have been associated with a long-term risk of not only decreased fertility, but 
also systemic inflammation and metabolic syndrome, developing further understanding 
of the effect observed here is of clear importance (Bandak et al., 2017).  
In addition to tubular effects, further key differences were observed in the interstitium, 
for example, presentation of NM-300 treated animals with generalised inflammation. 
As already discussed, inflammation is generally associated with immune influx and 
cytokine secretion, which in turn can lead to an increase in permeability of the BTB. 
Should exposure to silver be chronic rather than sub-chronic in nature, a potential for 
downstream compromise of the BTB and associated access of immune cells to adluminal 
compartment, leading to an autoimmune response to spermatozoa could be posited. 
This would require further investigation over a longer period of exposure and inclusion 
of assays to appraise caspase and immune cell populations, but would be justified given 
the strong evidence presented. A further outcome highlighted was that animals exposed 
to AgNO3 were the only group to show evidence of Leydig cell hyperplasia. As a known 
sensitive indicator of disturbance in the HPG axis, and precursor of testicular adenoma, 
this new finding is particularly relevant.  
Taken together, these results indicate strongly a role for silver ENM as reproductive 
toxicants and as potential endocrine disruptors. Evaluation of endocrine function via 
immunohistochemical analysis further aided in reaching this conclusion. It was possible 
to show an increase in StaR expression following exposure to both silver ENM and ionic 
AgNO3, a decrease in LHR expression following NM-300 exposure (but not Nano Amor 
or AgNO3), and no change to AR expression following any treatment. Results indicated 
that further optimisation of antibodies may be required, which would be undertaken at 
the commencement of any future research. However, a clear case is presented for 
further investigation of endocrine-relevant endpoints following ENM exposure, using 
either an expanded range of antibodies (comparable to those discussed for work in 
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vitro), or preferably, via measurement of hormone levels from both testicular tissue 
homogenates and blood samples, to measure local and systemic effects respectively.  
As previously highlighted, mechanical changes in tissues do not always manifest as 
phenotypic changes, as the body is often capable of compensating for damage to a 
certain extent. This is especially relevant as the tissue effects identified were localised 
in their nature. To assist in this, an additional endpoint which can be strongly 
recommended for future studies would be the inclusion of sperm analysis from both 
testicular and epididymal samples. This would allow for consideration of whether the 
focal areas of dysgenesis contributed to a decrease in sperm normality, motility and 
function, (via CASA, Eosin Y stain and acridine orange respectively) and therefore their 
potential to fertilise an oocyte.  
 
Comparison of results in vitro to in vivo   
The penultimate aim from the data accumulated was to compare results generated in 
vitro to those in vivo to guide a decision on the suitability of in vitro testing to predict 
outcomes in vivo. Of the ENM panel selected for examination at the commencement of 
this work, the most comprehensive analysis was undertaken for silver, and results are 
summarised in Table 42.  
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Table 42:Comparative summary of findings for silver ENM. Where cells are blank, no assay was performed for this endpoint. AR = 
Androgen Receptor, LHR = Luteinising Hormone Receptor, WB = Western Blot, IHC = Immunohistochemistry, PCR = Polymerase 
Chain Reaction. *=additional result for Androgen Receptor expression, generated from pilot data using TM4 cells. 
Cell/Animal 
model Endpoint & Assay 
Silver 
300 AgNO3 
Nano 
Amor 300dis 
M
ur
in
e  
In
 v
itr
o 
TM3 
Leydig 
Cytotoxicity WST-1 + +  - 
Timecourse Alamar Blue 
LC50  
7.88µg/cm2 
>0.94μg/cm2 
4h 
LC50   
0.282µg/cm2 
  
TM4 
Sertoli 
Cytotoxicity WST-1 +    
Timecourse Alamar Blue 
>1.875μg/cm2  
4h    
In vitro (murine 
TM3) 
 
In vivo 
(Sprague-
Dawley rat) 
AR 
expression 
WB (in 
vitro) 
IHC (in 
vivo) 
↓     
↓* • • • 
 
LHR 
expression 
PCR (in 
vitro) 
IHC (in 
vivo) 
↑ ↓ • •  
StaR 
expression 
PCR (in 
vitro) 
IHC (in 
vivo) 
↑ ↑ ↑ ↑  
CYP11A1 
expression 
PCR (in 
vitro) ↑ 
    
3b-HSD 
expression 
PCR (in 
vitro) 
IHC (in 
vivo) 
↑ ? ? ?  
 
The data clearly show that identification of cytotoxicity in vitro using the WST-1 test was 
able to predict adverse outcomes following exposure in vivo. As no previous studies 
concomitantly examining the same male reproductive nanotoxicity endpoints in vitro 
and in vivo have been identified, this comparison is being reported for the first time. It 
represents an encouraging first step in the development of future IATAs to reduce the 
use of animals in DART for ENM.  
It was also possible to observe changes in expression of StaR observed following a sub-
acute exposure to NM-300 via oral gavage in vivo, based on outcomes from PCR on TM3 
LC in vitro. Three published studies were found with which to compare this outcome. 
Garcia et al (2014) found a non-significant increase of StaR expression in CD1 mice 
(measured via PCR), following 12 day IV exposure to  14nm Ag ENM (Garcia et al., 2014). 
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By comparison, Zhang et al (2015a&b) showed in two separate studies that while 
exposure to 10 and 20nm Ag NPs decreased expression of StaR in TM3 cells following 
24hr exposure in vitro, but that 4 doses of ~15nm Ag NPs to neonatal mice over 15 days 
increased expression at a low dose (1mg/kg) but decreased expression in vivo at a higher 
dose (5mg/kg) (Zhang et al., 2015a, Zhang et al., 2015b). Despite the ENM used in each 
study being of similar sizes, they were all from different sources and held different 
characteristics, making it difficult to draw a direct comparison between the data in vitro, 
and even harder to reach conclusion on effects of Ag ENM on StaR expression when 
considering the data in vivo, given that the ENM were different from either study in vitro. 
However, this does serve to highlight the importance of use of reference material, and 
of considering not only ENM characteristics, but exposure length, dose and animal 
model and maturity in interpretation of results. Had such a reference material been 
employed for these studies, it would have been easier to usefully compare the outcomes 
of the three.  
Evaluation of AR expression led to some interesting findings. in vitro, NM-300 exposure 
appeared to decrease in expression of AR in TM3 and TM4 cells. Results in vitro are in 
agreement with those published by Zhang (2015), showing a decrease in AR expression 
in TM4 cells following Ag ENM exposure (Zhang et al., 2015a). The outcome is not only 
interesting because of the alignment with other published work on testicular cell lines 
in vitro, but because it confirms for the first time that ENM are able to alter expression 
of AR in the TM3 Leydig cell.  By comparison to the outcomes generated in vitro no 
change in expression of AR was observed in vivo. However, discussed in Chapter 5, issues 
with specificity of the antibody used led to problems in drawing conclusions on the 
relevance of this disparity in findings. There is a strong possibility that with further 
optimisation and use of an alternative antibody the results generated may be different. 
As no published in vivo studies using silver ENM were identified against which to 
compare this, further work to optimise the protocol for AR IHC is strongly 
recommended, in order to draw a definitive conclusion on comparability in vitro to in 
vivo. 
One clear difference between findings in vitro and in vivo was for LHR. PCR in vitro 
reported a non-significant increase in expression of LHR in TM3 cells following exposure 
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to NM-300, whereas IHC in vivo reported a slight decrease. Based on this data alone, it 
appears that the current methods employed to examine TM3 cells may not be 
particularly accurate in predicting changes to LHR expression in vivo. It would be well 
worth repeating evaluation of LHR expression using both TM3 cells in vitro and the 
tissues exposed in vivo, to look for reproducibility before drawing any final conclusions. 
Ultimately though, hormone assays to measure circulating LHR from future studies in 
vivo would be the most robust method by which to measure this and compare outcomes 
to those in vitro in future.  
One steroidogenic enzyme for which no clear in vitro in vivo comparison was possible 
was 3b-HSD. Whilst a slight increase in expression was observed in vitro, (non-
significant), it was not possible to optimise the antibody used to evaluate tissues from 
animals exposed in vivo. Development of this aspect of the research would be justified 
as a next step, especially as results from other studies in vitro and in vivo currently reveal 
contrasting results. Further work to understand the potential for comparability between 
the two would be recommended before any final conclusions can be made.  
Although evaluation of P450scc (protein) or CYP11A1 (gene) expression was not 
conducted in vivo, it was encouraging to see that our results matched those of Garcia et 
al, who identified a clear increase in CYP11A1 expression following Ag ENM exposure in 
vivo (details of study described above) (Garcia et al., 2014). Interestingly, Zhang et al did 
not find a significant change in expression of CYP11A1 when they exposed TM3 cells to 
10µg/µl 10 or 20nm Ag ENM (Zhang et al., 2015a). Again, it is difficult to draw an exact 
comparison between the datasets when the ENM tested are not exactly the same. In 
order to understand this further, it would be very interesting to undertake IHC for 
P450scc or CYP11A1 on the tissues from animals exposed in vivo to see whether they 
matched those generated in vitro.  
In summary, appraisal of silver ENM cytotoxicity using testicular cell lines in vitro have 
been shown to be predictive of adverse outcomes recorded in vivo following exposure 
to the same ENM. Some clear comparability between functional and endocrine markers 
of testicular health was identified (e.g. increased expression of StaR). There is however 
a clear need to develop further methods for appraisal of other endpoints in both 
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systems. For completeness of this comparative evaluation, it would be useful to expose 
TM4 cells to AgNO3 to establish cytotoxicity, a timecourse for effect, together with 
appraisal of the full complement of endocrine endpoints, as would appraisal of Nano 
Amor for both cell lines in vitro (something which was not possible during this research 
as no access to a Nano Amor preparation was available).  
Should further funding be procured with which to continue this research, expansion of 
the comparative dataset with minimal time, expense and no additional animal burden 
would be possible by examination of pristine CuO. Tissues from a short-term inhalation 
exposure in vivo are available, as is more of the ENM with which to appraise functional 
and endocrine parameters in vitro. This would, relatively quickly, add further data to the 
dataset from an alternative ENM and exposure protocol, with which to examine ability 
of outcomes in vitro to predict those measured in vivo. Following this, evaluation of 
additional ENM could be added in vitro, alongside additional cell lines from multiple 
animal types, allowing for identification of commonality or differences across species 
and thus potentially animal models. Following careful appraisal and comparison of 
results, further work in vivo could then be added where its use in building a comparative 
model is justified without question. 
In conducting any future research, there are a number of considerations and limitations 
from the design of the current that ideally should be considered and improved on where 
possible. For most of these, there may not be either i) any solution or ii) a solution which 
is not high cost and high effort at the current time, but their continued consideration in 
design of future work is nonetheless warranted.  
The first is that for this research, the exposure times in vitro do not match those in vivo 
(24h vs 28-days). It is important to consider for future research how a more accurate 
representation for longer-term exposure could be achieved in vitro. This remains a 
problem that is recognised by the scientific community, and for which currently there is 
no immediate solution. On one hand, it would be possible to simply apply repeated 
doses of ENM following the same regimen as applied in vivo. On the other, this would 
still not represent the system in vivo as it applies only to an isolated cell line, with no 
ability to interact with other cells from the same organ. Use of microfluidics systems as 
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mentioned earlier may be one way this could be tackled; however, this would require 
considerable further time and effort to develop into a working system. The second is the 
potential influence of the spermatogenic cycle on outcomes reported in vivo. As the 
spermatogenic cycle in a rat lasts ~12 days, and development of basal spermatogonia to 
mature spermatozoa takes ~56days, it may be that exposure duration has an even more 
important impact for male reproductive endpoints than in other organs. Finally, as 
discussed, the influence of biocoronae on ENM interactions in vitro and in vivo remains 
an important consideration for any study.  
Finally, alongside the shorter-term animal studies that have been undertaken to date, 
consideration of longer term, low level exposure regimens in animal research should be 
given. On average, is far more likely that humans will come into contact with small doses 
of ENM over a much longer time (potentially with ‘spikes’ of exposure) than larger doses 
in a short time period, potentially leading to cumulative effects on fertility.  
Epidemiological studies of the link between exposure to larger particles in air pollution 
(PM) and spontaneous pregnancy loss have identified a significant link between the two, 
both for short-term, and longer-term exposures (Carrington, 2019). It may therefore be 
argued that as clear reproductive effects from particulate matter are already proven, 
further investigation for their nano- counterparts using an animal model in vivo is both 
relevant and justified at the current time.  
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Formation of an integrated approach to testing and assessment (IATA) for male 
DART following exposure to nanomaterials.  
 
The final aim of this thesis was to propose a framework on which to develop an 
Integrated Approach to Testing and Assessment (IATA) for male reproductive toxicity 
from ENM. Similar approaches are beginning to emerge in other regulatory frameworks 
to assist with both maximising the impact of available data and reduce and/or refine the 
use of animals in testing where possible. For example, ICH S5 details an integrated 
testing strategy (ITS) for detection of adverse effects on embryo-foetal development, 
ECHA includes a simple ITS for sampling strategy and preparation for testing human 
health endpoints with ENM, and the OECD recently published a guidance document on 
defined approaches to be used within Integrated approaches to testing and assessment 
(ECHA, 2017, OECD, 2016, EMA, 2017).  
The proposed IATA is outlined overleaf. It must be recognised that this is a starting point, 
and further refinement, development and additions will be necessary as knowledge in 
the area is grown. However, to our knowledge, this is the first time production of such 
an ENM-specific IATA has been undertaken for male reproductive toxicity endpoints.  
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Figure 107: Proposed IATA for consideration of male DART following ENM exposure 
Bryony L Ross PhD 317 
Note 1: The use of in silico models for ENM is on the whole yet to be established. However, development of 
Quantitative Structure Activity Relationships (QSARs), Physiologically Based Pharmacokinetic Models (PBPK) are under 
development and useful output should be available soon. The use of grouping an read-across should also be considered 
at this stage, but is only applicable to certain ENM under REACH, details of which may be found in ECHA Appendix R7-
1 for nanomaterials applicable to Chapter R71a Endpoint specific guidance (ECHA, 2017).  
Note 2: DART screening in vitro should be undertaken according to guidelines detailed in Fig. 108.  
 
Figure 108: Proposed IATA, Note 1. Detail on requirements for In vitro toxicity testing endpoints. 
Note 3: Alongside the traditional test guidelines, the following guidance should be consulted to ensure robust study 
design:   
• PHARMACEUTICALS: ICH S5 (R3) Guideline on Reproductive Toxicology (EMA, 2017) 
• CHEMICALS: ECHA Appendix R7-1 for nanomaterials applicable to Chapter R71a Endpoint specific guidance (ECHA, 2017) 
• OECD Revised guidance document No 150: Standardised test guideline for evaluating chemicals for endocrine disruption 
(OECD, 2018b) 
• OECD Guidance document on good in vitro method practices (GIVMP) (OECD, 2018a) 
• Series on Testing & Assessment No 178: Review paper on novel in vitro and in vivo screening and testing methods and 
endpoints for evaluating endocrine disruptors (2012) 
• Series on Testing & Assessment No 255: Guidance Document on defined approaches to be used within Integrated 
approaches to testing and assessment (OECD, 2016) 
Note 4: Analysis of stage using hybrid technique combining Dazl immunostaining with a decision key (for key cell 
populations, morphological and stereological identifiers). Method outlined in full within Chapter 4.  
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Conclusions and Future work  
Reports of reduced serum testosterone levels, a decline in sperm morphology & 
motility, and an increase in use of assisted reproductive techniques, all indicate clearly 
that male fertility rates are in decline in the Western world (Odermatt et al., 2016, 
Rolland et al., 2013). With fertility now below the replacement level in some countries, 
it has never been more important to understand and manage potential threats to 
reproductive health (Makarow and Hojgaard, 2010).  
To this end, this research has aimed to assess the toxicity of engineered nanomaterials 
in the male reproductive system and develop an improved testing strategy for hazard 
assessment. Assays to evaluate cytotoxicity and the effect of time- and dose- on effect 
were established and optimised for ENM. A panel of ENM were then evaluated for 
toxicity to male testicular cell lines. For the first time, these results were compared to 
those from multiple other cell lines representing six organs in the body and found to be 
generally in agreement. It was possible to conclude that the assays used were suitable 
for screening ENM for toxicity to the male reproductive system in a reliable and 
reproducible manner.  
Functional assessment of cell lines in vitro provided a deeper understanding of the 
response of TM3 and TM4 cell lines to acute ENM exposure. Comparison of outcomes 
to tissues from animals exposed in vivo indicated that for a selected ENM (silver), 
screening tests in vitro were capable of predicting toxicity in vivo. Furthermore, whilst 
future work will refine the approach and establish fully the comparability between 
functional endpoints in vitro and in vivo, it was possible to generate sufficient data to 
conclude that silver ENM are both potential male reproductive toxicants and an 
endocrine disruptor.  
To develop this work programme further, a number of key steps could be taken to 
strengthen and develop the findings so far. A first step would be to expand testing in 
vitro to a panel of cell lines both from the same animal to compare reproducibility of 
results, and different animals to examine the potential for cross-species differences in 
response. As the potential for ENM to translocate to and accumulate within the testis 
has been demonstrated (van der Zande et al., 2012, van der Zande et al., 2014a), 
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evaluation of cellular integrity in single cell culture, and interaction of the ENM panel 
with cell co-cultures would be warranted, especially for parameters related to the 
integrity of the BTB. In order to facilitate more accurate measurement of endpoints 
related to fertility, cell integrity and endocrine function at sub-lethal doses, 
development of a model using Primary cells in co-culture is justified, as this would allow 
(amongst other things) direct evaluation of hormone levels rather than reliance on RNA 
or protein expression in estimation of effect. Collection of hormone levels (both 
intratesticular and circulating) from future animal studies would enable a direct 
comparison between results in vitro and in vivo and allow for a more accurate evaluation 
of comparability between the two. Evaluation of additional testicular samples from 
animals treated with an alternative ENM in vivo would also be useful in building an 
evidence base for comparing in vitro to in vivo (for example, animals exposed to CuO 
short-term). The potential for a long-term low-exposure animal model should be also be 
seriously considered as a method through which to evaluate realistic ENM exposures. 
Such developments could then easily be fed into further development and refinement 
of the proposed IATA detailed above.  
As toxicology models in vitro have not been well explored, this plan both ensures 
development of relevant new findings for male DART endpoints following ENM 
exposure, and an active contribution to develop a protocol that regulators would in 
future accept as a validated pre-screening technique, further supporting refinement and 
reduction of the use of animals in testing.  
The work in this thesis has made a significant contribution to developing the underlying 
knowledge on ENM as potential reproductive toxicants and endocrine disruptors and 
has contributed to development of an initial IATA framework through which to refine 
and reduce the number of animals used in regulatory DART testing.  
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Abstract
Nanomaterials (NMs) display many unique and useful physico-chemical properties. Howev-
er, reliable approaches are needed for risk assessment of NMs. The present study was per-
formed in the FP7-MARINA project, with the objective to identify and evaluate in vitro test
methods for toxicity assessment in order to facilitate the development of an intelligent test-
ing strategy (ITS). Six representative oxide NMs provided by the EC-JRC Nanomaterials
Repository were tested in nine laboratories. The in vitro toxicity of NMs was evaluated in 12
cellular models representing 6 different target organs/systems (immune system, respiratory
system, gastrointestinal system, reproductive organs, kidney and embryonic tissues). The
toxicity assessment was conducted using 10 different assays for cytotoxicity, embryotoxi-
city, epithelial integrity, cytokine secretion and oxidative stress. Thorough physico-chemical
characterization was performed for all tested NMs. Commercially relevant NMs with differ-
ent physico-chemical properties were selected: two TiO2 NMs with different surface chemis-
try – hydrophilic (NM-103) and hydrophobic (NM-104), two forms of ZnO – uncoated (NM-
110) and coated with triethoxycapryl silane (NM-111) and two SiO2 NMs produced by two
different manufacturing techniques – precipitated (NM-200) and pyrogenic (NM-203). Cell
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Appendix 2: Experimental Outline for WST-1 & Alamar Blue assays 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 01 0.125 1.25 12.5 25 50 100 200 
200 + 
Triton5 
Media + 
Triton2 
  
B 01 0.125 1.25 12.5 25 50 100 200 
200 + 
Triton5 
Media + 
Triton2 
  
C 01 0.125 1.25 12.5 25 50 100 200 
200 + 
Triton55 
Media + 
Triton2 
  
D 0 0.1256 1.256 12.56 256 506 1006 2006 
200 + 
Triton 
Control 
+ Triton 
  
E 0 0.1256 1.256 12.56 256 506 1006 2006 
200 + 
Triton 
Control 
+ Triton 
  
F 0 0.1256 1.256 12.56 256 506 1006 2006 
200 + 
Triton 
Control 
+ Triton 
  
G 03 0.1254 1.254 12.54 254 504 1004 2004 
200 + 
Triton 
Control 
+ Triton 
  
H 03 0.1254 1.254 12.54 254 504 1004 2004 
200 + 
Triton 
Control 
+ Triton 
  
             
 
1. Add 200μl TM3 cells to wells A-C. Incubate for 24 hrs.  
2. Remove media. Add prepared treatments to wells in triplicate. Incubate for 24 hrs.  
3. Remove and store supernatants from TM3 cells, pooling triplicate wells.  
4. Add 90μl DMEM+10μl WST-1 to these wells for WST-1 Assay. 
 
1. Add 200μl of TM3 cells to wells D-F. Incubate for 24 hrs.  
2. Remove media. Add prepared treatments to wells in triplicate. Incubate for 24 hrs.  
3. Remove and store supernatants from TM3 cells, pooling triplicate wells. 4. Add 100μl of DMEM to 
each well. No WST-1. 
 
1. Leave wells empty for the first 24hrs.  
2. Add prepared treatments for the next 24 hrs.  
3. Remove and store supernatants from TM3 cells, pooling triplicate wells.  
4. Leave wells empty for WST-1 assay. 
Figure 109: Experimental design for WST-1 assay, based on a 96 well plate. Plate rows are annotated A-H, and columns 1-12.  
Protocol denoted by grey shading. is noted in superscript and outlined in full within the body of the text. 
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Appendix 3: Preparation of RNA samples for PCR  
Table 43: Sample preparation for PCR 
  RT Reaction setup:  
Each reaction set to make 2000ng cDNA where possible 
Final PCR Reaction setup:  
Final concentration of 5ng/μl per well  
Nanomaterial Sample RNA Quantity ng/μl VOLUME TO ADD (μl) 
RNAse free H20 
to add 
cDNA quantity after 
RT (ng) 
Total Reaction 
Volume (μl) 
Concentration cDNA 
(ng/μl) 
Final Volume required for 5ng/μl 
concentration Vol cDNA (μl) Vol H20 (μl) 
NM-300 n1 0μg/cm2 394.03 5.08 3.92 2000 29 68.96551724 400 29 371 
NM-300 n1 1.26µg/cm2 145.7862 9 0 1312.0758 29 45.2439931 262.41516 30 233.41516 
NM-300 n1 2.52μg/cm2 - - - - - - - - - 
NM-300 n2 0μg/cm2 716.0984 2.79 6.21 2000 29 68.96551724 400 29 371 
NM-300 n2 1.26µg/cm2 759.9938 2.63 6.37 2000 29 68.96551724 400 29 371 
NM-300 n2 2.52μg/cm2 - - - - - - - - - 
NM-300 n3 0μg/cm2 1257.97 1.59 7.41 2000 29 68.96551724 400 29 371 
NM-300 n3 1.26µg/cm2 470.7 4.25 4.75 2000 29 68.96551724 400 29 371 
NM-300 n3 2.52μg/cm2 - - - - - - - - - 
NM-110 n1 0μg/cm2 208.03 9 0 1872.27 29 64.56103448 374.454 29 345.454 
NM-110 n1 1.26µg/cm2 182.04 9 0 1638.36 29 56.49517241 327.672 29 298.672 
NM-110 n1 2.52μg/cm2 383.94 5.21 3.79 2000 29 68.96551724 400 29 371 
NM-110 n2 0μg/cm2 371.64 5.38 3.62 2000 29 68.96551724 400 29 371 
NM-110 n2 1.26µg/cm2 171.4 9 0 1542.6 29 53.19310345 308.52 29 279.52 
NM-110 n2 2.52μg/cm2 357.77 5.59 3.41 2000 29 68.96551724 400 29 371 
NM-110 n3 0μg/cm2 830.03 2.41 6.59 2000 29 68.96551724 400 29 371 
NM-110 n3 1.26µg/cm2 578.6 3.46 5.54 2000 29 68.96551724 400 29 371 
NM-110 n3 2.52μg/cm2 358.755 5.57 3.43 2001 29 68.96551724 400 30 371 
NM-111 n1 0μg/cm2 473.45 4.22 4.78 2000 29 68.96551724 400 29 371 
NM-111 n1 1.26µg/cm2 372.32 5.37 3.63 2000 29 68.96551724 400 29 371 
NM-111 n1 2.52μg/cm2 135.26 9 0 1217.34 29 41.97724138 243.468 29 214.468 
NM-111 n2 0μg/cm2 750.36 2.67 6.33 2000 29 68.96551724 400  371 
NM-111 n2 1.26µg/cm2 1137.38 1.76 7.24 2000 29 68.96551724 400  371 
NM-111 n2 2.52μg/cm2 376.3 5.31 3.69 2001 29 68.96551724 400  371 
NM-111 n3 0μg/cm2 237.86 8.41 0.59 2000 29 68.96551724 400 29 371 
NM-111 n3 1.26µg/cm2 458.95 4.36 4.64 2000 29 68.96551724 400 29 371 
NM-111 n3 2.52μg/cm2 241.29 8.29 0.71 2000 29 68.96551724 400 29 371 
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Appendix 4: RNA Sample Quantification & Integrity Scoring  
 
Table 44: RNA sample quantification and integrity scoring using spectrophotometry and chip-based gel electrophoresis. 
 
NANODROP BIOANALYZER 
ENM Sample 
RNA 
Concentration 
(ng/μl) 
RNA Purity 
(A260/A280) 
RNA Concentration 
(ng/μl) 
RNA integrity number 
(RIN) 
NM-
300 n1 0μg/cm
2 524.9 2.07 394.03 10 
NM-
300 n1 1.26µg/cm
2 112.3 2.07 145.7862 9.3 
NM-
300 n1 2.52μg/cm
2 2.14 (no reading) <3 N/A 
NM-
300 n2 0μg/cm
2 539 2.09 716.0984 9.6 
NM-
300 n2 1.26µg/cm
2 572.2 2.11 759.9938 9.7 
NM-
300 n2 2.52μg/cm
2 45.8 2.05 - N/A 
NM-
300 n3 0μg/cm
2 458.3 2.08 1257.97 10 
NM-
300 n3 1.26µg/cm
2 182.3 2.09 470.7 10 
NM-
300 n3 2.52μg/cm
2 14.1 (no reading) - N/A 
NM-
110 n1 0μg/cm
2 262.9 2.08 208.03 7.5 
NM-
110 n1 1.26µg/cm
2 173.9 2.08 182.04 9.5 
NM-
110 n1 2.52μg/cm
2 316 2.07 383.94 9.7 
NM-
110 n2 0μg/cm
2 193.3 2.08 371.64 9.9 
NM-
110 n2 1.26µg/cm
2 141.9 2.06 171.4 9.8 
NM-
110 n2 2.52μg/cm
2 268.7 2.11 357.77 9.2 
NM-
110 n3 0μg/cm
2 913.9 2.10 830.03 10 
NM-
110 n3 1.26µg/cm
2 290.4 2.10 578.6 9.3 
NM-
110 n3 2.52μg/cm
2 263.1 2.10 358.755 8.1 
NM-
111 n1 0μg/cm
2 420.2 2.11 473.45 10 
NM-
111 n1 1.26µg/cm
2 427.4 2.11 372.32 10 
NM-
111 n1 2.52μg/cm
2 157.8 2.08 135.26 9.6 
NM-
111 n2 0μg/cm
2 598.4 2.11 750.36 10 
NM-
111 n2 1.26µg/cm
2 857.2 2.09 1137.38 10 
NM-
111 n2 2.52μg/cm
2 179.2 2.07 376.3 8.9 
NM-
111 n3 0μg/cm
2 179.6 2.11 237.86 10 
NM-
111 n3 1.26µg/cm
2 844.6 2.07 458.95 10 
NM-
111 n3 2.52μg/cm
2 175.1 2.07 241.29 9.7 
 
